Filtered
hsa-let-7a	acute myeloid leukemia
hsa-let-7a	breast cancer	down	Arsenic trioxide inhibits cell growth and motility via
hsa-let-7a	breast cancer
hsa-let-7a	breast cancer
hsa-let-7a	breast cancer	down	MicroRNA let-7a s
hsa-let-7a	breast cancer
hsa-let-7a	breast cancer
hsa-let-7a	chondrosarcoma
hsa-let-7a	colon cancer
hsa-let-7a	colon cancer
hsa-let-7a	colorectal cancer
hsa-let-7a	colorectal cancer
hsa-let-7a	colorectal cancer
hsa-let-7a	colorectal cancer
hsa-let-7a	esophageal squamous cell carcinoma
hsa-let-7a	esophageal squamous cell carcinoma
hsa-let-7a	gastric cancer
hsa-let-7a	gastric cancer	down	Lentiviral vector-mediated
hsa-let-7a	gastric cancer
hsa-let-7a	gastric cancer	down	miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor s
hsa-let-7a	gastric cancer
hsa-let-7a	gastric cancer
hsa-let-7a	glioma	down	Let-7a s
hsa-let-7a	laryngeal cancer
hsa-let-7a	nasopharyngeal carcinoma
hsa-let-7a	nasopharyngeal carcinoma
hsa-let-7a	non-small cell lung cancer
hsa-let-7a	oral squamous cell carcinoma
hsa-let-7a	osteosarcoma	down	Tumor-s
hsa-let-7a	osteosarcoma
hsa-let-7a	osteosarcoma
hsa-let-7a	pancreatic ductal adenocarcinoma
hsa-let-7a	papillary thyroid carcinoma
hsa-let-7a	renal cell carcinoma	down	Hsa-let-7a functions as a tumor s
hsa-let-7a-1	breast cancer
hsa-let-7a-1	breast cancer
hsa-let-7a-1	colon cancer	down	let-7 microRNA functions as a potential growth s
hsa-let-7a-1	esophageal squamous cell carcinoma
hsa-let-7a-1	esophageal squamous cell carcinoma
hsa-let-7a-1	gastric cancer
hsa-let-7a-1	hepatocellular carcinoma
hsa-let-7a-1	lung cancer
hsa-let-7a-1	lung cancer
hsa-let-7a-1	lung cancer	down	Let-7a elevates p21(WAF1) levels by targeting of NIRF and s
hsa-let-7a-1	nasopharyngeal carcinoma	down	MicroRNA let-7 s
hsa-let-7a-1	neuroblastoma	down	LIN28B induces neuroblastoma and enhances MYCN levels via let-7 s
hsa-let-7a-1	pancreatic ductal adenocarcinoma
hsa-let-7a-2	breast cancer
hsa-let-7a-2	breast cancer
hsa-let-7a-2	colon cancer	down	let-7 microRNA functions as a potential growth s
hsa-let-7a-2	esophageal squamous cell carcinoma
hsa-let-7a-2	esophageal squamous cell carcinoma
hsa-let-7a-2	gastric cancer
hsa-let-7a-2	hepatocellular carcinoma
hsa-let-7a-2	lung cancer
hsa-let-7a-2	lung cancer
hsa-let-7a-2	lung cancer	down	Let-7a elevates p21(WAF1) levels by targeting of NIRF and s
hsa-let-7a-2	nasopharyngeal carcinoma	down	MicroRNA let-7 s
hsa-let-7a-2	neuroblastoma	down	LIN28B induces neuroblastoma and enhances MYCN levels via let-7 s
hsa-let-7a-2	pancreatic ductal adenocarcinoma
hsa-let-7a-3	breast cancer
hsa-let-7a-3	breast cancer
hsa-let-7a-3	colon cancer	down	let-7 microRNA functions as a potential growth s
hsa-let-7a-3	esophageal squamous cell carcinoma
hsa-let-7a-3	esophageal squamous cell carcinoma
hsa-let-7a-3	gastric cancer
hsa-let-7a-3	hepatocellular carcinoma
hsa-let-7a-3	lung cancer
hsa-let-7a-3	lung cancer
hsa-let-7a-3	lung cancer	down	Let-7a elevates p21(WAF1) levels by targeting of NIRF and s
hsa-let-7a-3	nasopharyngeal carcinoma	down	MicroRNA let-7 s
hsa-let-7a-3	neuroblastoma	down	LIN28B induces neuroblastoma and enhances MYCN levels via let-7 s
hsa-let-7a-3	pancreatic ductal adenocarcinoma
hsa-let-7a-3p	prostate cancer
hsa-let-7b	acute lymphoblastic leukemia	down	S
hsa-let-7b	breast cancer
hsa-let-7b	breast cancer
hsa-let-7b	breast cancer
hsa-let-7b	breast cancer
hsa-let-7b	colon cancer	down	let-7 microRNA functions as a potential growth s
hsa-let-7b	colorectal cancer
hsa-let-7b	esophageal squamous cell carcinoma
hsa-let-7b	esophageal squamous cell carcinoma
hsa-let-7b	gastric cancer
hsa-let-7b	gastric cancer	down	MicroRNA let-7b s
hsa-let-7b	gastric cancer
hsa-let-7b	glioma
hsa-let-7b	hepatocellular carcinoma
hsa-let-7b	hepatocellular carcinoma
hsa-let-7b	lung cancer
hsa-let-7b	lung cancer
hsa-let-7b	lung cancer	down	Let-7a elevates p21(WAF1) levels by targeting of NIRF and s
hsa-let-7b	malignant melanoma
hsa-let-7b	nasopharyngeal carcinoma	down	MicroRNA let-7 s
hsa-let-7b	neuroblastoma	down	LIN28B induces neuroblastoma and enhances MYCN levels via let-7 s
hsa-let-7b	pancreatic ductal adenocarcinoma
hsa-let-7b	papillary thyroid carcinoma
hsa-let-7b	renal clear cell carcinoma
hsa-let-7b-5p	chronic myelogenous leukemia
hsa-let-7c	acute myeloid leukemia
hsa-let-7c	acute promyelocytic leukemia
hsa-let-7c	breast cancer
hsa-let-7c	breast cancer
hsa-let-7c	cholangiocarcinoma
hsa-let-7c	colon cancer	down	let-7 microRNA functions as a potential growth s
hsa-let-7c	esophageal squamous cell carcinoma
hsa-let-7c	esophageal squamous cell carcinoma
hsa-let-7c	gastric cancer
hsa-let-7c	hepatocellular carcinoma
hsa-let-7c	hepatocellular carcinoma
hsa-let-7c	hepatocellular carcinoma
hsa-let-7c	lung cancer
hsa-let-7c	lung cancer
hsa-let-7c	lung cancer	down	Let-7a elevates p21(WAF1) levels by targeting of NIRF and s
hsa-let-7c	nasopharyngeal carcinoma	down	MicroRNA let-7 s
hsa-let-7c	nasopharyngeal carcinoma	down	Knocking down CDK4 mediates the elevation of let-7c s
hsa-let-7c	neuroblastoma	down	LIN28B induces neuroblastoma and enhances MYCN levels via let-7 s
hsa-let-7c	non-small cell lung cancer
hsa-let-7c	pancreatic ductal adenocarcinoma
hsa-let-7c	prostate cancer	down	MicroRNA let-7c s
hsa-let-7c	prostate cancer	down	MicroRNA let-7c is downregulated in prostate cancer and s
hsa-let-7c	renal clear cell carcinoma
hsa-let-7d	breast cancer
hsa-let-7d	breast cancer
hsa-let-7d	breast cancer
hsa-let-7d	chronic myelogenous leukemia	down	microRNA expression profiling as s
hsa-let-7d	colon cancer	down	let-7 microRNA functions as a potential growth s
hsa-let-7d	esophageal squamous cell carcinoma
hsa-let-7d	esophageal squamous cell carcinoma
hsa-let-7d	gastric cancer
hsa-let-7d	head and neck squamous cell carcinoma
hsa-let-7d	head and neck squamous cell carcinoma
hsa-let-7d	hepatocellular carcinoma
hsa-let-7d	lung cancer
hsa-let-7d	lung cancer
hsa-let-7d	lung cancer	down	Let-7a elevates p21(WAF1) levels by targeting of NIRF and s
hsa-let-7d	nasopharyngeal carcinoma	down	MicroRNA let-7 s
hsa-let-7d	neuroblastoma	down	LIN28B induces neuroblastoma and enhances MYCN levels via let-7 s
hsa-let-7d	oral cancer
hsa-let-7d	oral squamous cell carcinoma
hsa-let-7d	pancreatic ductal adenocarcinoma
hsa-let-7d	pancreatic ductal adenocarcinoma
hsa-let-7e	breast cancer
hsa-let-7e	breast cancer
hsa-let-7e	colon cancer	down	let-7 microRNA functions as a potential growth s
hsa-let-7e	colorectal cancer
hsa-let-7e	colorectal cancer
hsa-let-7e	esophageal squamous cell carcinoma
hsa-let-7e	esophageal squamous cell carcinoma
hsa-let-7e	gastric cancer
hsa-let-7e	glioblastoma
hsa-let-7e	hepatocellular carcinoma
hsa-let-7e	lung cancer
hsa-let-7e	lung cancer
hsa-let-7e	lung cancer	down	Let-7a elevates p21(WAF1) levels by targeting of NIRF and s
hsa-let-7e	nasopharyngeal carcinoma	down	MicroRNA let-7 s
hsa-let-7e	neuroblastoma	down	LIN28B induces neuroblastoma and enhances MYCN levels via let-7 s
hsa-let-7e	pancreatic ductal adenocarcinoma
hsa-let-7e	papillary thyroid carcinoma
hsa-let-7f	oral squamous cell carcinoma
hsa-let-7f-1	breast cancer
hsa-let-7f-1	breast cancer
hsa-let-7f-1	colon cancer	down	let-7 microRNA functions as a potential growth s
hsa-let-7f-1	esophageal squamous cell carcinoma
hsa-let-7f-1	esophageal squamous cell carcinoma
hsa-let-7f-1	gastric cancer
hsa-let-7f-1	hepatocellular carcinoma
hsa-let-7f-1	lung cancer
hsa-let-7f-1	lung cancer
hsa-let-7f-1	lung cancer	down	Let-7a elevates p21(WAF1) levels by targeting of NIRF and s
hsa-let-7f-1	nasopharyngeal carcinoma	down	MicroRNA let-7 s
hsa-let-7f-1	neuroblastoma	down	LIN28B induces neuroblastoma and enhances MYCN levels via let-7 s
hsa-let-7f-1	pancreatic ductal adenocarcinoma
hsa-let-7f-2	breast cancer
hsa-let-7f-2	breast cancer
hsa-let-7f-2	colon cancer	down	let-7 microRNA functions as a potential growth s
hsa-let-7f-2	esophageal squamous cell carcinoma
hsa-let-7f-2	esophageal squamous cell carcinoma
hsa-let-7f-2	gastric cancer
hsa-let-7f-2	hepatocellular carcinoma
hsa-let-7f-2	lung cancer
hsa-let-7f-2	lung cancer
hsa-let-7f-2	lung cancer	down	Let-7a elevates p21(WAF1) levels by targeting of NIRF and s
hsa-let-7f-2	nasopharyngeal carcinoma	down	MicroRNA let-7 s
hsa-let-7f-2	neuroblastoma	down	LIN28B induces neuroblastoma and enhances MYCN levels via let-7 s
hsa-let-7f-2	pancreatic ductal adenocarcinoma
hsa-let-7g	breast cancer
hsa-let-7g	breast cancer
hsa-let-7g	breast cancer
hsa-let-7g	breast cancer
hsa-let-7g	colon cancer	down	let-7 microRNA functions as a potential growth s
hsa-let-7g	esophageal squamous cell carcinoma
hsa-let-7g	esophageal squamous cell carcinoma
hsa-let-7g	gastric cancer
hsa-let-7g	gastric cancer
hsa-let-7g	hepatocellular carcinoma
hsa-let-7g	hepatocellular carcinoma
hsa-let-7g	lung cancer
hsa-let-7g	lung cancer
hsa-let-7g	lung cancer	down	Let-7a elevates p21(WAF1) levels by targeting of NIRF and s
hsa-let-7g	nasopharyngeal carcinoma	down	MicroRNA let-7 s
hsa-let-7g	neuroblastoma	down	LIN28B induces neuroblastoma and enhances MYCN levels via let-7 s
hsa-let-7g	osteosarcoma
hsa-let-7g	pancreatic ductal adenocarcinoma
hsa-let-7g-5p	glioblastoma
hsa-let-7i	breast cancer
hsa-let-7i	breast cancer
hsa-let-7i	colon cancer	down	let-7 microRNA functions as a potential growth s
hsa-let-7i	esophageal squamous cell carcinoma
hsa-let-7i	esophageal squamous cell carcinoma
hsa-let-7i	gastric cancer
hsa-let-7i	hepatocellular carcinoma
hsa-let-7i	hepatocellular carcinoma
hsa-let-7i	lung cancer
hsa-let-7i	lung cancer
hsa-let-7i	lung cancer	down	Let-7a elevates p21(WAF1) levels by targeting of NIRF and s
hsa-let-7i	nasopharyngeal carcinoma	down	MicroRNA let-7 s
hsa-let-7i	neuroblastoma	down	LIN28B induces neuroblastoma and enhances MYCN levels via let-7 s
hsa-let-7i	ovarian cancer
hsa-let-7i	pancreatic ductal adenocarcinoma
hsa-mir-1	bladder cancer	down	The tumour-s
hsa-mir-1	bladder cancer
hsa-mir-1	breast cancer	down	Hsa-miR-1 s
hsa-mir-1	breast cancer
hsa-mir-1	cervical cancer
hsa-mir-1	cervical cancer
hsa-mir-1	chordoma
hsa-mir-1	chordoma
hsa-mir-1	colorectal cancer	down	Tumor s
hsa-mir-1	colorectal cancer	down	MiR-1 s
hsa-mir-1	esophageal cancer	down	miR-1 s
hsa-mir-1	esophageal squamous cell carcinoma
hsa-mir-1	esophageal squamous cell carcinoma
hsa-mir-1	gastric cancer	down	MicroRNA-1 acts as a tumor s
hsa-mir-1	gastric cancer
hsa-mir-1	gastric cancer
hsa-mir-1	head and neck squamous cell carcinoma	down	Dual-receptor (EGFR and c-MET) inhibition by tumor-s
hsa-mir-1	head and neck squamous cell carcinoma
hsa-mir-1	head and neck squamous cell carcinoma	down	miR-1 as a tumor s
hsa-mir-1	hepatocellular carcinoma
hsa-mir-1	hepatocellular carcinoma
hsa-mir-1	kidney cancer
hsa-mir-1	lung cancer	down	Down-regulation of micro-RNA-1 (miR-1) in lung cancer. S
hsa-mir-1	lung cancer	down	Down-regulation of micro-RNA-1 (miR-1) in lung cancer. S
hsa-mir-1	mucinous cystadenocarcinoma
hsa-mir-1	nasopharyngeal carcinoma
hsa-mir-1	non-small cell lung cancer
hsa-mir-1	non-small cell lung cancer
hsa-mir-1	oral squamous cell carcinoma
hsa-mir-1	osteosarcoma	down	MicroRNA-1 functions as a potential tumor s
hsa-mir-1	ovarian cancer
hsa-mir-1	prostate cancer
hsa-mir-1	prostate cancer
hsa-mir-1	prostate cancer	down	Cell-type specific expression of oncogenic and tumor s
hsa-mir-1	renal cell carcinoma
hsa-mir-1-3p	bladder cancer
hsa-mir-1-3p	bladder cancer
hsa-mir-1-3p	breast cancer
hsa-mir-1-3p	hepatocellular carcinoma	down	miR-1-3p s
hsa-mir-1-3p	lung adenocarcinoma
hsa-mir-100	bladder cancer
hsa-mir-100	breast cancer	down	miR-100 s
hsa-mir-100	breast cancer	down	MicroRNA-100 s
hsa-mir-100	cervical carcinoma
hsa-mir-100	chondrosarcoma
hsa-mir-100	chondrosarcoma
hsa-mir-100	colon cancer	down	MicroRNA-100 functions as a tumor s
hsa-mir-100	colorectal cancer
hsa-mir-100	colorectal cancer
hsa-mir-100	colorectal cancer
hsa-mir-100	esophageal cancer	down	miR-100 s
hsa-mir-100	esophageal squamous cell carcinoma
hsa-mir-100	esophageal squamous cell carcinoma
hsa-mir-100	esophageal squamous cell carcinoma
hsa-mir-100	gastric cancer
hsa-mir-100	gastric cancer	down	MicroRNA-100 s
hsa-mir-100	gastric cancer	down	C/EBP?-induced miR-100 expression s
hsa-mir-100	glioblastoma
hsa-mir-100	glioma
hsa-mir-100	hepatocellular carcinoma
hsa-mir-100	hepatocellular carcinoma
hsa-mir-100	mesenchymal cancer
hsa-mir-100	non-small cell lung cancer	down	MicroRNA-100 is a potential molecular marker of non-small cell lung cancer and functions as a tumor s
hsa-mir-100	oral squamous cell carcinoma
hsa-mir-100	osteosarcoma
hsa-mir-100	osteosarcoma	down	MicroRNA-100 s
hsa-mir-100	ovarian cancer
hsa-mir-100	ovarian carcinoma
hsa-mir-100	renal cell carcinoma
hsa-mir-100-5p	esophageal adenocarcinoma
hsa-mir-100-5p	gastric cancer	down	Identification and characterization of tumor s
hsa-mir-101	adrenal cortical carcinoma
hsa-mir-101	bladder cancer
hsa-mir-101	bladder cancer
hsa-mir-101	bladder cancer	down	MicroRNA-101 s
hsa-mir-101	bladder cancer	down	miR-101 S
hsa-mir-101	breast cancer
hsa-mir-101	breast cancer	down	MicroRNA-101 targets von Hippel-Lindau tumor s
hsa-mir-101	breast cancer
hsa-mir-101	breast cancer
hsa-mir-101	cervical cancer
hsa-mir-101	cervical cancer
hsa-mir-101	cervical cancer
hsa-mir-101	cholangiocarcinoma
hsa-mir-101	colon cancer
hsa-mir-101	colon cancer
hsa-mir-101	colon cancer	down	Upregulation of miR-101 enhances the cytotoxic effect of anticancer drugs through inhibition of colon cancer cell proliferation.
hsa-mir-101	colorectal cancer
hsa-mir-101	colorectal cancer	down	Gene module based regulator inference identifying miR-139 as a tumor s
hsa-mir-101	colorectal cancer
hsa-mir-101	colorectal cancer
hsa-mir-101	endometrial cancer
hsa-mir-101	endometrial cancer
hsa-mir-101	esophageal cancer
hsa-mir-101	gastric cancer
hsa-mir-101	gastric cancer
hsa-mir-101	gastric cancer	down	Lack of microRNA-101 causes E-cadherin functional deregulation through EZH2
hsa-mir-101	gastric cancer
hsa-mir-101	gastric cancer
hsa-mir-101	gastric cancer
hsa-mir-101	gastric cancer
hsa-mir-101	glioblastoma
hsa-mir-101	glioblastoma
hsa-mir-101	glioma
hsa-mir-101	glioma	down	miR-101 reverses hypomethylation of the PRDM16 promoter to disr
hsa-mir-101	glioma	down	Long non-coding RNA MALAT1 promotes proliferation and s
hsa-mir-101	hepatocellular carcinoma
hsa-mir-101	hepatocellular carcinoma
hsa-mir-101	hepatocellular carcinoma
hsa-mir-101	hepatocellular carcinoma
hsa-mir-101	hepatocellular carcinoma
hsa-mir-101	hepatocellular carcinoma
hsa-mir-101	hepatocellular carcinoma
hsa-mir-101	hepatocellular carcinoma	down	MicroRNA-101 s
hsa-mir-101	hepatocellular carcinoma
hsa-mir-101	hepatocellular carcinoma	down	miR-101 s
hsa-mir-101	laryngeal squamous cell carcinoma
hsa-mir-101	liver cancer	down	MiR-101 functions as a tumor s
hsa-mir-101	lung cancer
hsa-mir-101	lung cancer
hsa-mir-101	lung cancer
hsa-mir-101	malignant melanoma
hsa-mir-101	medulloblastoma
hsa-mir-101	nasopharyngeal carcinoma
hsa-mir-101	nasopharyngeal carcinoma
hsa-mir-101	non-small cell lung cancer
hsa-mir-101	non-small cell lung cancer	down	MicroRNA-101 exerts tumor-s
hsa-mir-101	non-small cell lung cancer
hsa-mir-101	osteosarcoma
hsa-mir-101	osteosarcoma
hsa-mir-101	ovarian cancer
hsa-mir-101	ovarian carcinoma	down	MiR-101 s
hsa-mir-101	pancreatic cancer	down	miRNA-101 s
hsa-mir-101	pancreatic ductal adenocarcinoma
hsa-mir-101	papillary thyroid carcinoma
hsa-mir-101	papillary thyroid carcinoma
hsa-mir-101	papillary thyroid carcinoma	down	Hsa-microRNA-101 s
hsa-mir-101	papillary thyroid carcinoma
hsa-mir-101	prostate cancer
hsa-mir-101	prostate cancer
hsa-mir-101	renal clear cell carcinoma
hsa-mir-101	retinoblastoma
hsa-mir-101-3p	acute myeloid leukemia
hsa-mir-101-3p	esophageal cancer
hsa-mir-101-3p	esophageal squamous cell carcinoma
hsa-mir-101-3p	gastric cancer	down	MiR-101-3p S
hsa-mir-101-3p	glioma
hsa-mir-101-3p	hepatocellular carcinoma
hsa-mir-101-3p	hepatocellular carcinoma	down	MicroRNA-101-3p s
hsa-mir-101-3p	hepatocellular carcinoma
hsa-mir-101-3p	retinoblastoma
hsa-mir-101-5p	non-small cell lung cancer
hsa-mir-103	colorectal cancer
hsa-mir-103	colorectal cancer
hsa-mir-103	gastric cancer
hsa-mir-103	gastric cancer
hsa-mir-103	glioma	down	MicroRNA-103 s
hsa-mir-103	hepatocellular carcinoma
hsa-mir-103	nasopharyngeal carcinoma
hsa-mir-103	non-small cell lung cancer	down	MiR-103 Functions as a Tumor S
hsa-mir-103	prostate cancer	down	MicroRNA-103 s
hsa-mir-103a	colorectal cancer
hsa-mir-103a	lung cancer
hsa-mir-103a-3p	bladder cancer
hsa-mir-103a-3p	colorectal cancer
hsa-mir-103a-3p	gastric cancer
hsa-mir-103a-3p	glioma
hsa-mir-105	gastric cancer
hsa-mir-105	gastric cancer	down	Up-regulation of miRNA-105 inhibits the progression of gastric carcinoma by directly targeting SOX9.
hsa-mir-105	glioma
hsa-mir-105	glioma
hsa-mir-105	hepatocellular carcinoma	down	MicroRNA-105 s
hsa-mir-105	prostate cancer	down	miR-105 Inhibits Prostate Tumour Growth by S
hsa-mir-106a	breast cancer
hsa-mir-106a	cervical cancer
hsa-mir-106a	cervical squamous cell carcinoma
hsa-mir-106a	colorectal cancer
hsa-mir-106a	colorectal cancer
hsa-mir-106a	colorectal cancer	down	miR-106a s
hsa-mir-106a	colorectal cancer
hsa-mir-106a	colorectal cancer
hsa-mir-106a	colorectal cancer
hsa-mir-106a	endometrial cancer
hsa-mir-106a	esophageal squamous cell carcinoma
hsa-mir-106a	gastric cancer
hsa-mir-106a	gastric cancer
hsa-mir-106a	gastric cancer
hsa-mir-106a	gastric cancer
hsa-mir-106a	gastric cancer
hsa-mir-106a	gastric cancer
hsa-mir-106a	gastric cancer
hsa-mir-106a	gastric cancer
hsa-mir-106a	glioblastoma	down	Decreased miR-106a inhibits glioma cell glucose
hsa-mir-106a	glioma
hsa-mir-106a	glioma
hsa-mir-106a	hepatocellular carcinoma
hsa-mir-106a	malignant melanoma
hsa-mir-106a	non-small cell lung cancer
hsa-mir-106a	non-small cell lung cancer
hsa-mir-106a	ovarian cancer
hsa-mir-106a	ovarian cancer
hsa-mir-106a	prostate cancer
hsa-mir-106a	renal cell carcinoma
hsa-mir-106a*	follicular lymphoma
hsa-mir-106a*	oral squamous cell carcinoma	down	MiR-106a* inhibits oral squamous cell carcinoma progression by directly targeting MeCP2 and s
hsa-mir-106a*	renal cell carcinoma
hsa-mir-106a-5p	clear cell renal cell cancer
hsa-mir-106a-5p	renal cell carcinoma
hsa-mir-106b	basal cell carcinoma
hsa-mir-106b	breast cancer
hsa-mir-106b	cervical carcinoma
hsa-mir-106b	colorectal cancer
hsa-mir-106b	endometrial cancer	down	S
hsa-mir-106b	esophageal squamous cell carcinoma
hsa-mir-106b	esophageal squamous cell carcinoma
hsa-mir-106b	esophageal squamous cell carcinoma
hsa-mir-106b	gastric cancer
hsa-mir-106b	gastric cancer
hsa-mir-106b	gastric cancer
hsa-mir-106b	gastric cancer
hsa-mir-106b	glioma
hsa-mir-106b	head and neck squamous cell carcinoma
hsa-mir-106b	hepatocellular carcinoma
hsa-mir-106b	hepatocellular carcinoma
hsa-mir-106b	hepatocellular carcinoma
hsa-mir-106b	hepatocellular carcinoma
hsa-mir-106b	hepatocellular carcinoma
hsa-mir-106b	laryngeal carcinoma
hsa-mir-106b	laryngeal carcinoma
hsa-mir-106b	medulloblastoma
hsa-mir-106b	non-small cell lung cancer
hsa-mir-106b	osteosarcoma
hsa-mir-106b	pituitary carcinoma
hsa-mir-106b	renal cell carcinoma
hsa-mir-106b	thyroid cancer	down	microRNA-106b-mediated down-regulation of C1orf24 expression induces apoptosis and s
hsa-mir-106b-5p	cervical cancer
hsa-mir-106b-5p	colorectal cancer
hsa-mir-106b-5p	glioma
hsa-mir-106b-5p	hepatocellular carcinoma
hsa-mir-106b-5p	hepatocellular carcinoma
hsa-mir-106b-5p	non-small cell lung cancer
hsa-mir-106b-5p	renal cell carcinoma
hsa-mir-107	acute promyelocytic leukemia
hsa-mir-107	breast cancer
hsa-mir-107	breast cancer	down	MicroRNA-107 is downregulated and having tumor s
hsa-mir-107	breast cancer
hsa-mir-107	colorectal cancer	down	MiR-107 function as a tumor s
hsa-mir-107	esophageal squamous cell carcinoma	down	miR-107 functions as a tumor s
hsa-mir-107	gastric cancer
hsa-mir-107	gastric cancer
hsa-mir-107	gastric cancer
hsa-mir-107	gastric cancer
hsa-mir-107	gastric cancer
hsa-mir-107	gastric cancer
hsa-mir-107	gastric cancer
hsa-mir-107	glioblastoma
hsa-mir-107	glioma
hsa-mir-107	glioma
hsa-mir-107	glioma	down	Low-expression of microRNA-107 inhibits cell apoptosis in glioma by
hsa-mir-107	glioma	down	Upregulation of miR-107 Inhibits Glioma Angiogenesis and VEGF Expression.
hsa-mir-107	glioma
hsa-mir-107	head and neck squamous cell carcinoma	down	microRNA-107 functions as a candidate tumor-s
hsa-mir-107	head and neck squamous cell carcinoma
hsa-mir-107	hepatocellular carcinoma
hsa-mir-107	hepatocellular carcinoma
hsa-mir-107	hepatocellular carcinoma	down	MiR-107 s
hsa-mir-107	non-small cell lung cancer
hsa-mir-107	non-small cell lung cancer
hsa-mir-107	osteosarcoma
hsa-mir-107	ovarian cancer
hsa-mir-107	pancreatic ductal adenocarcinoma
hsa-mir-107	prostate carcinoma	down	Dysregulation of the mitogen granulin in human cancer through the miR-15/107 microRNA gene gro
hsa-mir-10a	acute myeloid leukemia
hsa-mir-10a	breast cancer
hsa-mir-10a	breast cancer	down	MicroRNA-10a s
hsa-mir-10a	cervical cancer
hsa-mir-10a	chronic myelogenous leukemia
hsa-mir-10a	colorectal cancer	down	miR-10a s
hsa-mir-10a	colorectal cancer
hsa-mir-10a	diffuse large B-cell lymphoma
hsa-mir-10a	ependymoma
hsa-mir-10a	esophageal squamous cell carcinoma	down	Tumor-s
hsa-mir-10a	gastric cancer
hsa-mir-10a	gastric cancer	down	MicroRNA-10a Is Down-Regulated by DNA Methylation and Functions as a Tumor S
hsa-mir-10a	glioma
hsa-mir-10a	lung cancer
hsa-mir-10a	non-small cell lung cancer
hsa-mir-10a	oral squamous cell carcinoma
hsa-mir-10a	pancreatic cancer
hsa-mir-10a	prostate cancer	down	MiR-10a functions as a tumor s
hsa-mir-10a-5p	breast cancer
hsa-mir-10a-5p	liver cancer
hsa-mir-10a-5p	papillary thyroid carcinoma
hsa-mir-10a-5p	renal cell carcinoma
hsa-mir-10b	acute myeloid leukemia
hsa-mir-10b	acute myeloid leukemia
hsa-mir-10b	bladder cancer
hsa-mir-10b	breast cancer
hsa-mir-10b	breast cancer
hsa-mir-10b	breast cancer
hsa-mir-10b	breast cancer
hsa-mir-10b	breast cancer
hsa-mir-10b	breast carcinoma
hsa-mir-10b	colorectal cancer
hsa-mir-10b	colorectal cancer
hsa-mir-10b	colorectal cancer
hsa-mir-10b	colorectal cancer
hsa-mir-10b	endometrial cancer
hsa-mir-10b	ependymoma
hsa-mir-10b	esophageal cancer
hsa-mir-10b	esophageal cancer
hsa-mir-10b	gastric cancer
hsa-mir-10b	gastric cancer
hsa-mir-10b	gastric cancer	down	DNA methylation downregulated mir-10b acts as a tumor s
hsa-mir-10b	gastric cancer
hsa-mir-10b	gastric cancer
hsa-mir-10b	glioblastoma
hsa-mir-10b	glioblastoma
hsa-mir-10b	glioma
hsa-mir-10b	hepatocellular carcinoma
hsa-mir-10b	hepatocellular carcinoma
hsa-mir-10b	hepatocellular carcinoma
hsa-mir-10b	lung cancer
hsa-mir-10b	malignant melanoma
hsa-mir-10b	malignant melanoma
hsa-mir-10b	malignant melanoma
hsa-mir-10b	medulloblastoma
hsa-mir-10b	nasopharyngeal carcinoma
hsa-mir-10b	nasopharyngeal carcinoma
hsa-mir-10b	non-small cell lung cancer
hsa-mir-10b	non-small cell lung cancer
hsa-mir-10b	oral cancer
hsa-mir-10b	osteosarcoma
hsa-mir-10b	pancreatic cancer
hsa-mir-10b	pancreatic ductal adenocarcinoma
hsa-mir-10b	pancreatic ductal adenocarcinoma
hsa-mir-10b	pancreatic ductal adenocarcinoma
hsa-mir-10b	renal clear cell carcinoma
hsa-mir-10b*	osteosarcoma
hsa-mir-10b-3p	esophageal squamous cell carcinoma
hsa-mir-10b-3p	hepatocellular carcinoma
hsa-mir-10b-5p	gastric cancer
hsa-mir-1178	pancreatic cancer
hsa-mir-1179	breast cancer
hsa-mir-1179	colorectal cancer
hsa-mir-1179	esophageal squamous cell carcinoma
hsa-mir-1179	glioblastoma
hsa-mir-1179	hepatocellular carcinoma	down	MiRNA-1179 s
hsa-mir-1179	non-small cell lung cancer	down	MicroRNA-1179 s
hsa-mir-1180	bladder cancer	down	Up-regulation of p21(WAF1/CIP1) by miRNAs and its implications in bladder cancer cells.
hsa-mir-1180	hepatocellular carcinoma
hsa-mir-1180	hepatocellular carcinoma
hsa-mir-1180	ovarian cancer
hsa-mir-1180	prostate cancer
hsa-mir-1181	ovarian cancer
hsa-mir-1181	pancreatic cancer	down	MiR-1181 inhibits stem cell-like phenotypes and s
hsa-mir-1181	pancreatic cancer
hsa-mir-1182	ovarian cancer
hsa-mir-1197	non-small cell lung cancer
hsa-mir-1202	glioma	down	MiR-1202 functions as a tumor s
hsa-mir-1202	hepatocellular carcinoma	down	MiR-1202 s
hsa-mir-1204	hepatocellular carcinoma
hsa-mir-1204	non-small cell lung cancer
hsa-mir-1204	non-small cell lung cancer
hsa-mir-1205	lung adenocarcinoma
hsa-mir-1205	non-small cell lung cancer	down	MiR-1205 functions as a tumor s
hsa-mir-1207	nasopharyngeal carcinoma
hsa-mir-1207	ovarian cancer
hsa-mir-1207-5p	breast cancer
hsa-mir-1207-5p	colorectal cancer
hsa-mir-1207-5p	gastric cancer	down	miR-1207-5p and miR-1266 s
hsa-mir-1207-5p	hepatocellular carcinoma
hsa-mir-1207-5p	lung cancer	down	miR-1207-5p s
hsa-mir-1208	renal cell carcinoma
hsa-mir-122	acute myeloid leukemia
hsa-mir-122	bladder cancer
hsa-mir-122	breast cancer
hsa-mir-122	breast cancer
hsa-mir-122	gallbladder carcinoma
hsa-mir-122	gastric cancer
hsa-mir-122	gastric cancer
hsa-mir-122	glioma
hsa-mir-122	glioma
hsa-mir-122	glioma	down	Knockdown of SOX2OT inhibits the malignant biological behaviors of glioblastoma stem cells via
hsa-mir-122	hepatocellular carcinoma
hsa-mir-122	hepatocellular carcinoma
hsa-mir-122	hepatocellular carcinoma
hsa-mir-122	hepatocellular carcinoma
hsa-mir-122	hepatocellular carcinoma
hsa-mir-122	hepatocellular carcinoma
hsa-mir-122	hepatocellular carcinoma	down	MicroRNA-122 s
hsa-mir-122	hepatocellular carcinoma
hsa-mir-122	hepatocellular carcinoma
hsa-mir-122	hepatocellular carcinoma
hsa-mir-122	hepatocellular carcinoma
hsa-mir-122	hepatocellular carcinoma	down	MiR-122 inhibits epithelial-mesenchymal transition in hepatocellular carcinoma by targeting Snail1 and Snail2 and s
hsa-mir-122	hepatocellular carcinoma	down	miR-122-mediated translational repression of PEG10 and its s
hsa-mir-122	hepatocellular carcinoma
hsa-mir-122	hepatocellular carcinoma
hsa-mir-122	hepatocellular carcinoma
hsa-mir-122	hepatocellular carcinoma	down	Hepatitis B virus X protein mediated s
hsa-mir-122	hepatocellular carcinoma	down	LncRNA HOTAIR epigenetically s
hsa-mir-122	hepatocellular carcinoma
hsa-mir-122	osteosarcoma
hsa-mir-122	pituitary carcinoma
hsa-mir-122	renal cell carcinoma
hsa-mir-122	renal clear cell carcinoma
hsa-mir-122-3p	lung cancer
hsa-mir-122-5p	gastric cancer
hsa-mir-122-5p	gastric cancer
hsa-mir-122-5p	hepatocellular carcinoma
hsa-mir-122-5p	malignant melanoma
hsa-mir-122-5p	non-small cell lung cancer
hsa-mir-122-5p	ovarian cancer
hsa-mir-1225-5p	gastric cancer
hsa-mir-1225-5p	thyroid cancer
hsa-mir-1228	breast cancer
hsa-mir-1228	gastric cancer
hsa-mir-1228	hepatocellular carcinoma
hsa-mir-1228*	gastric cancer	down	Restoration of miR-1228* expression s
hsa-mir-1229	breast cancer
hsa-mir-1229	colorectal cancer
hsa-mir-122a	gastrointestinal cancer	down	MicroRNA-122a functions as a novel tumor s
hsa-mir-122a	hepatocellular carcinoma
hsa-mir-122a	hepatocellular carcinoma
hsa-mir-1231	glioma	down	MicroRNA-1231 exerts a tumor s
hsa-mir-1233	renal cell carcinoma
hsa-mir-1236	bladder cancer	down	Up-regulation of p21(WAF1/CIP1) by miRNAs and its implications in bladder cancer cells.
hsa-mir-1236	renal cell carcinoma
hsa-mir-1236-3p	gastric cancer
hsa-mir-1236-3p	gastric cancer
hsa-mir-1236-3p	gastric cancer
hsa-mir-1236-3p	lung adenocarcinoma	down	miR-1236-3p s
hsa-mir-1236-3p	lung cancer
hsa-mir-1238	non-small cell lung cancer
hsa-mir-124	anaplastic astrocytoma
hsa-mir-124	breast cancer	down	miR-124 s
hsa-mir-124	breast cancer
hsa-mir-124	breast cancer
hsa-mir-124	breast cancer	down	MicroRNA-124 s
hsa-mir-124	breast cancer
hsa-mir-124	breast cancer
hsa-mir-124	breast cancer
hsa-mir-124	breast cancer
hsa-mir-124	breast cancer
hsa-mir-124	cervical cancer
hsa-mir-124	cervical squamous cell carcinoma
hsa-mir-124	colorectal cancer
hsa-mir-124	colorectal cancer
hsa-mir-124	colorectal cancer	down	MiR-124 S
hsa-mir-124	colorectal cancer
hsa-mir-124	colorectal cancer	down	KITENIN-targeting MicroRNA-124 S
hsa-mir-124	colorectal cancer	down	Gene module based regulator inference identifying miR-139 as a tumor s
hsa-mir-124	colorectal cancer
hsa-mir-124	colorectal cancer
hsa-mir-124	colorectal cancer
hsa-mir-124	colorectal cancer
hsa-mir-124	colorectal cancer	down	MicroRNA-124 inhibits colorectal cancer cell proliferation and s
hsa-mir-124	colorectal cancer
hsa-mir-124	esophageal cancer
hsa-mir-124	esophageal cancer
hsa-mir-124	esophageal cancer	down	STAT3 is involved in miR-124-mediated s
hsa-mir-124	esophageal squamous cell carcinoma
hsa-mir-124	gastric adenocarcinoma
hsa-mir-124	gastric cancer
hsa-mir-124	gastric cancer
hsa-mir-124	gastric cancer
hsa-mir-124	gastric cancer
hsa-mir-124	gastric cancer	down	[miR-124 s
hsa-mir-124	gastric cancer
hsa-mir-124	gastric cancer	down	Lentivirus-mediated overexpression of miR-124 s
hsa-mir-124	glioblastoma	down	miR-124 s
hsa-mir-124	glioblastoma	down	miR-124 Acts as a Tumor S
hsa-mir-124	glioblastoma	down	MiR-124 Functions as a Tumor S
hsa-mir-124	glioblastoma
hsa-mir-124	glioblastoma	down	Downregulation of miR-124 promotes the growth and invasiveness of glioblastoma cells involving
hsa-mir-124	glioblastoma	down	miR-124 s
hsa-mir-124	glioma
hsa-mir-124	glioma
hsa-mir-124	glioma
hsa-mir-124	glioma
hsa-mir-124	glioma	down	Inhibition of the Hedgehog signaling pathway s
hsa-mir-124	hepatocellular carcinoma
hsa-mir-124	hepatocellular carcinoma	down	The putative tumour s
hsa-mir-124	hepatocellular carcinoma	down	MiR-124 s
hsa-mir-124	hepatocellular carcinoma	down	MicroRNA-124 s
hsa-mir-124	hepatocellular carcinoma
hsa-mir-124	lung cancer	down	Circular RNA HIPK3 exerts oncogenic properties through s
hsa-mir-124	malignant melanoma	down	Upregulation of miR-124 by physcion 8-O-?-glucopyranoside inhibits proliferation and invasion of malignant melanoma cells via repressing RLIP76.
hsa-mir-124	medulloblastoma
hsa-mir-124	nasopharyngeal carcinoma	down	MiR-124 s
hsa-mir-124	nasopharyngeal carcinoma
hsa-mir-124	nasopharyngeal carcinoma	down	miR-124 s
hsa-mir-124	non-small cell lung cancer	down	miRNA-124 down-regulates SOX8 expression and s
hsa-mir-124	non-small cell lung cancer	down	miRNA-124 down-regulates SOX8 expression and s
hsa-mir-124	non-small cell lung cancer
hsa-mir-124	non-small cell lung cancer
hsa-mir-124	non-small cell lung cancer
hsa-mir-124	non-small cell lung cancer	down	MicroRNA-124 s
hsa-mir-124	non-small cell lung cancer	down	Inhibition of LHX2 by miR-124 s
hsa-mir-124	non-small cell lung cancer
hsa-mir-124	non-small cell lung cancer	down	MicroRNA-124 s
hsa-mir-124	non-small cell lung cancer	down	MicroRNA-124 Functions as a Tumor S
hsa-mir-124	non-small cell lung cancer	down	MicroRNA-124 s
hsa-mir-124	oral squamous cell carcinoma	down	MicroRNA-124 s
hsa-mir-124	osteosarcoma	down	The tumor s
hsa-mir-124	osteosarcoma	down	MicroRNA-124 functions as a tumor s
hsa-mir-124	osteosarcoma	down	The tumor s
hsa-mir-124	ovarian cancer
hsa-mir-124	ovarian cancer
hsa-mir-124	pancreatic cancer
hsa-mir-124	pancreatic ductal adenocarcinoma
hsa-mir-124	pancreatic ductal adenocarcinoma	down	miR-124 S
hsa-mir-124	prostate cancer	down	MiR-124 s
hsa-mir-124	renal cell carcinoma
hsa-mir-124	retinoblastoma
hsa-mir-124-3p	bladder cancer
hsa-mir-124-3p	bladder cancer	down	MiR-124-3p s
hsa-mir-124-3p	bladder cancer	down	MicroRNA-124-3p s
hsa-mir-124-3p	breast cancer
hsa-mir-124-3p	breast cancer
hsa-mir-124-3p	breast cancer	down	miR-124-3p functions as a tumor s
hsa-mir-124-3p	cervical cancer
hsa-mir-124-3p	esophageal squamous cell carcinoma
hsa-mir-124-3p	gastric cancer	down	miR-124-3p acts as a potential marker and s
hsa-mir-124-3p	glioma
hsa-mir-124-3p	glioma	down	MiR-124-3p s
hsa-mir-124-3p	glioma	down	Amentoflavone induces apoptosis and s
hsa-mir-124-3p	hepatocellular carcinoma
hsa-mir-124-5p	glioma
hsa-mir-1244	lung carcinoma
hsa-mir-1246	breast cancer
hsa-mir-1246	cervical cancer
hsa-mir-1246	colorectal cancer
hsa-mir-1246	hepatocellular carcinoma
hsa-mir-1246	lung cancer
hsa-mir-1246	lung cancer
hsa-mir-1246	non-small cell lung cancer
hsa-mir-1246	ovarian cancer
hsa-mir-1246	prostate cancer
hsa-mir-1247	bladder cancer
hsa-mir-1247	non-small cell lung cancer
hsa-mir-1247	pancreatic cancer	down	Epigenetically altered miR-1247 functions as a tumor s
hsa-mir-1247	pancreatic cancer
hsa-mir-1247	renal cell carcinoma	down	Epigenetically altered miR-1247 functions as a tumor s
hsa-mir-1247-5p	breast cancer
hsa-mir-1247-5p	hepatocellular carcinoma	down	miR-1247-5p functions as a tumor s
hsa-mir-124a	acute lymphoblastic leukemia	down	Epigenetic silencing of the tumor s
hsa-mir-124a	epithelial ovarian cancer
hsa-mir-124a	glioblastoma
hsa-mir-124a	glioma	down	miR-124a restoration inhibits glioma cell proliferation and invasion by s
hsa-mir-124a	liver cancer
hsa-mir-124a	mantle cell lymphoma
hsa-mir-1250	oral squamous cell carcinoma
hsa-mir-1251-5p	ovarian cancer
hsa-mir-1253	non-small cell lung cancer	down	MicroRNA-1253 s
hsa-mir-1254	cervical cancer
hsa-mir-1254	colorectal cancer
hsa-mir-1254	lung cancer
hsa-mir-1254	oral squamous cell carcinoma	down	MiR-1254 Functions as a Tumor S
hsa-mir-1256	non-small cell lung cancer	down	MiR-1256 s
hsa-mir-1258	breast cancer	down	MicroRNA-1258 s
hsa-mir-1258	breast cancer
hsa-mir-1258	colorectal cancer	down	Upregulated miR-1258 regulates cell cycle and inhibits cell proliferation by directly targeting E2F8 in CRC.
hsa-mir-1258	hepatocellular carcinoma
hsa-mir-1258	non-small cell lung cancer	down	MicroRNA-1258 s
hsa-mir-1258	osteosarcoma
hsa-mir-1259	gastric cancer
hsa-mir-125a	acute myeloid leukemia
hsa-mir-125a	breast cancer
hsa-mir-125a	colorectal cancer
hsa-mir-125a	colorectal cancer
hsa-mir-125a	colorectal carcinoma
hsa-mir-125a	esophageal squamous cell carcinoma
hsa-mir-125a	glioblastoma	down	miR-29b and miR-125a regulate podoplanin and s
hsa-mir-125a	hepatocellular carcinoma	down	Mutual s
hsa-mir-125a	hepatocellular carcinoma
hsa-mir-125a	hepatocellular carcinoma
hsa-mir-125a	laryngeal carcinoma
hsa-mir-125a	laryngeal squamous cell carcinoma	down	miR-125a s
hsa-mir-125a	osteosarcoma
hsa-mir-125a	ovarian cancer
hsa-mir-125a	ovarian cancer
hsa-mir-125a-3p	acute myeloid leukemia
hsa-mir-125a-3p	gastric cancer
hsa-mir-125a-3p	non-small cell lung cancer
hsa-mir-125a-3p	pancreatic ductal adenocarcinoma
hsa-mir-125a-5p	basal cell carcinoma
hsa-mir-125a-5p	bladder cancer	down	MiR-125a-5p s
hsa-mir-125a-5p	breast cancer
hsa-mir-125a-5p	colorectal cancer	down	miR-125a-5p s
hsa-mir-125a-5p	gastric cancer
hsa-mir-125a-5p	gastric cancer
hsa-mir-125a-5p	glioblastoma
hsa-mir-125a-5p	hepatocellular carcinoma
hsa-mir-125a-5p	hepatocellular carcinoma
hsa-mir-125a-5p	lung adenocarcinoma	down	miR-125a-5p
hsa-mir-125a-5p	lung cancer	down	MicroRNA-125a-5p plays a role as a tumor s
hsa-mir-125a-5p	malignant melanoma
hsa-mir-125a-5p	non-small cell lung cancer
hsa-mir-125a-5p	non-small cell lung cancer	down	PDGFR-modulated miR-23b cluster and miR-125a-5p s
hsa-mir-125a-5p	prostate carcinoma
hsa-mir-125a-5p	retinoblastoma	down	S
hsa-mir-125a-5p	thyroid cancer
hsa-mir-125b	acute myeloid leukemia
hsa-mir-125b	acute myeloid leukemia
hsa-mir-125b	anaplastic thyroid carcinoma
hsa-mir-125b	bladder cancer	down	MicroRNA-125b s
hsa-mir-125b	bladder cancer
hsa-mir-125b	bladder cancer
hsa-mir-125b	breast cancer
hsa-mir-125b	breast cancer
hsa-mir-125b	breast cancer	down	MUCIN 1 ONCOPROTEIN EXPRESSION IS SUPPRESSED BY THE miR-125b ONCOMIR.
hsa-mir-125b	breast cancer	down	miR-125b is methylated and functions as a tumor s
hsa-mir-125b	breast cancer
hsa-mir-125b	breast cancer
hsa-mir-125b	chronic lymphocytic leukemia
hsa-mir-125b	chronic myelogenous leukemia
hsa-mir-125b	colorectal cancer
hsa-mir-125b	colorectal cancer
hsa-mir-125b	colorectal cancer
hsa-mir-125b	colorectal cancer
hsa-mir-125b	esophageal squamous cell carcinoma
hsa-mir-125b	follicular cancer
hsa-mir-125b	gastric cancer
hsa-mir-125b	gastric cancer
hsa-mir-125b	gastric cancer	down	miR-125b S
hsa-mir-125b	gastric cancer
hsa-mir-125b	glioblastoma
hsa-mir-125b	glioblastoma
hsa-mir-125b	glioma
hsa-mir-125b	glioma
hsa-mir-125b	glioma
hsa-mir-125b	hepatocellular carcinoma
hsa-mir-125b	hepatocellular carcinoma
hsa-mir-125b	hepatocellular carcinoma	down	MicroRNA-125b Functions as a Tumor S
hsa-mir-125b	hepatocellular carcinoma
hsa-mir-125b	hepatocellular carcinoma	down	miR-125b s
hsa-mir-125b	lung cancer
hsa-mir-125b	lung cancer	down	Up-regulation of miR-125b reverses epithelial-mesenchymal transition in paclitaxel-resistant lung cancer cells.
hsa-mir-125b	malignant melanoma	down	MicroRNA-125b s
hsa-mir-125b	malignant melanoma
hsa-mir-125b	malignant melanoma
hsa-mir-125b	nasopharyngeal carcinoma
hsa-mir-125b	neuroblastoma
hsa-mir-125b	non-small cell lung cancer
hsa-mir-125b	oral squamous cell carcinoma
hsa-mir-125b	oral squamous cell carcinoma
hsa-mir-125b	oral squamous cell carcinoma	down	miR-125b s
hsa-mir-125b	osteosarcoma	down	MiR-125b Functions as a Tumor S
hsa-mir-125b	osteosarcoma	down	miR-125b s
hsa-mir-125b	ovarian cancer
hsa-mir-125b	ovarian cancer
hsa-mir-125b	ovarian cancer	down	PPAR? inhibits ovarian cancer cells proliferation through
hsa-mir-125b	ovarian cancer
hsa-mir-125b	ovarian cancer	down	MicroRNA-125b S
hsa-mir-125b	ovarian cancer
hsa-mir-125b	prostate cancer	down	Dual Action of miR-125b As a Tumor S
hsa-mir-125b	prostate cancer
hsa-mir-125b	prostate cancer
hsa-mir-125b	retinoblastoma
hsa-mir-125b-1-3p	mesenchymal cancer
hsa-mir-125b-2*	colorectal cancer
hsa-mir-125b-5p	esophageal squamous cell carcinoma	down	miR-125b-5p functions as a tumor s
hsa-mir-125b-5p	laryngeal squamous cell carcinoma	down	MiR-125b-5p s
hsa-mir-126	bladder cancer
hsa-mir-126	breast cancer
hsa-mir-126	breast cancer
hsa-mir-126	breast cancer
hsa-mir-126	cervical cancer
hsa-mir-126	chronic myelogenous leukemia
hsa-mir-126	colon cancer	down	MiR-126 s
hsa-mir-126	colon cancer	down	Expression of miR-126 s
hsa-mir-126	colon cancer
hsa-mir-126	colorectal cancer
hsa-mir-126	colorectal cancer
hsa-mir-126	colorectal cancer	down	MicroRNA-126 functions as a tumor s
hsa-mir-126	colorectal cancer
hsa-mir-126	esophageal cancer
hsa-mir-126	esophageal cancer
hsa-mir-126	esophageal squamous cell carcinoma
hsa-mir-126	esophageal squamous cell carcinoma
hsa-mir-126	gastric cancer	down	miR-126 functions as a tumour s
hsa-mir-126	gastric cancer
hsa-mir-126	gastric cancer	down	miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor s
hsa-mir-126	gastric cancer
hsa-mir-126	gastric cancer
hsa-mir-126	gastric cancer
hsa-mir-126	gastric cancer
hsa-mir-126	gastric cancer	down	MiR-126 functions as a tumor s
hsa-mir-126	gastric cancer
hsa-mir-126	gastric cancer
hsa-mir-126	glioblastoma
hsa-mir-126	glioblastoma
hsa-mir-126	glioma	down	MicroRNA-126 acts as a tumor s
hsa-mir-126	hepatocellular carcinoma
hsa-mir-126	hepatocellular carcinoma
hsa-mir-126	hepatocellular carcinoma
hsa-mir-126	liver cancer
hsa-mir-126	malignant melanoma
hsa-mir-126	malignant mesothelioma	down	MicroRNA-126 S
hsa-mir-126	malignant mesothelioma
hsa-mir-126	non-small cell lung cancer
hsa-mir-126	non-small cell lung cancer
hsa-mir-126	non-small cell lung cancer
hsa-mir-126	non-small cell lung cancer
hsa-mir-126	non-small cell lung cancer
hsa-mir-126	non-small cell lung cancer
hsa-mir-126	oral squamous cell carcinoma
hsa-mir-126	oral squamous cell carcinoma	down	S
hsa-mir-126	osteosarcoma
hsa-mir-126	osteosarcoma	down	miR-126 functions as a tumor s
hsa-mir-126	osteosarcoma
hsa-mir-126	osteosarcoma
hsa-mir-126	ovarian cancer	down	microRNA-126 s
hsa-mir-126	pancreatic adenocarcinoma	down	Simultaneous overexpression of miR-126 and miR-34a induces a s
hsa-mir-126	pancreatic ductal adenocarcinoma
hsa-mir-126	papillary thyroid carcinoma
hsa-mir-126	prostate cancer
hsa-mir-126	renal cell carcinoma
hsa-mir-126	renal cell carcinoma
hsa-mir-126	small cell lung cancer
hsa-mir-126	thyroid cancer
hsa-mir-126*	non-small cell lung cancer
hsa-mir-126-3p	non-small cell lung cancer
hsa-mir-126-3p	pancreatic cancer
hsa-mir-126-5p	acute myeloid leukemia
hsa-mir-126-5p	cervical cancer
hsa-mir-126-5p	non-small cell lung cancer
hsa-mir-1260b	hepatocellular carcinoma
hsa-mir-1260b	non-small cell lung cancer
hsa-mir-1260b	non-small cell lung cancer
hsa-mir-1260b	renal cell carcinoma
hsa-mir-1261	glioma
hsa-mir-1266	colorectal cancer
hsa-mir-1266	gastric cancer	down	miR-1207-5p and miR-1266 s
hsa-mir-1266	papillary thyroid carcinoma	down	MicroRNA-1266 s
hsa-mir-1266-5p	prostate cancer
hsa-mir-1269	hepatocellular carcinoma
hsa-mir-1269	hepatocellular carcinoma
hsa-mir-1269	hepatocellular carcinoma
hsa-mir-1269	lung cancer
hsa-mir-1269a	colorectal cancer
hsa-mir-1269a	hepatocellular carcinoma
hsa-mir-1269a	non-small cell lung cancer
hsa-mir-1269b	hepatocellular carcinoma
hsa-mir-127	breast cancer
hsa-mir-127	breast cancer
hsa-mir-127	esophageal squamous cell carcinoma	down	MicroRNA-127 is a tumor s
hsa-mir-127	gastric cancer	down	miR-127 s
hsa-mir-127	gastric cancer	down	The Tumor S
hsa-mir-127	hepatocellular carcinoma
hsa-mir-127	hepatocellular carcinoma	down	MicroRNA-127 Post-Transcriptionally Downregulates Sept7 and S
hsa-mir-127	lung cancer
hsa-mir-127	ovarian cancer	down	MiR-127 inhibits ovarian cancer migration and invasion by
hsa-mir-127	pancreatic carcinoma	down	MicroRNA-127 is aberrantly downregulated and acted as a functional tumor s
hsa-mir-127-3p	colorectal cancer
hsa-mir-127-3p	glioblastoma
hsa-mir-127-3p	glioblastoma
hsa-mir-127-3p	osteosarcoma
hsa-mir-127-3p	osteosarcoma
hsa-mir-127-3p	osteosarcoma
hsa-mir-127-5p	hepatocellular carcinoma	down	MiR-127-5p targets the biliverdin reductase B/NF-?B pathway to s
hsa-mir-1270	osteosarcoma
hsa-mir-1271	breast cancer
hsa-mir-1271	breast cancer	down	MiR-1271 as a tumor s
hsa-mir-1271	breast cancer
hsa-mir-1271	colorectal cancer	down	S
hsa-mir-1271	colorectal cancer	down	MicroRNA-1271 s
hsa-mir-1271	colorectal cancer
hsa-mir-1271	endometrial cancer
hsa-mir-1271	endometrial cancer
hsa-mir-1271	hepatocellular carcinoma
hsa-mir-1271	hepatocellular carcinoma
hsa-mir-1271	non-small cell lung cancer
hsa-mir-1271	oral squamous cell carcinoma
hsa-mir-1271	osteosarcoma
hsa-mir-1271	ovarian cancer
hsa-mir-1271	pancreatic cancer
hsa-mir-1271	prostate cancer
hsa-mir-1273e	gastric cancer
hsa-mir-1274a	gastric cancer
hsa-mir-1274a	renal clear cell carcinoma
hsa-mir-1275	chronic myelogenous leukemia
hsa-mir-1275	gastric cancer
hsa-mir-1275	non-small cell lung cancer
hsa-mir-1277	hepatocellular carcinoma	down	MicroRNA-1277 inhibits proliferation and migration of hepatocellular carcinoma HepG2 cells by targeting and s
hsa-mir-128	acute lymphoblastic leukemia
hsa-mir-128	acute myeloid leukemia
hsa-mir-128	colorectal cancer	down	MicroRNA-128 s
hsa-mir-128	colorectal cancer
hsa-mir-128	gastric cancer	down	Long noncoding RNA PVT1-214 enhances gastric cancer progression by
hsa-mir-128	glioblastoma
hsa-mir-128	glioblastoma
hsa-mir-128	glioblastoma
hsa-mir-128	glioblastoma
hsa-mir-128	glioma
hsa-mir-128	glioma
hsa-mir-128	glioma
hsa-mir-128	glioma
hsa-mir-128	glioma
hsa-mir-128	glioma
hsa-mir-128	head and neck squamous cell carcinoma
hsa-mir-128	hepatocellular carcinoma
hsa-mir-128	lung cancer
hsa-mir-128	meningioma
hsa-mir-128	osteosarcoma
hsa-mir-128	osteosarcoma
hsa-mir-128	pancreatic cancer
hsa-mir-128	prostate cancer
hsa-mir-128	prostate cancer	down	miRNA-128 s
hsa-mir-128-3p	anaplastic thyroid carcinoma	down	Knockdown of HCP5 exerts tumor-s
hsa-mir-128-3p	glioma
hsa-mir-128-3p	glioma
hsa-mir-128-3p	hepatocellular carcinoma
hsa-mir-128-3p	hepatocellular carcinoma	down	miR-128-3p s
hsa-mir-128-3p	lung cancer
hsa-mir-1280	bladder cancer
hsa-mir-1280	colorectal cancer	down	tRF/miR-1280 S
hsa-mir-1280	malignant melanoma
hsa-mir-1280	non-small cell lung cancer
hsa-mir-1283	glioma
hsa-mir-1284	breast cancer
hsa-mir-1284	gastric cancer
hsa-mir-1284	gastric cancer	down	MiR-1284 s
hsa-mir-1285	renal cell carcinoma	down	Tumor s
hsa-mir-1285-3p	osteosarcoma	down	miR-1285-3p is a potential prognostic marker in human osteosarcoma and functions as a tumor s
hsa-mir-1288	esophageal squamous cell carcinoma
hsa-mir-128a	hepatocellular carcinoma
hsa-mir-128a	medulloblastoma
hsa-mir-128b	gastric cancer
hsa-mir-128b	gastric cancer	down	MicroRNA-128b s
hsa-mir-128b	gastric cancer
hsa-mir-129	breast cancer
hsa-mir-129	breast cancer
hsa-mir-129	colorectal cancer
hsa-mir-129	esophageal squamous cell carcinoma
hsa-mir-129	gastric cancer
hsa-mir-129	glioblastoma
hsa-mir-129	glioma
hsa-mir-129	glioma
hsa-mir-129	hepatocellular carcinoma	down	miR-129 s
hsa-mir-129	non-small cell lung cancer
hsa-mir-129	prostate cancer
hsa-mir-129	prostate cancer
hsa-mir-129-1-3p	gastric cancer
hsa-mir-129-2-3p	gastric cancer
hsa-mir-129-3p	gastric cancer
hsa-mir-129-3p	glioblastoma	down	MicroRNA-129-3p s
hsa-mir-129-5p	breast cancer	down	microRNA-129-5p s
hsa-mir-129-5p	breast cancer
hsa-mir-129-5p	breast cancer	down	miR-129-5p s
hsa-mir-129-5p	breast cancer
hsa-mir-129-5p	chondrosarcoma
hsa-mir-129-5p	colon cancer
hsa-mir-129-5p	gastric cancer
hsa-mir-129-5p	gastric cancer
hsa-mir-129-5p	gastric cancer	down	lncRNA-AC130710 targeting by miR-129-5p is
hsa-mir-129-5p	gastric cancer	down	MiR-129-5p s
hsa-mir-129-5p	gastric cancer	down	MiR-129-5p functions as a tumor s
hsa-mir-129-5p	glioma
hsa-mir-129-5p	glioma
hsa-mir-129-5p	hepatocellular carcinoma
hsa-mir-129-5p	laryngeal squamous cell carcinoma
hsa-mir-129-5p	lung cancer	down	Tumor s
hsa-mir-129-5p	malignant melanoma	down	Long Noncoding RNA Taurine-Upregulated Gene1 (TUG1) Promotes Tumor Growth and Metastasis Through TUG1/Mir-129-5p/Astrocyte-Elevated Gene-1 (AEG-1) Axis in Malignant Melanoma.
hsa-mir-129-5p	non-small cell lung cancer
hsa-mir-129-5p	ovarian cancer	down	A novel role for microRNA-129-5p in inhibiting ovarian cancer cell proliferation and survival via direct s
hsa-mir-129-5p	prostate cancer
hsa-mir-1290	colon cancer
hsa-mir-1290	esophageal squamous cell carcinoma
hsa-mir-1290	esophageal squamous cell carcinoma
hsa-mir-1290	esophageal squamous cell carcinoma
hsa-mir-1290	gastric cancer
hsa-mir-1290	gastric cancer
hsa-mir-1290	lung adenocarcinoma
hsa-mir-1290	non-small cell lung cancer
hsa-mir-1290	non-small cell lung cancer
hsa-mir-1290	non-small cell lung cancer
hsa-mir-1290	pancreatic ductal adenocarcinoma
hsa-mir-1290	renal clear cell carcinoma
hsa-mir-1291	hepatocellular carcinoma
hsa-mir-1291	pancreatic cancer
hsa-mir-1291	renal cell carcinoma	down	Tumor-s
hsa-mir-1294	esophageal squamous cell carcinoma
hsa-mir-1294	gastric cancer
hsa-mir-1294	glioma
hsa-mir-1294	oral squamous cell carcinoma
hsa-mir-1295b-3p	colorectal cancer
hsa-mir-1296	hepatocellular carcinoma
hsa-mir-1296	prostate cancer
hsa-mir-1296-5p	breast cancer
hsa-mir-1296-5p	gastric cancer	down	The tumor-s
hsa-mir-1296-5p	gastric cancer
hsa-mir-1297	cervical cancer
hsa-mir-1297	cervical cancer
hsa-mir-1297	gastric cancer
hsa-mir-1297	liver cancer
hsa-mir-1297	lung adenocarcinoma
hsa-mir-1297	oral squamous cell carcinoma
hsa-mir-1297	pancreatic adenocarcinoma	down	MiR-1297 s
hsa-mir-1297	pancreatic cancer	down	MiR-1297 s
hsa-mir-1297	prostate cancer
hsa-mir-1298	gastric cancer
hsa-mir-1299	hepatocellular carcinoma	down	miR-1299 s
hsa-mir-1301	glioma
hsa-mir-1301	liver cancer
hsa-mir-1301	osteosarcoma
hsa-mir-1301	prostate cancer
hsa-mir-1301-3p	breast cancer
hsa-mir-1301-3p	prostate cancer
hsa-mir-1303	gastric cancer
hsa-mir-1303	neuroblastoma
hsa-mir-1304	non-small cell lung cancer	down	MicroRNA-1304 s
hsa-mir-1306-3p	gastric cancer
hsa-mir-1307	colorectal cancer
hsa-mir-1307	prostate cancer
hsa-mir-1307-3p	breast cancer
hsa-mir-1307-3p	lung cancer
hsa-mir-130a	acute myeloid leukemia
hsa-mir-130a	basal cell carcinoma
hsa-mir-130a	breast cancer	down	microRNA-130a s
hsa-mir-130a	cervical cancer
hsa-mir-130a	chronic myelogenous leukemia
hsa-mir-130a	colorectal cancer
hsa-mir-130a	endometrial cancer
hsa-mir-130a	esophageal cancer
hsa-mir-130a	gastric cancer
hsa-mir-130a	gastric cancer
hsa-mir-130a	glioma
hsa-mir-130a	hepatocellular carcinoma
hsa-mir-130a	hepatocellular carcinoma
hsa-mir-130a	hepatocellular carcinoma
hsa-mir-130a	hepatocellular carcinoma
hsa-mir-130a	non-small cell lung cancer	down	MiR-130 exerts tumor s
hsa-mir-130a	osteosarcoma
hsa-mir-130a	prostate cancer	down	Epigenetic Disr
hsa-mir-130a	serous ovarian cancer
hsa-mir-130a-3p	breast cancer
hsa-mir-130a-3p	gastric cancer	down	MicroRNA-130a-3p s
hsa-mir-130b	colorectal cancer
hsa-mir-130b	colorectal cancer
hsa-mir-130b	colorectal cancer	down	Microrna 130b S
hsa-mir-130b	endometrial cancer
hsa-mir-130b	esophageal squamous cell carcinoma
hsa-mir-130b	gastric cancer
hsa-mir-130b	glioblastoma
hsa-mir-130b	glioma
hsa-mir-130b	glioma
hsa-mir-130b	glioma
hsa-mir-130b	hepatocellular carcinoma
hsa-mir-130b	hepatocellular carcinoma
hsa-mir-130b	hepatocellular carcinoma
hsa-mir-130b	hepatocellular carcinoma
hsa-mir-130b	lung cancer
hsa-mir-130b	neuroblastoma
hsa-mir-130b	non-small cell lung cancer	down	MiR-130 exerts tumor s
hsa-mir-130b	non-small cell lung cancer
hsa-mir-130b	non-small cell lung cancer
hsa-mir-130b	osteosarcoma	down	Restoration of microRNA-130b expression s
hsa-mir-130b	osteosarcoma
hsa-mir-130b	ovarian cancer
hsa-mir-130b	papillary thyroid carcinoma
hsa-mir-130b	prostate cancer	down	MiR-130b s
hsa-mir-130b	prostate cancer
hsa-mir-130b	renal cell carcinoma
hsa-mir-130b*	gastric cancer
hsa-mir-130b-3p	bladder cancer
hsa-mir-130b-3p	breast carcinoma
hsa-mir-130b-3p	nephroblastoma
hsa-mir-132	breast cancer	down	MicroRNA-132 s
hsa-mir-132	colorectal cancer
hsa-mir-132	colorectal cancer
hsa-mir-132	colorectal cancer
hsa-mir-132	colorectal cancer
hsa-mir-132	gastric cancer
hsa-mir-132	gastric cancer
hsa-mir-132	glioma
hsa-mir-132	glioma
hsa-mir-132	glioma
hsa-mir-132	hepatocellular carcinoma
hsa-mir-132	hepatocellular carcinoma
hsa-mir-132	liver cancer
hsa-mir-132	lung cancer
hsa-mir-132	osteosarcoma
hsa-mir-132	osteosarcoma
hsa-mir-132	osteosarcoma	down	miR-132 targeting cyclin E1 s
hsa-mir-132	pancreatic cancer
hsa-mir-132	pancreatic carcinoma
hsa-mir-132	prostate cancer	down	Identification of tumor s
hsa-mir-132	thyroid cancer	down	miR-132 targets FOXA1 and exerts tumor-s
hsa-mir-132-3p	breast cancer
hsa-mir-132-3p	gastric cancer
hsa-mir-132-3p	glioma
hsa-mir-1323	hepatocellular carcinoma
hsa-mir-133a	bladder cancer	down	The tumour-s
hsa-mir-133a	breast cancer
hsa-mir-133a	breast cancer	down	MicroRNA-133a acts as a tumour s
hsa-mir-133a	breast cancer
hsa-mir-133a	cervical cancer
hsa-mir-133a	cervical cancer
hsa-mir-133a	colorectal cancer
hsa-mir-133a	colorectal cancer	down	Tumor s
hsa-mir-133a	colorectal cancer
hsa-mir-133a	colorectal cancer
hsa-mir-133a	colorectal cancer	down	MicroRNA-133a s
hsa-mir-133a	esophageal squamous cell carcinoma	down	CD47 expression regulated by the miR-133a tumor s
hsa-mir-133a	gastric cancer	down	MicroRNA-133a functions as a tumor s
hsa-mir-133a	gastric cancer	down	Tumor s
hsa-mir-133a	gastric cancer
hsa-mir-133a	glioma	down	miR-150-5p and miR-133a s
hsa-mir-133a	head and neck squamous cell carcinoma
hsa-mir-133a	head and neck squamous cell carcinoma	down	Tumor s
hsa-mir-133a	hepatocellular carcinoma	down	MicroRNA-133a functions as a tumor s
hsa-mir-133a	hepatocellular carcinoma
hsa-mir-133a	lung squamous cell carcinoma	down	Tumor s
hsa-mir-133a	non-small cell lung cancer
hsa-mir-133a	non-small cell lung cancer
hsa-mir-133a	non-small cell lung cancer	down	MiR-133a s
hsa-mir-133a	non-small cell lung cancer
hsa-mir-133a	osteosarcoma
hsa-mir-133a	ovarian cancer	down	miR-133a s
hsa-mir-133a	pancreatic cancer	down	miR-133a Functions as a Tumor S
hsa-mir-133a	renal cell carcinoma
hsa-mir-133a-1	glioma
hsa-mir-133a-1	hepatocellular carcinoma
hsa-mir-133a-1	lung adenocarcinoma
hsa-mir-133a-1	lung cancer
hsa-mir-133a-2	glioma
hsa-mir-133a-2	hepatocellular carcinoma
hsa-mir-133a-2	lung adenocarcinoma
hsa-mir-133a-2	lung cancer
hsa-mir-133a-3p	colorectal cancer
hsa-mir-133a-3p	esophageal adenocarcinoma
hsa-mir-133a-3p	oral squamous cell carcinoma	down	MiR-133a-3p Inhibits Oral Squamous Cell Carcinoma (OSCC) Proliferation and Invasion by S
hsa-mir-133a-3p	prostate cancer
hsa-mir-133b	bladder cancer	down	MicroRNA-133b s
hsa-mir-133b	breast cancer
hsa-mir-133b	breast cancer
hsa-mir-133b	cervical carcinoma
hsa-mir-133b	colorectal cancer
hsa-mir-133b	colorectal cancer	down	miR-133b s
hsa-mir-133b	colorectal cancer
hsa-mir-133b	esophageal squamous cell carcinoma
hsa-mir-133b	esophageal squamous cell carcinoma	down	MicroRNA-133b/EGFR axis regulates esophageal squamous cell carcinoma metastases by s
hsa-mir-133b	gastric cancer	down	miR-133b acts as a tumor s
hsa-mir-133b	gastric cancer
hsa-mir-133b	gastric cancer
hsa-mir-133b	gastric cancer	down	Identification and characterization of tumor s
hsa-mir-133b	gastric cancer	down	MiR-133b inhibits proliferation and invasion of gastric cancer cells by
hsa-mir-133b	gastric cancer	down	miR-133b acts as a tumor s
hsa-mir-133b	gastric cancer
hsa-mir-133b	glioblastoma
hsa-mir-133b	glioma
hsa-mir-133b	glioma
hsa-mir-133b	glioma	down	miR-133b acts as a tumor s
hsa-mir-133b	glioma
hsa-mir-133b	hepatocellular carcinoma
hsa-mir-133b	hepatocellular carcinoma
hsa-mir-133b	hepatocellular carcinoma
hsa-mir-133b	lung adenocarcinoma
hsa-mir-133b	lung cancer
hsa-mir-133b	lung cancer
hsa-mir-133b	non-small cell lung cancer
hsa-mir-133b	osteosarcoma
hsa-mir-133b	osteosarcoma
hsa-mir-133b	prostate cancer
hsa-mir-134	cervical cancer
hsa-mir-134	colorectal cancer
hsa-mir-134	endometrial cancer	down	MicroRNA-134 s
hsa-mir-134	esophageal squamous cell carcinoma
hsa-mir-134	gastric cancer	down	MicroRNA-134 functions as a tumor s
hsa-mir-134	gastric cancer	down	MicroRNA-134 s
hsa-mir-134	glioblastoma
hsa-mir-134	glioma	down	MicroRNA-134 modulates glioma cell U251 proliferation and invasion by targeting KRAS and s
hsa-mir-134	head and neck squamous cell carcinoma
hsa-mir-134	hepatocellular carcinoma	down	Genome-Wide Screening Identified That miR-134 Acts as a Metastasis S
hsa-mir-134	non-small cell lung cancer
hsa-mir-134	non-small cell lung cancer	down	Hsa-miR-134 s
hsa-mir-134	non-small cell lung cancer	down	miR-134 s
hsa-mir-134	osteosarcoma
hsa-mir-134	osteosarcoma
hsa-mir-134	osteosarcoma	down	Decreased miR-134 expression and its tumor-s
hsa-mir-134	renal cell carcinoma	down	miR-134 Functions as a Tumor S
hsa-mir-134-5p	nasopharyngeal carcinoma
hsa-mir-135a	bladder cancer
hsa-mir-135a	breast cancer
hsa-mir-135a	breast cancer
hsa-mir-135a	breast cancer	down	Tumor-s
hsa-mir-135a	colorectal cancer
hsa-mir-135a	colorectal cancer
hsa-mir-135a	gastric cancer	down	miR-135a s
hsa-mir-135a	gastric cancer	down	miR-135a acts as a tumor s
hsa-mir-135a	gastric cancer
hsa-mir-135a	glioblastoma
hsa-mir-135a	glioma
hsa-mir-135a	hepatocellular carcinoma
hsa-mir-135a	hepatocellular carcinoma
hsa-mir-135a	lung cancer
hsa-mir-135a	malignant melanoma
hsa-mir-135a	nasopharyngeal carcinoma
hsa-mir-135a	nasopharyngeal carcinoma
hsa-mir-135a	non-small cell lung cancer
hsa-mir-135a	pancreatic ductal adenocarcinoma
hsa-mir-135a	prostate cancer
hsa-mir-135a	prostate cancer
hsa-mir-135a	renal cell carcinoma	down	Tumor-s
hsa-mir-135a-1	colorectal cancer
hsa-mir-135a-1	esophageal squamous cell carcinoma
hsa-mir-135a-1	non-small cell lung cancer
hsa-mir-135a-1	pancreatic ductal adenocarcinoma
hsa-mir-135a-2	colorectal cancer
hsa-mir-135a-2	esophageal squamous cell carcinoma
hsa-mir-135a-2	non-small cell lung cancer
hsa-mir-135a-2	pancreatic ductal adenocarcinoma
hsa-mir-135a-3p	ovarian cancer	down	MicroRNA-135a-3p is downregulated and serves as a tumour s
hsa-mir-135a-3p	ovarian cancer
hsa-mir-135a-5p	clear cell renal cell cancer
hsa-mir-135a-5p	gastric cancer
hsa-mir-135a-5p	hepatocellular carcinoma
hsa-mir-135a-5p	lung cancer
hsa-mir-135a-5p	thyroid carcinoma
hsa-mir-135b	cervical cancer
hsa-mir-135b	colonic adenocarcinoma
hsa-mir-135b	colorectal cancer
hsa-mir-135b	colorectal cancer
hsa-mir-135b	colorectal cancer
hsa-mir-135b	colorectal cancer
hsa-mir-135b	colorectal cancer
hsa-mir-135b	colorectal cancer
hsa-mir-135b	colorectal cancer
hsa-mir-135b	colorectal cancer
hsa-mir-135b	colorectal cancer
hsa-mir-135b	esophageal squamous cell carcinoma
hsa-mir-135b	gastric cancer
hsa-mir-135b	glioblastoma
hsa-mir-135b	hepatocellular carcinoma
hsa-mir-135b	lung adenocarcinoma
hsa-mir-135b	lung cancer
hsa-mir-135b	malignant melanoma
hsa-mir-135b	non-small cell lung cancer
hsa-mir-135b	non-small cell lung cancer
hsa-mir-135b	pancreatic ductal adenocarcinoma
hsa-mir-135b	prostate cancer
hsa-mir-135b-5p	gastric cancer
hsa-mir-135b-5p	gastric cancer
hsa-mir-135b-5p	gastric cancer
hsa-mir-135b-5p	pancreatic cancer
hsa-mir-136	cervical carcinoma
hsa-mir-136	chondrosarcoma
hsa-mir-136	colon cancer
hsa-mir-136	colon cancer	down	miR-136 targets MIEN1 and involves the metastasis of colon cancer by s
hsa-mir-136	gallbladder carcinoma	down	Overexpressed microRNA-136 works as a cancer s
hsa-mir-136	gastric cancer
hsa-mir-136	gastric cancer
hsa-mir-136	glioblastoma
hsa-mir-136	glioma
hsa-mir-136	non-small cell lung cancer
hsa-mir-136	oral squamous cell carcinoma
hsa-mir-136	osteosarcoma	down	MicroRNA-136 functions as a tumor s
hsa-mir-136	osteosarcoma
hsa-mir-136	renal cell carcinoma	down	Tumor s
hsa-mir-136-5p	lung adenocarcinoma
hsa-mir-137	acute lymphoblastic leukemia
hsa-mir-137	anaplastic astrocytoma
hsa-mir-137	astrocytoma	down	miR-137 acts as a tumor s
hsa-mir-137	bladder cancer
hsa-mir-137	colorectal cancer
hsa-mir-137	colorectal cancer	down	Overexpression of paxillin induced by miR-137 s
hsa-mir-137	colorectal cancer
hsa-mir-137	endometrial cancer	down	miR-137 is a tumor s
hsa-mir-137	gastric cancer	down	miR-137 plays tumor s
hsa-mir-137	gastric cancer
hsa-mir-137	gastric cancer
hsa-mir-137	glioblastoma
hsa-mir-137	glioblastoma
hsa-mir-137	glioblastoma
hsa-mir-137	glioblastoma
hsa-mir-137	glioblastoma
hsa-mir-137	glioblastoma
hsa-mir-137	glioblastoma
hsa-mir-137	glioma
hsa-mir-137	glioma
hsa-mir-137	hepatocellular carcinoma
hsa-mir-137	hepatocellular carcinoma	down	MiR-137 s
hsa-mir-137	hepatocellular carcinoma	down	FoxD3-regulated microRNA-137 s
hsa-mir-137	hepatocellular carcinoma
hsa-mir-137	lung cancer
hsa-mir-137	lung cancer
hsa-mir-137	lung cancer
hsa-mir-137	malignant melanoma
hsa-mir-137	malignant melanoma
hsa-mir-137	malignant melanoma
hsa-mir-137	malignant melanoma
hsa-mir-137	malignant melanoma
hsa-mir-137	malignant melanoma	down	miR-137 s
hsa-mir-137	multiple myeloma	down	miR-137 s
hsa-mir-137	multiple myeloma	down	miR-137 and miR-197 Induce Apoptosis and S
hsa-mir-137	neuroblastoma	down	MiR-137 functions as a tumor s
hsa-mir-137	non-small cell lung cancer	down	microRNA-137 functions as a tumor s
hsa-mir-137	non-small cell lung cancer
hsa-mir-137	non-small cell lung cancer
hsa-mir-137	non-small cell lung cancer
hsa-mir-137	oral squamous cell carcinoma
hsa-mir-137	osteosarcoma
hsa-mir-137	ovarian cancer	down	miR-137 s
hsa-mir-137	ovarian cancer	down	MicroRNA-137 s
hsa-mir-137	ovarian cancer
hsa-mir-137	ovarian cancer
hsa-mir-137	pancreatic cancer	down	MiR-137 functions as a tumor s
hsa-mir-137	pancreatic cancer
hsa-mir-137	papillary thyroid carcinoma
hsa-mir-137	papillary thyroid carcinoma	down	miR-137 acts as a tumor s
hsa-mir-137	prostate cancer
hsa-mir-137	renal cell carcinoma
hsa-mir-137	renal clear cell carcinoma	down	MiR-137 s
hsa-mir-137	squamous carcinoma
hsa-mir-137	thyroid cancer
hsa-mir-138	anaplastic thyroid carcinoma
hsa-mir-138	breast cancer
hsa-mir-138	breast cancer
hsa-mir-138	cervical cancer
hsa-mir-138	chronic lymphocytic leukemia
hsa-mir-138	chronic myelogenous leukemia
hsa-mir-138	colorectal cancer
hsa-mir-138	esophageal cancer
hsa-mir-138	esophageal squamous cell carcinoma
hsa-mir-138	esophageal squamous cell carcinoma
hsa-mir-138	gastric cancer
hsa-mir-138	gastric cancer	down	miR-138 inhibits gastric cancer growth by s
hsa-mir-138	glioblastoma
hsa-mir-138	head and neck squamous cell carcinoma	down	MicroRNA-138 s
hsa-mir-138	head and neck squamous cell carcinoma	down	Role of microRNA-138 as a potential tumor s
hsa-mir-138	hepatocellular carcinoma
hsa-mir-138	hepatocellular carcinoma
hsa-mir-138	hepatocellular carcinoma
hsa-mir-138	hepatocellular carcinoma	down	miR-138 s
hsa-mir-138	hepatocellular carcinoma
hsa-mir-138	laryngeal carcinoma
hsa-mir-138	laryngeal squamous cell carcinoma	down	MicroRNA-138 s
hsa-mir-138	lung cancer	down	Up-regulation of microRNA-138 induce radiosensitization in lung cancer cells.
hsa-mir-138	lung cancer
hsa-mir-138	multiple myeloma
hsa-mir-138	nasopharyngeal carcinoma	down	MiR-138 s
hsa-mir-138	non-small cell lung cancer
hsa-mir-138	non-small cell lung cancer
hsa-mir-138	non-small cell lung cancer
hsa-mir-138	non-small cell lung cancer
hsa-mir-138	non-small cell lung cancer
hsa-mir-138	non-small cell lung cancer	down	MicroRNA-138 acts as a tumor s
hsa-mir-138	non-small cell lung cancer	down	HOXA4-regulated miR-138 s
hsa-mir-138	non-small cell lung cancer
hsa-mir-138	oral squamous cell carcinoma	down	miR-138 s
hsa-mir-138	oral squamous cell carcinoma	down	In situ measurement of miR-138 expression in oral squamous cell carcinoma tissue s
hsa-mir-138	osteosarcoma	down	MicroRNA-138 functions as a tumor s
hsa-mir-138	osteosarcoma	down	MiR-138 Acts as a Tumor S
hsa-mir-138	ovarian cancer	down	MicroRNA-138 s
hsa-mir-138	papillary thyroid carcinoma
hsa-mir-138	papillary thyroid carcinoma
hsa-mir-138	prostate cancer
hsa-mir-138	renal cell carcinoma
hsa-mir-138	renal cell carcinoma
hsa-mir-138	renal cell carcinoma	down	MicroRNA-138 s
hsa-mir-138	renal clear cell carcinoma	down	MiR-138 s
hsa-mir-138	small cell lung cancer
hsa-mir-138-5p	bladder cancer
hsa-mir-138-5p	cervical cancer
hsa-mir-138-5p	colorectal cancer	down	The tumor s
hsa-mir-138-5p	nasopharyngeal carcinoma
hsa-mir-138-5p	pancreatic cancer	down	miR-138-5p s
hsa-mir-138-5p	retinoblastoma	down	Mir-138-5p acts as a tumor s
hsa-mir-139	breast cancer
hsa-mir-139	colorectal cancer	down	Regulation of RAP1B by miR-139 s
hsa-mir-139	colorectal cancer	down	Gene module based regulator inference identifying miR-139 as a tumor s
hsa-mir-139	colorectal carcinoma	down	Regulation of RAP1B by miR-139 s
hsa-mir-139	glioma
hsa-mir-139	hepatocellular carcinoma	down	The microRNA miR-139 s
hsa-mir-139	hepatocellular carcinoma
hsa-mir-139	hepatocellular carcinoma
hsa-mir-139	hepatocellular carcinoma
hsa-mir-139	hepatocellular carcinoma	down	MicroRNA-139 s
hsa-mir-139	medulloblastoma
hsa-mir-139	non-small cell lung cancer
hsa-mir-139	osteosarcoma
hsa-mir-139	papillary thyroid carcinoma
hsa-mir-139	prostate cancer
hsa-mir-139-3p	colorectal cancer
hsa-mir-139-3p	colorectal cancer
hsa-mir-139-3p	head and neck cancer
hsa-mir-139-3p	hepatocellular carcinoma	down	MicroRNA-139-3p s
hsa-mir-139-3p	laryngeal cancer
hsa-mir-139-5p	adrenal cortical carcinoma
hsa-mir-139-5p	basal cell carcinoma
hsa-mir-139-5p	bladder cancer
hsa-mir-139-5p	breast cancer
hsa-mir-139-5p	colorectal cancer
hsa-mir-139-5p	colorectal cancer
hsa-mir-139-5p	colorectal cancer
hsa-mir-139-5p	colorectal cancer
hsa-mir-139-5p	endometrial cancer	down	Tumor-s
hsa-mir-139-5p	gallbladder carcinoma
hsa-mir-139-5p	gastric cancer
hsa-mir-139-5p	glioblastoma	down	miR-139-5p s
hsa-mir-139-5p	glioma
hsa-mir-139-5p	glioma	down	MicroRNA-139-5p acts as a tumor s
hsa-mir-139-5p	hepatocellular carcinoma	down	Up-regulation of SNHG6 activates SERPINH1 expression by competitive binding to miR-139-5p to promote hepatocellular carcinoma progression.
hsa-mir-139-5p	hepatocellular carcinoma
hsa-mir-139-5p	nasopharyngeal carcinoma
hsa-mir-139-5p	non-small cell lung cancer
hsa-mir-139-5p	non-small cell lung cancer
hsa-mir-139-5p	oral squamous cell carcinoma
hsa-mir-139-5p	osteosarcoma	down	MiR-139-5p s
hsa-mir-139-5p	ovarian cancer
hsa-mir-139-5p	prostate cancer
hsa-mir-139-5p	prostate cancer
hsa-mir-140	breast cancer
hsa-mir-140	colorectal cancer
hsa-mir-140	colorectal cancer
hsa-mir-140	esophageal cancer
hsa-mir-140	gastric cancer	down	MicroRNA-140 Inhibits Cell Proliferation in Gastric Cancer Cell Line HGC-27 by S
hsa-mir-140	non-small cell lung cancer
hsa-mir-140	non-small cell lung cancer	down	miR-140 S
hsa-mir-140	osteosarcoma	down	MicroRNA-140 s
hsa-mir-140	prostate cancer
hsa-mir-140	uveal melanoma
hsa-mir-140-3p	basal cell carcinoma
hsa-mir-140-3p	breast cancer
hsa-mir-140-3p	chordoma
hsa-mir-140-3p	chordoma
hsa-mir-140-3p	non-small cell lung cancer	down	MiR-140-3p s
hsa-mir-140-5p	breast cancer
hsa-mir-140-5p	breast cancer	down	Analysis of miRNA-mRNA network reveals miR-140-5p as a s
hsa-mir-140-5p	breast cancer
hsa-mir-140-5p	cervical cancer	down	Up-regulated lncRNA XIST contributes to progression of cervical cancer via regulating miR-140-5p and ORC1.
hsa-mir-140-5p	chronic myelogenous leukemia
hsa-mir-140-5p	colorectal cancer	down	Inhibition of colorectal cancer stem cell survival and invasive potential by hsa-miR-140-5p mediated s
hsa-mir-140-5p	colorectal carcinoma
hsa-mir-140-5p	gastric cancer	down	MicroRNA-140-5p s
hsa-mir-140-5p	glioma
hsa-mir-140-5p	hepatocellular carcinoma
hsa-mir-140-5p	hepatocellular carcinoma	down	MicroRNA-140-5p s
hsa-mir-140-5p	hepatocellular carcinoma
hsa-mir-140-5p	hypopharyngeal carcinoma
hsa-mir-140-5p	hypopharyngeal squamous cell carcinoma	down	MicroR-140-5p s
hsa-mir-140-5p	liver cancer	down	MicroRNA-140-5p s
hsa-mir-140-5p	non-small cell lung cancer
hsa-mir-140-5p	oral squamous cell carcinoma
hsa-mir-140-5p	ovarian cancer
hsa-mir-140-5p	retinoblastoma	down	MiR-140-5p s
hsa-mir-141	bladder cancer
hsa-mir-141	bladder cancer
hsa-mir-141	breast cancer
hsa-mir-141	breast cancer
hsa-mir-141	cervical cancer
hsa-mir-141	colon cancer
hsa-mir-141	colorectal cancer
hsa-mir-141	colorectal cancer
hsa-mir-141	colorectal cancer
hsa-mir-141	colorectal cancer	down	MiR-200 s
hsa-mir-141	colorectal cancer
hsa-mir-141	colorectal cancer
hsa-mir-141	esophageal cancer
hsa-mir-141	esophageal squamous cell carcinoma
hsa-mir-141	gastric cancer
hsa-mir-141	gastric cancer	down	miR-141 s
hsa-mir-141	gastric cancer
hsa-mir-141	gastric cancer
hsa-mir-141	gastric cancer
hsa-mir-141	glioma
hsa-mir-141	glioma
hsa-mir-141	glioma	down	MiR-200c and miR-141 inhibit ZEB1 synergistically and s
hsa-mir-141	head and neck squamous cell carcinoma	down	MicroRNA-141 s
hsa-mir-141	hepatocellular carcinoma
hsa-mir-141	hepatocellular carcinoma	down	miR-141 s
hsa-mir-141	hepatocellular carcinoma
hsa-mir-141	lung adenocarcinoma
hsa-mir-141	lung adenocarcinoma
hsa-mir-141	lung cancer
hsa-mir-141	malignant melanoma
hsa-mir-141	mesenchymal cancer
hsa-mir-141	nasopharyngeal carcinoma
hsa-mir-141	non-small cell lung cancer	down	Inhibition of miR-141 reverses cisplatin resistance in non-small cell lung cancer cells via
hsa-mir-141	non-small cell lung cancer
hsa-mir-141	non-small cell lung cancer
hsa-mir-141	non-small cell lung cancer
hsa-mir-141	oral cancer
hsa-mir-141	osteosarcoma	down	Tumor-S
hsa-mir-141	ovarian cancer
hsa-mir-141	ovarian cancer
hsa-mir-141	ovarian cancer
hsa-mir-141	prostate cancer
hsa-mir-141	prostate cancer
hsa-mir-141	prostate cancer	down	Re: MicroRNA-141 S
hsa-mir-141	prostate cancer
hsa-mir-141	prostate cancer	down	MicroRNA-141 s
hsa-mir-141	renal cell carcinoma
hsa-mir-141	renal clear cell carcinoma
hsa-mir-141	thyroid cancer
hsa-mir-141-3p	esophageal squamous cell carcinoma
hsa-mir-141-3p	gastric cancer	down	MiR-141-3p s
hsa-mir-141-3p	gastric cancer
hsa-mir-141-3p	glioblastoma
hsa-mir-141-3p	glioma	down	miR-141-3p functions as a tumor s
hsa-mir-141-3p	hepatocellular carcinoma
hsa-mir-141-3p	hepatocellular carcinoma
hsa-mir-141-3p	non-small cell lung cancer	down	MiR-141-3p functions as a tumor s
hsa-mir-141-3p	osteosarcoma	down	miR-141-3p s
hsa-mir-141-3p	prostate cancer
hsa-mir-141-3p	prostate cancer
hsa-mir-142	breast cancer
hsa-mir-142	endometrial cancer	down	miR-142 S
hsa-mir-142	hepatocellular carcinoma
hsa-mir-142	hepatocellular carcinoma
hsa-mir-142	nasopharyngeal carcinoma
hsa-mir-142-3p	acute lymphoblastic leukemia
hsa-mir-142-3p	acute myeloid leukemia	down	Upregulation of miR-142-3p Improves Drug Sensitivity of Acute Myelogenous Leukemia through Reducing P-Glycoprotein and Repressing Autophagy by Targeting HMGB1.
hsa-mir-142-3p	breast cancer
hsa-mir-142-3p	colorectal cancer
hsa-mir-142-3p	colorectal cancer
hsa-mir-142-3p	colorectal cancer	down	miR-142-3p S
hsa-mir-142-3p	colorectal cancer
hsa-mir-142-3p	gastric cancer
hsa-mir-142-3p	gastric cancer	down	Downregulation of microRNA-142-3p and its tumor s
hsa-mir-142-3p	glioblastoma
hsa-mir-142-3p	hepatocellular carcinoma
hsa-mir-142-3p	hepatocellular carcinoma
hsa-mir-142-3p	hepatocellular carcinoma
hsa-mir-142-3p	hepatocellular carcinoma
hsa-mir-142-3p	hepatocellular carcinoma
hsa-mir-142-3p	mantle cell lymphoma
hsa-mir-142-3p	nasopharyngeal carcinoma
hsa-mir-142-3p	nasopharyngeal carcinoma
hsa-mir-142-3p	non-small cell lung cancer
hsa-mir-142-3p	non-small cell lung cancer
hsa-mir-142-3p	non-small cell lung cancer	down	MiR-142-3p functions as a potential tumor s
hsa-mir-142-3p	oral squamous cell carcinoma
hsa-mir-142-3p	osteosarcoma	down	MiR-142-3p Functions as a Potential Tumor S
hsa-mir-142-3p	ovarian cancer
hsa-mir-142-5p	clear cell renal cell cancer
hsa-mir-142-5p	colorectal cancer
hsa-mir-142-5p	colorectal cancer
hsa-mir-142-5p	colorectal cancer
hsa-mir-142-5p	hepatocellular carcinoma
hsa-mir-142-5p	intrahepatic cholangiocarcinoma
hsa-mir-142-5p	lung cancer	down	Uncovering growth-s
hsa-mir-142-5p	malt lymphoma
hsa-mir-142-5p	mantle cell lymphoma
hsa-mir-142-5p	non-small cell lung cancer	down	MiR-142-5p S
hsa-mir-142-5p	non-small cell lung cancer
hsa-mir-142-5p	osteosarcoma
hsa-mir-142-5p	pancreatic cancer
hsa-mir-142-5p	renal cell carcinoma
hsa-mir-143	acute myeloid leukemia
hsa-mir-143	bladder cancer
hsa-mir-143	bladder cancer
hsa-mir-143	bladder cancer	down	MicroRNA-143 as a tumor s
hsa-mir-143	bladder cancer	down	MicroRNA-143 functions as a tumor s
hsa-mir-143	bladder cancer
hsa-mir-143	bladder cancer
hsa-mir-143	breast cancer
hsa-mir-143	breast cancer
hsa-mir-143	breast cancer	down	miR-143 s
hsa-mir-143	breast cancer
hsa-mir-143	cervical cancer
hsa-mir-143	cervical cancer
hsa-mir-143	cervical cancer
hsa-mir-143	colon cancer
hsa-mir-143	colon cancer
hsa-mir-143	colon cancer
hsa-mir-143	colon cancer	down	Overexpression of miRNA-143 Inhibits Colon Cancer Cell Proliferation by Inhibiting Glucose Uptake.
hsa-mir-143	colon cancer
hsa-mir-143	colorectal cancer
hsa-mir-143	colorectal cancer
hsa-mir-143	colorectal cancer
hsa-mir-143	colorectal cancer
hsa-mir-143	colorectal cancer
hsa-mir-143	colorectal cancer
hsa-mir-143	colorectal cancer
hsa-mir-143	colorectal cancer
hsa-mir-143	colorectal cancer	down	The regulation of Toll-like receptor 2 by miR-143 s
hsa-mir-143	colorectal carcinoma
hsa-mir-143	colorectal carcinoma
hsa-mir-143	colorectal carcinoma	down	Altered levels of the onco-microRNA 21 and the tumor-s
hsa-mir-143	endometrial cancer
hsa-mir-143	endometrial cancer
hsa-mir-143	esophageal cancer
hsa-mir-143	esophageal squamous cell carcinoma	down	MicroRNA-143 functions as a tumor s
hsa-mir-143	esophageal squamous cell carcinoma
hsa-mir-143	esophageal squamous cell carcinoma
hsa-mir-143	esophageal squamous cell carcinoma
hsa-mir-143	gastric cancer	down	MicroRNA-143 s
hsa-mir-143	gastric cancer
hsa-mir-143	gastric cancer
hsa-mir-143	gastric cancer	down	miR-143 and miR-145 inhibit gastric cancer cell migration and metastasis by s
hsa-mir-143	gastric cancer
hsa-mir-143	gastric cancer
hsa-mir-143	gastric cancer
hsa-mir-143	gastric cancer	down	Synthetic miR-143 Inhibits Growth of HER2-Positive Gastric Cancer Cells by S
hsa-mir-143	glioblastoma
hsa-mir-143	glioblastoma
hsa-mir-143	glioblastoma
hsa-mir-143	glioma
hsa-mir-143	hepatocellular carcinoma
hsa-mir-143	hepatocellular carcinoma
hsa-mir-143	hepatocellular carcinoma
hsa-mir-143	lung cancer
hsa-mir-143	lung cancer
hsa-mir-143	malignant melanoma
hsa-mir-143	nasopharyngeal carcinoma
hsa-mir-143	nasopharyngeal carcinoma	down	Identification of miR-143 as a tumour s
hsa-mir-143	nasopharyngeal carcinoma	down	Upregulated microRNA-143 inhibits cell proliferation in human nasopharyngeal carcinoma.
hsa-mir-143	nasopharyngeal carcinoma
hsa-mir-143	non-small cell lung cancer	down	miR-143 s
hsa-mir-143	non-small cell lung cancer
hsa-mir-143	non-small cell lung cancer
hsa-mir-143	oral squamous cell carcinoma	down	Decreased microRNA-143 expression and its tumor s
hsa-mir-143	oral squamous cell carcinoma
hsa-mir-143	osteosarcoma
hsa-mir-143	pancreatic ductal adenocarcinoma
hsa-mir-143	prostate cancer	down	miR-143 decreases prostate cancer cells proliferation and migration and enhances their sensitivity to docetaxel through s
hsa-mir-143	prostate cancer
hsa-mir-143	prostate cancer	down	The tumor-s
hsa-mir-143	prostate cancer
hsa-mir-143	prostate cancer	down	Cell-type specific expression of oncogenic and tumor s
hsa-mir-143	renal cell carcinoma	down	The tumor-s
hsa-mir-143	retinoblastoma	down	S
hsa-mir-143-3p	breast cancer	down	miR-143-3p targeting LIM domain kinase 1 s
hsa-mir-143-3p	cervical cancer
hsa-mir-143-3p	colorectal cancer	down	MicroRNA-143-3p s
hsa-mir-143-3p	colorectal cancer
hsa-mir-143-3p	gallbladder carcinoma	down	miR-143-3p targeting of ITGA6 s
hsa-mir-143-3p	malignant melanoma
hsa-mir-143-3p	ovarian cancer	down	MiR-143-3p s
hsa-mir-144	acute lymphoblastic leukemia
hsa-mir-144	bladder cancer
hsa-mir-144	breast cancer	down	miR-144 functions as a tumor s
hsa-mir-144	cervical cancer
hsa-mir-144	cholangiocarcinoma	down	MicroRNA-144 s
hsa-mir-144	esophageal squamous cell carcinoma
hsa-mir-144	gastric cancer	down	MicroRNA-144 functions as a tumor s
hsa-mir-144	gastric cancer
hsa-mir-144	gastric cancer
hsa-mir-144	gastric cancer	down	miR-144 s
hsa-mir-144	hepatocellular carcinoma
hsa-mir-144	hepatocellular carcinoma
hsa-mir-144	hepatocellular carcinoma	down	miR-144 s
hsa-mir-144	laryngeal squamous cell carcinoma	down	miR-144 s
hsa-mir-144	lung cancer
hsa-mir-144	lung cancer
hsa-mir-144	medullary thyroid carcinoma
hsa-mir-144	non-small cell lung cancer	down	A novel circular RNA hsa_circ_0020123 exerts oncogenic properties through s
hsa-mir-144	oral squamous cell carcinoma
hsa-mir-144	osteosarcoma
hsa-mir-144	osteosarcoma	down	MicroRNA-144 s
hsa-mir-144	osteosarcoma	down	MiR-144 Inhibits Tumor Growth and Metastasis in Osteosarcoma via Dual-s
hsa-mir-144	ovarian cancer
hsa-mir-144	pancreatic ductal adenocarcinoma
hsa-mir-144	papillary thyroid carcinoma
hsa-mir-144	renal cell carcinoma
hsa-mir-144	thyroid cancer
hsa-mir-144	uveal melanoma
hsa-mir-144-3p	gastric cancer	down	MicroRNA-144-3p s
hsa-mir-144-3p	glioma
hsa-mir-144-3p	glioma
hsa-mir-144-3p	hepatocellular carcinoma	down	MicroRNA-144-3p s
hsa-mir-144-3p	hepatocellular carcinoma
hsa-mir-144-3p	multiple myeloma
hsa-mir-144-3p	neuroblastoma	down	microRNA-144-3p s
hsa-mir-144-3p	osteosarcoma	down	TUG1 promotes osteosarcoma tumorigenesis by
hsa-mir-144-3p	papillary thyroid carcinoma
hsa-mir-144-3p	prostate cancer
hsa-mir-144-3p	renal cell carcinoma	down	miR-144-3p serves as a tumor s
hsa-mir-145	basal cell carcinoma
hsa-mir-145	bladder cancer
hsa-mir-145	bladder cancer
hsa-mir-145	bladder cancer	down	MicroRNA-143 functions as a tumor s
hsa-mir-145	bladder cancer
hsa-mir-145	bladder cancer
hsa-mir-145	bladder cancer
hsa-mir-145	bladder cancer
hsa-mir-145	breast cancer
hsa-mir-145	breast cancer
hsa-mir-145	breast cancer
hsa-mir-145	breast cancer
hsa-mir-145	breast cancer
hsa-mir-145	breast cancer
hsa-mir-145	breast cancer
hsa-mir-145	breast cancer
hsa-mir-145	cervical cancer
hsa-mir-145	cervical cancer
hsa-mir-145	cervical cancer
hsa-mir-145	cervical cancer
hsa-mir-145	cervical carcinoma
hsa-mir-145	chondrosarcoma
hsa-mir-145	colon cancer	down	Putative tumor s
hsa-mir-145	colon cancer
hsa-mir-145	colon cancer
hsa-mir-145	colon cancer
hsa-mir-145	colon cancer	down	Epigenetically regulated miR-145 s
hsa-mir-145	colon cancer
hsa-mir-145	colon cancer	down	Inhibition of SW620 human colon cancer cells by
hsa-mir-145	colorectal cancer
hsa-mir-145	colorectal cancer
hsa-mir-145	colorectal cancer
hsa-mir-145	colorectal cancer
hsa-mir-145	colorectal cancer
hsa-mir-145	colorectal cancer
hsa-mir-145	colorectal cancer	down	MicroRNA-145 s
hsa-mir-145	colorectal cancer
hsa-mir-145	colorectal cancer
hsa-mir-145	colorectal cancer	down	miR-145 s
hsa-mir-145	colorectal cancer	down	microRNA-145 regulates tumor s
hsa-mir-145	colorectal cancer
hsa-mir-145	colorectal carcinoma	down	Altered levels of the onco-microRNA 21 and the tumor-s
hsa-mir-145	endometrial cancer
hsa-mir-145	endometrial cancer
hsa-mir-145	esophageal cancer	down	miR-145 targets the SOX11 3'UTR to s
hsa-mir-145	esophageal cancer
hsa-mir-145	esophageal cancer
hsa-mir-145	esophageal squamous cell carcinoma	down	MicroRNA-143 functions as a tumor s
hsa-mir-145	esophageal squamous cell carcinoma
hsa-mir-145	esophageal squamous cell carcinoma
hsa-mir-145	esophageal squamous cell carcinoma
hsa-mir-145	esophageal squamous cell carcinoma	down	MicroRNA-145 performs as a tumor s
hsa-mir-145	gallbladder carcinoma
hsa-mir-145	gastric cancer
hsa-mir-145	gastric cancer	down	MicroRNA-145 exerts tumor-s
hsa-mir-145	gastric cancer	down	miR-143 and miR-145 inhibit gastric cancer cell migration and metastasis by s
hsa-mir-145	glioblastoma
hsa-mir-145	glioblastoma
hsa-mir-145	glioblastoma
hsa-mir-145	glioblastoma
hsa-mir-145	glioma
hsa-mir-145	glioma
hsa-mir-145	glioma
hsa-mir-145	hepatocellular carcinoma
hsa-mir-145	hepatocellular carcinoma	down	miR-145 s
hsa-mir-145	hepatocellular carcinoma
hsa-mir-145	hepatocellular carcinoma	down	MicroRNA-145 s
hsa-mir-145	hepatocellular carcinoma
hsa-mir-145	hepatocellular carcinoma
hsa-mir-145	hepatocellular carcinoma	down	MiR-145 s
hsa-mir-145	hepatocellular carcinoma
hsa-mir-145	hepatocellular carcinoma
hsa-mir-145	intrahepatic cholangiocarcinoma	down	MiR-145 functions as a tumor s
hsa-mir-145	kidney cancer	down	MicroRNA-145 Targets the Metalloprotease ADAM17 and Is S
hsa-mir-145	laryngeal squamous cell carcinoma
hsa-mir-145	laryngeal squamous cell carcinoma	down	Curcumin s
hsa-mir-145	laryngeal squamous cell carcinoma
hsa-mir-145	liver cancer	down	MiR-145 functions as a tumor s
hsa-mir-145	lung adenocarcinoma	down	Restoration of tumour s
hsa-mir-145	lung adenocarcinoma
hsa-mir-145	lung adenocarcinoma	down	microRNA-145 s
hsa-mir-145	lung adenocarcinoma
hsa-mir-145	lung adenocarcinoma
hsa-mir-145	lung adenocarcinoma	down	MiRNA-145 s
hsa-mir-145	lung cancer
hsa-mir-145	lung cancer	down	Uncovering growth-s
hsa-mir-145	lung cancer
hsa-mir-145	lung cancer
hsa-mir-145	lung cancer
hsa-mir-145	nasopharyngeal carcinoma
hsa-mir-145	nasopharyngeal carcinoma
hsa-mir-145	nasopharyngeal carcinoma
hsa-mir-145	non-small cell lung cancer
hsa-mir-145	non-small cell lung cancer
hsa-mir-145	non-small cell lung cancer	down	MiR-145 acts as a metastasis s
hsa-mir-145	non-small cell lung cancer
hsa-mir-145	non-small cell lung cancer
hsa-mir-145	non-small cell lung cancer
hsa-mir-145	non-small cell lung cancer	down	miR-145 and miR-497 s
hsa-mir-145	non-small cell lung cancer
hsa-mir-145	oral squamous cell carcinoma
hsa-mir-145	oral squamous cell carcinoma
hsa-mir-145	osteosarcoma
hsa-mir-145	osteosarcoma
hsa-mir-145	osteosarcoma
hsa-mir-145	osteosarcoma
hsa-mir-145	osteosarcoma	down	MicroRNA-145 S
hsa-mir-145	ovarian cancer
hsa-mir-145	ovarian cancer
hsa-mir-145	ovarian cancer
hsa-mir-145	ovarian cancer
hsa-mir-145	ovarian cancer	down	Quercetin induces the apoptosis of human ovarian carcinoma cells by
hsa-mir-145	ovarian cancer
hsa-mir-145	pancreatic adenocarcinoma
hsa-mir-145	pancreatic cancer	down	MiR-145 functions as a tumor s
hsa-mir-145	pancreatic ductal adenocarcinoma
hsa-mir-145	primary cns lymphomas
hsa-mir-145	prostate cancer
hsa-mir-145	prostate cancer
hsa-mir-145	prostate cancer	down	The tumor-s
hsa-mir-145	prostate cancer	down	miR-145 s
hsa-mir-145	renal cell carcinoma	down	The tumor-s
hsa-mir-145	retinoblastoma	down	miR-145 s
hsa-mir-145	uveal melanoma
hsa-mir-145-3p	non-small cell lung cancer
hsa-mir-145-5p	breast cancer	down	miR-145-5p S
hsa-mir-145-5p	colorectal cancer
hsa-mir-145-5p	gastric cancer
hsa-mir-145-5p	gastric cancer	down	MicroRNA-145-5p inhibits gastric cancer invasiveness through targeting N-cadherin and ZEB2 to s
hsa-mir-145-5p	gastric cancer
hsa-mir-145-5p	hepatocellular carcinoma	down	miR-145-5p Acts as a Novel Tumor S
hsa-mir-145-5p	laryngeal squamous cell carcinoma
hsa-mir-145-5p	malignant melanoma
hsa-mir-145-5p	non-small cell lung cancer
hsa-mir-1468	hepatocellular carcinoma
hsa-mir-1468-5p	glioma
hsa-mir-1469	lung cancer
hsa-mir-146a	breast cancer	down	Expression of microRNA-146 s
hsa-mir-146a	breast cancer
hsa-mir-146a	breast cancer
hsa-mir-146a	cervical cancer
hsa-mir-146a	chronic myelogenous leukemia
hsa-mir-146a	colon cancer
hsa-mir-146a	colorectal cancer
hsa-mir-146a	esophageal squamous cell carcinoma
hsa-mir-146a	gastric cancer
hsa-mir-146a	gastric cancer
hsa-mir-146a	gastric cancer
hsa-mir-146a	gastric cancer
hsa-mir-146a	gastric cancer
hsa-mir-146a	gastric cancer
hsa-mir-146a	gastric cancer	down	microRNA-146a targets the L1 cell adhesion molecule and s
hsa-mir-146a	gastric cancer
hsa-mir-146a	gastric cancer
hsa-mir-146a	glioma
hsa-mir-146a	glioma	down	Microglial SMAD4 regulated by microRNA-146a promotes migration of microglia which s
hsa-mir-146a	hepatocellular carcinoma	down	MiR-146a s
hsa-mir-146a	hepatocellular carcinoma
hsa-mir-146a	hepatocellular carcinoma
hsa-mir-146a	hepatocellular carcinoma
hsa-mir-146a	lung cancer
hsa-mir-146a	lung cancer
hsa-mir-146a	malignant melanoma
hsa-mir-146a	malignant melanoma
hsa-mir-146a	neuroblastoma
hsa-mir-146a	non-small cell lung cancer
hsa-mir-146a	non-small cell lung cancer
hsa-mir-146a	pancreatic cancer	down	miR-146a s
hsa-mir-146a	pancreatic cancer
hsa-mir-146a	papillary thyroid carcinoma
hsa-mir-146a	prostate cancer
hsa-mir-146a	prostate cancer	down	miR-146a functions as a tumor s
hsa-mir-146a	prostate cancer
hsa-mir-146a-5p	bladder cancer
hsa-mir-146a-5p	hepatocellular carcinoma
hsa-mir-146a-5p	non-small cell lung cancer
hsa-mir-146a-5p	non-small cell lung cancer	down	Transcriptomic studies provide insights into the tumor s
hsa-mir-146b	anaplastic thyroid carcinoma
hsa-mir-146b	anaplastic thyroid carcinoma
hsa-mir-146b	bladder cancer
hsa-mir-146b	breast cancer	down	Expression of microRNA-146 s
hsa-mir-146b	breast cancer
hsa-mir-146b	esophageal cancer
hsa-mir-146b	follicular thyroid carcinoma
hsa-mir-146b	gastric cancer
hsa-mir-146b	glioblastoma
hsa-mir-146b	glioma
hsa-mir-146b	malignant melanoma
hsa-mir-146b	non-small cell lung cancer
hsa-mir-146b	non-small cell lung cancer
hsa-mir-146b	papillary thyroid carcinoma
hsa-mir-146b	papillary thyroid carcinoma
hsa-mir-146b	papillary thyroid carcinoma
hsa-mir-146b	papillary thyroid carcinoma
hsa-mir-146b	papillary thyroid carcinoma
hsa-mir-146b	papillary thyroid carcinoma
hsa-mir-146b	primary thyroid lymphoma
hsa-mir-146b	prostate cancer	down	MicroRNA-146b acts as a potential tumor s
hsa-mir-146b	prostate cancer
hsa-mir-146b	thyroid cancer
hsa-mir-146b-3p	thyroid cancer
hsa-mir-146b-5p	gallbladder carcinoma
hsa-mir-146b-5p	gallbladder carcinoma
hsa-mir-146b-5p	glioblastoma	down	MiR-146b-5p s
hsa-mir-146b-5p	glioma
hsa-mir-146b-5p	hepatocellular carcinoma
hsa-mir-146b-5p	non-small cell lung cancer	down	MiR-146b-5p functions as a s
hsa-mir-146b-5p	osteosarcoma
hsa-mir-146b-5p	papillary thyroid carcinoma
hsa-mir-146b-5p	papillary thyroid carcinoma
hsa-mir-146b-5p	papillary thyroid carcinoma
hsa-mir-146b-5p	papillary thyroid carcinoma
hsa-mir-146b-5p	papillary thyroid carcinoma
hsa-mir-146b-5p	thyroid cancer
hsa-mir-147	breast cancer
hsa-mir-147	colon cancer
hsa-mir-147	gastric cancer
hsa-mir-147	gastric cancer
hsa-mir-147	hepatocellular carcinoma	down	MicroRNA-147 s
hsa-mir-147	non-small cell lung cancer
hsa-mir-147	oral squamous cell carcinoma
hsa-mir-147b	colorectal cancer
hsa-mir-147b	colorectal cancer
hsa-mir-147b	hepatocellular carcinoma
hsa-mir-148a	anaplastic thyroid carcinoma
hsa-mir-148a	bladder cancer
hsa-mir-148a	breast cancer
hsa-mir-148a	breast cancer
hsa-mir-148a	cervical squamous cell carcinoma
hsa-mir-148a	chordoma
hsa-mir-148a	colorectal cancer
hsa-mir-148a	colorectal cancer
hsa-mir-148a	colorectal cancer
hsa-mir-148a	colorectal cancer
hsa-mir-148a	esophageal squamous cell carcinoma	down	MicroRNA-148a regulates the MAPK/ERK signaling pathway and s
hsa-mir-148a	esophageal squamous cell carcinoma
hsa-mir-148a	gastric cancer
hsa-mir-148a	gastric cancer	down	MicroRNA-148a s
hsa-mir-148a	gastric cancer
hsa-mir-148a	gastric cancer	down	microRNA-148a s
hsa-mir-148a	gastric cancer
hsa-mir-148a	gastric cancer
hsa-mir-148a	gastric cancer	down	MiR-148a Functions as a Tumor S
hsa-mir-148a	gastric cancer	down	miR-148a s
hsa-mir-148a	gastric cancer
hsa-mir-148a	gastrointestinal cancer	down	MicroRNA-148b is frequently down-regulated in gastric cancer and acts as a tumor s
hsa-mir-148a	glioblastoma
hsa-mir-148a	glioma
hsa-mir-148a	hepatocellular carcinoma
hsa-mir-148a	hepatocellular carcinoma	down	MicroRNA-148a s
hsa-mir-148a	hepatocellular carcinoma
hsa-mir-148a	kidney cancer
hsa-mir-148a	laryngeal squamous cell carcinoma
hsa-mir-148a	lung adenocarcinoma
hsa-mir-148a	nasopharyngeal carcinoma
hsa-mir-148a	non-small cell lung cancer	down	MicroRNA-148a s
hsa-mir-148a	non-small cell lung cancer	down	Decreased miRNA-148a is associated with lymph node metastasis and poor clinical outcomes and functions as a s
hsa-mir-148a	non-small cell lung cancer
hsa-mir-148a	non-small cell lung cancer	down	MicroRNA-148a S
hsa-mir-148a	non-small cell lung cancer	down	MicroRNA-148a s
hsa-mir-148a	oral squamous cell carcinoma
hsa-mir-148a	osteosarcoma
hsa-mir-148a	ovarian cancer
hsa-mir-148a	ovarian cancer
hsa-mir-148a	ovarian cancer
hsa-mir-148a	pancreatic cancer
hsa-mir-148a	pancreatic ductal adenocarcinoma
hsa-mir-148a	pancreatic ductal adenocarcinoma
hsa-mir-148a	papillary thyroid carcinoma	down	Downregulation of cyclin-dependent kinase 8 by microRNA-148a s
hsa-mir-148a	renal cell carcinoma	down	miR-148a s
hsa-mir-148a-3p	bladder cancer
hsa-mir-148a-3p	esophageal cancer	down	miR-148a-3p S
hsa-mir-148a-3p	non-small cell lung cancer
hsa-mir-148b	colorectal cancer	down	MicroRNA-148b s
hsa-mir-148b	endometrial cancer	down	MiR-148b functions as a tumor s
hsa-mir-148b	gastric cancer	down	MicroRNA-148b is frequently down-regulated in gastric cancer and acts as a tumor s
hsa-mir-148b	hepatocellular carcinoma
hsa-mir-148b	hepatocellular carcinoma	down	MiR-148b s
hsa-mir-148b	hepatocellular carcinoma
hsa-mir-148b	hepatocellular carcinoma
hsa-mir-148b	liver cancer	down	microRNA-148b s
hsa-mir-148b	lung cancer	down	Restoration of BRG1 inhibits proliferation and metastasis of lung cancer by regulating tumor s
hsa-mir-148b	non-small cell lung cancer	down	miR-148b functions as a tumor s
hsa-mir-148b	non-small cell lung cancer
hsa-mir-148b	non-small cell lung cancer
hsa-mir-148b	non-small cell lung cancer
hsa-mir-148b	non-small cell lung cancer
hsa-mir-148b	ovarian cancer
hsa-mir-148b	ovarian carcinoma
hsa-mir-148b	pancreatic cancer	down	miR-148b functions as a tumor s
hsa-mir-148b	pancreatic cancer	down	MicroRNA-148b and microRNA-152 reactivate tumor s
hsa-mir-148b-3p	breast cancer
hsa-mir-148b-3p	gastric cancer
hsa-mir-148b-3p	gastrointestinal stromal tumor	down	miR-148b-3p functions as a tumor s
hsa-mir-148b-3p	glioma
hsa-mir-148b-3p	renal cell carcinoma
hsa-mir-149	breast cancer	down	MicroRNA-149 targets GIT1 to s
hsa-mir-149	colorectal cancer	down	MicroRNA-149 S
hsa-mir-149	colorectal cancer
hsa-mir-149	gastric cancer
hsa-mir-149	glioblastoma
hsa-mir-149	head and neck squamous cell carcinoma
hsa-mir-149	hepatocellular carcinoma
hsa-mir-149	nasopharyngeal carcinoma
hsa-mir-149	neuroblastoma
hsa-mir-149	non-small cell lung cancer
hsa-mir-149	non-small cell lung cancer	down	miR-149 s
hsa-mir-149	ovarian cancer	down	MicroRNA-149 s
hsa-mir-149	renal cell carcinoma
hsa-mir-149*	colorectal cancer
hsa-mir-149-3p	gastric cancer
hsa-mir-149-3p	gastric cancer	down	18?-glycyrrhetinic acid s
hsa-mir-149-3p	non-small cell lung cancer
hsa-mir-149-5p	osteosarcoma
hsa-mir-150	adult t-cell leukemia
hsa-mir-150	breast cancer
hsa-mir-150	breast cancer
hsa-mir-150	Burkitt lymphoma
hsa-mir-150	cervical cancer
hsa-mir-150	chronic lymphocytic leukemia
hsa-mir-150	chronic myelogenous leukemia
hsa-mir-150	colorectal cancer
hsa-mir-150	colorectal cancer
hsa-mir-150	colorectal cancer
hsa-mir-150	colorectal cancer
hsa-mir-150	cutaneous t-cell lymphoma	down	Histone deacetylase inhibitors inhibit metastasis by restoring a tumor s
hsa-mir-150	esophageal cancer
hsa-mir-150	esophageal squamous cell carcinoma
hsa-mir-150	gastric cancer
hsa-mir-150	hepatocellular carcinoma
hsa-mir-150	hepatocellular carcinoma	down	MicroRNA-150 s
hsa-mir-150	intrahepatic cholangiocarcinoma	down	Upregulated circulating miR-150 is associated with the risk of intrahepatic cholangiocarcinoma.
hsa-mir-150	lung adenocarcinoma
hsa-mir-150	lung cancer
hsa-mir-150	malignant melanoma
hsa-mir-150	malignant melanoma	down	MiR-150 s
hsa-mir-150	mantle cell lymphoma
hsa-mir-150	non-small cell lung cancer
hsa-mir-150	non-small cell lung cancer
hsa-mir-150	non-small cell lung cancer
hsa-mir-150	non-small cell lung cancer
hsa-mir-150	osteosarcoma	down	MicroRNA-150 functions as a tumor s
hsa-mir-150	osteosarcoma
hsa-mir-150	osteosarcoma
hsa-mir-150	osteosarcoma
hsa-mir-150	ovarian cancer
hsa-mir-150	pancreatic cancer
hsa-mir-150	pancreatic ductal adenocarcinoma
hsa-mir-150	pancreatic ductal adenocarcinoma
hsa-mir-150	prostate cancer
hsa-mir-150*	colorectal cancer
hsa-mir-150*	pancreatic cancer	down	Upregulation of miR-150* and miR-630 Induces Apoptosis in Pancreatic Cancer Cells by Targeting IGF-1R.
hsa-mir-150-3p	esophageal squamous cell carcinoma
hsa-mir-150-3p	head and neck squamous cell carcinoma
hsa-mir-150-5p	acute myeloid leukemia
hsa-mir-150-5p	breast cancer
hsa-mir-150-5p	colonic adenocarcinoma
hsa-mir-150-5p	colorectal cancer	down	miR-150-5p s
hsa-mir-150-5p	colorectal cancer	down	MiR-150-5p S
hsa-mir-150-5p	colorectal cancer
hsa-mir-150-5p	esophageal squamous cell carcinoma
hsa-mir-150-5p	glioma	down	miR-150-5p and miR-133a s
hsa-mir-150-5p	head and neck squamous cell carcinoma
hsa-mir-150-5p	hepatocellular carcinoma
hsa-mir-150-5p	nasopharyngeal carcinoma
hsa-mir-150-5p	non-small cell lung cancer
hsa-mir-150-5p	pancreatic cancer
hsa-mir-151	chronic myelogenous leukemia
hsa-mir-151-3p	osteosarcoma
hsa-mir-151-5p	gastric cancer
hsa-mir-151-5p	papillary thyroid carcinoma
hsa-mir-151a-3p	esophageal adenocarcinoma
hsa-mir-151a-5p	colorectal cancer
hsa-mir-152	breast cancer
hsa-mir-152	cervical cancer
hsa-mir-152	colorectal cancer
hsa-mir-152	colorectal cancer	down	miR-152 functions as a tumor s
hsa-mir-152	endometrial cancer
hsa-mir-152	endometrial cancer	down	miR-152 inhibits proliferation of human endometrial cancer cells via inducing G2/M phase arrest by s
hsa-mir-152	endometrial cancer	down	miR-152 is a tumor s
hsa-mir-152	gastric cancer	down	miR-152 s
hsa-mir-152	gastrointestinal cancer	down	MicroRNA-148b is frequently down-regulated in gastric cancer and acts as a tumor s
hsa-mir-152	gastrointestinal stromal tumor
hsa-mir-152	glioblastoma	down	MiR-152 functions as a tumor s
hsa-mir-152	glioma
hsa-mir-152	hepatocellular carcinoma
hsa-mir-152	multiple myeloma
hsa-mir-152	nasopharyngeal carcinoma	down	MiR-152 functioning as a tumor s
hsa-mir-152	non-small cell lung cancer
hsa-mir-152	non-small cell lung cancer	down	MicroRNA-152 targets ADAM17 to s
hsa-mir-152	osteosarcoma	down	MicroRNA-152 S
hsa-mir-152	osteosarcoma
hsa-mir-152	ovarian cancer
hsa-mir-152	ovarian cancer
hsa-mir-152	pancreatic cancer	down	MicroRNA-148b and microRNA-152 reactivate tumor s
hsa-mir-152	prostate cancer
hsa-mir-152-3p	glioblastoma
hsa-mir-152-3p	hepatocellular carcinoma	down	Function of MiR-152 As a Tumor S
hsa-mir-152-3p	hepatocellular carcinoma
hsa-mir-152-3p	malignant melanoma
hsa-mir-152-3p	prostate cancer
hsa-mir-153	breast cancer
hsa-mir-153	breast cancer
hsa-mir-153	breast cancer
hsa-mir-153	colon cancer	down	miR-153 s
hsa-mir-153	esophageal squamous cell carcinoma
hsa-mir-153	gastric cancer	down	MicroRNA-153 functions as a tumor s
hsa-mir-153	gastric cancer
hsa-mir-153	glioblastoma	down	MicroRNA-153 is tumor s
hsa-mir-153	glioblastoma
hsa-mir-153	glioblastoma	down	MiR-153 as a Tumor S
hsa-mir-153	glioma	down	MicroRNA-153 s
hsa-mir-153	hepatocellular carcinoma
hsa-mir-153	hepatocellular carcinoma
hsa-mir-153	laryngeal squamous cell carcinoma
hsa-mir-153	laryngeal squamous cell carcinoma	down	MicroRNA-153 s
hsa-mir-153	lung cancer	down	S
hsa-mir-153	non-small cell lung cancer
hsa-mir-153	osteosarcoma
hsa-mir-153	osteosarcoma
hsa-mir-153	ovarian cancer	down	MicroRNA-153 functions as a tumor s
hsa-mir-153	prostate cancer
hsa-mir-153-3p	acute lymphoblastic leukemia	down	miR-153-3p S
hsa-mir-153-3p	glioma
hsa-mir-153-3p	malignant melanoma	down	MicroRNA-153-3p s
hsa-mir-154	breast cancer
hsa-mir-154	colorectal cancer	down	miR-154 s
hsa-mir-154	gastric cancer
hsa-mir-154	gastric cancer
hsa-mir-154	glioma
hsa-mir-154	hepatocellular carcinoma	down	miR-154 targeting ZEB2 in hepatocellular carcinoma functions as a potential tumor s
hsa-mir-154	malignant melanoma
hsa-mir-154	non-small cell lung cancer
hsa-mir-154	non-small cell lung cancer
hsa-mir-154	non-small cell lung cancer	down	miR-154 s
hsa-mir-154	non-small cell lung cancer	down	MicroRNA-154 functions as a tumor s
hsa-mir-154	non-small cell lung cancer	down	MicroRNA-154 functions as a tumor s
hsa-mir-154	osteosarcoma	down	MicroRNA-154 functions as a tumor s
hsa-mir-154	prostate cancer
hsa-mir-154-5p	breast cancer
hsa-mir-154-5p	glioblastoma
hsa-mir-155	acute myeloid leukemia
hsa-mir-155	acute myeloid leukemia
hsa-mir-155	acute myeloid leukemia
hsa-mir-155	acute myeloid leukemia
hsa-mir-155	anaplastic large-cell lymphoma
hsa-mir-155	bladder cancer
hsa-mir-155	bladder cancer
hsa-mir-155	bladder cancer
hsa-mir-155	bladder cancer
hsa-mir-155	breast cancer
hsa-mir-155	breast cancer
hsa-mir-155	breast cancer
hsa-mir-155	breast cancer
hsa-mir-155	breast cancer
hsa-mir-155	breast cancer
hsa-mir-155	breast cancer
hsa-mir-155	breast cancer
hsa-mir-155	breast cancer
hsa-mir-155	breast cancer
hsa-mir-155	breast cancer
hsa-mir-155	cervical cancer
hsa-mir-155	chronic lymphocytic leukemia
hsa-mir-155	chronic lymphocytic leukemia
hsa-mir-155	chronic lymphocytic leukemia
hsa-mir-155	chronic myelogenous leukemia
hsa-mir-155	clear cell renal cell cancer
hsa-mir-155	colon cancer
hsa-mir-155	colorectal cancer
hsa-mir-155	colorectal cancer	down	MicroRNA-155 acts as a tumor s
hsa-mir-155	colorectal cancer
hsa-mir-155	cutaneous t-cell lymphoma
hsa-mir-155	diffuse large B-cell lymphoma
hsa-mir-155	endometrial cancer
hsa-mir-155	esophageal cancer
hsa-mir-155	gallbladder carcinoma
hsa-mir-155	gastric cancer
hsa-mir-155	gastric cancer
hsa-mir-155	gastric cancer
hsa-mir-155	glioma
hsa-mir-155	glioma
hsa-mir-155	glioma
hsa-mir-155	hepatocellular carcinoma
hsa-mir-155	hepatocellular carcinoma
hsa-mir-155	hepatocellular carcinoma
hsa-mir-155	hepatocellular carcinoma
hsa-mir-155	hepatocellular carcinoma
hsa-mir-155	laryngeal squamous cell carcinoma
hsa-mir-155	laryngeal squamous cell carcinoma
hsa-mir-155	liver cancer
hsa-mir-155	lung adenocarcinoma
hsa-mir-155	lung cancer
hsa-mir-155	lung cancer
hsa-mir-155	malignant melanoma
hsa-mir-155	malignant melanoma
hsa-mir-155	malt lymphoma
hsa-mir-155	mantle cell lymphoma
hsa-mir-155	nasopharyngeal carcinoma
hsa-mir-155	nasopharyngeal carcinoma
hsa-mir-155	nasopharyngeal carcinoma
hsa-mir-155	non-small cell lung cancer
hsa-mir-155	non-small cell lung cancer
hsa-mir-155	ovarian cancer	down	MicroRNA-155 is a novel s
hsa-mir-155	papillary thyroid carcinoma
hsa-mir-155	papillary thyroid carcinoma
hsa-mir-155	prostate cancer
hsa-mir-155	rectal carcinoma
hsa-mir-155	renal clear cell carcinoma
hsa-mir-155	squamous carcinoma
hsa-mir-155	uveal melanoma
hsa-mir-155	waldenstrom's macroglobulinemia
hsa-mir-155	waldenstrom's macroglobulinemia
hsa-mir-155-3p	breast cancer	down	MiR-155-3p acts as a tumor s
hsa-mir-155-3p	hepatocellular carcinoma
hsa-mir-155-5p	cervical cancer
hsa-mir-155-5p	cervical cancer
hsa-mir-155-5p	gastric cancer	down	The tumor s
hsa-mir-155-5p	hepatocellular carcinoma
hsa-mir-15a	breast cancer
hsa-mir-15a	cervical carcinoma
hsa-mir-15a	chronic lymphocytic leukemia
hsa-mir-15a	chronic lymphocytic leukemia
hsa-mir-15a	chronic lymphocytic leukemia
hsa-mir-15a	chronic lymphocytic leukemia
hsa-mir-15a	chronic lymphocytic leukemia
hsa-mir-15a	colon cancer
hsa-mir-15a	colorectal cancer
hsa-mir-15a	colorectal cancer
hsa-mir-15a	esophageal cancer
hsa-mir-15a	gastric cancer	down	Reduction of gastric cancer proliferation and invasion by miR-15a mediated s
hsa-mir-15a	glioma
hsa-mir-15a	hepatocellular carcinoma	down	MiR-15a s
hsa-mir-15a	lung cancer
hsa-mir-15a	neuroblastoma
hsa-mir-15a	neuroblastoma
hsa-mir-15a	non-small cell lung cancer
hsa-mir-15a	pancreatic cancer
hsa-mir-15a	pancreatic cancer
hsa-mir-15a	pancreatic ductal adenocarcinoma
hsa-mir-15a	prostate cancer
hsa-mir-15a	renal cell carcinoma	down	Downregulation of microRNA-15a s
hsa-mir-15a	squamous carcinoma
hsa-mir-15a-3p	cervical cancer
hsa-mir-15a-3p	colorectal cancer
hsa-mir-15a-3p	gastric cancer
hsa-mir-15a-3p	osteosarcoma
hsa-mir-15a-3p	ovarian cancer	down	MiR-15a-3p s
hsa-mir-15a-3p	prostate cancer	down	miR-15a-3p S
hsa-mir-15a-5p	chronic myelogenous leukemia
hsa-mir-15a-5p	endometrial cancer	down	miR-15a-5p s
hsa-mir-15a-5p	hepatocellular carcinoma	down	MicroRNA-15a-5p s
hsa-mir-15b	cervical carcinoma
hsa-mir-15b	chronic lymphocytic leukemia
hsa-mir-15b	chronic lymphocytic leukemia
hsa-mir-15b	colon cancer
hsa-mir-15b	colorectal cancer
hsa-mir-15b	colorectal cancer
hsa-mir-15b	glioblastoma
hsa-mir-15b	glioma
hsa-mir-15b	hepatocellular carcinoma
hsa-mir-15b	lung cancer
hsa-mir-15b	malignant melanoma
hsa-mir-15b	neuroblastoma
hsa-mir-15b	non-small cell lung cancer
hsa-mir-15b	pancreatic cancer
hsa-mir-15b	prostate cancer
hsa-mir-15b	tongue cancer
hsa-mir-15b-5p	colorectal cancer
hsa-mir-15b-5p	gastric cancer
hsa-mir-15b-5p	non-small cell lung cancer
hsa-mir-15b-5p	osteosarcoma
hsa-mir-16	bladder cancer
hsa-mir-16	brain cancer
hsa-mir-16	breast cancer	down	MicroRNA-16 sensitizes breast cancer cells to paclitaxel through s
hsa-mir-16	breast cancer	down	Downregulation of the tumor-s
hsa-mir-16	cervical carcinoma
hsa-mir-16	chronic lymphocytic leukemia
hsa-mir-16	chronic myelogenous leukemia
hsa-mir-16	colorectal adenocarcinoma
hsa-mir-16	colorectal cancer
hsa-mir-16	colorectal cancer
hsa-mir-16	colorectal cancer
hsa-mir-16	colorectal cancer
hsa-mir-16	colorectal cancer
hsa-mir-16	esophageal squamous cell carcinoma
hsa-mir-16	gastric cancer
hsa-mir-16	glioblastoma	down	Tumor s
hsa-mir-16	glioma
hsa-mir-16	glioma	down	MicroRNA-16 inhibits glioma cell growth and invasion through s
hsa-mir-16	glioma	down	Up-regulation of microRNA-16 in glioblastoma inhibits the function of endothelial cells and tumor angiogenesis by targeting Bmi-1.
hsa-mir-16	head and neck squamous cell carcinoma
hsa-mir-16	hepatocellular carcinoma
hsa-mir-16	hepatocellular carcinoma
hsa-mir-16	laryngeal carcinoma
hsa-mir-16	lung adenocarcinoma	down	Quercetin Decreases Claudin-2 Expression Mediated by Up-Regulation of microRNA miR-16 in Lung Adenocarcinoma A549 Cells.
hsa-mir-16	nasopharyngeal carcinoma
hsa-mir-16	non-small cell lung cancer
hsa-mir-16	non-small cell lung cancer
hsa-mir-16	oral squamous cell carcinoma
hsa-mir-16	oral squamous cell carcinoma
hsa-mir-16	oral squamous cell carcinoma	down	MiRNA-16 inhibited oral squamous carcinoma tumor growth in vitro and in vivo via s
hsa-mir-16	oral squamous cell carcinoma	down	MicroRNA-16 functions as a tumor-s
hsa-mir-16	osteosarcoma	down	MicroRNA-16 s
hsa-mir-16	osteosarcoma
hsa-mir-16	osteosarcoma
hsa-mir-16	ovarian cancer
hsa-mir-16	pancreatic ductal adenocarcinoma
hsa-mir-16	papillary thyroid carcinoma
hsa-mir-16	prostate cancer
hsa-mir-16	renal cell carcinoma
hsa-mir-16	squamous carcinoma
hsa-mir-16-1	chronic lymphocytic leukemia
hsa-mir-16-1	chronic lymphocytic leukemia
hsa-mir-16-1	colon cancer
hsa-mir-16-1	lung cancer
hsa-mir-16-1	neuroblastoma
hsa-mir-16-1	prostate cancer
hsa-mir-16-1-3p	chronic lymphocytic leukemia
hsa-mir-16-1-3p	gastric cancer
hsa-mir-16-2	chronic lymphocytic leukemia
hsa-mir-16-2	chronic lymphocytic leukemia
hsa-mir-16-2	colon cancer
hsa-mir-16-2	lung cancer
hsa-mir-16-2	neuroblastoma
hsa-mir-16-2	prostate cancer
hsa-mir-16-5p	breast cancer
hsa-mir-16-5p	breast carcinoma	down	MicroRNA-16-5p overexpression s
hsa-mir-16-5p	non-small cell lung cancer
hsa-mir-17	acute myeloid leukemia
hsa-mir-17	basal cell carcinoma
hsa-mir-17	bladder cancer
hsa-mir-17	brain cancer
hsa-mir-17	breast cancer
hsa-mir-17	breast carcinoma
hsa-mir-17	cholangiocarcinoma
hsa-mir-17	chronic myelogenous leukemia
hsa-mir-17	chronic myelogenous leukemia
hsa-mir-17	colorectal cancer
hsa-mir-17	colorectal cancer
hsa-mir-17	colorectal cancer
hsa-mir-17	colorectal cancer
hsa-mir-17	esophageal adenocarcinoma
hsa-mir-17	esophageal squamous cell carcinoma
hsa-mir-17	gastric cancer
hsa-mir-17	gastric cancer
hsa-mir-17	gastric cancer
hsa-mir-17	glioma
hsa-mir-17	glioma
hsa-mir-17	hepatocellular carcinoma
hsa-mir-17	lung cancer
hsa-mir-17	malignant melanoma
hsa-mir-17	malignant melanoma
hsa-mir-17	mantle cell lymphoma
hsa-mir-17	medulloblastoma
hsa-mir-17	nasopharyngeal carcinoma
hsa-mir-17	non-small cell lung cancer
hsa-mir-17	osteosarcoma
hsa-mir-17	osteosarcoma
hsa-mir-17	osteosarcoma
hsa-mir-17	osteosarcoma
hsa-mir-17	ovarian cancer
hsa-mir-17	prostate cancer
hsa-mir-17	t-cell lymphoblastic lymphoma
hsa-mir-17-5p	bladder cancer
hsa-mir-17-5p	breast cancer
hsa-mir-17-5p	breast cancer
hsa-mir-17-5p	breast cancer
hsa-mir-17-5p	cervical cancer
hsa-mir-17-5p	cervical cancer
hsa-mir-17-5p	cervical cancer
hsa-mir-17-5p	colorectal cancer
hsa-mir-17-5p	colorectal cancer
hsa-mir-17-5p	gastric cancer
hsa-mir-17-5p	gastric cancer
hsa-mir-17-5p	gastric cancer
hsa-mir-17-5p	hepatocellular carcinoma
hsa-mir-17-5p	hepatocellular carcinoma
hsa-mir-17-5p	hepatocellular carcinoma
hsa-mir-17-5p	malignant melanoma
hsa-mir-17-5p	malignant melanoma
hsa-mir-17-5p	nasopharyngeal carcinoma
hsa-mir-17-5p	non-small cell lung cancer
hsa-mir-17-5p	non-small cell lung cancer
hsa-mir-17-5p	non-small cell lung cancer
hsa-mir-17-5p	osteosarcoma
hsa-mir-17-5p	ovarian cancer
hsa-mir-17-5p	pancreatic adenocarcinoma
hsa-mir-17-5p	pancreatic cancer
hsa-mir-17-5p	pancreatic cancer
hsa-mir-17-5p	pituitary carcinoma
hsa-mir-181a	acute myeloid leukemia
hsa-mir-181a	acute myeloid leukemia
hsa-mir-181a	acute promyelocytic leukemia
hsa-mir-181a	breast cancer
hsa-mir-181a	breast cancer
hsa-mir-181a	cervical cancer
hsa-mir-181a	cervical cancer
hsa-mir-181a	cervical cancer
hsa-mir-181a	chondrosarcoma
hsa-mir-181a	chronic lymphocytic leukemia
hsa-mir-181a	chronic lymphocytic leukemia
hsa-mir-181a	colon cancer
hsa-mir-181a	colon cancer
hsa-mir-181a	colorectal cancer
hsa-mir-181a	colorectal cancer
hsa-mir-181a	gastric cancer
hsa-mir-181a	gastric cancer
hsa-mir-181a	gastric cancer
hsa-mir-181a	glioblastoma
hsa-mir-181a	glioblastoma	down	Upregulation of miR-181a s
hsa-mir-181a	glioma	down	hsa-mir-181a and hsa-mir-181b function as tumor s
hsa-mir-181a	glioma
hsa-mir-181a	glioma
hsa-mir-181a	hepatocellular carcinoma
hsa-mir-181a	hepatocellular carcinoma
hsa-mir-181a	laryngeal cancer
hsa-mir-181a	laryngeal squamous cell carcinoma
hsa-mir-181a	malignant melanoma	down	Piceatannol induced apoptosis through
hsa-mir-181a	non-small cell lung cancer
hsa-mir-181a	oral squamous cell carcinoma	down	miR-181a shows tumor s
hsa-mir-181a	osteosarcoma
hsa-mir-181a	osteosarcoma
hsa-mir-181a	pancreatic cancer
hsa-mir-181a	prostate cancer
hsa-mir-181a	thyroid cancer
hsa-mir-181a-1	glioblastoma
hsa-mir-181a-1	glioma
hsa-mir-181a-1	hepatocellular carcinoma
hsa-mir-181a-1	non-small cell lung cancer	down	MicroRNA-181 functions as a tumor s
hsa-mir-181a-1	ovarian cancer
hsa-mir-181a-1	papillary thyroid carcinoma
hsa-mir-181a-1	prostate cancer
hsa-mir-181a-2	glioblastoma
hsa-mir-181a-2	glioma
hsa-mir-181a-2	hepatocellular carcinoma
hsa-mir-181a-2	non-small cell lung cancer	down	MicroRNA-181 functions as a tumor s
hsa-mir-181a-2	ovarian cancer
hsa-mir-181a-2	papillary thyroid carcinoma
hsa-mir-181a-2	prostate cancer
hsa-mir-181a-2*	gastric cancer
hsa-mir-181a-5p	cervical cancer	down	Interference of the long noncoding RNA CDKN2B-AS1
hsa-mir-181a-5p	colorectal cancer
hsa-mir-181a-5p	endometrial cancer
hsa-mir-181a-5p	gastric cancer
hsa-mir-181a-5p	hepatocellular carcinoma	down	MicroRNA-181a-5p s
hsa-mir-181a-5p	non-small cell lung cancer
hsa-mir-181a-5p	non-small cell lung cancer
hsa-mir-181b	acute myeloid leukemia
hsa-mir-181b	acute promyelocytic leukemia
hsa-mir-181b	breast cancer
hsa-mir-181b	breast cancer
hsa-mir-181b	cervical cancer
hsa-mir-181b	chronic lymphocytic leukemia
hsa-mir-181b	chronic lymphocytic leukemia
hsa-mir-181b	gastric adenocarcinoma
hsa-mir-181b	gastric cancer	down	miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor s
hsa-mir-181b	glioblastoma	down	Upregulation of miR-181s reverses mesenchymal transition by targeting KPNA4 in glioblastoma.
hsa-mir-181b	glioma	down	hsa-mir-181a and hsa-mir-181b function as tumor s
hsa-mir-181b	glioma	down	MiRNA-181b s
hsa-mir-181b	glioma	down	MiR-181b s
hsa-mir-181b	glioma
hsa-mir-181b	glioma
hsa-mir-181b	hepatocellular carcinoma
hsa-mir-181b	lung cancer	down	microRNA-181b s
hsa-mir-181b	non-small cell lung cancer
hsa-mir-181b	non-small cell lung cancer
hsa-mir-181b	oral squamous cell carcinoma
hsa-mir-181b	osteosarcoma
hsa-mir-181b	osteosarcoma
hsa-mir-181b	ovarian cancer
hsa-mir-181b	papillary thyroid carcinoma
hsa-mir-181b	prostate cancer
hsa-mir-181b	retinoblastoma
hsa-mir-181b-1	glioblastoma
hsa-mir-181b-1	glioma
hsa-mir-181b-1	hepatocellular carcinoma
hsa-mir-181b-1	non-small cell lung cancer	down	MicroRNA-181 functions as a tumor s
hsa-mir-181b-1	ovarian cancer
hsa-mir-181b-1	papillary thyroid carcinoma
hsa-mir-181b-1	prostate cancer
hsa-mir-181b-2	glioblastoma
hsa-mir-181b-2	glioma
hsa-mir-181b-2	hepatocellular carcinoma
hsa-mir-181b-2	non-small cell lung cancer	down	MicroRNA-181 functions as a tumor s
hsa-mir-181b-2	ovarian cancer
hsa-mir-181b-2	papillary thyroid carcinoma
hsa-mir-181b-2	prostate cancer
hsa-mir-181b-3p	breast cancer
hsa-mir-181b-5p	squamous carcinoma
hsa-mir-181c	basal cell carcinoma
hsa-mir-181c	gastric cancer
hsa-mir-181c	glioblastoma
hsa-mir-181c	glioblastoma
hsa-mir-181c	glioma
hsa-mir-181c	hepatocellular carcinoma
hsa-mir-181c	medulloblastoma
hsa-mir-181c	neuroblastoma
hsa-mir-181c	non-small cell lung cancer	down	MicroRNA-181 functions as a tumor s
hsa-mir-181c	non-small cell lung cancer
hsa-mir-181c	osteosarcoma
hsa-mir-181c	ovarian cancer
hsa-mir-181c	ovarian cancer
hsa-mir-181c	pancreatic cancer
hsa-mir-181c	papillary thyroid carcinoma
hsa-mir-181c	prostate cancer
hsa-mir-181c*	basal cell carcinoma
hsa-mir-181c-5p	pancreatic cancer
hsa-mir-181d	basal cell carcinoma
hsa-mir-181d	esophageal squamous cell carcinoma	down	MicroRNA-181d is a tumor s
hsa-mir-181d	gastric cancer
hsa-mir-181d	glioblastoma
hsa-mir-181d	glioma	down	MiR-181d acts as a tumor s
hsa-mir-181d	glioma
hsa-mir-181d	hepatocellular carcinoma
hsa-mir-181d	medulloblastoma
hsa-mir-181d	non-small cell lung cancer	down	MicroRNA-181 functions as a tumor s
hsa-mir-181d	ovarian cancer
hsa-mir-181d	papillary thyroid carcinoma
hsa-mir-181d	prostate cancer
hsa-mir-181d-5p	non-small cell lung cancer	down	Tumor-s
hsa-mir-182	basal cell carcinoma
hsa-mir-182	bladder cancer
hsa-mir-182	breast cancer
hsa-mir-182	breast cancer
hsa-mir-182	breast cancer
hsa-mir-182	breast cancer
hsa-mir-182	breast cancer
hsa-mir-182	cervical cancer
hsa-mir-182	colorectal adenocarcinoma
hsa-mir-182	colorectal cancer
hsa-mir-182	colorectal cancer
hsa-mir-182	colorectal cancer
hsa-mir-182	colorectal cancer
hsa-mir-182	colorectal cancer
hsa-mir-182	colorectal cancer
hsa-mir-182	colorectal cancer
hsa-mir-182	colorectal carcinoma
hsa-mir-182	endometrial cancer
hsa-mir-182	gallbladder carcinoma
hsa-mir-182	gastric adenocarcinoma	down	MicroRNA-182 targets cAMP-responsive element-binding protein?1 and s
hsa-mir-182	gastric cancer
hsa-mir-182	glioma
hsa-mir-182	glioma
hsa-mir-182	head and neck squamous cell carcinoma
hsa-mir-182	hepatocellular carcinoma
hsa-mir-182	hepatocellular carcinoma
hsa-mir-182	hepatocellular carcinoma
hsa-mir-182	hepatocellular carcinoma
hsa-mir-182	hepatocellular carcinoma
hsa-mir-182	hepatocellular carcinoma
hsa-mir-182	lung cancer
hsa-mir-182	lung cancer
hsa-mir-182	lung cancer
hsa-mir-182	malignant melanoma
hsa-mir-182	malignant melanoma
hsa-mir-182	malignant mesothelioma
hsa-mir-182	medullary thyroid carcinoma
hsa-mir-182	mesenchymal cancer
hsa-mir-182	non-small cell lung cancer
hsa-mir-182	non-small cell lung cancer	down	miR-182 s
hsa-mir-182	osteosarcoma
hsa-mir-182	ovarian cancer
hsa-mir-182	ovarian cancer
hsa-mir-182	pancreatic cancer
hsa-mir-182	papillary thyroid carcinoma
hsa-mir-182	prostate cancer
hsa-mir-182	prostate cancer
hsa-mir-182	prostate cancer
hsa-mir-182	prostate cancer
hsa-mir-182	renal clear cell carcinoma	down	MicroRNA-182 s
hsa-mir-182-5p	acute myeloid leukemia
hsa-mir-182-5p	bladder cancer
hsa-mir-182-5p	breast cancer
hsa-mir-182-5p	hepatocellular carcinoma
hsa-mir-182-5p	hepatocellular carcinoma
hsa-mir-182-5p	oral squamous cell carcinoma
hsa-mir-182-5p	oral squamous cell carcinoma
hsa-mir-182-5p	prostate cancer
hsa-mir-182-5p	renal cell carcinoma
hsa-mir-1826	colorectal cancer
hsa-mir-1826	kidney cancer
hsa-mir-1827	colorectal cancer
hsa-mir-1827	colorectal cancer	down	microRNA-1827 represses MDM2 to positively regulate tumor s
hsa-mir-1827	medulloblastoma
hsa-mir-183	astrocytoma
hsa-mir-183	bladder cancer
hsa-mir-183	bladder cancer
hsa-mir-183	bladder cancer
hsa-mir-183	breast cancer
hsa-mir-183	breast cancer
hsa-mir-183	breast cancer
hsa-mir-183	cervical cancer	down	MicroRNA-183 functions as the tumor s
hsa-mir-183	colon cancer
hsa-mir-183	colorectal cancer
hsa-mir-183	colorectal cancer
hsa-mir-183	colorectal cancer
hsa-mir-183	colorectal cancer
hsa-mir-183	endometrial cancer
hsa-mir-183	esophageal cancer
hsa-mir-183	esophageal cancer
hsa-mir-183	esophageal squamous cell carcinoma
hsa-mir-183	follicular thyroid carcinoma
hsa-mir-183	gastric cancer
hsa-mir-183	gastric cancer
hsa-mir-183	gastric cancer
hsa-mir-183	gastric cancer
hsa-mir-183	gastric cancer
hsa-mir-183	glioblastoma
hsa-mir-183	glioma
hsa-mir-183	glioma
hsa-mir-183	hepatocellular carcinoma
hsa-mir-183	hepatocellular carcinoma
hsa-mir-183	hepatocellular carcinoma
hsa-mir-183	hepatocellular carcinoma
hsa-mir-183	hepatocellular carcinoma	down	Potential Role of microRNA-183 as a Tumor S
hsa-mir-183	hepatocellular carcinoma
hsa-mir-183	hepatocellular carcinoma
hsa-mir-183	malignant mesothelioma
hsa-mir-183	nasopharyngeal carcinoma	down	MicroRNA-183 s
hsa-mir-183	nasopharyngeal carcinoma
hsa-mir-183	osteosarcoma
hsa-mir-183	osteosarcoma
hsa-mir-183	papillary thyroid carcinoma
hsa-mir-183	prostate cancer
hsa-mir-183	prostate cancer
hsa-mir-183	renal cell carcinoma
hsa-mir-183*	cervical cancer
hsa-mir-183-3p	lung cancer
hsa-mir-183-3p	prostate cancer	down	microRNA-183-3p Inhibits Progression of Human Prostate Cancer by Downregulating High-Mobility Gro
hsa-mir-183-5p	adrenal cortical carcinoma
hsa-mir-183-5p	breast cancer
hsa-mir-183-5p	cervical cancer
hsa-mir-183-5p	colorectal cancer
hsa-mir-183-5p	lung cancer	down	miR-183-5p functions as a tumor s
hsa-mir-183-5p	non-small cell lung cancer
hsa-mir-184	adrenal cortical carcinoma
hsa-mir-184	colorectal cancer
hsa-mir-184	endometrial cancer
hsa-mir-184	glioma
hsa-mir-184	glioma
hsa-mir-184	head and neck squamous cell carcinoma
hsa-mir-184	hepatocellular carcinoma
hsa-mir-184	malignant melanoma
hsa-mir-184	neuroblastoma
hsa-mir-184	neuroblastoma
hsa-mir-184	non-small cell lung cancer
hsa-mir-184	non-small cell lung cancer
hsa-mir-185	bladder cancer
hsa-mir-185	breast cancer
hsa-mir-185	breast cancer
hsa-mir-185	chondrosarcoma	down	Downregulation of miR-185 and
hsa-mir-185	colon cancer	down	miRNA-185 serves as a prognostic factor and s
hsa-mir-185	colorectal cancer	down	MicroRNA-185 is a novel tumor s
hsa-mir-185	esophageal squamous cell carcinoma	down	Plasma miR-185 is decreased in esophageal squamous cell carcinoma patients and might s
hsa-mir-185	gastric cancer
hsa-mir-185	gastric cancer	down	miR-185 is an independent prognosis factor and s
hsa-mir-185	gastric cancer
hsa-mir-185	glioma
hsa-mir-185	hepatocellular carcinoma
hsa-mir-185	hepatocellular carcinoma
hsa-mir-185	malignant melanoma
hsa-mir-185	nasopharyngeal carcinoma
hsa-mir-185	non-small cell lung cancer
hsa-mir-185	non-small cell lung cancer	down	miR-185 acts as a tumor s
hsa-mir-185	pancreatic cancer	down	MicroRNA-185 s
hsa-mir-185-5p	cutaneous t-cell lymphoma	down	Histone deacetylase inhibitors inhibit metastasis by restoring a tumor s
hsa-mir-185-5p	gastric cancer
hsa-mir-185-5p	glioma
hsa-mir-185-5p	glioma
hsa-mir-185-5p	hepatocellular carcinoma
hsa-mir-185-5p	malignant melanoma
hsa-mir-185-5p	prostate cancer
hsa-mir-186	bladder cancer	down	MiR-186 s
hsa-mir-186	cervical cancer
hsa-mir-186	cervical cancer	down	Upregulation of kazrin F by miR-186 s
hsa-mir-186	colon carcinoma
hsa-mir-186	esophageal squamous cell carcinoma
hsa-mir-186	gastric cancer
hsa-mir-186	gastrointestinal stromal tumor
hsa-mir-186	hepatocellular carcinoma
hsa-mir-186	lung cancer	down	MicroRNA-186 s
hsa-mir-186	lung cancer	down	MicroRNA-186 s
hsa-mir-186	malignant melanoma
hsa-mir-186	multiple myeloma
hsa-mir-186	neuroblastoma
hsa-mir-186	non-small cell lung cancer	down	MiR-186 targets ROCK1 to s
hsa-mir-186	oral squamous cell carcinoma	down	MicroRNA-186 serves as a tumor s
hsa-mir-186	pancreatic ductal adenocarcinoma
hsa-mir-186	prostate cancer
hsa-mir-186	prostate cancer
hsa-mir-186	retinoblastoma	down	S
hsa-mir-186-5p	colon cancer
hsa-mir-186-5p	osteosarcoma	down	miR-186-5p Functions as a Tumor S
hsa-mir-187	cervical cancer
hsa-mir-187	colorectal cancer
hsa-mir-187	gastric cancer
hsa-mir-187	gastric cancer
hsa-mir-187	gastric cancer
hsa-mir-187	hepatocellular carcinoma
hsa-mir-187	non-small cell lung cancer
hsa-mir-187	oral squamous cell carcinoma
hsa-mir-187	osteosarcoma
hsa-mir-187	prostate cancer
hsa-mir-187*	oral squamous cell carcinoma
hsa-mir-187-3p	hepatocellular carcinoma
hsa-mir-187-3p	hepatocellular carcinoma
hsa-mir-187-5p	non-small cell lung cancer	down	MicroRNA-187-5p s
hsa-mir-188	glioma
hsa-mir-188	nasopharyngeal carcinoma	down	MicroRNA-188 s
hsa-mir-188	oral squamous cell carcinoma
hsa-mir-188-5p	gastric cancer	down	MiR-188-5p s
hsa-mir-188-5p	gastric cancer
hsa-mir-188-5p	gastric cancer
hsa-mir-188-5p	hepatocellular carcinoma	down	MicroRNA-188-5p S
hsa-mir-188-5p	prostate cancer
hsa-mir-18a	basal cell carcinoma
hsa-mir-18a	breast cancer
hsa-mir-18a	breast carcinoma
hsa-mir-18a	cholangiocarcinoma
hsa-mir-18a	chronic myelogenous leukemia
hsa-mir-18a	chronic myelogenous leukemia
hsa-mir-18a	colon cancer
hsa-mir-18a	colorectal cancer
hsa-mir-18a	colorectal cancer
hsa-mir-18a	colorectal cancer
hsa-mir-18a	colorectal cancer	down	miR-18a Inhibits CDC42 and Plays a Tumour S
hsa-mir-18a	colorectal cancer
hsa-mir-18a	esophageal squamous cell carcinoma
hsa-mir-18a	esophageal squamous cell carcinoma
hsa-mir-18a	gastric cancer
hsa-mir-18a	gastric cancer
hsa-mir-18a	gastric cancer
hsa-mir-18a	glioblastoma
hsa-mir-18a	hepatocellular carcinoma
hsa-mir-18a	hepatocellular carcinoma
hsa-mir-18a	hepatocellular carcinoma
hsa-mir-18a	hepatocellular carcinoma
hsa-mir-18a	hepatocellular carcinoma
hsa-mir-18a	lung cancer
hsa-mir-18a	malignant melanoma
hsa-mir-18a	malignant melanoma
hsa-mir-18a	mantle cell lymphoma
hsa-mir-18a	medulloblastoma
hsa-mir-18a	nasopharyngeal carcinoma
hsa-mir-18a	nasopharyngeal carcinoma
hsa-mir-18a	neuroblastoma
hsa-mir-18a	non-small cell lung cancer
hsa-mir-18a	osteosarcoma
hsa-mir-18a	osteosarcoma
hsa-mir-18a	osteosarcoma
hsa-mir-18a	ovarian cancer
hsa-mir-18a	pancreatic cancer
hsa-mir-18a	pancreatic ductal adenocarcinoma
hsa-mir-18a	prostate cancer
hsa-mir-18a-5p	colorectal cancer
hsa-mir-18a-5p	lung cancer
hsa-mir-18a-5p	nasopharyngeal carcinoma
hsa-mir-18a-5p	non-small cell lung cancer
hsa-mir-18a-5p	renal cell carcinoma
hsa-mir-18b	basal cell carcinoma
hsa-mir-18b	breast cancer
hsa-mir-18b	colorectal cancer
hsa-mir-18b	malignant melanoma
hsa-mir-18b-5p	colorectal cancer
hsa-mir-190	breast cancer	down	miR-190 s
hsa-mir-190	gastric cancer
hsa-mir-190	hepatocellular carcinoma
hsa-mir-1908	glioblastoma
hsa-mir-1908	glioma
hsa-mir-1908	osteosarcoma
hsa-mir-190b	hepatocellular carcinoma
hsa-mir-191	breast cancer
hsa-mir-191	breast cancer
hsa-mir-191	breast cancer
hsa-mir-191	colorectal cancer
hsa-mir-191	colorectal cancer
hsa-mir-191	colorectal carcinoma
hsa-mir-191	colorectal carcinoma
hsa-mir-191	esophageal squamous cell carcinoma
hsa-mir-191	gastric cancer
hsa-mir-191	glioblastoma
hsa-mir-191	hepatocellular carcinoma
hsa-mir-191	hepatocellular carcinoma
hsa-mir-191	intrahepatic cholangiocarcinoma
hsa-mir-191	non-small cell lung cancer
hsa-mir-191	osteosarcoma
hsa-mir-191	osteosarcoma
hsa-mir-191	osteosarcoma
hsa-mir-191	pancreatic cancer
hsa-mir-191	prostate cancer
hsa-mir-191	prostate cancer
hsa-mir-191-5p	renal cell carcinoma	down	MicroRNA-191-5p exerts a tumor s
hsa-mir-1915-3p	breast cancer
hsa-mir-192	acute lymphoblastic leukemia	down	Tumor s
hsa-mir-192	acute myeloid leukemia
hsa-mir-192	bladder cancer
hsa-mir-192	bladder cancer
hsa-mir-192	chronic lymphocytic leukemia
hsa-mir-192	colon cancer
hsa-mir-192	colon cancer
hsa-mir-192	colorectal cancer
hsa-mir-192	epithelial ovarian cancer
hsa-mir-192	esophageal squamous cell carcinoma
hsa-mir-192	gastric cancer
hsa-mir-192	gastric cancer
hsa-mir-192	gastric cancer
hsa-mir-192	hepatocellular carcinoma
hsa-mir-192	lung cancer
hsa-mir-192	ovarian carcinoma
hsa-mir-192	pancreatic ductal adenocarcinoma
hsa-mir-192	prostate cancer
hsa-mir-192-3p	colon cancer
hsa-mir-192-5p	bladder cancer	down	MiR-192-5p s
hsa-mir-192-5p	colon cancer
hsa-mir-192-5p	esophageal squamous cell carcinoma
hsa-mir-192-5p	osteosarcoma	down	MicroRNA-192-5p s
hsa-mir-193a	acute myeloid leukemia
hsa-mir-193a	breast cancer
hsa-mir-193a	colon cancer
hsa-mir-193a	colon cancer
hsa-mir-193a	epithelial ovarian cancer
hsa-mir-193a	non-small cell lung cancer
hsa-mir-193a-3p	breast cancer
hsa-mir-193a-3p	lung cancer	down	miR-193a-3p functions as a tumor s
hsa-mir-193a-3p	non-small cell lung cancer
hsa-mir-193a-3p	non-small cell lung cancer	down	miR-193a-3p inhibition of the Slug activator PAK4 s
hsa-mir-193a-3p	pancreatic ductal adenocarcinoma
hsa-mir-193a-3p	prostate cancer
hsa-mir-193a-3p	renal cell carcinoma
hsa-mir-193a-3p	renal cell carcinoma
hsa-mir-193a-5p	colorectal cancer
hsa-mir-193a-5p	gastric cancer	down	MiR-193a-5p and -3p Play a Distinct Role in Gastric Cancer: miR-193a-3p S
hsa-mir-193a-5p	glioblastoma	down	MicroRNA-193a-5p exerts a tumor s
hsa-mir-193a-5p	glioma	down	MicroRNA-193a-5p exerts a tumor s
hsa-mir-193a-5p	hepatocellular carcinoma
hsa-mir-193b	breast cancer
hsa-mir-193b	breast cancer	down	Downregulation of tumor s
hsa-mir-193b	breast cancer	down	Downregulation of miR-193b contributes to enhance urokinase-type plasminogen activator (uPA) expression and tumor progression and invasion in human breast cancer.
hsa-mir-193b	cervical cancer
hsa-mir-193b	colon cancer	down	MicroRNA-193b acts as a tumor s
hsa-mir-193b	colorectal cancer
hsa-mir-193b	esophageal cancer	down	MicroRNA-193b acts as a tumor s
hsa-mir-193b	glioma
hsa-mir-193b	hepatocellular carcinoma
hsa-mir-193b	liver cancer
hsa-mir-193b	malignant melanoma
hsa-mir-193b	malignant melanoma
hsa-mir-193b	ovarian cancer
hsa-mir-193b	primary cns lymphomas
hsa-mir-193b	prostate cancer
hsa-mir-194	bladder cancer
hsa-mir-194	colorectal cancer
hsa-mir-194	colorectal cancer
hsa-mir-194	esophageal squamous cell carcinoma
hsa-mir-194	gastric cancer
hsa-mir-194	gastric cancer
hsa-mir-194	gastric cancer
hsa-mir-194	gastric cancer
hsa-mir-194	glioma
hsa-mir-194	hepatocellular carcinoma	down	NF-?B signaling relieves negative regulation by miR-194 in hepatocellular carcinoma by s
hsa-mir-194	hepatocellular carcinoma
hsa-mir-194	hepatocellular carcinoma
hsa-mir-194	laryngeal squamous cell carcinoma	down	MiR-194 functions as a tumor s
hsa-mir-194	liver cancer
hsa-mir-194	lung cancer	down	miR-194 s
hsa-mir-194	nasopharyngeal carcinoma
hsa-mir-194	non-small cell lung cancer	down	miR-194 s
hsa-mir-194	osteosarcoma	down	microRNA-194 s
hsa-mir-194	osteosarcoma
hsa-mir-194	osteosarcoma	down	miR-194 S
hsa-mir-194	ovarian carcinoma
hsa-mir-194	pancreatic ductal adenocarcinoma
hsa-mir-194	prostate cancer
hsa-mir-194	prostate cancer	down	MicroRNA-194 s
hsa-mir-194-5p	bladder cancer
hsa-mir-194-5p	bladder cancer
hsa-mir-194-5p	gastric cancer	down	The SOX2OT/miR-194-5p axis regulates cell proliferation and mobility of gastric cancer through s
hsa-mir-194-5p	glioma	down	Knockdown of SOX2OT inhibits the malignant biological behaviors of glioblastoma stem cells via
hsa-mir-195	adrenal cortical carcinoma
hsa-mir-195	adrenal cortical carcinoma
hsa-mir-195	bladder cancer
hsa-mir-195	bladder cancer
hsa-mir-195	breast cancer	down	Upregulation of miR-195 increases the sensitivity of breast cancer cells to Adriamycin treatment through inhibition of Raf-1.
hsa-mir-195	breast cancer
hsa-mir-195	breast cancer
hsa-mir-195	cervical cancer
hsa-mir-195	cervical cancer	down	MiR-195 S
hsa-mir-195	chronic lymphocytic leukemia
hsa-mir-195	chronic lymphocytic leukemia
hsa-mir-195	colon cancer
hsa-mir-195	colon carcinoma	down	MiR-195 s
hsa-mir-195	colorectal cancer	down	MicroRNA-195 s
hsa-mir-195	colorectal cancer	down	Tumor s
hsa-mir-195	colorectal cancer	down	microRNA-195 promotes apoptosis and s
hsa-mir-195	colorectal cancer
hsa-mir-195	colorectal cancer
hsa-mir-195	colorectal cancer	down	Integrated analysis identifies microRNA-195 as a s
hsa-mir-195	esophageal cancer
hsa-mir-195	esophageal squamous cell carcinoma
hsa-mir-195	gastric cancer	down	MicroRNA-195 and microRNA-378 mediate tumor growth s
hsa-mir-195	gastric cancer
hsa-mir-195	glioblastoma	down	MicroRNA-195 plays a tumor-s
hsa-mir-195	glioma
hsa-mir-195	glioma
hsa-mir-195	hepatocellular carcinoma
hsa-mir-195	hepatocellular carcinoma	down	MicroRNA-195 acts as a tumor s
hsa-mir-195	hepatocellular carcinoma	down	microRNA-195 functions as a tumor s
hsa-mir-195	hepatocellular carcinoma	down	MiR-195 s
hsa-mir-195	hepatocellular carcinoma
hsa-mir-195	hepatocellular carcinoma
hsa-mir-195	hepatocellular carcinoma
hsa-mir-195	hepatocellular carcinoma
hsa-mir-195	hepatocellular carcinoma
hsa-mir-195	laryngeal carcinoma
hsa-mir-195	laryngeal squamous cell carcinoma
hsa-mir-195	lung adenocarcinoma	down	MicroRNA-195 s
hsa-mir-195	lung cancer
hsa-mir-195	lung cancer	down	MiR-195 s
hsa-mir-195	neuroblastoma
hsa-mir-195	non-small cell lung cancer
hsa-mir-195	non-small cell lung cancer	down	MiR-195 s
hsa-mir-195	non-small cell lung cancer
hsa-mir-195	non-small cell lung cancer
hsa-mir-195	osteosarcoma	down	microRNA-195 s
hsa-mir-195	osteosarcoma	down	MicroRNA profiling identifies MiR-195 s
hsa-mir-195	pancreatic cancer
hsa-mir-195	papillary thyroid carcinoma	down	microRNA-339-5p modulates Na+/I- symporter-mediated radioiodide
hsa-mir-195	papillary thyroid carcinoma
hsa-mir-195	prostate cancer
hsa-mir-195	prostate cancer
hsa-mir-195	prostate cancer
hsa-mir-195	prostate cancer
hsa-mir-195	prostate carcinoma	down	MicroRNA-195 s
hsa-mir-195	renal clear cell carcinoma	down	MicroRNA-195 targets VEGFR2 and has a tumor s
hsa-mir-195-5p	colorectal cancer
hsa-mir-195-5p	gastric cancer
hsa-mir-195-5p	hepatocellular carcinoma
hsa-mir-195-5p	non-small cell lung cancer	down	MiRNA-195-5p Functions as a Tumor S
hsa-mir-195-5p	osteosarcoma
hsa-mir-195-5p	osteosarcoma	down	MicroRNA-195-5p s
hsa-mir-195-5p	ovarian cancer
hsa-mir-195-5p	renal cell carcinoma
hsa-mir-196a	breast cancer
hsa-mir-196a	cervical cancer
hsa-mir-196a	cervical cancer
hsa-mir-196a	colorectal cancer
hsa-mir-196a	colorectal cancer
hsa-mir-196a	esophageal adenocarcinoma
hsa-mir-196a	esophageal squamous cell carcinoma
hsa-mir-196a	esophageal squamous cell carcinoma
hsa-mir-196a	gastric cancer
hsa-mir-196a	gastric cancer
hsa-mir-196a	gastrointestinal stromal tumor
hsa-mir-196a	glioblastoma
hsa-mir-196a	head and neck squamous cell carcinoma
hsa-mir-196a	hepatocellular carcinoma
hsa-mir-196a	laryngeal cancer
hsa-mir-196a	liver cancer
hsa-mir-196a	lung cancer
hsa-mir-196a	non-small cell lung cancer
hsa-mir-196a	non-small cell lung cancer
hsa-mir-196a	ovarian carcinoma
hsa-mir-196a	pancreatic cancer
hsa-mir-196a	squamous carcinoma
hsa-mir-196a*	gastric cancer
hsa-mir-196a-1	glioblastoma
hsa-mir-196a-1	oral cancer
hsa-mir-196a-1	oral squamous cell carcinoma
hsa-mir-196a-2	glioblastoma
hsa-mir-196a-2	oral cancer
hsa-mir-196a-2	oral squamous cell carcinoma
hsa-mir-196a-5p	gastric cancer
hsa-mir-196a-5p	gastric cancer
hsa-mir-196a-5p	gastric cancer
hsa-mir-196a-5p	prostate cancer
hsa-mir-196b	colorectal cancer
hsa-mir-196b	colorectal cancer
hsa-mir-196b	esophageal cancer
hsa-mir-196b	gastric cancer
hsa-mir-196b	gastric cancer
hsa-mir-196b	gastric cancer
hsa-mir-196b	glioblastoma
hsa-mir-196b	glioblastoma
hsa-mir-196b	glioblastoma
hsa-mir-196b	lung cancer
hsa-mir-196b	oral cancer
hsa-mir-196b	oral squamous cell carcinoma
hsa-mir-196b	oral squamous cell carcinoma
hsa-mir-196b	pancreatic cancer
hsa-mir-196b-5p	breast cancer
hsa-mir-196b-5p	colorectal cancer
hsa-mir-196b-5p	gastric cancer
hsa-mir-197	cervical cancer	down	miR-197 is downregulated in cervical carcinogenesis and s
hsa-mir-197	esophageal cancer
hsa-mir-197	follicular thyroid carcinoma
hsa-mir-197	gastric cancer	down	miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor s
hsa-mir-197	gastric cancer
hsa-mir-197	glioblastoma
hsa-mir-197	hepatocellular carcinoma
hsa-mir-197	hepatocellular carcinoma
hsa-mir-197	hepatocellular carcinoma
hsa-mir-197	multiple myeloma	down	miR-137 and miR-197 Induce Apoptosis and S
hsa-mir-197	uterine leiomyoma	down	Upregulation of miR-197 inhibits cell proliferation by directly targeting IGFBP5 in human uterine leiomyoma cells.
hsa-mir-197-3p	hepatocellular carcinoma
hsa-mir-197-5p	mesenchymal cancer
hsa-mir-1974	adrenal cortical carcinoma
hsa-mir-1976	non-small cell lung cancer	down	MicroRNA-1976 functions as a tumor s
hsa-mir-198	breast cancer	down	miR-198 functions as a tumor s
hsa-mir-198	colorectal cancer
hsa-mir-198	colorectal cancer
hsa-mir-198	gastric cancer	down	MicroRNA-198 inhibits proliferation and induces apoptosis by directly s
hsa-mir-198	glioblastoma
hsa-mir-198	glioma
hsa-mir-198	hepatocellular carcinoma
hsa-mir-198	hepatocellular carcinoma
hsa-mir-198	lung cancer
hsa-mir-198	osteosarcoma
hsa-mir-198	pancreatic cancer	down	A Tumorigenic Factor Interactome Connected Through Tumor S
hsa-mir-199a	chondrosarcoma
hsa-mir-199a	colon cancer	down	Downregulation of miR-199a/b-5p is associated with GCNT2 induction
hsa-mir-199a	colorectal cancer
hsa-mir-199a	gastric cancer
hsa-mir-199a	hepatocellular carcinoma
hsa-mir-199a	hepatocellular carcinoma
hsa-mir-199a	hepatocellular carcinoma
hsa-mir-199a	hepatocellular carcinoma
hsa-mir-199a	hepatocellular carcinoma	down	S
hsa-mir-199a	kidney cancer	down	Re-expression of miR-199a s
hsa-mir-199a	mantle cell lymphoma
hsa-mir-199a	non-small cell lung cancer	down	MiR-199a s
hsa-mir-199a	ovarian cancer
hsa-mir-199a	ovarian cancer
hsa-mir-199a	ovarian cancer	down	S
hsa-mir-199a	primary cns lymphomas
hsa-mir-199a	prostate cancer	down	MiR-199a s
hsa-mir-199a-1	acute myeloid leukemia
hsa-mir-199a-2	acute myeloid leukemia
hsa-mir-199a-3p	clear cell renal cell cancer
hsa-mir-199a-3p	esophageal adenocarcinoma
hsa-mir-199a-3p	esophageal cancer
hsa-mir-199a-3p	gastric cancer
hsa-mir-199a-3p	gastric cancer
hsa-mir-199a-3p	gastric cancer
hsa-mir-199a-3p	glioma	down	MicroRNA-199a-3p s
hsa-mir-199a-3p	glioma
hsa-mir-199a-3p	kidney cancer
hsa-mir-199a-3p	malignant melanoma
hsa-mir-199a-3p	osteosarcoma
hsa-mir-199a-3p	osteosarcoma
hsa-mir-199a-3p	osteosarcoma
hsa-mir-199a-3p	osteosarcoma
hsa-mir-199a-3p	osteosarcoma
hsa-mir-199a-3p	papillary thyroid carcinoma	down	miR-199a-3p displays tumor s
hsa-mir-199a-3p	renal cell carcinoma
hsa-mir-199a-5p	bladder cancer	down	miR-199a-5p s
hsa-mir-199a-5p	cervical carcinoma
hsa-mir-199a-5p	colorectal cancer
hsa-mir-199a-5p	colorectal cancer
hsa-mir-199a-5p	esophageal adenocarcinoma
hsa-mir-199a-5p	esophageal cancer
hsa-mir-199a-5p	gastric cancer
hsa-mir-199a-5p	glioma	down	microRNA-199a-5p s
hsa-mir-199a-5p	hepatocellular carcinoma
hsa-mir-199a-5p	hepatocellular carcinoma
hsa-mir-199a-5p	hepatocellular carcinoma
hsa-mir-199a-5p	hepatocellular carcinoma	down	MiR-199a-5p s
hsa-mir-199a-5p	hepatocellular carcinoma
hsa-mir-199a-5p	malignant melanoma
hsa-mir-199a-5p	non-small cell lung cancer	down	miR-199a-5p and miR-495 target GRP78 within UPR pathway of lung cancer.
hsa-mir-199a-5p	non-small cell lung cancer	down	MiR-199a-5p s
hsa-mir-199a-5p	osteosarcoma
hsa-mir-199a-5p	ovarian cancer	down	miRNA-199a-5p s
hsa-mir-199a-5p	papillary thyroid carcinoma
hsa-mir-199a-5p	prostate adenocarcinoma
hsa-mir-199b	acute myeloid leukemia
hsa-mir-199b	choriocarcinoma
hsa-mir-199b	colorectal cancer
hsa-mir-199b	follicular thyroid carcinoma
hsa-mir-199b	hepatocellular carcinoma
hsa-mir-199b	hepatocellular carcinoma
hsa-mir-199b	prostate cancer	down	MiR199b S
hsa-mir-199b-3p	esophageal adenocarcinoma
hsa-mir-199b-5p	breast cancer
hsa-mir-199b-5p	breast cancer
hsa-mir-199b-5p	cervical cancer
hsa-mir-199b-5p	colon cancer	down	Downregulation of miR-199a/b-5p is associated with GCNT2 induction
hsa-mir-199b-5p	hepatocellular carcinoma
hsa-mir-199b-5p	hepatocellular carcinoma
hsa-mir-199b-5p	mesenchymal cancer
hsa-mir-199b-5p	papillary thyroid carcinoma
hsa-mir-199b-5p	renal cell carcinoma	down	miR-199b-5p serves as a tumor s
hsa-mir-19a	acute myeloid leukemia
hsa-mir-19a	bladder cancer
hsa-mir-19a	breast cancer
hsa-mir-19a	breast cancer
hsa-mir-19a	breast carcinoma
hsa-mir-19a	cervical cancer
hsa-mir-19a	cholangiocarcinoma
hsa-mir-19a	chronic myelogenous leukemia
hsa-mir-19a	colorectal cancer
hsa-mir-19a	colorectal cancer
hsa-mir-19a	colorectal cancer
hsa-mir-19a	colorectal cancer	down	Overexpression of miR-19a inhibits colorectal cancer angiogenesis by s
hsa-mir-19a	colorectal cancer
hsa-mir-19a	esophageal squamous cell carcinoma
hsa-mir-19a	esophageal squamous cell carcinoma
hsa-mir-19a	gastric cancer
hsa-mir-19a	gastric cancer
hsa-mir-19a	gastric cancer
hsa-mir-19a	gastric cancer
hsa-mir-19a	gastric cancer
hsa-mir-19a	gastric cancer
hsa-mir-19a	glioma
hsa-mir-19a	glioma
hsa-mir-19a	glioma
hsa-mir-19a	hepatocellular carcinoma
hsa-mir-19a	hepatocellular carcinoma
hsa-mir-19a	laryngeal squamous cell carcinoma
hsa-mir-19a	lung cancer
hsa-mir-19a	mantle cell lymphoma
hsa-mir-19a	medulloblastoma
hsa-mir-19a	multiple myeloma
hsa-mir-19a	nasopharyngeal carcinoma
hsa-mir-19a	neuroblastoma
hsa-mir-19a	non-small cell lung cancer
hsa-mir-19a	non-small cell lung cancer
hsa-mir-19a	non-small cell lung cancer
hsa-mir-19a	osteosarcoma
hsa-mir-19a	osteosarcoma
hsa-mir-19a	osteosarcoma
hsa-mir-19a	osteosarcoma
hsa-mir-19a	osteosarcoma
hsa-mir-19a	ovarian cancer
hsa-mir-19a	t-cell lymphoblastic lymphoma
hsa-mir-19a-3p	breast cancer
hsa-mir-19a-3p	colorectal cancer
hsa-mir-19a-3p	hepatocellular carcinoma
hsa-mir-19a-3p	multiple myeloma
hsa-mir-19b	acute myeloid leukemia
hsa-mir-19b	basal cell carcinoma
hsa-mir-19b	breast cancer
hsa-mir-19b	breast cancer
hsa-mir-19b	breast cancer
hsa-mir-19b	breast cancer
hsa-mir-19b	breast carcinoma
hsa-mir-19b	cervical cancer
hsa-mir-19b	cholangiocarcinoma
hsa-mir-19b	chronic myelogenous leukemia
hsa-mir-19b	colorectal cancer
hsa-mir-19b	esophageal squamous cell carcinoma
hsa-mir-19b	gastric cancer
hsa-mir-19b	gastric cancer
hsa-mir-19b	glioma
hsa-mir-19b	glioma
hsa-mir-19b	hepatocellular carcinoma
hsa-mir-19b	hepatocellular carcinoma
hsa-mir-19b	lung cancer
hsa-mir-19b	mantle cell lymphoma
hsa-mir-19b	medulloblastoma
hsa-mir-19b	multiple myeloma
hsa-mir-19b	nasopharyngeal carcinoma	down	MicroRNA-19b Promotes Nasopharyngeal Carcinoma More Sensitive to Cisplatin by S
hsa-mir-19b	osteosarcoma
hsa-mir-19b	osteosarcoma
hsa-mir-19b-1	gastric cancer
hsa-mir-19b-1	non-small cell lung cancer
hsa-mir-19b-1	osteosarcoma
hsa-mir-19b-1	osteosarcoma
hsa-mir-19b-1	t-cell lymphoblastic lymphoma
hsa-mir-19b-1*	basal cell carcinoma
hsa-mir-19b-2	gastric cancer
hsa-mir-19b-2	non-small cell lung cancer
hsa-mir-19b-2	osteosarcoma
hsa-mir-19b-2	osteosarcoma
hsa-mir-19b-2	t-cell lymphoblastic lymphoma
hsa-mir-19b-3p	breast cancer
hsa-mir-19b-3p	colon cancer
hsa-mir-19b-3p	lung cancer
hsa-mir-19b-3p	malignant melanoma
hsa-mir-19b-3p	nasopharyngeal carcinoma
hsa-mir-19b-3p	pancreatic cancer
hsa-mir-200a	bladder cancer
hsa-mir-200a	breast cancer
hsa-mir-200a	breast cancer
hsa-mir-200a	breast cancer
hsa-mir-200a	breast cancer
hsa-mir-200a	breast cancer
hsa-mir-200a	colorectal cancer	down	MiR-200 s
hsa-mir-200a	endometrial cancer
hsa-mir-200a	esophageal adenocarcinoma
hsa-mir-200a	esophageal cancer
hsa-mir-200a	esophageal cancer
hsa-mir-200a	gastric adenocarcinoma
hsa-mir-200a	gastric adenocarcinoma
hsa-mir-200a	glioma	down	microRNA-200a functions as a tumor s
hsa-mir-200a	hepatocellular carcinoma
hsa-mir-200a	hepatocellular carcinoma	down	MicroRNA-200a S
hsa-mir-200a	hepatocellular carcinoma
hsa-mir-200a	hepatocellular carcinoma
hsa-mir-200a	hepatocellular carcinoma
hsa-mir-200a	hepatocellular carcinoma	down	miR-200a s
hsa-mir-200a	hepatocellular carcinoma	down	MicroRNA-200a s
hsa-mir-200a	hepatocellular carcinoma
hsa-mir-200a	lung adenocarcinoma
hsa-mir-200a	lung cancer
hsa-mir-200a	malignant melanoma
hsa-mir-200a	malignant melanoma
hsa-mir-200a	meningioma
hsa-mir-200a	mesenchymal cancer
hsa-mir-200a	nasopharyngeal carcinoma
hsa-mir-200a	neuroblastoma
hsa-mir-200a	non-small cell lung cancer
hsa-mir-200a	oral cancer
hsa-mir-200a	ovarian cancer
hsa-mir-200a	ovarian cancer
hsa-mir-200a	ovarian cancer
hsa-mir-200a	ovarian cancer
hsa-mir-200a	pancreatic cancer
hsa-mir-200a	pancreatic ductal adenocarcinoma
hsa-mir-200a	pancreatic ductal adenocarcinoma	down	MiR-200a S
hsa-mir-200a	prostate cancer	down	MicroRNA-200a s
hsa-mir-200a	renal cell carcinoma	down	Tumor s
hsa-mir-200a	renal cell carcinoma
hsa-mir-200a-3p	breast cancer
hsa-mir-200a-3p	gastric cancer
hsa-mir-200a-3p	hepatocellular carcinoma	down	Circ-ZEB1.33 promotes the proliferation of human HCC by sponging miR-200a-3p and
hsa-mir-200a-3p	renal cell carcinoma	down	MicroRNA-200a-3p s
hsa-mir-200b	astrocytoma
hsa-mir-200b	bladder cancer
hsa-mir-200b	breast cancer
hsa-mir-200b	breast cancer
hsa-mir-200b	breast cancer
hsa-mir-200b	cervical carcinoma	down	MicroRNA-200b s
hsa-mir-200b	cholangiocarcinoma
hsa-mir-200b	colon cancer
hsa-mir-200b	colorectal cancer
hsa-mir-200b	colorectal cancer
hsa-mir-200b	colorectal cancer	down	MiR-200 s
hsa-mir-200b	endometrial cancer
hsa-mir-200b	esophageal squamous cell carcinoma	down	miR-200b s
hsa-mir-200b	esophageal squamous cell carcinoma
hsa-mir-200b	gastric cancer
hsa-mir-200b	glioma
hsa-mir-200b	glioma
hsa-mir-200b	glioma	down	[miR-200b s
hsa-mir-200b	glioma
hsa-mir-200b	glioma
hsa-mir-200b	hepatocellular carcinoma
hsa-mir-200b	hepatocellular carcinoma	down	Upregulation of miR-200b Inhibits Hepatocellular Carcinoma Cell Proliferation and Migration by Targeting HMGB3 Protein.
hsa-mir-200b	hepatocellular carcinoma
hsa-mir-200b	lung adenocarcinoma
hsa-mir-200b	lung cancer
hsa-mir-200b	malignant melanoma
hsa-mir-200b	mesenchymal cancer
hsa-mir-200b	mucinous cystadenocarcinoma
hsa-mir-200b	non-small cell lung cancer
hsa-mir-200b	non-small cell lung cancer
hsa-mir-200b	oral cancer
hsa-mir-200b	osteosarcoma	down	MicroRNA-200b acts as a tumor s
hsa-mir-200b	ovarian cancer
hsa-mir-200b	ovarian cancer
hsa-mir-200b	ovarian cancer
hsa-mir-200b	pancreatic ductal adenocarcinoma
hsa-mir-200b	renal cell carcinoma	down	MicroRNA-200b is downregulated and s
hsa-mir-200b	tongue cancer
hsa-mir-200b-3p	glioma	down	MicroRNA-200b-3p s
hsa-mir-200b-3p	oral squamous cell carcinoma
hsa-mir-200b-3p	ovarian cancer
hsa-mir-200c	bladder cancer
hsa-mir-200c	bladder cancer
hsa-mir-200c	bladder cancer
hsa-mir-200c	breast cancer
hsa-mir-200c	breast cancer	down	MiR-200c s
hsa-mir-200c	breast cancer	down	HDAC inhibitor s
hsa-mir-200c	breast cancer
hsa-mir-200c	cervical cancer	down	MicroRNA-200c s
hsa-mir-200c	cholangiocarcinoma
hsa-mir-200c	colon cancer
hsa-mir-200c	colon cancer
hsa-mir-200c	colorectal cancer
hsa-mir-200c	colorectal cancer
hsa-mir-200c	colorectal cancer
hsa-mir-200c	colorectal cancer
hsa-mir-200c	colorectal cancer	down	MiR-200 s
hsa-mir-200c	colorectal cancer
hsa-mir-200c	colorectal cancer
hsa-mir-200c	endometrial cancer
hsa-mir-200c	endometrial cancer
hsa-mir-200c	gastric cancer
hsa-mir-200c	gastric cancer
hsa-mir-200c	gastric cancer
hsa-mir-200c	gastric cancer
hsa-mir-200c	glioma
hsa-mir-200c	glioma	down	MiR-200c and miR-141 inhibit ZEB1 synergistically and s
hsa-mir-200c	head and neck squamous cell carcinoma
hsa-mir-200c	hepatocellular carcinoma
hsa-mir-200c	hepatocellular carcinoma
hsa-mir-200c	kidney cancer	down	MicroRNA-200c s
hsa-mir-200c	laryngeal cancer
hsa-mir-200c	lung adenocarcinoma
hsa-mir-200c	lung cancer
hsa-mir-200c	malignant melanoma
hsa-mir-200c	malignant melanoma
hsa-mir-200c	malignant melanoma
hsa-mir-200c	mesenchymal cancer
hsa-mir-200c	mucinous cystadenocarcinoma
hsa-mir-200c	nasopharyngeal carcinoma
hsa-mir-200c	non-small cell lung cancer
hsa-mir-200c	non-small cell lung cancer
hsa-mir-200c	non-small cell lung cancer
hsa-mir-200c	oral cancer
hsa-mir-200c	oral squamous cell carcinoma
hsa-mir-200c	oropharyngeal cancer
hsa-mir-200c	ovarian cancer
hsa-mir-200c	ovarian cancer
hsa-mir-200c	ovarian cancer
hsa-mir-200c	ovarian cancer
hsa-mir-200c	ovarian cancer
hsa-mir-200c	ovarian cancer
hsa-mir-200c	ovarian cancer
hsa-mir-200c	pancreatic ductal adenocarcinoma
hsa-mir-200c	renal clear cell carcinoma
hsa-mir-200c	renal clear cell carcinoma
hsa-mir-200c-3p	gastric cancer
hsa-mir-200c-3p	pancreatic ductal adenocarcinoma
hsa-mir-202	colorectal cancer
hsa-mir-202	esophageal adenocarcinoma	down	miR-202 S
hsa-mir-202	esophageal squamous cell carcinoma
hsa-mir-202	hepatocellular carcinoma	down	miR-202 s
hsa-mir-202	lung cancer
hsa-mir-202	non-small cell lung cancer	down	miR-202 functions as a tumor s
hsa-mir-202	osteosarcoma
hsa-mir-202	prostate cancer	down	miR-202 s
hsa-mir-202	retinoblastoma	down	Shikonin-mediated
hsa-mir-202-3p	colorectal carcinoma
hsa-mir-202-3p	papillary thyroid carcinoma	down	MiR-202-3p functions as a tumor s
hsa-mir-202-5p	colorectal carcinoma	down	MicroRNA-202-5p functions as a tumor s
hsa-mir-202-5p	papillary thyroid carcinoma
hsa-mir-203	basal cell carcinoma	down	MicroRNA-203 functions as a tumor s
hsa-mir-203	bladder cancer
hsa-mir-203	bladder cancer	down	microRNA-203 s
hsa-mir-203	bladder cancer
hsa-mir-203	bladder cancer	down	MiR-203 S
hsa-mir-203	breast cancer
hsa-mir-203	breast cancer
hsa-mir-203	breast cancer
hsa-mir-203	cervical cancer
hsa-mir-203	cervical cancer	down	miR-203 S
hsa-mir-203	cervical cancer
hsa-mir-203	cervical cancer
hsa-mir-203	colon cancer
hsa-mir-203	colorectal cancer
hsa-mir-203	colorectal cancer	down	MiR-203 S
hsa-mir-203	colorectal cancer
hsa-mir-203	esophageal adenocarcinoma
hsa-mir-203	esophageal cancer	down	MiR-203 s
hsa-mir-203	esophageal cancer	down	miR-203 inhibits the proliferation and self-renewal of esophageal cancer stem-like cells by s
hsa-mir-203	esophageal cancer
hsa-mir-203	esophageal squamous cell carcinoma
hsa-mir-203	esophageal squamous cell carcinoma
hsa-mir-203	esophageal squamous cell carcinoma
hsa-mir-203	gastric cancer
hsa-mir-203	gastric cancer	down	Retraction Note: MicroRNA-203 s
hsa-mir-203	gastric cancer
hsa-mir-203	gastric cancer
hsa-mir-203	gastric cancer
hsa-mir-203	gastric cancer	down	MicroRNA-203 s
hsa-mir-203	glioblastoma
hsa-mir-203	glioblastoma
hsa-mir-203	glioma
hsa-mir-203	glioma
hsa-mir-203	glioma	down	Bufalin Inhibits Cellular Proliferation and Cancer Stem Cell-Like Phenotypes via Upregulation of MiR-203 in Glioma.
hsa-mir-203	head and neck squamous cell carcinoma	down	microRNA-203 s
hsa-mir-203	hepatocellular carcinoma
hsa-mir-203	hepatocellular carcinoma
hsa-mir-203	hepatocellular carcinoma	down	miR-203 s
hsa-mir-203	hypopharyngeal cancer
hsa-mir-203	laryngeal squamous cell carcinoma	down	MiR-203 is downregulated in laryngeal squamous cell carcinoma and can s
hsa-mir-203	laryngeal squamous cell carcinoma
hsa-mir-203	lung adenocarcinoma	down	Direct interaction between miR-203 and ZEB2 s
hsa-mir-203	lung cancer
hsa-mir-203	lung cancer	down	miR-203 S
hsa-mir-203	lung cancer
hsa-mir-203	lung carcinoma
hsa-mir-203	malignant melanoma
hsa-mir-203	malignant melanoma
hsa-mir-203	malignant melanoma
hsa-mir-203	malignant melanoma	down	MiR-203 inhibits melanoma invasive and proliferative abilities by targeting the polycomb gro
hsa-mir-203	malignant melanoma
hsa-mir-203	malignant melanoma
hsa-mir-203	malignant melanoma
hsa-mir-203	malignant melanoma
hsa-mir-203	multiple myeloma
hsa-mir-203	non-small cell lung cancer
hsa-mir-203	non-small cell lung cancer
hsa-mir-203	non-small cell lung cancer
hsa-mir-203	non-small cell lung cancer
hsa-mir-203	oral squamous cell carcinoma
hsa-mir-203	osteosarcoma
hsa-mir-203	osteosarcoma
hsa-mir-203	osteosarcoma	down	MiR-203 Determines Poor Outcome and S
hsa-mir-203	osteosarcoma	down	miR-203 Acts as a Tumor S
hsa-mir-203	ovarian cancer	down	miR-203 Functions as a Tumor S
hsa-mir-203	ovarian cancer
hsa-mir-203	ovarian cancer
hsa-mir-203	pancreatic adenocarcinoma
hsa-mir-203	pancreatic cancer
hsa-mir-203	pancreatic ductal adenocarcinoma
hsa-mir-203	prostate cancer
hsa-mir-203	renal cell carcinoma
hsa-mir-203	squamous carcinoma
hsa-mir-203	squamous carcinoma
hsa-mir-203a	bladder cancer	down	MiR-203a functions as a tumor s
hsa-mir-203a	esophageal cancer	down	Methylation-mediated repression of potential tumor s
hsa-mir-203a	gastric cancer	down	miR-203a s
hsa-mir-203a	hepatocellular carcinoma	down	EGR1 mediates miR-203a s
hsa-mir-203a	hepatocellular carcinoma	down	HOXD3 targeted by miR-203a s
hsa-mir-203a	multiple myeloma
hsa-mir-203a-3p	colorectal cancer
hsa-mir-203a-3p	nasopharyngeal carcinoma	down	MiR-203a-3p s
hsa-mir-204	breast cancer
hsa-mir-204	breast cancer
hsa-mir-204	breast cancer
hsa-mir-204	breast cancer
hsa-mir-204	cervical cancer
hsa-mir-204	colon cancer
hsa-mir-204	endometrial cancer
hsa-mir-204	esophageal cancer
hsa-mir-204	gastric cancer	down	miR-204 regulates the EMT by targeting snai1 to s
hsa-mir-204	gastric cancer
hsa-mir-204	gastric cancer
hsa-mir-204	glioma
hsa-mir-204	glioma
hsa-mir-204	head and neck squamous cell carcinoma
hsa-mir-204	head and neck squamous cell carcinoma
hsa-mir-204	hepatocellular carcinoma
hsa-mir-204	intrahepatic cholangiocarcinoma
hsa-mir-204	lung adenocarcinoma
hsa-mir-204	lung adenocarcinoma
hsa-mir-204	lung carcinoma	down	miR-204 s
hsa-mir-204	malignant melanoma
hsa-mir-204	malignant melanoma	down	BANCR contributes to the growth and invasion of melanoma by functioning as a competing endogenous RNA to
hsa-mir-204	medulloblastoma	down	Downregulation of miR-204 expression defines a highly aggressive subset of Gro
hsa-mir-204	nasopharyngeal carcinoma
hsa-mir-204	neuroblastoma
hsa-mir-204	non-small cell lung cancer	down	miR-204 functions as a tumor s
hsa-mir-204	non-small cell lung cancer	down	MiR-204 inhibits human NSCLC metastasis through s
hsa-mir-204	non-small cell lung cancer	down	miRNA-204 s
hsa-mir-204	non-small cell lung cancer
hsa-mir-204	ovarian cancer
hsa-mir-204	papillary thyroid carcinoma
hsa-mir-204	prostate cancer
hsa-mir-204	prostate cancer
hsa-mir-204	prostate cancer
hsa-mir-204	renal cell carcinoma
hsa-mir-204	renal clear cell carcinoma	down	VHL-regulated MiR-204 s
hsa-mir-204	retinoblastoma
hsa-mir-204	thyroid cancer
hsa-mir-204-3p	glioma
hsa-mir-204-3p	hepatocellular carcinoma
hsa-mir-204-5p	breast cancer
hsa-mir-204-5p	colorectal cancer
hsa-mir-204-5p	colorectal cancer
hsa-mir-204-5p	gastric cancer
hsa-mir-204-5p	hepatocellular carcinoma	down	miR-204-5p s
hsa-mir-204-5p	hepatocellular carcinoma
hsa-mir-204-5p	malignant melanoma	down	miR-204-5p acts as a tumor s
hsa-mir-204-5p	papillary thyroid carcinoma	down	miR-204-5p s
hsa-mir-204-5p	prostate cancer	down	Tumor s
hsa-mir-205	adrenal cortical carcinoma	down	MicroRNA-205 s
hsa-mir-205	bladder cancer
hsa-mir-205	bladder cancer
hsa-mir-205	bladder cancer
hsa-mir-205	bladder cancer
hsa-mir-205	breast cancer	down	S
hsa-mir-205	breast cancer
hsa-mir-205	breast cancer
hsa-mir-205	breast cancer
hsa-mir-205	breast cancer
hsa-mir-205	breast cancer
hsa-mir-205	breast cancer
hsa-mir-205	cervical cancer	down	MiR-205 serves as a prognostic factor and s
hsa-mir-205	cervical cancer
hsa-mir-205	cervical cancer
hsa-mir-205	cervical squamous cell carcinoma
hsa-mir-205	chronic myelogenous leukemia	down	microRNA expression profiling as s
hsa-mir-205	colon cancer
hsa-mir-205	colorectal cancer	down	MicroRNA-205 functions as a tumor s
hsa-mir-205	colorectal cancer
hsa-mir-205	endometrial cancer
hsa-mir-205	endometrial cancer
hsa-mir-205	endometrial cancer
hsa-mir-205	endometrial cancer
hsa-mir-205	endometrial cancer
hsa-mir-205	esophageal cancer
hsa-mir-205	gastric cancer
hsa-mir-205	gastric cancer
hsa-mir-205	glioblastoma
hsa-mir-205	glioma	down	MicroRNA-205 functions as a tumor s
hsa-mir-205	glioma
hsa-mir-205	glioma
hsa-mir-205	glioma
hsa-mir-205	glioma	down	MiR-205 s
hsa-mir-205	head and neck squamous cell carcinoma
hsa-mir-205	head and neck squamous cell carcinoma
hsa-mir-205	hepatocellular carcinoma	down	Hepatitis B virus X protein inhibits tumor s
hsa-mir-205	hepatocellular carcinoma
hsa-mir-205	hepatocellular carcinoma
hsa-mir-205	kidney cancer
hsa-mir-205	laryngeal carcinoma
hsa-mir-205	laryngeal squamous cell carcinoma	down	MicroRNA-205 s
hsa-mir-205	laryngeal squamous cell carcinoma
hsa-mir-205	lung cancer
hsa-mir-205	lung cancer
hsa-mir-205	malignant melanoma	down	miRNA-205 s
hsa-mir-205	malignant melanoma
hsa-mir-205	neuroblastoma
hsa-mir-205	non-small cell lung cancer
hsa-mir-205	non-small cell lung cancer
hsa-mir-205	osteosarcoma	down	MiR-205 functions as a tumor s
hsa-mir-205	osteosarcoma	down	Long noncoding RNA MALAT1 promotes cell proliferation through s
hsa-mir-205	ovarian cancer
hsa-mir-205	ovarian cancer
hsa-mir-205	ovarian cancer
hsa-mir-205	pancreatic cancer
hsa-mir-205	prostate cancer
hsa-mir-205	prostate cancer
hsa-mir-205	prostate cancer	down	miR-205 is frequently downregulated in prostate cancer and acts as a tumor s
hsa-mir-205	prostate cancer	down	Polycomb protein EZH2 s
hsa-mir-205	prostate cancer
hsa-mir-205	prostate cancer
hsa-mir-205	prostate carcinoma
hsa-mir-205	renal cell carcinoma	down	miRNA-205 Is a Candidate Tumor S
hsa-mir-205	squamous carcinoma
hsa-mir-205	thyroid cancer
hsa-mir-205-5p	bladder cancer
hsa-mir-205-5p	breast cancer
hsa-mir-205-5p	esophageal cancer
hsa-mir-205-5p	gastric cancer
hsa-mir-205-5p	non-small cell lung cancer
hsa-mir-205-5p	prostate cancer
hsa-mir-205-5p	prostate cancer
hsa-mir-2053	hepatocellular carcinoma
hsa-mir-206	bladder cancer	down	MicroRNA-206 acts as a tumor s
hsa-mir-206	breast cancer
hsa-mir-206	breast cancer	down	miR-206 is down-regulated in breast cancer and inhibits cell proliferation through the
hsa-mir-206	cervical cancer
hsa-mir-206	clear cell renal cell cancer
hsa-mir-206	colorectal cancer
hsa-mir-206	colorectal cancer	down	MicroRNA-206 functions as a tumor s
hsa-mir-206	colorectal cancer
hsa-mir-206	gastric cancer
hsa-mir-206	gastric cancer
hsa-mir-206	gastric cancer	down	MicroRNA-206 s
hsa-mir-206	gastric cancer
hsa-mir-206	gastric cancer
hsa-mir-206	gastric cancer
hsa-mir-206	glioblastoma
hsa-mir-206	head and neck squamous cell carcinoma
hsa-mir-206	head and neck squamous cell carcinoma	down	Dual-receptor (EGFR and c-MET) inhibition by tumor-s
hsa-mir-206	hepatocellular carcinoma
hsa-mir-206	hepatocellular carcinoma
hsa-mir-206	hepatocellular carcinoma
hsa-mir-206	laryngeal squamous cell carcinoma
hsa-mir-206	laryngeal squamous cell carcinoma
hsa-mir-206	lung adenocarcinoma
hsa-mir-206	lung adenocarcinoma	down	MicroRNA-206 s
hsa-mir-206	lung cancer
hsa-mir-206	lung cancer
hsa-mir-206	malignant melanoma
hsa-mir-206	medulloblastoma
hsa-mir-206	non-small cell lung cancer
hsa-mir-206	non-small cell lung cancer
hsa-mir-206	oral squamous cell carcinoma	down	MiR-206 functions as a tumor s
hsa-mir-206	oral squamous cell carcinoma	down	MiR-206 functions as a tumor s
hsa-mir-206	osteosarcoma
hsa-mir-206	osteosarcoma
hsa-mir-206	ovarian cancer
hsa-mir-206	papillary thyroid carcinoma
hsa-mir-206	prostate cancer
hsa-mir-206	prostate cancer
hsa-mir-206	rhabdomyosarcoma
hsa-mir-206	thyroid cancer
hsa-mir-208	esophageal squamous cell carcinoma
hsa-mir-208a	gastric cancer
hsa-mir-208a	lung cancer
hsa-mir-208a	osteosarcoma
hsa-mir-208a-3p	colorectal cancer
hsa-mir-208a-3p	gastric cancer	down	miR-208a-3p s
hsa-mir-208b	osteosarcoma
hsa-mir-20a	acute myeloid leukemia
hsa-mir-20a	breast cancer
hsa-mir-20a	breast cancer
hsa-mir-20a	breast cancer
hsa-mir-20a	breast cancer
hsa-mir-20a	breast cancer
hsa-mir-20a	breast carcinoma
hsa-mir-20a	cervical cancer
hsa-mir-20a	cervical cancer
hsa-mir-20a	cervical cancer
hsa-mir-20a	cervical cancer
hsa-mir-20a	cervical cancer
hsa-mir-20a	cervical carcinoma
hsa-mir-20a	cholangiocarcinoma
hsa-mir-20a	chronic myelogenous leukemia
hsa-mir-20a	chronic myelogenous leukemia
hsa-mir-20a	colorectal cancer
hsa-mir-20a	colorectal cancer
hsa-mir-20a	colorectal cancer
hsa-mir-20a	colorectal cancer
hsa-mir-20a	colorectal cancer
hsa-mir-20a	colorectal cancer
hsa-mir-20a	colorectal cancer
hsa-mir-20a	colorectal cancer
hsa-mir-20a	colorectal cancer
hsa-mir-20a	colorectal cancer
hsa-mir-20a	colorectal cancer
hsa-mir-20a	esophageal squamous cell carcinoma
hsa-mir-20a	esophageal squamous cell carcinoma
hsa-mir-20a	gastric cancer
hsa-mir-20a	gastric cancer
hsa-mir-20a	glioma
hsa-mir-20a	glioma
hsa-mir-20a	hepatocellular carcinoma
hsa-mir-20a	hepatocellular carcinoma
hsa-mir-20a	hepatocellular carcinoma
hsa-mir-20a	lung cancer
hsa-mir-20a	malignant melanoma
hsa-mir-20a	malignant melanoma
hsa-mir-20a	mantle cell lymphoma
hsa-mir-20a	medulloblastoma
hsa-mir-20a	nasopharyngeal carcinoma
hsa-mir-20a	non-small cell lung cancer
hsa-mir-20a	osteosarcoma
hsa-mir-20a	osteosarcoma	down	miRNA-20a
hsa-mir-20a	osteosarcoma
hsa-mir-20a	ovarian cancer
hsa-mir-20a	ovarian cancer
hsa-mir-20a	pituitary carcinoma
hsa-mir-20a	prostate cancer
hsa-mir-20a-3p	gastric cancer
hsa-mir-20a-5p	colorectal cancer
hsa-mir-20a-5p	colorectal cancer
hsa-mir-20a-5p	colorectal cancer
hsa-mir-20a-5p	glioma
hsa-mir-20a-5p	neuroblastoma	down	MiR-20a-5p s
hsa-mir-20a-5p	non-small cell lung cancer
hsa-mir-20b	breast cancer
hsa-mir-20b	breast cancer
hsa-mir-20b	breast cancer
hsa-mir-20b	cervical cancer
hsa-mir-20b	gastric cancer
hsa-mir-20b	hepatocellular carcinoma
hsa-mir-20b	hepatocellular carcinoma
hsa-mir-20b	prostate cancer
hsa-mir-20b-5p	esophageal squamous cell carcinoma
hsa-mir-20b-5p	non-small cell lung cancer
hsa-mir-21	adrenal cortical carcinoma
hsa-mir-21	ampullary adenocarcinoma
hsa-mir-21	b-cell lymphoma
hsa-mir-21	b-cell lymphoma
hsa-mir-21	b-cell lymphoma
hsa-mir-21	brain cancer
hsa-mir-21	breast cancer
hsa-mir-21	breast cancer
hsa-mir-21	breast cancer
hsa-mir-21	breast cancer
hsa-mir-21	breast cancer
hsa-mir-21	breast cancer
hsa-mir-21	breast cancer
hsa-mir-21	breast cancer
hsa-mir-21	breast cancer
hsa-mir-21	breast cancer
hsa-mir-21	breast cancer
hsa-mir-21	breast cancer
hsa-mir-21	breast cancer
hsa-mir-21	breast cancer
hsa-mir-21	breast cancer
hsa-mir-21	breast cancer
hsa-mir-21	breast cancer
hsa-mir-21	breast cancer
hsa-mir-21	breast cancer
hsa-mir-21	breast cancer
hsa-mir-21	breast cancer
hsa-mir-21	cervical cancer
hsa-mir-21	cervical cancer
hsa-mir-21	cervical cancer
hsa-mir-21	cervical carcinoma
hsa-mir-21	cholangiocarcinoma
hsa-mir-21	cholangiocarcinoma
hsa-mir-21	cholangiocarcinoma
hsa-mir-21	cholangiocarcinoma
hsa-mir-21	chronic myelogenous leukemia
hsa-mir-21	colon cancer
hsa-mir-21	colon cancer
hsa-mir-21	colorectal cancer
hsa-mir-21	colorectal cancer
hsa-mir-21	colorectal cancer
hsa-mir-21	colorectal cancer
hsa-mir-21	colorectal cancer
hsa-mir-21	colorectal cancer
hsa-mir-21	colorectal cancer
hsa-mir-21	colorectal cancer
hsa-mir-21	colorectal cancer
hsa-mir-21	colorectal cancer
hsa-mir-21	colorectal cancer
hsa-mir-21	colorectal carcinoma
hsa-mir-21	colorectal carcinoma
hsa-mir-21	diffuse large B-cell lymphoma
hsa-mir-21	endometrial cancer
hsa-mir-21	esophageal cancer
hsa-mir-21	esophageal cancer
hsa-mir-21	esophageal cancer
hsa-mir-21	esophageal squamous cell carcinoma
hsa-mir-21	esophageal squamous cell carcinoma
hsa-mir-21	esophageal squamous cell carcinoma
hsa-mir-21	esophageal squamous cell carcinoma
hsa-mir-21	esophageal squamous cell carcinoma
hsa-mir-21	esophageal squamous cell carcinoma
hsa-mir-21	esophageal squamous cell carcinoma
hsa-mir-21	esophageal squamous cell carcinoma
hsa-mir-21	esophageal squamous cell carcinoma
hsa-mir-21	gastric cancer
hsa-mir-21	gastric cancer
hsa-mir-21	gastric cancer
hsa-mir-21	gastric cancer
hsa-mir-21	gastric cancer
hsa-mir-21	gastric cancer
hsa-mir-21	gastric cancer
hsa-mir-21	gastric cancer
hsa-mir-21	gastric cancer
hsa-mir-21	gastric cancer
hsa-mir-21	gastric cancer
hsa-mir-21	gastric cancer
hsa-mir-21	gastric cancer
hsa-mir-21	gastric cancer
hsa-mir-21	gastric cancer
hsa-mir-21	gastric cancer
hsa-mir-21	gastric cancer
hsa-mir-21	gastric cancer
hsa-mir-21	gastric cancer
hsa-mir-21	gastrointestinal stromal tumor
hsa-mir-21	glioblastoma
hsa-mir-21	glioblastoma
hsa-mir-21	glioblastoma
hsa-mir-21	glioblastoma
hsa-mir-21	glioblastoma
hsa-mir-21	glioblastoma
hsa-mir-21	glioblastoma
hsa-mir-21	glioblastoma
hsa-mir-21	glioblastoma
hsa-mir-21	glioblastoma
hsa-mir-21	glioblastoma
hsa-mir-21	glioblastoma
hsa-mir-21	glioblastoma
hsa-mir-21	glioblastoma
hsa-mir-21	glioblastoma
hsa-mir-21	glioblastoma
hsa-mir-21	glioblastoma
hsa-mir-21	glioblastoma
hsa-mir-21	glioma
hsa-mir-21	glioma
hsa-mir-21	glioma
hsa-mir-21	head and neck cancer
hsa-mir-21	head and neck cancer
hsa-mir-21	head and neck squamous cell carcinoma
hsa-mir-21	head and neck squamous cell carcinoma
hsa-mir-21	head and neck squamous cell carcinoma
hsa-mir-21	head and neck squamous cell carcinoma
hsa-mir-21	hepatoblastoma
hsa-mir-21	hepatocellular carcinoma
hsa-mir-21	hepatocellular carcinoma
hsa-mir-21	hepatocellular carcinoma
hsa-mir-21	hepatocellular carcinoma
hsa-mir-21	hepatocellular carcinoma
hsa-mir-21	hepatocellular carcinoma
hsa-mir-21	hepatocellular carcinoma
hsa-mir-21	hepatocellular carcinoma
hsa-mir-21	hepatocellular carcinoma
hsa-mir-21	hepatocellular carcinoma
hsa-mir-21	hepatocellular carcinoma
hsa-mir-21	hepatocellular carcinoma
hsa-mir-21	hepatocellular carcinoma
hsa-mir-21	hepatocellular carcinoma
hsa-mir-21	hepatocellular carcinoma
hsa-mir-21	hepatocellular carcinoma
hsa-mir-21	hepatocellular carcinoma
hsa-mir-21	hepatocellular carcinoma
hsa-mir-21	hepatocellular carcinoma
hsa-mir-21	hepatocellular carcinoma
hsa-mir-21	hepatocellular carcinoma
hsa-mir-21	hepatocellular carcinoma
hsa-mir-21	hepatocellular carcinoma
hsa-mir-21	hepatocellular carcinoma
hsa-mir-21	hypopharyngeal squamous cell carcinoma
hsa-mir-21	kidney cancer
hsa-mir-21	laryngeal cancer
hsa-mir-21	laryngeal squamous cell carcinoma
hsa-mir-21	laryngeal squamous cell carcinoma
hsa-mir-21	laryngeal squamous cell carcinoma
hsa-mir-21	liver cancer
hsa-mir-21	liver cancer
hsa-mir-21	lung cancer
hsa-mir-21	lung cancer
hsa-mir-21	malignant melanoma
hsa-mir-21	malignant melanoma
hsa-mir-21	malignant melanoma
hsa-mir-21	malignant melanoma
hsa-mir-21	medullary thyroid carcinoma
hsa-mir-21	mucinous cystadenocarcinoma
hsa-mir-21	multiple myeloma
hsa-mir-21	multiple myeloma
hsa-mir-21	nasopharyngeal carcinoma
hsa-mir-21	nasopharyngeal carcinoma
hsa-mir-21	neuroblastoma
hsa-mir-21	non-small cell lung cancer
hsa-mir-21	non-small cell lung cancer
hsa-mir-21	non-small cell lung cancer
hsa-mir-21	non-small cell lung cancer
hsa-mir-21	non-small cell lung cancer
hsa-mir-21	non-small cell lung cancer
hsa-mir-21	non-small cell lung cancer
hsa-mir-21	non-small cell lung cancer
hsa-mir-21	non-small cell lung cancer
hsa-mir-21	non-small cell lung cancer
hsa-mir-21	non-small cell lung cancer
hsa-mir-21	non-small cell lung cancer
hsa-mir-21	non-small cell lung cancer
hsa-mir-21	non-small cell lung cancer
hsa-mir-21	non-small cell lung cancer
hsa-mir-21	non-small cell lung cancer
hsa-mir-21	non-small cell lung cancer
hsa-mir-21	non-small cell lung cancer
hsa-mir-21	non-small cell lung cancer
hsa-mir-21	oral cancer
hsa-mir-21	oral carcinoma
hsa-mir-21	oral squamous cell carcinoma
hsa-mir-21	oral squamous cell carcinoma
hsa-mir-21	oral squamous cell carcinoma
hsa-mir-21	oropharyngeal cancer
hsa-mir-21	osteosarcoma
hsa-mir-21	osteosarcoma
hsa-mir-21	osteosarcoma
hsa-mir-21	osteosarcoma
hsa-mir-21	osteosarcoma
hsa-mir-21	osteosarcoma
hsa-mir-21	ovarian cancer
hsa-mir-21	ovarian cancer
hsa-mir-21	pancreatic cancer
hsa-mir-21	pancreatic ductal adenocarcinoma
hsa-mir-21	pancreatic ductal adenocarcinoma
hsa-mir-21	pancreatic ductal adenocarcinoma
hsa-mir-21	pancreatic ductal adenocarcinoma
hsa-mir-21	pancreatic ductal adenocarcinoma
hsa-mir-21	pancreatic ductal adenocarcinoma
hsa-mir-21	pancreatic ductal adenocarcinoma
hsa-mir-21	pancreatic ductal adenocarcinoma
hsa-mir-21	papillary thyroid carcinoma
hsa-mir-21	papillary thyroid carcinoma
hsa-mir-21	papillary thyroid carcinoma
hsa-mir-21	papillary thyroid carcinoma
hsa-mir-21	papillary thyroid carcinoma
hsa-mir-21	papillary thyroid carcinoma
hsa-mir-21	prostate cancer
hsa-mir-21	prostate cancer
hsa-mir-21	prostate cancer
hsa-mir-21	prostate cancer
hsa-mir-21	renal cell carcinoma
hsa-mir-21	renal cell carcinoma
hsa-mir-21	renal cell carcinoma
hsa-mir-21	renal cell carcinoma
hsa-mir-21	renal cell carcinoma
hsa-mir-21	renal cell carcinoma
hsa-mir-21	renal cell carcinoma
hsa-mir-21	renal cell carcinoma
hsa-mir-21	renal cell carcinoma
hsa-mir-21	retinoblastoma
hsa-mir-21	squamous carcinoma
hsa-mir-21	uveal melanoma
hsa-mir-21-3p	colorectal cancer
hsa-mir-21-3p	laryngeal cancer
hsa-mir-21-3p	liver cancer
hsa-mir-21-3p	oral cancer
hsa-mir-21-3p	oral squamous cell carcinoma
hsa-mir-21-5p	clear cell renal cell cancer
hsa-mir-21-5p	colorectal cancer
hsa-mir-21-5p	colorectal cancer
hsa-mir-21-5p	lung adenocarcinoma
hsa-mir-21-5p	non-small cell lung cancer
hsa-mir-21-5p	rectal cancer
hsa-mir-21-5p	squamous carcinoma
hsa-mir-210	adrenal cortical carcinoma
hsa-mir-210	bladder cancer
hsa-mir-210	breast cancer
hsa-mir-210	cervical cancer
hsa-mir-210	colorectal cancer
hsa-mir-210	colorectal cancer
hsa-mir-210	colorectal cancer
hsa-mir-210	esophageal cancer
hsa-mir-210	esophageal squamous cell carcinoma
hsa-mir-210	esophageal squamous cell carcinoma
hsa-mir-210	esophageal squamous cell carcinoma
hsa-mir-210	gastric cancer	down	miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor s
hsa-mir-210	glioblastoma
hsa-mir-210	glioblastoma
hsa-mir-210	glioblastoma
hsa-mir-210	glioma
hsa-mir-210	glioma
hsa-mir-210	hepatocellular carcinoma
hsa-mir-210	hepatocellular carcinoma
hsa-mir-210	hepatocellular carcinoma
hsa-mir-210	hepatocellular carcinoma
hsa-mir-210	lung cancer
hsa-mir-210	malignant melanoma
hsa-mir-210	malignant melanoma
hsa-mir-210	malignant melanoma
hsa-mir-210	medulloblastoma
hsa-mir-210	multiple myeloma
hsa-mir-210	osteosarcoma
hsa-mir-210	osteosarcoma
hsa-mir-210	osteosarcoma
hsa-mir-210	renal cell carcinoma
hsa-mir-210	renal clear cell carcinoma
hsa-mir-210	renal clear cell carcinoma
hsa-mir-210-3p	glioblastoma
hsa-mir-210-3p	non-small cell lung cancer
hsa-mir-210-3p	prostate cancer
hsa-mir-210-3p	renal clear cell carcinoma
hsa-mir-211	breast cancer
hsa-mir-211	colon cancer
hsa-mir-211	colorectal cancer
hsa-mir-211	gastric cancer
hsa-mir-211	gastric cancer
hsa-mir-211	glioblastoma
hsa-mir-211	glioma
hsa-mir-211	glioma
hsa-mir-211	hepatocellular carcinoma	down	miR-211 s
hsa-mir-211	hepatocellular carcinoma
hsa-mir-211	malignant melanoma
hsa-mir-211	malignant melanoma
hsa-mir-211	malignant melanoma	down	Intronic miR-211 assumes the tumor s
hsa-mir-211	malignant melanoma	down	Melanoma cell invasiveness is regulated by miR-211 s
hsa-mir-211	non-small cell lung cancer
hsa-mir-211	non-small cell lung cancer
hsa-mir-211	oral squamous cell carcinoma
hsa-mir-211	prostate cancer	down	MicroRNA-211 s
hsa-mir-211-5p	hepatocellular carcinoma
hsa-mir-211-5p	kidney cancer	down	miR-211-5p S
hsa-mir-211-5p	osteosarcoma
hsa-mir-212	cervical cancer
hsa-mir-212	colorectal cancer
hsa-mir-212	gastric cancer	down	miR-212 is downregulated and s
hsa-mir-212	gastric cancer
hsa-mir-212	hepatocellular carcinoma
hsa-mir-212	hepatocellular carcinoma
hsa-mir-212	hepatocellular carcinoma
hsa-mir-212	nasopharyngeal carcinoma
hsa-mir-212	non-small cell lung cancer	down	MicroRNA-212 functions as a tumor-s
hsa-mir-212	non-small cell lung cancer
hsa-mir-212	non-small cell lung cancer
hsa-mir-212	non-small cell lung cancer
hsa-mir-212	osteosarcoma
hsa-mir-212	osteosarcoma	down	MicroRNA-212 s
hsa-mir-212	ovarian cancer	down	MiR-212 exerts s
hsa-mir-212	pancreatic cancer
hsa-mir-212	pancreatic ductal adenocarcinoma
hsa-mir-212	pancreatic ductal adenocarcinoma
hsa-mir-212	prostate cancer
hsa-mir-212	prostate cancer
hsa-mir-212	thyroid cancer	down	Function of miR-212 as a tumor s
hsa-mir-212-3p	glioblastoma
hsa-mir-212-3p	hepatocellular carcinoma	down	MicroRNA-212-3p inhibits the Proliferation and Invasion of Human Hepatocellular Carcinoma Cells by S
hsa-mir-212-5p	acute myeloid leukemia
hsa-mir-214	bladder cancer	down	MicroRNA-214 S
hsa-mir-214	breast cancer
hsa-mir-214	breast cancer	down	Tumor-s
hsa-mir-214	breast cancer
hsa-mir-214	cervical cancer	down	MicroRNA-214 s
hsa-mir-214	cervical cancer
hsa-mir-214	cervical squamous cell carcinoma
hsa-mir-214	colon cancer	down	microRNA-214 functions as a tumor s
hsa-mir-214	colon cancer
hsa-mir-214	colorectal cancer	down	The FOXD3/miR-214/MED19 axis s
hsa-mir-214	esophageal cancer
hsa-mir-214	esophageal squamous cell carcinoma
hsa-mir-214	esophageal squamous cell carcinoma
hsa-mir-214	gastric cancer
hsa-mir-214	gastric cancer
hsa-mir-214	gastric cancer
hsa-mir-214	gastric cancer
hsa-mir-214	gastric cancer
hsa-mir-214	gastric cancer
hsa-mir-214	glioma
hsa-mir-214	glioma
hsa-mir-214	hepatocellular carcinoma	down	MicroRNA-214 s
hsa-mir-214	hepatocellular carcinoma	down	Dynamic regulation of unco
hsa-mir-214	hepatocellular carcinoma	down	MicroRNA-214 s
hsa-mir-214	hepatocellular carcinoma
hsa-mir-214	hepatocellular carcinoma
hsa-mir-214	hepatocellular carcinoma	down	MiR-214 inhibits cell growth in hepatocellular carcinoma through s
hsa-mir-214	hepatocellular carcinoma
hsa-mir-214	hepatocellular carcinoma
hsa-mir-214	hepatocellular carcinoma
hsa-mir-214	lung adenocarcinoma
hsa-mir-214	lung adenocarcinoma
hsa-mir-214	lung cancer
hsa-mir-214	malignant melanoma
hsa-mir-214	malignant melanoma
hsa-mir-214	multiple myeloma
hsa-mir-214	nasopharyngeal carcinoma
hsa-mir-214	nasopharyngeal carcinoma
hsa-mir-214	non-small cell lung cancer
hsa-mir-214	oral cancer
hsa-mir-214	osteosarcoma
hsa-mir-214	osteosarcoma
hsa-mir-214	ovarian cancer	down	MiR-214 s
hsa-mir-214	ovarian cancer
hsa-mir-214	ovarian cancer	down	MicroRNA-214 S
hsa-mir-214	pancreatic cancer
hsa-mir-214	pancreatic cancer
hsa-mir-214	papillary thyroid carcinoma
hsa-mir-214	primary cns lymphomas
hsa-mir-214	renal cell carcinoma
hsa-mir-214-3p	bladder cancer
hsa-mir-214-3p	breast cancer
hsa-mir-214-3p	esophageal cancer
hsa-mir-214-3p	gastric cancer
hsa-mir-214-3p	hepatocellular carcinoma
hsa-mir-214-3p	hepatocellular carcinoma
hsa-mir-214-3p	oral squamous cell carcinoma	down	LncRNA HOXA11-AS Promotes Proliferation and Cisplatin Resistance of Oral Squamous Cell Carcinoma by S
hsa-mir-214-5p	glioblastoma
hsa-mir-214-5p	hepatocellular carcinoma
hsa-mir-214-5p	hepatocellular carcinoma	down	miR-214-5p targets KLF5 and s
hsa-mir-214-5p	prostate cancer
hsa-mir-215	breast cancer	down	MicroRNA-215 acts as a tumor s
hsa-mir-215	cervical cancer
hsa-mir-215	colon cancer
hsa-mir-215	colon cancer
hsa-mir-215	colorectal cancer
hsa-mir-215	colorectal cancer
hsa-mir-215	gastric cancer
hsa-mir-215	gastric cancer
hsa-mir-215	gastric cancer
hsa-mir-215	gastric cancer
hsa-mir-215	gastric cancer
hsa-mir-215	gastric cancer
hsa-mir-215	glioma
hsa-mir-215	hepatocellular carcinoma
hsa-mir-215	hepatocellular carcinoma
hsa-mir-215	hepatocellular carcinoma
hsa-mir-215	non-small cell lung cancer	down	miR-215 s
hsa-mir-215	non-small cell lung cancer	down	miR-215 functions as a tumor s
hsa-mir-215	ovarian carcinoma
hsa-mir-215	pancreatic cancer	down	MicroRNA-215 functions as a tumor s
hsa-mir-215-3p	cervical cancer	down	MicroRNA-215-3p s
hsa-mir-215-5p	colorectal cancer	down	MiR-215-5p is a tumor s
hsa-mir-216a	breast cancer	down	MicroRNA-216a s
hsa-mir-216a	colorectal cancer
hsa-mir-216a	colorectal cancer	down	Down-regulation of KIAA1199/CEMIP by miR-216a s
hsa-mir-216a	esophageal squamous cell carcinoma
hsa-mir-216a	gastric cancer
hsa-mir-216a	gastric cancer
hsa-mir-216a	hepatocellular carcinoma
hsa-mir-216a	hepatocellular carcinoma
hsa-mir-216a	oral squamous cell carcinoma
hsa-mir-216a	pancreatic cancer
hsa-mir-216a	pancreatic cancer
hsa-mir-216a	pancreatic cancer
hsa-mir-216a	renal cell carcinoma	down	MiR-216a exerts tumor-s
hsa-mir-216a-3p	colorectal cancer
hsa-mir-216a-3p	pancreatic ductal adenocarcinoma
hsa-mir-216a-5p	colorectal cancer	down	Downregulation of miR-216a-5p by long noncoding RNA PVT1 s
hsa-mir-216a-5p	pancreatic ductal adenocarcinoma
hsa-mir-216a-5p	renal cell carcinoma
hsa-mir-216a-5p	small cell lung cancer
hsa-mir-216a-5p	uveal melanoma
hsa-mir-216b	acute myeloid leukemia
hsa-mir-216b	breast cancer
hsa-mir-216b	breast cancer	down	miR-216b s
hsa-mir-216b	cervical cancer
hsa-mir-216b	colorectal cancer	down	MiR-216b functions as a tumor s
hsa-mir-216b	esophageal squamous cell carcinoma
hsa-mir-216b	gastric adenocarcinoma
hsa-mir-216b	gastric adenocarcinoma
hsa-mir-216b	gastric cancer
hsa-mir-216b	glioma	down	miR-216b inhibits glioma cell migration and invasion through s
hsa-mir-216b	glioma
hsa-mir-216b	hepatocellular carcinoma
hsa-mir-216b	malignant melanoma
hsa-mir-216b	nasopharyngeal carcinoma	down	miR-216b s
hsa-mir-216b	nasopharyngeal carcinoma	down	[miR-216b s
hsa-mir-216b	ovarian cancer
hsa-mir-216b	pancreatic cancer
hsa-mir-216b	renal clear cell carcinoma
hsa-mir-216b-3p	lung adenocarcinoma
hsa-mir-216b-3p	pancreatic ductal adenocarcinoma
hsa-mir-216b-5p	pancreatic cancer	down	MicroRNA-216b-5p Functions as a Tumor-s
hsa-mir-216b-5p	pancreatic ductal adenocarcinoma
hsa-mir-217	acute myeloid leukemia
hsa-mir-217	breast cancer
hsa-mir-217	cervical cancer	down	MicroRNA-217 functions as a tumor s
hsa-mir-217	colorectal cancer
hsa-mir-217	gastric cancer
hsa-mir-217	gastric cancer	down	The MicroRNA-217 Functions as a Potential Tumor S
hsa-mir-217	gastric cancer	down	MicroRNA-217 s
hsa-mir-217	gastric cancer
hsa-mir-217	gastric cancer
hsa-mir-217	glioblastoma
hsa-mir-217	glioma
hsa-mir-217	glioma
hsa-mir-217	hepatocellular carcinoma
hsa-mir-217	hepatocellular carcinoma
hsa-mir-217	hepatocellular carcinoma	down	miR-217 inhibits invasion of hepatocellular carcinoma cells through direct s
hsa-mir-217	hepatocellular carcinoma
hsa-mir-217	laryngeal cancer
hsa-mir-217	liver cancer
hsa-mir-217	lung cancer	down	MicroRNA-217 functions as a tumour s
hsa-mir-217	malignant melanoma
hsa-mir-217	non-small cell lung cancer
hsa-mir-217	non-small cell lung cancer
hsa-mir-217	osteosarcoma
hsa-mir-217	osteosarcoma	down	MicroRNA-217 regulates WASF3 expression and s
hsa-mir-217	osteosarcoma	down	The microRNA-217 functions as a tumor s
hsa-mir-217	ovarian cancer	down	MiR-217 Inhibits M2-Like Macrophage Polarization by S
hsa-mir-217	pancreatic ductal adenocarcinoma
hsa-mir-217	pancreatic ductal adenocarcinoma	down	The miR-217 microRNA functions as a potential tumor s
hsa-mir-217	renal cell carcinoma
hsa-mir-218	breast cancer
hsa-mir-218	breast cancer	down	Tumor-s
hsa-mir-218	breast cancer	down	CCAT1 promotes triple-negative breast cancer progression by s
hsa-mir-218	cervical cancer
hsa-mir-218	cervical cancer
hsa-mir-218	cervical cancer
hsa-mir-218	cervical cancer
hsa-mir-218	cervical squamous cell carcinoma	down	Tumor s
hsa-mir-218	chondrosarcoma
hsa-mir-218	choriocarcinoma
hsa-mir-218	colorectal cancer
hsa-mir-218	colorectal cancer
hsa-mir-218	colorectal cancer
hsa-mir-218	colorectal cancer
hsa-mir-218	colorectal cancer
hsa-mir-218	colorectal cancer
hsa-mir-218	esophageal cancer
hsa-mir-218	esophageal cancer	down	MiR-218 s
hsa-mir-218	esophageal squamous cell carcinoma
hsa-mir-218	esophageal squamous cell carcinoma
hsa-mir-218	gastric cancer
hsa-mir-218	gastric cancer
hsa-mir-218	gastric cancer
hsa-mir-218	gastric cancer	down	MicroRNA-218 is
hsa-mir-218	gastric cancer	down	Thermo-chemotherapy Induced miR-218
hsa-mir-218	gastric cancer	down	miR-218 s
hsa-mir-218	gastric cancer
hsa-mir-218	gastric cancer	down	miR-218 s
hsa-mir-218	gastric cancer
hsa-mir-218	gastrointestinal stromal tumor
hsa-mir-218	glioma
hsa-mir-218	glioma
hsa-mir-218	glioma
hsa-mir-218	head and neck squamous cell carcinoma	down	Tumor s
hsa-mir-218	hepatocellular carcinoma
hsa-mir-218	hepatocellular carcinoma
hsa-mir-218	hepatocellular carcinoma
hsa-mir-218	laryngeal squamous cell carcinoma
hsa-mir-218	lung adenocarcinoma	down	miR-218 s
hsa-mir-218	lung cancer
hsa-mir-218	lung cancer	down	MicroRNA-218 functions as a tumor s
hsa-mir-218	lung cancer
hsa-mir-218	lung cancer	down	ADAM9 enhances CDCP1 protein expression by s
hsa-mir-218	lung cancer
hsa-mir-218	lung squamous cell carcinoma	down	Regulation of TPD52 by antitumor microRNA-218 s
hsa-mir-218	lung squamous cell carcinoma
hsa-mir-218	malignant melanoma
hsa-mir-218	nasopharyngeal cancer	down	MiR-218 s
hsa-mir-218	non-small cell lung cancer
hsa-mir-218	oral cancer	down	The tumor s
hsa-mir-218	oral cancer
hsa-mir-218	osteosarcoma
hsa-mir-218	osteosarcoma
hsa-mir-218	osteosarcoma	down	miR-218 s
hsa-mir-218	ovarian cancer
hsa-mir-218	pancreatic ductal adenocarcinoma
hsa-mir-218	prostate cancer	down	Tumor-s
hsa-mir-218	prostate cancer
hsa-mir-218	prostate cancer
hsa-mir-218	prostate cancer	down	Tumor-s
hsa-mir-218	renal cell carcinoma
hsa-mir-218	renal cell carcinoma	down	miR-218 s
hsa-mir-218	renal clear cell carcinoma
hsa-mir-218	renal clear cell carcinoma
hsa-mir-218-5p	cervical cancer
hsa-mir-218-5p	gallbladder carcinoma
hsa-mir-218-5p	glioma	down	miR-218-5p inhibits the stem cell properties and invasive ability of the A2B5+CD133- subgro
hsa-mir-218-5p	non-small cell lung cancer	down	Tumor-s
hsa-mir-219	glioma	down	MicroRNA-219 exerts a tumor s
hsa-mir-219	non-small cell lung cancer
hsa-mir-219-5p	chordoma
hsa-mir-219-5p	colorectal cancer	down	MicroRNA-219-5p functions as a?tumor s
hsa-mir-219-5p	colorectal cancer	down	miR-219-5p s
hsa-mir-219-5p	colorectal cancer
hsa-mir-219-5p	esophageal squamous cell carcinoma	down	MiR-219-5p s
hsa-mir-219-5p	glioblastoma
hsa-mir-219-5p	glioma
hsa-mir-219-5p	hepatocellular carcinoma
hsa-mir-219-5p	hepatocellular carcinoma	down	Propofol-induced miR-219-5p inhibits growth and invasion of hepatocellular carcinoma through s
hsa-mir-219-5p	papillary thyroid carcinoma
hsa-mir-219a-5p	breast cancer
hsa-mir-22	bladder cancer	down	MiR-22 s
hsa-mir-22	breast cancer	down	miR-22 s
hsa-mir-22	breast cancer
hsa-mir-22	breast cancer
hsa-mir-22	breast cancer
hsa-mir-22	breast cancer	down	MicroRNA-22 S
hsa-mir-22	colon cancer
hsa-mir-22	colon cancer	down	miRNA-22 s
hsa-mir-22	colorectal cancer
hsa-mir-22	colorectal cancer
hsa-mir-22	esophageal squamous cell carcinoma
hsa-mir-22	esophageal squamous cell carcinoma
hsa-mir-22	gastric cancer
hsa-mir-22	gastric cancer	down	miR-22 s
hsa-mir-22	gastric cancer	down	microRNA-22 acts as a metastasis s
hsa-mir-22	gastric cancer
hsa-mir-22	hepatocellular carcinoma
hsa-mir-22	hepatocellular carcinoma
hsa-mir-22	hepatocellular carcinoma
hsa-mir-22	kidney cancer	down	MicroRNA-22 functions as a tumor s
hsa-mir-22	liver cancer
hsa-mir-22	lung cancer	down	Tumor s
hsa-mir-22	lung cancer
hsa-mir-22	malignant melanoma
hsa-mir-22	multiple myeloma	down	miR-22 s
hsa-mir-22	osteosarcoma
hsa-mir-22	osteosarcoma
hsa-mir-22	osteosarcoma	down	Roles of microRNA-22 in S
hsa-mir-22	prostate cancer
hsa-mir-22	prostate cancer
hsa-mir-22	t-cell lymphoma	down	miRNA-22 s
hsa-mir-22-3p	hepatocellular carcinoma	down	Berberine
hsa-mir-220a	oral squamous cell carcinoma
hsa-mir-221	anaplastic thyroid carcinoma
hsa-mir-221	bladder cancer
hsa-mir-221	bladder cancer
hsa-mir-221	brain cancer
hsa-mir-221	breast cancer
hsa-mir-221	breast cancer
hsa-mir-221	breast cancer
hsa-mir-221	breast cancer
hsa-mir-221	breast cancer
hsa-mir-221	breast cancer
hsa-mir-221	breast cancer
hsa-mir-221	breast cancer
hsa-mir-221	cervical cancer
hsa-mir-221	cervical cancer
hsa-mir-221	colon carcinoma
hsa-mir-221	colorectal cancer
hsa-mir-221	colorectal cancer
hsa-mir-221	colorectal cancer
hsa-mir-221	colorectal cancer
hsa-mir-221	colorectal cancer
hsa-mir-221	extrahepatic cholangiocarcinoma
hsa-mir-221	follicular thyroid carcinoma
hsa-mir-221	gastric cancer
hsa-mir-221	gastric cancer
hsa-mir-221	gastric cancer
hsa-mir-221	gastric cancer
hsa-mir-221	gastrointestinal stromal tumor
hsa-mir-221	gastrointestinal stromal tumor
hsa-mir-221	glioblastoma
hsa-mir-221	glioma
hsa-mir-221	glioma
hsa-mir-221	glioma
hsa-mir-221	glioma
hsa-mir-221	glioma
hsa-mir-221	glioma	down	S
hsa-mir-221	hepatocellular carcinoma
hsa-mir-221	hepatocellular carcinoma
hsa-mir-221	hepatocellular carcinoma
hsa-mir-221	hepatocellular carcinoma
hsa-mir-221	hepatocellular carcinoma
hsa-mir-221	hepatocellular carcinoma
hsa-mir-221	hepatocellular carcinoma
hsa-mir-221	hepatocellular carcinoma
hsa-mir-221	hepatocellular carcinoma
hsa-mir-221	hepatocellular carcinoma
hsa-mir-221	hepatocellular carcinoma
hsa-mir-221	hepatocellular carcinoma
hsa-mir-221	hepatocellular carcinoma
hsa-mir-221	laryngeal squamous cell carcinoma
hsa-mir-221	liver cancer
hsa-mir-221	liver cancer
hsa-mir-221	malignant melanoma
hsa-mir-221	medulloblastoma
hsa-mir-221	non-small cell lung cancer
hsa-mir-221	non-small cell lung cancer
hsa-mir-221	non-small cell lung cancer
hsa-mir-221	non-small cell lung cancer
hsa-mir-221	non-small cell lung cancer
hsa-mir-221	non-small cell lung cancer
hsa-mir-221	oral squamous cell carcinoma
hsa-mir-221	oral squamous cell carcinoma
hsa-mir-221	oral squamous cell carcinoma
hsa-mir-221	oral squamous cell carcinoma
hsa-mir-221	osteosarcoma
hsa-mir-221	osteosarcoma
hsa-mir-221	osteosarcoma
hsa-mir-221	ovarian cancer
hsa-mir-221	ovarian cancer
hsa-mir-221	ovarian cancer
hsa-mir-221	pancreatic cancer
hsa-mir-221	pancreatic cancer
hsa-mir-221	papillary thyroid carcinoma
hsa-mir-221	papillary thyroid carcinoma
hsa-mir-221	papillary thyroid carcinoma
hsa-mir-221	papillary thyroid carcinoma
hsa-mir-221	papillary thyroid carcinoma
hsa-mir-221	papillary thyroid carcinoma
hsa-mir-221	papillary thyroid carcinoma
hsa-mir-221	papillary thyroid carcinoma
hsa-mir-221	prostate cancer
hsa-mir-221	prostate cancer
hsa-mir-221	prostate cancer	down	MicroRNA expression signature of castration-resistant prostate cancer: the microRNA-221/222 cluster functions as a tumour s
hsa-mir-221	prostate cancer
hsa-mir-221	retinoblastoma
hsa-mir-221	squamous carcinoma
hsa-mir-221*	gastric cancer
hsa-mir-221-3p	cervical squamous cell carcinoma
hsa-mir-221-3p	hepatocellular carcinoma
hsa-mir-221-3p	hepatocellular carcinoma
hsa-mir-221-3p	hepatocellular carcinoma
hsa-mir-221-3p	pancreatic cancer
hsa-mir-222	acute myeloid leukemia
hsa-mir-222	adenoid cystic carcinoma
hsa-mir-222	anaplastic thyroid carcinoma
hsa-mir-222	bladder cancer
hsa-mir-222	bladder cancer
hsa-mir-222	breast cancer
hsa-mir-222	breast cancer
hsa-mir-222	breast cancer
hsa-mir-222	breast cancer
hsa-mir-222	breast cancer
hsa-mir-222	cervical cancer
hsa-mir-222	chondrosarcoma
hsa-mir-222	chordoma
hsa-mir-222	colorectal cancer
hsa-mir-222	gastric cancer
hsa-mir-222	gastric cancer
hsa-mir-222	gastric cancer
hsa-mir-222	gastric cancer
hsa-mir-222	gastric cancer
hsa-mir-222	gastric cancer
hsa-mir-222	gastric cancer
hsa-mir-222	gastric cancer
hsa-mir-222	gastrointestinal stromal tumor
hsa-mir-222	gastrointestinal stromal tumor
hsa-mir-222	glioblastoma
hsa-mir-222	glioma
hsa-mir-222	glioma
hsa-mir-222	glioma
hsa-mir-222	hepatocellular carcinoma
hsa-mir-222	hepatocellular carcinoma
hsa-mir-222	hepatocellular carcinoma
hsa-mir-222	hepatocellular carcinoma
hsa-mir-222	hepatocellular carcinoma
hsa-mir-222	malignant melanoma
hsa-mir-222	medulloblastoma
hsa-mir-222	nasopharyngeal carcinoma
hsa-mir-222	non-small cell lung cancer
hsa-mir-222	non-small cell lung cancer
hsa-mir-222	non-small cell lung cancer
hsa-mir-222	oral squamous cell carcinoma
hsa-mir-222	oral squamous cell carcinoma
hsa-mir-222	ovarian carcinoma
hsa-mir-222	pancreatic cancer
hsa-mir-222	pancreatic cancer
hsa-mir-222	papillary thyroid carcinoma
hsa-mir-222	papillary thyroid carcinoma
hsa-mir-222	papillary thyroid carcinoma
hsa-mir-222	papillary thyroid carcinoma
hsa-mir-222	papillary thyroid carcinoma
hsa-mir-222	papillary thyroid carcinoma
hsa-mir-222	papillary thyroid carcinoma
hsa-mir-222	papillary thyroid carcinoma
hsa-mir-222	papillary thyroid carcinoma
hsa-mir-222	prostate cancer
hsa-mir-222	prostate cancer
hsa-mir-222	prostate cancer	down	MicroRNA expression signature of castration-resistant prostate cancer: the microRNA-221/222 cluster functions as a tumour s
hsa-mir-222	retinoblastoma
hsa-mir-222-3p	endometrial cancer
hsa-mir-222-3p	hepatocellular carcinoma
hsa-mir-222-3p	oral cancer
hsa-mir-222-3p	osteosarcoma
hsa-mir-223	acute myeloid leukemia
hsa-mir-223	acute myeloid leukemia
hsa-mir-223	bladder cancer
hsa-mir-223	breast cancer
hsa-mir-223	breast cancer
hsa-mir-223	cervical cancer
hsa-mir-223	chronic lymphocytic leukemia
hsa-mir-223	chronic lymphocytic leukemia
hsa-mir-223	chronic myelogenous leukemia
hsa-mir-223	colon cancer
hsa-mir-223	colonic adenocarcinoma
hsa-mir-223	colorectal cancer
hsa-mir-223	colorectal cancer
hsa-mir-223	colorectal cancer
hsa-mir-223	colorectal cancer
hsa-mir-223	colorectal cancer
hsa-mir-223	colorectal cancer
hsa-mir-223	endometrial cancer	down	MiR-223 s
hsa-mir-223	esophageal adenocarcinoma
hsa-mir-223	esophageal cancer
hsa-mir-223	esophageal squamous cell carcinoma
hsa-mir-223	gallbladder carcinoma
hsa-mir-223	gastric cancer
hsa-mir-223	gastric cancer
hsa-mir-223	gastric cancer
hsa-mir-223	gastric cancer
hsa-mir-223	glioblastoma
hsa-mir-223	glioblastoma
hsa-mir-223	hepatocellular carcinoma
hsa-mir-223	hepatocellular carcinoma
hsa-mir-223	hepatocellular carcinoma
hsa-mir-223	hepatocellular carcinoma
hsa-mir-223	hepatocellular carcinoma
hsa-mir-223	kidney cancer
hsa-mir-223	lung cancer	down	miR-223 functions as a potent tumor s
hsa-mir-223	lung cancer
hsa-mir-223	mantle cell lymphoma
hsa-mir-223	mantle cell lymphoma
hsa-mir-223	mantle cell lymphoma
hsa-mir-223	mantle cell lymphoma
hsa-mir-223	mucinous cystadenocarcinoma
hsa-mir-223	nasopharyngeal carcinoma	down	MiR-223 targeting MAFB s
hsa-mir-223	non-small cell lung cancer
hsa-mir-223	oral cancer
hsa-mir-223	oral squamous cell carcinoma
hsa-mir-223	oral squamous cell carcinoma
hsa-mir-223	osteosarcoma
hsa-mir-223	pancreatic ductal adenocarcinoma
hsa-mir-223	prostate cancer
hsa-mir-223	prostate cancer	down	Tumor-s
hsa-mir-223	splenic marginal zone lymphoma
hsa-mir-223	splenic marginal zone lymphoma
hsa-mir-223-3p	bladder cancer
hsa-mir-223-3p	bladder cancer
hsa-mir-223-3p	clear cell renal cell cancer
hsa-mir-223-3p	esophageal squamous cell carcinoma
hsa-mir-223-3p	gastric cancer
hsa-mir-223-3p	glioblastoma
hsa-mir-223-3p	head and neck squamous cell carcinoma
hsa-mir-223-3p	lung squamous cell carcinoma	down	MiR-223-3p functions as a tumor s
hsa-mir-223-3p	osteosarcoma
hsa-mir-223-3p	ovarian cancer
hsa-mir-223-3p	prostate cancer
hsa-mir-223-5p	non-small cell lung cancer	down	MiR-223-5p s
hsa-mir-224	bladder cancer
hsa-mir-224	breast cancer
hsa-mir-224	breast cancer
hsa-mir-224	cervical cancer
hsa-mir-224	cervical cancer
hsa-mir-224	colorectal cancer
hsa-mir-224	colorectal cancer
hsa-mir-224	colorectal cancer
hsa-mir-224	colorectal cancer	down	MicroRNA-224 s
hsa-mir-224	colorectal cancer
hsa-mir-224	colorectal cancer
hsa-mir-224	colorectal cancer
hsa-mir-224	esophageal squamous cell carcinoma	tissue;	Expression and role of oncogenic miRNA-224 in esophageal squamous cell carcinoma.
hsa-mir-224	esophageal squamous cell carcinoma
hsa-mir-224	gastric cancer
hsa-mir-224	glioma
hsa-mir-224	hepatocellular carcinoma
hsa-mir-224	hepatocellular carcinoma
hsa-mir-224	hepatocellular carcinoma
hsa-mir-224	hepatocellular carcinoma
hsa-mir-224	hepatocellular carcinoma
hsa-mir-224	hepatocellular carcinoma
hsa-mir-224	hepatocellular carcinoma
hsa-mir-224	hepatocellular carcinoma
hsa-mir-224	meningioma
hsa-mir-224	non-small cell lung cancer
hsa-mir-224	non-small cell lung cancer
hsa-mir-224	non-small cell lung cancer
hsa-mir-224	non-small cell lung cancer
hsa-mir-224	osteosarcoma
hsa-mir-224	ovarian cancer
hsa-mir-224	pancreatic cancer
hsa-mir-224	prostate cancer
hsa-mir-224	prostate cancer	down	Tumour-s
hsa-mir-224	prostate cancer
hsa-mir-224	renal clear cell carcinoma
hsa-mir-224	renal clear cell carcinoma
hsa-mir-224-3p	cervical cancer
hsa-mir-224-5p	breast cancer
hsa-mir-224-5p	ovarian cancer
hsa-mir-224-5p	uveal melanoma
"hsa-mir-2278	chronic myelogenous leukemia	down	Revealing genome-wide mRNA and microRNA expression patterns in leukemic cells highlighted ""hsa-miR-2278"" as a tumor s"
hsa-mir-2392	gastric cancer	down	MiR-2392 s
hsa-mir-23a	bladder cancer
hsa-mir-23a	breast cancer
hsa-mir-23a	breast cancer
hsa-mir-23a	colon carcinoma
hsa-mir-23a	colorectal cancer
hsa-mir-23a	colorectal cancer
hsa-mir-23a	colorectal cancer
hsa-mir-23a	colorectal cancer
hsa-mir-23a	gastric adenocarcinoma
hsa-mir-23a	gastric adenocarcinoma
hsa-mir-23a	gastric cancer
hsa-mir-23a	gastric cancer
hsa-mir-23a	gastric cancer
hsa-mir-23a	gastric cancer
hsa-mir-23a	gastric cancer
hsa-mir-23a	glioma
hsa-mir-23a	glioma
hsa-mir-23a	hepatocellular carcinoma
hsa-mir-23a	hepatocellular carcinoma
hsa-mir-23a	hepatocellular carcinoma
hsa-mir-23a	laryngeal cancer
hsa-mir-23a	laryngeal carcinoma
hsa-mir-23a	neuroblastoma
hsa-mir-23a	non-small cell lung cancer
hsa-mir-23a	osteosarcoma	down	MiR-23a Functions as a Tumor S
hsa-mir-23a	osteosarcoma	down	miR-23a s
hsa-mir-23a	pancreatic cancer
hsa-mir-23a	papillary thyroid carcinoma
hsa-mir-23a	prostate cancer	down	Downregulation of microRNA-23a s
hsa-mir-23a-3p	acute myeloid leukemia
hsa-mir-23a-3p	oral squamous cell carcinoma	down	miR-23a-3p s
hsa-mir-23a-3p	renal cell carcinoma
hsa-mir-23a-5p	pancreatic ductal adenocarcinoma	down	miR-23a-5p inhibits cell proliferation and invasion in pancreatic ductal adenocarcinoma by s
hsa-mir-23b	bladder cancer
hsa-mir-23b	bladder cancer	down	MicroRNA-23b functions as a tumor s
hsa-mir-23b	breast cancer
hsa-mir-23b	cervical cancer	down	MicroRNA-23b s
hsa-mir-23b	cervical cancer	down	miR-23b as a potential tumor s
hsa-mir-23b	cervical cancer
hsa-mir-23b	chondrosarcoma
hsa-mir-23b	colorectal cancer
hsa-mir-23b	endometrial cancer
hsa-mir-23b	gastric cancer
hsa-mir-23b	gastric cancer
hsa-mir-23b	gastric cancer
hsa-mir-23b	gastric cancer
hsa-mir-23b	gastric cancer
hsa-mir-23b	glioma
hsa-mir-23b	hepatocellular carcinoma	down	microRNA-23b s
hsa-mir-23b	hepatocellular carcinoma
hsa-mir-23b	lung carcinoma	down	miR-23b s
hsa-mir-23b	nasopharyngeal carcinoma
hsa-mir-23b	non-small cell lung cancer	down	PDGFR-modulated miR-23b cluster and miR-125a-5p s
hsa-mir-23b	oral squamous cell carcinoma	down	The tumor-s
hsa-mir-23b	ovarian cancer
hsa-mir-23b	prostate cancer	down	miR-23b represses proto-oncogene Src kinase and functions as methylation-silenced tumor s
hsa-mir-23b	renal cell carcinoma
hsa-mir-23b-3p	osteosarcoma
hsa-mir-23b-5p	acute myeloid leukemia
hsa-mir-23c	hepatocellular carcinoma	down	miR-23c s
hsa-mir-24	breast cancer
hsa-mir-24	breast carcinoma
hsa-mir-24	gastric cancer	down	Tumor s
hsa-mir-24	gastric cancer
hsa-mir-24	glioma
hsa-mir-24	glioma
hsa-mir-24	hepatocellular carcinoma
hsa-mir-24	hepatocellular carcinoma
hsa-mir-24	hepatocellular carcinoma
hsa-mir-24	laryngeal squamous cell carcinoma	down	miR-24 functions as a tumor s
hsa-mir-24	lung cancer
hsa-mir-24	lung carcinoma
hsa-mir-24	nasopharyngeal carcinoma
hsa-mir-24	nasopharyngeal carcinoma	down	MiR-24 functions as a tumor s
hsa-mir-24	nasopharyngeal carcinoma
hsa-mir-24	nasopharyngeal carcinoma
hsa-mir-24	non-small cell lung cancer
hsa-mir-24	non-small cell lung cancer
hsa-mir-24	oral squamous cell carcinoma
hsa-mir-24	oral squamous cell carcinoma
hsa-mir-24	osteosarcoma
hsa-mir-24	prostate cancer
hsa-mir-24-2-5p	breast cancer
hsa-mir-24-3p	breast cancer
hsa-mir-24-3p	colorectal cancer
hsa-mir-24-3p	glioma
hsa-mir-24-3p	hepatocellular carcinoma
hsa-mir-24-3p	Hodgkin's lymphoma
hsa-mir-24-3p	lung adenocarcinoma
hsa-mir-24-3p	lung cancer
hsa-mir-25	astrocytoma
hsa-mir-25	cervical carcinoma
hsa-mir-25	colon cancer	down	MicroRNA-25 functions as a potential tumor s
hsa-mir-25	colorectal cancer
hsa-mir-25	colorectal cancer
hsa-mir-25	endometrial cancer
hsa-mir-25	esophageal squamous cell carcinoma
hsa-mir-25	esophageal squamous cell carcinoma
hsa-mir-25	gastric cancer
hsa-mir-25	gastric cancer
hsa-mir-25	gastric cancer
hsa-mir-25	glioblastoma
hsa-mir-25	glioma
hsa-mir-25	head and neck squamous cell carcinoma
hsa-mir-25	hepatocellular carcinoma
hsa-mir-25	hepatocellular carcinoma
hsa-mir-25	hepatocellular carcinoma
hsa-mir-25	hepatocellular carcinoma
hsa-mir-25	malignant melanoma
hsa-mir-25	malignant melanoma
hsa-mir-25	non-small cell lung cancer
hsa-mir-25	non-small cell lung cancer
hsa-mir-25	non-small cell lung cancer
hsa-mir-25	non-small cell lung cancer
hsa-mir-25	non-small cell lung cancer
hsa-mir-25	non-small cell lung cancer
hsa-mir-25	ovarian cancer
hsa-mir-25	ovarian cancer
hsa-mir-25	ovarian cancer
hsa-mir-25	prostate cancer
hsa-mir-25	small cell lung cancer
hsa-mir-25-3p	glioma
hsa-mir-25-3p	osteosarcoma
hsa-mir-25-3p	retinoblastoma
hsa-mir-26a	acute myeloid leukemia
hsa-mir-26a	bladder cancer
hsa-mir-26a	breast cancer
hsa-mir-26a	breast cancer
hsa-mir-26a	breast cancer	down	MicroRNA-26a inhibits proliferation by targeting high mobility gro
hsa-mir-26a	breast cancer	down	miR-26a s
hsa-mir-26a	cholangiocarcinoma
hsa-mir-26a	chronic myelogenous leukemia
hsa-mir-26a	colon cancer
hsa-mir-26a	colorectal cancer	down	Tumor-s
hsa-mir-26a	esophageal squamous cell carcinoma
hsa-mir-26a	esophageal squamous cell carcinoma	down	miR-26a and miR-26b inhibit esophageal squamous cancer cell proliferation through s
hsa-mir-26a	gastric cancer
hsa-mir-26a	gastric cancer	down	miR-26a S
hsa-mir-26a	glioblastoma
hsa-mir-26a	glioma
hsa-mir-26a	glioma
hsa-mir-26a	glioma
hsa-mir-26a	hepatocellular carcinoma
hsa-mir-26a	hepatocellular carcinoma
hsa-mir-26a	hepatocellular carcinoma
hsa-mir-26a	hepatocellular carcinoma	down	MicroRNA-26a s
hsa-mir-26a	hepatocellular carcinoma	down	Tumor-specific expression of microRNA-26a s
hsa-mir-26a	hepatocellular carcinoma	down	IL-6
hsa-mir-26a	hepatocellular carcinoma	down	MicroRNA-26a s
hsa-mir-26a	hepatocellular carcinoma
hsa-mir-26a	hepatocellular carcinoma	down	MicroRNA-26a s
hsa-mir-26a	hepatocellular carcinoma
hsa-mir-26a	hepatocellular carcinoma	down	microRNA-26a s
hsa-mir-26a	laryngeal squamous cell carcinoma
hsa-mir-26a	malignant melanoma
hsa-mir-26a	multiple myeloma	down	MicroRNA-26a inhibits multiple myeloma cell growth by s
hsa-mir-26a	oral squamous cell carcinoma
hsa-mir-26a	osteosarcoma
hsa-mir-26a	osteosarcoma	down	miR-26a s
hsa-mir-26a	osteosarcoma
hsa-mir-26a	osteosarcoma
hsa-mir-26a	ovarian cancer
hsa-mir-26a	papillary thyroid carcinoma
hsa-mir-26a	primary thyroid lymphoma
hsa-mir-26a	prostate cancer
hsa-mir-26a	prostate cancer
hsa-mir-26a	prostate cancer
hsa-mir-26a	prostate cancer
hsa-mir-26a	renal cell carcinoma	down	Regulation of the collagen cross-linking enzymes LOXL2 and PLOD2 by tumor-s
hsa-mir-26a	thyroid cancer
hsa-mir-26a-5p	acute myeloid leukemia
hsa-mir-26a-5p	bladder cancer	down	Tumour-s
hsa-mir-26a-5p	breast cancer	down	MicroRNA-26a-5p inhibits breast cancer cell growth by s
hsa-mir-26a-5p	colorectal cancer
hsa-mir-26a-5p	hepatocellular carcinoma	down	miR-26a-5p s
hsa-mir-26a-5p	hepatocellular carcinoma
hsa-mir-26b	b-cell lymphoma
hsa-mir-26b	bladder cancer
hsa-mir-26b	breast cancer
hsa-mir-26b	breast cancer
hsa-mir-26b	breast cancer
hsa-mir-26b	cervical cancer
hsa-mir-26b	colorectal cancer
hsa-mir-26b	colorectal cancer	down	Tumor-s
hsa-mir-26b	colorectal cancer
hsa-mir-26b	esophageal squamous cell carcinoma	down	miR-26a and miR-26b inhibit esophageal squamous cancer cell proliferation through s
hsa-mir-26b	gastric cancer
hsa-mir-26b	gastric cancer
hsa-mir-26b	gastric cancer
hsa-mir-26b	glioblastoma	down	MiR-26b s
hsa-mir-26b	glioma
hsa-mir-26b	hepatocellular carcinoma
hsa-mir-26b	hepatocellular carcinoma
hsa-mir-26b	hepatocellular carcinoma
hsa-mir-26b	laryngeal carcinoma
hsa-mir-26b	lung cancer
hsa-mir-26b	malignant melanoma	down	MiR-26b inhibits melanoma cell proliferation and enhances apoptosis by s
hsa-mir-26b	nasopharyngeal carcinoma
hsa-mir-26b	non-small cell lung cancer
hsa-mir-26b	non-small cell lung cancer
hsa-mir-26b	non-small cell lung cancer	down	MicroRNA-26b s
hsa-mir-26b	oral squamous cell carcinoma
hsa-mir-26b	osteosarcoma
hsa-mir-26b	osteosarcoma
hsa-mir-26b	prostate cancer
hsa-mir-26b	prostate cancer
hsa-mir-26b	renal cell carcinoma	down	Regulation of the collagen cross-linking enzymes LOXL2 and PLOD2 by tumor-s
hsa-mir-26b	small cell lung cancer	down	MicroRNA-26b s
hsa-mir-26b-5p	bladder cancer	down	Tumour-s
hsa-mir-26b-5p	gastric cancer
hsa-mir-26b-5p	hepatocellular carcinoma
hsa-mir-26b-5p	multiple myeloma	down	miR-26b-5p s
hsa-mir-27a	acute leukemia	down	MiR-27a functions as a tumor s
hsa-mir-27a	acute myeloid leukemia
hsa-mir-27a	breast cancer
hsa-mir-27a	breast cancer
hsa-mir-27a	breast cancer
hsa-mir-27a	cervical adenocarcinoma
hsa-mir-27a	cervical cancer
hsa-mir-27a	chronic myelogenous leukemia
hsa-mir-27a	colorectal cancer
hsa-mir-27a	colorectal cancer	down	Tumor S
hsa-mir-27a	colorectal cancer
hsa-mir-27a	esophageal cancer
hsa-mir-27a	esophageal squamous cell carcinoma	down	microRNA-27a functions as a tumor s
hsa-mir-27a	esophageal squamous cell carcinoma
hsa-mir-27a	esophageal squamous cell carcinoma
hsa-mir-27a	esophageal squamous cell carcinoma
hsa-mir-27a	gastric adenocarcinoma
hsa-mir-27a	gastric cancer
hsa-mir-27a	gastric cancer
hsa-mir-27a	gastric cancer
hsa-mir-27a	glioma
hsa-mir-27a	glioma
hsa-mir-27a	glioma
hsa-mir-27a	hepatocellular carcinoma
hsa-mir-27a	hepatocellular carcinoma
hsa-mir-27a	laryngeal carcinoma
hsa-mir-27a	liver cancer
hsa-mir-27a	lung cancer
hsa-mir-27a	malignant melanoma
hsa-mir-27a	multiple myeloma
hsa-mir-27a	non-small cell lung cancer
hsa-mir-27a	osteosarcoma
hsa-mir-27a	osteosarcoma
hsa-mir-27a	osteosarcoma
hsa-mir-27a	ovarian cancer
hsa-mir-27a	ovarian cancer
hsa-mir-27a	ovarian cancer
hsa-mir-27a	ovarian cancer
hsa-mir-27a	pancreatic cancer
hsa-mir-27a	pancreatic ductal adenocarcinoma
hsa-mir-27a	prostate cancer	down	Androgen-induced miR-27A acted as a tumor s
hsa-mir-27a	renal cell carcinoma	down	MicroRNA-27a functions as a tumor s
hsa-mir-27a	renal cell carcinoma
hsa-mir-27a	small cell lung cancer
hsa-mir-27a	squamous carcinoma
hsa-mir-27a*	head and neck squamous cell carcinoma
hsa-mir-27a-3p	colorectal cancer
hsa-mir-27a-3p	esophageal squamous cell carcinoma
hsa-mir-27a-3p	gastric cancer
hsa-mir-27a-3p	glioma
hsa-mir-27a-3p	hepatocellular carcinoma
hsa-mir-27a-3p	hepatocellular carcinoma	down	miR-27a-3p s
hsa-mir-27a-3p	nasopharyngeal carcinoma
hsa-mir-27a-3p	oral squamous cell carcinoma
hsa-mir-27b	acute myeloid leukemia
hsa-mir-27b	breast cancer
hsa-mir-27b	cervical cancer
hsa-mir-27b	cervical cancer
hsa-mir-27b	cervical carcinoma
hsa-mir-27b	colorectal cancer
hsa-mir-27b	gastric cancer
hsa-mir-27b	gastric cancer
hsa-mir-27b	glioma
hsa-mir-27b	glioma
hsa-mir-27b	hepatocellular carcinoma
hsa-mir-27b	hepatocellular carcinoma
hsa-mir-27b	multiple myeloma
hsa-mir-27b	non-small cell lung cancer	down	MicroRNA-27b s
hsa-mir-27b	oral squamous cell carcinoma
hsa-mir-27b	oral squamous cell carcinoma	down	The tumor-s
hsa-mir-27b	oral squamous cell carcinoma
hsa-mir-27b	ovarian cancer
hsa-mir-27b	ovarian cancer	down	MicroRNA-27b functions as a new inhibitor of ovarian cancer-mediated vasculogenic mimicry through s
hsa-mir-27b	pancreatic ductal adenocarcinoma
hsa-mir-27b-3p	breast cancer
hsa-mir-27b-3p	breast cancer
hsa-mir-27b-3p	gastric cancer	down	miR-27b-3p s
hsa-mir-27b-5p	oral squamous cell carcinoma
hsa-mir-28	gastric cancer
hsa-mir-28-3p	colorectal cancer
hsa-mir-28-3p	esophageal cancer
hsa-mir-28-3p	esophageal squamous cell carcinoma
hsa-mir-28-5p	chronic lymphocytic leukemia
hsa-mir-28-5p	colorectal cancer
hsa-mir-28-5p	gastric cancer	down	MicroRNA-28-5p inhibits the migration and invasion of gastric cancer cells by s
hsa-mir-28-5p	hepatocellular carcinoma
hsa-mir-28-5p	ovarian cancer
hsa-mir-28-5p	renal cell carcinoma
hsa-mir-28-5p	renal cell carcinoma	down	miR-28-5p acts as a tumor s
hsa-mir-2861	basal cell carcinoma
hsa-mir-2861	cervical cancer	down	miR-2861 acts as a tumor s
hsa-mir-2861	papillary thyroid carcinoma
hsa-mir-296	cervical cancer	down	MicroRNA-296 targets specificity protein 1 to s
hsa-mir-296	colorectal cancer
hsa-mir-296	colorectal cancer
hsa-mir-296	hepatocellular carcinoma
hsa-mir-296-3p	non-small cell lung cancer
hsa-mir-296-5p	breast cancer
hsa-mir-296-5p	esophageal squamous cell carcinoma
hsa-mir-296-5p	esophageal squamous cell carcinoma
hsa-mir-296-5p	gastric cancer
hsa-mir-296-5p	gastric cancer
hsa-mir-296-5p	glioblastoma
hsa-mir-296-5p	papillary thyroid carcinoma	down	MiR-296-5p s
hsa-mir-297	lung adenocarcinoma
hsa-mir-297	oral squamous cell carcinoma
hsa-mir-298	hepatocellular carcinoma
hsa-mir-299	glioblastoma
hsa-mir-299-3p	colon carcinoma	down	MicroRNA-299-3p s
hsa-mir-299-3p	hepatocellular carcinoma	down	MiR-299-3p functions as a tumor s
hsa-mir-299-3p	thyroid cancer	down	MiR-299-3p functions as a tumor s
hsa-mir-299-5p	hepatocellular carcinoma
hsa-mir-29a	acute myeloid leukemia
hsa-mir-29a	breast cancer
hsa-mir-29a	breast cancer
hsa-mir-29a	breast cancer
hsa-mir-29a	breast cancer
hsa-mir-29a	cervical cancer
hsa-mir-29a	cervical squamous cell carcinoma	down	Tumor-s
hsa-mir-29a	cholangiocarcinoma
hsa-mir-29a	colon cancer
hsa-mir-29a	colorectal cancer
hsa-mir-29a	colorectal cancer
hsa-mir-29a	ependymoma
hsa-mir-29a	gastric cancer
hsa-mir-29a	gastric cancer
hsa-mir-29a	gastric cancer
hsa-mir-29a	gastric cancer	down	miR-29a s
hsa-mir-29a	gastric cancer
hsa-mir-29a	gastric cancer
hsa-mir-29a	gastric cancer	down	Cell-derived microvesicles mediate the delivery of miR-29a/c to s
hsa-mir-29a	glioblastoma
hsa-mir-29a	glioma
hsa-mir-29a	head and neck squamous cell carcinoma	down	Tumour-s
hsa-mir-29a	hepatocellular carcinoma	down	microRNA-29a s
hsa-mir-29a	hepatocellular carcinoma
hsa-mir-29a	hepatocellular carcinoma
hsa-mir-29a	hepatocellular carcinoma	down	MiR-29a s
hsa-mir-29a	hepatocellular carcinoma	down	miR-29a s
hsa-mir-29a	hepatocellular carcinoma	down	Up-regulation of histone methyltransferase SETDB1 by multiple mechanisms in hepatocellular carcinoma promotes cancer metastasis.
hsa-mir-29a	lung cancer
hsa-mir-29a	lung cancer	down	MicroRNA-29a Functions as a Tumor S
hsa-mir-29a	mantle cell lymphoma
hsa-mir-29a	mesenchymal cancer	down	miR-29 Acts as a Decoy in Sarcomas to Protect the Tumor S
hsa-mir-29a	nasopharyngeal carcinoma	down	microRNA-29a functions as a tumor s
hsa-mir-29a	neuroblastoma
hsa-mir-29a	non-small cell lung cancer	down	S
hsa-mir-29a	non-small cell lung cancer	down	MicroRNA-29a functions as a potential tumor s
hsa-mir-29a	oral squamous cell carcinoma	down	MicroRNA-29a
hsa-mir-29a	osteosarcoma
hsa-mir-29a	pancreatic cancer
hsa-mir-29a	pancreatic cancer
hsa-mir-29a	papillary thyroid carcinoma	down	miR-29a s
hsa-mir-29a	retinoblastoma
hsa-mir-29a-3p	colorectal cancer
hsa-mir-29a-3p	gastric cancer
hsa-mir-29a-3p	hepatocellular carcinoma	down	XPD s
hsa-mir-29a-3p	hepatocellular carcinoma	down	miR-29a-3p s
hsa-mir-29a-3p	oral squamous cell carcinoma
hsa-mir-29a-5p	endometrial cancer
hsa-mir-29b	acute myeloid leukemia
hsa-mir-29b	acute myeloid leukemia
hsa-mir-29b	cholangiocarcinoma	down	[Overpression of miR-29b s
hsa-mir-29b	chronic lymphocytic leukemia
hsa-mir-29b	colorectal cancer	down	miR-29b s
hsa-mir-29b	colorectal cancer
hsa-mir-29b	endometrial cancer
hsa-mir-29b	esophageal squamous cell carcinoma
hsa-mir-29b	gastric cancer
hsa-mir-29b	gastric cancer
hsa-mir-29b	gastric cancer	down	Methylation-induced downregulation and tumor s
hsa-mir-29b	gastric cancer	down	RUNX3-mediated
hsa-mir-29b	glioblastoma	down	miR-29b and miR-125a regulate podoplanin and s
hsa-mir-29b	glioblastoma
hsa-mir-29b	glioblastoma
hsa-mir-29b	glioma
hsa-mir-29b	lung adenocarcinoma
hsa-mir-29b	lung cancer
hsa-mir-29b	mantle cell lymphoma
hsa-mir-29b	non-small cell lung cancer
hsa-mir-29b	non-small cell lung cancer	down	S
hsa-mir-29b	non-small cell lung cancer
hsa-mir-29b	oral squamous cell carcinoma
hsa-mir-29b	osteosarcoma
hsa-mir-29b	ovarian cancer
hsa-mir-29b	pancreatic cancer	down	MiR-29b s
hsa-mir-29b	prostate cancer	down	miRNA-29b s
hsa-mir-29b-1	breast cancer
hsa-mir-29b-1	gastric cancer
hsa-mir-29b-1	gastric cancer
hsa-mir-29b-1	head and neck squamous cell carcinoma	down	Tumour-s
hsa-mir-29b-1	hepatocellular carcinoma
hsa-mir-29b-1	hepatocellular carcinoma
hsa-mir-29b-1	hepatocellular carcinoma	down	Up-regulation of histone methyltransferase SETDB1 by multiple mechanisms in hepatocellular carcinoma promotes cancer metastasis.
hsa-mir-29b-1	mesenchymal cancer	down	miR-29 Acts as a Decoy in Sarcomas to Protect the Tumor S
hsa-mir-29b-1	osteosarcoma
hsa-mir-29b-1	pancreatic cancer
hsa-mir-29b-1-5p	mesenchymal cancer	down	miR-29 Acts as a Decoy in Sarcomas to Protect the Tumor S
hsa-mir-29b-2	breast cancer
hsa-mir-29b-2	gastric cancer
hsa-mir-29b-2	gastric cancer
hsa-mir-29b-2	head and neck squamous cell carcinoma	down	Tumour-s
hsa-mir-29b-2	hepatocellular carcinoma
hsa-mir-29b-2	hepatocellular carcinoma
hsa-mir-29b-2	hepatocellular carcinoma	down	Up-regulation of histone methyltransferase SETDB1 by multiple mechanisms in hepatocellular carcinoma promotes cancer metastasis.
hsa-mir-29b-2	mesenchymal cancer	down	miR-29 Acts as a Decoy in Sarcomas to Protect the Tumor S
hsa-mir-29b-2	osteosarcoma
hsa-mir-29b-2	pancreatic cancer
hsa-mir-29c	acute myeloid leukemia
hsa-mir-29c	basal cell carcinoma
hsa-mir-29c	bladder cancer
hsa-mir-29c	breast cancer
hsa-mir-29c	breast cancer	down	miR-29c plays a s
hsa-mir-29c	breast cancer
hsa-mir-29c	esophageal squamous cell carcinoma
hsa-mir-29c	gastric cancer
hsa-mir-29c	gastric cancer
hsa-mir-29c	gastric cancer	down	Cell-derived microvesicles mediate the delivery of miR-29a/c to s
hsa-mir-29c	gastric cancer
hsa-mir-29c	gastric cancer	down	The tumor s
hsa-mir-29c	gastric cancer
hsa-mir-29c	gastric cancer
hsa-mir-29c	gastric cancer
hsa-mir-29c	gastric cancer
hsa-mir-29c	head and neck squamous cell carcinoma	down	Tumour-s
hsa-mir-29c	hepatocellular carcinoma
hsa-mir-29c	hepatocellular carcinoma	down	MicroRNA-29c functions as a tumor s
hsa-mir-29c	hepatocellular carcinoma
hsa-mir-29c	hepatocellular carcinoma
hsa-mir-29c	hepatocellular carcinoma	down	A s
hsa-mir-29c	hepatocellular carcinoma	down	Up-regulation of histone methyltransferase SETDB1 by multiple mechanisms in hepatocellular carcinoma promotes cancer metastasis.
hsa-mir-29c	hepatocellular carcinoma
hsa-mir-29c	lung adenocarcinoma	down	MicroRNA-29c functions as a tumor s
hsa-mir-29c	lung cancer	down	miRNA-29c S
hsa-mir-29c	malignant melanoma
hsa-mir-29c	mantle cell lymphoma
hsa-mir-29c	mesenchymal cancer	down	miR-29 Acts as a Decoy in Sarcomas to Protect the Tumor S
hsa-mir-29c	nasopharyngeal carcinoma	down	Downregulation of lncRNA X Inactive Specific Transcript (XIST) S
hsa-mir-29c	nasopharyngeal carcinoma	down	MiR-29c s
hsa-mir-29c	non-small cell lung cancer
hsa-mir-29c	non-small cell lung cancer	down	S
hsa-mir-29c	non-small cell lung cancer
hsa-mir-29c	non-small cell lung cancer
hsa-mir-29c	non-small cell lung cancer
hsa-mir-29c	osteosarcoma
hsa-mir-29c	osteosarcoma
hsa-mir-29c	pancreatic cancer
hsa-mir-29c	pancreatic cancer	down	miR-29c s
hsa-mir-29c	prostate cancer	down	Up-regulated miR-29c inhibits cell proliferation and glycolysis by inhibiting SLC2A3 expression in prostate cancer.
hsa-mir-29c*	basal cell carcinoma
hsa-mir-29c-3p	colon cancer	down	p53 target miR-29c-3p s
hsa-mir-29c-3p	colorectal cancer
hsa-mir-29c-3p	hepatocellular carcinoma
hsa-mir-29c-5p	gallbladder carcinoma	down	MicroRNA-29c-5p s
hsa-mir-300	breast cancer
hsa-mir-300	glioblastoma
hsa-mir-300	head and neck squamous cell carcinoma
hsa-mir-300	hepatocellular carcinoma
hsa-mir-300	laryngeal squamous cell carcinoma	down	MiR-300 s
hsa-mir-300	laryngeal squamous cell carcinoma
hsa-mir-300	non-small cell lung cancer
hsa-mir-300	oral squamous cell carcinoma	down	MicroRNA-300 s
hsa-mir-300	osteosarcoma
hsa-mir-301a	colorectal cancer
hsa-mir-301a	colorectal cancer
hsa-mir-301a	colorectal cancer
hsa-mir-301a	endometrial cancer
hsa-mir-301a	gastric cancer
hsa-mir-301a	gastric cancer
hsa-mir-301a	gastric cancer
hsa-mir-301a	glioma
hsa-mir-301a	hepatocellular carcinoma
hsa-mir-301a	multiple myeloma
hsa-mir-301a	non-small cell lung cancer
hsa-mir-301a	non-small cell lung cancer	down	MiR-130 exerts tumor s
hsa-mir-301a	pancreatic adenocarcinoma
hsa-mir-301a	pancreatic cancer
hsa-mir-301a	prostate cancer
hsa-mir-301a	prostate cancer
hsa-mir-301a	prostate cancer
hsa-mir-301a-3p	breast cancer
hsa-mir-301a-3p	colorectal cancer
hsa-mir-301a-3p	hepatocellular carcinoma
hsa-mir-301a-3p	laryngeal squamous cell carcinoma
hsa-mir-301a-3p	pancreatic cancer
hsa-mir-301b	endometrial cancer
hsa-mir-301b	gastric cancer
hsa-mir-301b	glioma
hsa-mir-301b	lung cancer
hsa-mir-301b	non-small cell lung cancer	down	MiR-130 exerts tumor s
hsa-mir-301b	pancreatic carcinoma
hsa-mir-301b	prostate cancer
hsa-mir-301b-3p	hepatocellular carcinoma
hsa-mir-302a	cervical cancer
hsa-mir-302a	chronic myelogenous leukemia
hsa-mir-302a	colon cancer	down	MicroRNA-302a functions as a putative tumor s
hsa-mir-302a	hepatocellular carcinoma
hsa-mir-302a	osteosarcoma
hsa-mir-302a	prostate cancer	down	MicroRNA-302a S
hsa-mir-302a-3p	hepatocellular carcinoma	down	MicroRNA-302a-3p s
hsa-mir-302a-5p	non-small cell lung cancer	down	MiR-302a-5p s
hsa-mir-302b	bladder cancer
hsa-mir-302b	cervical cancer
hsa-mir-302b	chronic myelogenous leukemia
hsa-mir-302b	esophageal squamous cell carcinoma	down	miR-302b is a potential molecular marker of esophageal squamous cell carcinoma and functions as a tumor s
hsa-mir-302b	gastric cancer
hsa-mir-302b	gastric cancer
hsa-mir-302b	glioblastoma
hsa-mir-302b	hepatocellular carcinoma	down	MicroRNA-302b s
hsa-mir-302b	hepatocellular carcinoma	down	miRNA-302b S
hsa-mir-302b	hepatocellular carcinoma	down	miR-302b s
hsa-mir-302b	lung cancer	down	Exosomes-Derived MiR-302b S
hsa-mir-302b	osteosarcoma	down	MiR-302b S
hsa-mir-302b-3p	esophageal cancer
hsa-mir-302b-3p	gastric cancer	down	MicroRNA-302b-3p S
hsa-mir-302c	cervical cancer
hsa-mir-302c	chronic myelogenous leukemia
hsa-mir-302c	hepatocellular carcinoma	down	MiR-302c inhibits tumor growth of hepatocellular carcinoma by s
hsa-mir-302c-3p	esophageal cancer
hsa-mir-302c-3p	hepatocellular carcinoma	down	The tumor s
hsa-mir-302c-3p	renal cell carcinoma
hsa-mir-302d	cervical cancer
hsa-mir-302d	chronic myelogenous leukemia
hsa-mir-302d	glioblastoma	down	Tumor s
hsa-mir-302d-3p	esophageal cancer
hsa-mir-302f	cervical cancer
hsa-mir-302f	gastric cancer
hsa-mir-3064	ovarian cancer
hsa-mir-30a	breast cancer
hsa-mir-30a	breast cancer
hsa-mir-30a	breast cancer	down	MicroRNA-30a s
hsa-mir-30a	breast cancer	down	miR-30a s
hsa-mir-30a	breast cancer	down	MicroRNA-30a increases tight junction protein expression to s
hsa-mir-30a	cervical cancer
hsa-mir-30a	chondrosarcoma	down	Association of SOX4 regulated by tumor s
hsa-mir-30a	colorectal cancer
hsa-mir-30a	colorectal cancer	down	MicroRNA-30a attenuates mutant KRAS-driven colorectal tumorigenesis via direct s
hsa-mir-30a	colorectal cancer
hsa-mir-30a	colorectal carcinoma	down	miR-30a s
hsa-mir-30a	gastric cancer
hsa-mir-30a	glioma
hsa-mir-30a	hepatocellular carcinoma	down	MicroRNA-30a s
hsa-mir-30a	hepatocellular carcinoma	down	MicroRNA-30a s
hsa-mir-30a	lung adenocarcinoma
hsa-mir-30a	lung cancer	down	miR-30a s
hsa-mir-30a	non-small cell lung cancer	down	MiR-30 s
hsa-mir-30a	non-small cell lung cancer	down	MicroRNA-30a s
hsa-mir-30a	non-small cell lung cancer
hsa-mir-30a	non-small cell lung cancer	down	MiR-30a s
hsa-mir-30a	non-small cell lung cancer
hsa-mir-30a	osteosarcoma	down	miR-30a s
hsa-mir-30a	ovarian carcinoma
hsa-mir-30a	pancreatic cancer
hsa-mir-30a	papillary thyroid carcinoma
hsa-mir-30a	prostate cancer	down	miR-30 as a tumor s
hsa-mir-30a	renal cell carcinoma
hsa-mir-30a-3p	colorectal cancer
hsa-mir-30a-5p	breast cancer	down	miR-30a-5p s
hsa-mir-30a-5p	colon cancer	down	MiR-30a-5p S
hsa-mir-30a-5p	colon carcinoma	down	MiR-30a-5p s
hsa-mir-30a-5p	colorectal cancer
hsa-mir-30a-5p	colorectal cancer	down	MiR-30a-5p S
hsa-mir-30a-5p	esophageal squamous cell carcinoma
hsa-mir-30a-5p	gastric cancer	down	miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor s
hsa-mir-30a-5p	gastric cancer
hsa-mir-30a-5p	glioma
hsa-mir-30a-5p	glioma
hsa-mir-30a-5p	glioma
hsa-mir-30a-5p	head and neck squamous cell carcinoma
hsa-mir-30a-5p	hepatocellular carcinoma
hsa-mir-30a-5p	liver cancer
hsa-mir-30a-5p	malignant melanoma
hsa-mir-30a-5p	non-small cell lung cancer
hsa-mir-30a-5p	non-small cell lung cancer
hsa-mir-30a-5p	osteosarcoma
hsa-mir-30a-5p	ovarian cancer
hsa-mir-30b	colorectal cancer
hsa-mir-30b	esophageal cancer
hsa-mir-30b	gastric cancer
hsa-mir-30b	gastric cancer	down	MiR-30b s
hsa-mir-30b	glioblastoma
hsa-mir-30b	hepatocellular carcinoma	down	MicroRNA-30b S
hsa-mir-30b	non-small cell lung cancer
hsa-mir-30b	non-small cell lung cancer
hsa-mir-30b	non-small cell lung cancer
hsa-mir-30b	non-small cell lung cancer
hsa-mir-30b	papillary thyroid carcinoma
hsa-mir-30b	prostate cancer	down	miR-30 as a tumor s
hsa-mir-30b-5p	glioma
hsa-mir-30b-5p	pancreatic ductal adenocarcinoma
hsa-mir-30c	acute myeloid leukemia
hsa-mir-30c	breast cancer
hsa-mir-30c	colorectal cancer	down	MiR-30c exerts tumor s
hsa-mir-30c	endometrial cancer
hsa-mir-30c	esophageal squamous cell carcinoma	down	MicroRNA-30c functions as a tumor s
hsa-mir-30c	gastric cancer
hsa-mir-30c	glioblastoma
hsa-mir-30c	non-small cell lung cancer
hsa-mir-30c	non-small cell lung cancer
hsa-mir-30c	papillary thyroid carcinoma
hsa-mir-30c	prostate cancer
hsa-mir-30c	renal cell carcinoma
hsa-mir-30c-1	gastric cancer
hsa-mir-30c-1	prostate cancer	down	miR-30 as a tumor s
hsa-mir-30c-2	gastric cancer
hsa-mir-30c-2	prostate cancer	down	miR-30 as a tumor s
hsa-mir-30d	colon cancer	down	Mir-30d s
hsa-mir-30d	gastric cancer
hsa-mir-30d	hepatocellular carcinoma
hsa-mir-30d	lung cancer
hsa-mir-30d	non-small cell lung cancer
hsa-mir-30d	non-small cell lung cancer	down	Non-small cell lung cancer: miR-30d s
hsa-mir-30d	papillary thyroid carcinoma
hsa-mir-30d	prostate cancer	down	miR-30 as a tumor s
hsa-mir-30d	prostate cancer
hsa-mir-30d	renal cell carcinoma
hsa-mir-30d-5p	non-small cell lung cancer
hsa-mir-30d-5p	non-small cell lung cancer
hsa-mir-30e	breast cancer
hsa-mir-30e	breast cancer
hsa-mir-30e	cervical carcinoma	down	MicroRNA-30e Functions as a Tumor S
hsa-mir-30e	cholangiocarcinoma	down	Extracellular vesicle-encapsulated miR-30e s
hsa-mir-30e	chronic myelogenous leukemia
hsa-mir-30e	gastric cancer
hsa-mir-30e	glioma
hsa-mir-30e	hepatocellular carcinoma
hsa-mir-30e	hepatocellular carcinoma
hsa-mir-30e	liver cancer	down	MiR-30e s
hsa-mir-30e	lung carcinoma
hsa-mir-30e	non-small cell lung cancer
hsa-mir-30e	papillary thyroid carcinoma
hsa-mir-30e	prostate cancer	down	miR-30 as a tumor s
hsa-mir-30e*	glioma
hsa-mir-30e*	prostate cancer
hsa-mir-30e-3p	renal clear cell carcinoma
hsa-mir-30e-5p	bladder cancer	down	miR-30e-5p s
hsa-mir-30e-5p	colorectal cancer
hsa-mir-30e-5p	lung adenocarcinoma
hsa-mir-30e-5p	non-small cell lung cancer	down	MicroRNA-30e-5p s
hsa-mir-30e-5p	non-small cell lung cancer
hsa-mir-31	breast cancer
hsa-mir-31	cervical cancer
hsa-mir-31	cervical cancer
hsa-mir-31	cervical cancer
hsa-mir-31	chordoma
hsa-mir-31	colon cancer
hsa-mir-31	colorectal cancer
hsa-mir-31	colorectal cancer
hsa-mir-31	colorectal cancer
hsa-mir-31	colorectal cancer
hsa-mir-31	colorectal cancer
hsa-mir-31	colorectal cancer
hsa-mir-31	esophageal cancer
hsa-mir-31	esophageal squamous cell carcinoma
hsa-mir-31	gastric cancer
hsa-mir-31	gastric cancer	down	Tumor s
hsa-mir-31	gastric cancer
hsa-mir-31	gastric cancer
hsa-mir-31	gastric cancer	down	Upregulation of microRNA-31 targeting integrin ?5 s
hsa-mir-31	gastric cancer	down	Downregulated miR-31 level associates with poor prognosis of gastric cancer and its restoration s
hsa-mir-31	gastric cancer	down	MicroRNA-31 Function as a S
hsa-mir-31	glioblastoma
hsa-mir-31	glioblastoma
hsa-mir-31	glioblastoma
hsa-mir-31	head and neck squamous cell carcinoma
hsa-mir-31	intrahepatic cholangiocarcinoma
hsa-mir-31	laryngeal squamous cell carcinoma
hsa-mir-31	liver cancer	down	MicroRNA-31 functions as a tumor s
hsa-mir-31	lung adenocarcinoma
hsa-mir-31	lung adenocarcinoma
hsa-mir-31	lung adenocarcinoma
hsa-mir-31	lung cancer
hsa-mir-31	lung carcinoma	down	MiR-31 Functions as a Tumor S
hsa-mir-31	malignant melanoma
hsa-mir-31	malignant melanoma
hsa-mir-31	malignant melanoma
hsa-mir-31	medulloblastoma	down	MicroRNA-31 s
hsa-mir-31	non-small cell lung cancer
hsa-mir-31	oral carcinoma
hsa-mir-31	oral carcinoma
hsa-mir-31	oral squamous cell carcinoma
hsa-mir-31	oral squamous cell carcinoma
hsa-mir-31	pancreatic ductal adenocarcinoma
hsa-mir-31	papillary thyroid carcinoma
hsa-mir-31	prostate cancer	down	Class I HDAC inhibitor mocetinostat induces apoptosis by activation of miR-31 expression and s
hsa-mir-31	prostate cancer
hsa-mir-31	prostate cancer
hsa-mir-31	prostate cancer	down	Polycomb protein EZH2 s
hsa-mir-31	rectal cancer
hsa-mir-31-3p	medullary thyroid carcinoma
hsa-mir-31-5p	renal cell carcinoma	down	MiR-31-5p acts as a tumor s
hsa-mir-3117	hepatocellular carcinoma
hsa-mir-3120-5p	colon cancer
hsa-mir-3127	hepatocellular carcinoma
hsa-mir-3129	gastric cancer
hsa-mir-3131	hepatocellular carcinoma
hsa-mir-3136-3p	breast cancer
hsa-mir-3163	retinoblastoma
hsa-mir-3174	gastric cancer
hsa-mir-3174	rectal cancer
hsa-mir-3175	glioma
hsa-mir-3188	non-small cell lung cancer
hsa-mir-3189-3p	astrocytoma
hsa-mir-3189-3p	glioblastoma
hsa-mir-3191	colorectal cancer
hsa-mir-3196	basal cell carcinoma
hsa-mir-32	colorectal cancer
hsa-mir-32	colorectal cancer
hsa-mir-32	colorectal cancer
hsa-mir-32	esophageal squamous cell carcinoma
hsa-mir-32	gastric cancer
hsa-mir-32	glioma
hsa-mir-32	hepatocellular carcinoma
hsa-mir-32	hepatocellular carcinoma
hsa-mir-32	liver cancer
hsa-mir-32	lung cancer
hsa-mir-32	nasopharyngeal carcinoma
hsa-mir-32	non-small cell lung cancer
hsa-mir-32	non-small cell lung cancer	down	Tanshinones s
hsa-mir-32	non-small cell lung cancer	down	miR-32 functions as a tumor s
hsa-mir-32	non-small cell lung cancer	down	miR-32 functions as a tumor s
hsa-mir-32	oral squamous cell carcinoma	down	MiR-32 functions as a tumor s
hsa-mir-32	osteosarcoma
hsa-mir-32	uveal melanoma	down	MicroRNA-32 functions as a tumor s
hsa-mir-32	uveal melanoma
hsa-mir-320	breast cancer
hsa-mir-320	cervical cancer
hsa-mir-320	chronic myelogenous leukemia	down	microRNA expression profiling as s
hsa-mir-320	colon cancer
hsa-mir-320	gastric cancer
hsa-mir-320	glioblastoma
hsa-mir-320	glioma
hsa-mir-320	osteosarcoma
hsa-mir-320	ovarian cancer
hsa-mir-3200-5p	osteosarcoma
hsa-mir-320a	breast cancer
hsa-mir-320a	colon cancer	down	MicroRNA-320a s
hsa-mir-320a	colorectal cancer
hsa-mir-320a	colorectal cancer	down	miR-320a s
hsa-mir-320a	colorectal cancer
hsa-mir-320a	gastric cancer
hsa-mir-320a	gastric cancer
hsa-mir-320a	glioblastoma	down	MicroRNA-320a s
hsa-mir-320a	glioma
hsa-mir-320a	hepatocellular carcinoma
hsa-mir-320a	leiomyosarcoma
hsa-mir-320a	non-small cell lung cancer
hsa-mir-320a	non-small cell lung cancer	down	MicroRNA-320a is downregulated in non-small cell lung cancer and s
hsa-mir-320a	osteosarcoma
hsa-mir-320a	pancreatic cancer
hsa-mir-320a-3p	non-small cell lung cancer
hsa-mir-320b	colorectal cancer
hsa-mir-320c	bladder cancer
hsa-mir-320c	glioma
hsa-mir-320d	glioma
hsa-mir-323	prostate cancer
hsa-mir-323	prostate cancer
hsa-mir-323-3p	pancreatic ductal adenocarcinoma	down	MicroRNA-323-3p inhibits cell invasion and metastasis in pancreatic ductal adenocarcinoma via direct s
hsa-mir-323-5p	oral squamous cell carcinoma
hsa-mir-323a-3p	glioblastoma
hsa-mir-323a-3p	osteosarcoma	down	MiR-323a-3p s
hsa-mir-324-3p	gastric cancer
hsa-mir-324-3p	hepatocellular carcinoma
hsa-mir-324-3p	nasopharyngeal carcinoma	down	The expression of microRNA-324-3p as a tumor s
hsa-mir-324-3p	nasopharyngeal carcinoma
hsa-mir-324-3p	nasopharyngeal carcinoma
hsa-mir-324-3p	nasopharyngeal carcinoma	down	miR-324-3p s
hsa-mir-324-5p	colorectal cancer	down	Up-regulation of miR-324-5p inhibits proliferation and invasion of colorectal cancer cells by targeting ELAVL1.
hsa-mir-324-5p	gastric cancer
hsa-mir-324-5p	hepatocellular carcinoma	down	MiR-324-5p S
hsa-mir-324-5p	ovarian cancer
hsa-mir-325	bladder cancer
hsa-mir-325	hepatocellular carcinoma	down	The microRNA-325 inhibits hepatocellular carcinoma progression by targeting high mobility gro
hsa-mir-326	breast cancer	down	MicroRNA-326 Functions as a Tumor S
hsa-mir-326	breast cancer
hsa-mir-326	cervical cancer	down	LncRNA-HOTAIR Activates Tumor Cell Proliferation and Migration by S
hsa-mir-326	chronic myelogenous leukemia
hsa-mir-326	colorectal cancer
hsa-mir-326	esophageal squamous cell carcinoma
hsa-mir-326	gastric cancer
hsa-mir-326	gastric cancer
hsa-mir-326	glioblastoma
hsa-mir-326	glioma
hsa-mir-326	glioma	down	MicroRNA-326 functions as a tumor s
hsa-mir-326	glioma
hsa-mir-326	glioma
hsa-mir-326	hepatocellular carcinoma
hsa-mir-326	lung cancer
hsa-mir-326	malignant melanoma	down	MicroRNA-326 inhibits melanoma progression by targeting KRAS and s
hsa-mir-326	osteosarcoma
hsa-mir-328	acute myeloid leukemia
hsa-mir-328	cervical cancer
hsa-mir-328	colon cancer
hsa-mir-328	colorectal cancer
hsa-mir-328	esophageal cancer	down	MiR-328 s
hsa-mir-328	gastric cancer	down	Macrophage-derived reactive oxygen species s
hsa-mir-328	glioma
hsa-mir-328	glioma	down	microRNA-328 is a favorable prognostic marker in human glioma via s
hsa-mir-328	hepatocellular carcinoma
hsa-mir-328	nasopharyngeal carcinoma
hsa-mir-328	non-small cell lung cancer
hsa-mir-328-3p	non-small cell lung cancer	down	Up- regulation of miR-328-3p sensitizes non-small cell lung cancer to radiotherapy.
hsa-mir-328-3p	osteosarcoma	down	Elevated expression of microRNA-328-3p s
hsa-mir-328-3p	ovarian cancer
hsa-mir-328-5p	breast cancer
hsa-mir-329	breast cancer
hsa-mir-329	breast cancer
hsa-mir-329	cholangiocarcinoma	down	microRNA-329 s
hsa-mir-329	colorectal cancer
hsa-mir-329	gastric cancer
hsa-mir-329	hepatocellular carcinoma
hsa-mir-329	non-small cell lung cancer	down	Hsa-miR-329 exerts tumor s
hsa-mir-329	oral squamous cell carcinoma
hsa-mir-329	osteosarcoma	down	MiR-329 s
hsa-mir-329	pancreatic cancer
hsa-mir-329	papillary thyroid carcinoma
hsa-mir-329-3p	cervical cancer
hsa-mir-329-3p	cervical cancer
hsa-mir-330	colorectal cancer
hsa-mir-330	colorectal cancer	down	miR-330 s
hsa-mir-330	glioblastoma
hsa-mir-330	osteosarcoma	down	MicroRNA-330-3p Expression Indicates Good Prognosis and S
hsa-mir-330	prostate cancer	down	MicroRNA-330 acts as tumor s
hsa-mir-330	prostate cancer
hsa-mir-330-3p	breast cancer
hsa-mir-330-3p	breast cancer
hsa-mir-330-3p	esophageal squamous cell carcinoma
hsa-mir-330-3p	gastric cancer
hsa-mir-330-3p	liver cancer	down	miR-330-3p s
hsa-mir-330-3p	non-small cell lung cancer
hsa-mir-330-3p	non-small cell lung cancer
hsa-mir-330-3p	non-small cell lung cancer
hsa-mir-330-3p	non-small cell lung cancer
hsa-mir-330-5p	glioblastoma	down	miR-330-5p s
hsa-mir-330-5p	non-small cell lung cancer
hsa-mir-330-5p	ovarian cancer
hsa-mir-331	acute myeloid leukemia
hsa-mir-331	malignant melanoma
hsa-mir-331-3p	cervical cancer
hsa-mir-331-3p	cervical cancer	down	MicroRNA-331-3p S
hsa-mir-331-3p	colorectal cancer
hsa-mir-331-3p	gastric cancer
hsa-mir-331-3p	glioblastoma
hsa-mir-331-3p	hepatocellular carcinoma
hsa-mir-331-3p	hepatocellular carcinoma
hsa-mir-331-3p	non-small cell lung cancer
hsa-mir-331-3p	pancreatic cancer
hsa-mir-331-3p	prostate cancer
hsa-mir-335	adrenal cortical carcinoma
hsa-mir-335	astrocytoma
hsa-mir-335	bladder cancer	down	MiR-335 s
hsa-mir-335	breast cancer
hsa-mir-335	breast cancer
hsa-mir-335	breast cancer
hsa-mir-335	cervical cancer
hsa-mir-335	chondrosarcoma
hsa-mir-335	colorectal cancer
hsa-mir-335	colorectal cancer
hsa-mir-335	esophageal squamous cell carcinoma	down	Up-regulation of miR-335 predicts a favorable prognosis in esophageal squamous cell carcinoma.
hsa-mir-335	glioma
hsa-mir-335	hepatocellular carcinoma
hsa-mir-335	hepatocellular carcinoma	down	MiR-335 acts as a potential tumor s
hsa-mir-335	meningioma
hsa-mir-335	mesenchymal cancer
hsa-mir-335	neuroblastoma	down	MiRNA-335 S
hsa-mir-335	non-small cell lung cancer	down	Effect of miR-335
hsa-mir-335	non-small cell lung cancer
hsa-mir-335	osteosarcoma
hsa-mir-335	osteosarcoma	down	MiR-335 functions as a tumor s
hsa-mir-335	osteosarcoma
hsa-mir-335	osteosarcoma	down	miR-335 s
hsa-mir-335	ovarian cancer	down	miR-335 represents an invasion s
hsa-mir-335	ovarian cancer
hsa-mir-335	pancreatic cancer	down	miR-335 functions as a tumor s
hsa-mir-335	primary gallbladder carcinoma
hsa-mir-335	prostate cancer	down	MicroRNA-335 and -543 s
hsa-mir-335	renal clear cell carcinoma
hsa-mir-335-5p	gastric cancer
hsa-mir-335-5p	gastric cancer	down	MicroRNA-335-5p is a potential s
hsa-mir-335-5p	thyroid cancer
hsa-mir-337	cervical cancer
hsa-mir-337	cutaneous t-cell lymphoma	down	miR-337 s
hsa-mir-337	non-small cell lung cancer
hsa-mir-337	non-small cell lung cancer
hsa-mir-337	pancreatic ductal adenocarcinoma
hsa-mir-337-3p	gastric cancer
hsa-mir-337-3p	gastric cancer
hsa-mir-337-3p	hepatocellular carcinoma	down	miR-337-3p s
hsa-mir-337-3p	neuroblastoma	down	miRNA-337-3p s
hsa-mir-338	cervical cancer
hsa-mir-338	glioma	down	MiR-338 s
hsa-mir-338	nasopharyngeal carcinoma
hsa-mir-338	oral squamous cell carcinoma	down	miR-338 s
hsa-mir-338-3p	cervical cancer
hsa-mir-338-3p	cervical cancer
hsa-mir-338-3p	colorectal cancer
hsa-mir-338-3p	colorectal carcinoma
hsa-mir-338-3p	gastric cancer
hsa-mir-338-3p	gastric cancer	down	miR-338-3p S
hsa-mir-338-3p	gastric cancer
hsa-mir-338-3p	gastric cancer	down	Hypermethylation of miR-338-3p and Impact of its S
hsa-mir-338-3p	gastric cancer	down	miR-338-3p functions as a tumor s
hsa-mir-338-3p	gastric cancer
hsa-mir-338-3p	glioma
hsa-mir-338-3p	hepatocellular carcinoma
hsa-mir-338-3p	hepatocellular carcinoma
hsa-mir-338-3p	hepatocellular carcinoma
hsa-mir-338-3p	hepatocellular carcinoma
hsa-mir-338-3p	hepatocellular carcinoma
hsa-mir-338-3p	hepatocellular carcinoma
hsa-mir-338-3p	liver cancer	down	miR-338-3p s
hsa-mir-338-3p	non-small cell lung cancer	down	microRNA-338-3p functions as a tumor s
hsa-mir-338-3p	non-small cell lung cancer	down	miR-338-3p s
hsa-mir-338-3p	non-small cell lung cancer
hsa-mir-338-3p	non-small cell lung cancer
hsa-mir-338-3p	osteosarcoma
hsa-mir-338-3p	prostate cancer	down	miR-338-3p targets RAB23 and s
hsa-mir-338-3p	prostate carcinoma
hsa-mir-338-3p	renal cell carcinoma
hsa-mir-338-3p	thyroid cancer
hsa-mir-338-5p	glioma	down	MicroRNA-338-5p plays a tumor s
hsa-mir-338-5p	glioma
hsa-mir-338-5p	malignant melanoma
hsa-mir-338-5p	retinoblastoma
hsa-mir-339	hepatocellular carcinoma
hsa-mir-339	non-small cell lung cancer
hsa-mir-339-3p	acute myeloid leukemia
hsa-mir-339-3p	colorectal cancer
hsa-mir-339-3p	malignant melanoma	down	miR-339-3p Is a Tumor S
hsa-mir-339-5p	breast cancer
hsa-mir-339-5p	hepatocellular carcinoma
hsa-mir-339-5p	lung adenocarcinoma
hsa-mir-339-5p	ovarian cancer
hsa-mir-339-5p	papillary thyroid carcinoma
hsa-mir-33a	breast cancer
hsa-mir-33a	breast cancer	down	MiR-33a s
hsa-mir-33a	cervical cancer
hsa-mir-33a	colorectal cancer
hsa-mir-33a	glioma
hsa-mir-33a	hepatocellular carcinoma
hsa-mir-33a	hepatocellular carcinoma
hsa-mir-33a	hepatocellular carcinoma
hsa-mir-33a	lung cancer
hsa-mir-33a	lung cancer
hsa-mir-33a	lung cancer
hsa-mir-33a	malignant melanoma	down	miR-33a functions as a tumor s
hsa-mir-33a	malignant melanoma
hsa-mir-33a	non-small cell lung cancer
hsa-mir-33a	pancreatic cancer	down	miR-33a s
hsa-mir-33a	prostate cancer	down	miR-33a is a tumor s
hsa-mir-33a	renal cell carcinoma
hsa-mir-33a-3p	hepatocellular carcinoma	down	MicroRNA-33a-3p s
hsa-mir-33a-5p	colorectal cancer	down	MicroRNA-33a-5p s
hsa-mir-33a-5p	esophageal squamous cell carcinoma	down	MicroRNA-33a-5p s
hsa-mir-33a-5p	glioma
hsa-mir-33a-5p	hepatocellular carcinoma
hsa-mir-33a-5p	lung cancer
hsa-mir-33a-5p	osteosarcoma	down	MicroRNA-33a-5p s
hsa-mir-33b	colorectal cancer
hsa-mir-33b	esophageal squamous cell carcinoma
hsa-mir-33b	gastric cancer	down	Curcumin inhibits cell growth and induces cell apoptosis through
hsa-mir-33b	hepatocellular carcinoma
hsa-mir-33b	malignant melanoma
hsa-mir-33b	non-small cell lung cancer
hsa-mir-33b	osteosarcoma	down	MiR-33b inhibits osteosarcoma cell proliferation through s
hsa-mir-33b	osteosarcoma	down	MicroRNA-33b s
hsa-mir-33b	osteosarcoma
hsa-mir-340	acute myeloid leukemia
hsa-mir-340	breast cancer
hsa-mir-340	breast cancer	down	miR-340 s
hsa-mir-340	breast cancer
hsa-mir-340	cervical cancer	down	MiR-340 s
hsa-mir-340	colorectal cancer	down	miR-340 s
hsa-mir-340	endometrial cancer
hsa-mir-340	esophageal squamous cell carcinoma
hsa-mir-340	gastric cancer
hsa-mir-340	gastric cancer
hsa-mir-340	gastric cancer
hsa-mir-340	glioblastoma
hsa-mir-340	glioblastoma	down	miR-340 s
hsa-mir-340	hepatocellular carcinoma
hsa-mir-340	hepatocellular carcinoma
hsa-mir-340	hepatocellular carcinoma
hsa-mir-340	non-small cell lung cancer
hsa-mir-340	non-small cell lung cancer
hsa-mir-340	oral cancer
hsa-mir-340	osteosarcoma	down	MicroRNA-340 s
hsa-mir-340	ovarian cancer
hsa-mir-340	pancreatic cancer	down	MicroRNA-340 s
hsa-mir-340	prostate cancer	down	microRNA-340 S
hsa-mir-340	prostate cancer
hsa-mir-340*	gastric cancer
hsa-mir-340-5p	acute myeloid leukemia	down	High expression of long intergenic non-coding RNA LINC00662 contributes to malignant growth of acute myeloid leukemia cells by
hsa-mir-340-5p	colorectal cancer
hsa-mir-340-5p	glioblastoma
hsa-mir-340-5p	glioblastoma	down	miR-340-5p S
hsa-mir-340-5p	multiple myeloma
hsa-mir-340-5p	non-small cell lung cancer	down	MicroRNA-340-5p s
hsa-mir-340-5p	osteosarcoma	down	MicroRNA-340-5p s
hsa-mir-340-5p	thyroid cancer
hsa-mir-342	acute promyelocytic leukemia
hsa-mir-342	colorectal cancer
hsa-mir-342	colorectal cancer	down	FOXM1 and FOXQ1 are promising prognostic biomarkers and novel targets of tumor s
hsa-mir-342	glioblastoma
hsa-mir-342	hepatocellular carcinoma
hsa-mir-342	malignant melanoma
hsa-mir-342	nasopharyngeal carcinoma
hsa-mir-342-3p	hepatocellular carcinoma
hsa-mir-342-3p	hepatocellular carcinoma	down	miR-342-3p s
hsa-mir-342-3p	nasopharyngeal carcinoma	down	microRNA-342-3p targets FOXQ1 to s
hsa-mir-342-3p	non-small cell lung cancer	down	miR-342-3p targets RAP2B to s
hsa-mir-342-3p	non-small cell lung cancer	down	miR-342-3p s
hsa-mir-342-3p	oral squamous cell carcinoma	down	MicroRNA-342-3p functions as a tumor s
hsa-mir-342-5p	colon cancer
hsa-mir-345	gastric cancer
hsa-mir-345	hepatocellular carcinoma
hsa-mir-345	hepatocellular carcinoma
hsa-mir-345	non-small cell lung cancer	down	MicroRNA-345 s
hsa-mir-345	non-small cell lung cancer
hsa-mir-345	oral squamous cell carcinoma
hsa-mir-345-5p	pancreatic cancer	down	MiR-345-5p functions as a tumor s
hsa-mir-345-5p	pancreatic ductal adenocarcinoma	down	MiR-345-5p functions as a tumor s
hsa-mir-346	breast cancer
hsa-mir-346	follicular thyroid carcinoma
hsa-mir-346	hepatocellular carcinoma
hsa-mir-346	hepatocellular carcinoma
hsa-mir-346	hepatocellular carcinoma	down	MiR-346 s
hsa-mir-346	nasopharyngeal carcinoma
hsa-mir-346	ovarian cancer
hsa-mir-346	papillary thyroid carcinoma
hsa-mir-34a	acute myeloid leukemia
hsa-mir-34a	acute myeloid leukemia
hsa-mir-34a	b-cell lymphoma	down	The Epstein-Barr virus (EBV)-induced tumor s
hsa-mir-34a	basal cell carcinoma
hsa-mir-34a	bladder cancer	down	MicroRNA-34a functions as an anti-metastatic microRNA and s
hsa-mir-34a	brain cancer
hsa-mir-34a	breast cancer
hsa-mir-34a	breast cancer	down	MicroRNA-34 s
hsa-mir-34a	breast cancer	down	Targeted Expression of miR-34a Using the T-VISA System S
hsa-mir-34a	breast cancer	down	MicroRNA-34a S
hsa-mir-34a	breast cancer	down	MicroRNA-34a s
hsa-mir-34a	breast cancer	down	MicroRNA-34a s
hsa-mir-34a	breast cancer
hsa-mir-34a	breast cancer	down	Tumor-s
hsa-mir-34a	breast cancer
hsa-mir-34a	breast cancer
hsa-mir-34a	cervical cancer	down	MicroRNA-34a-Upregulated Retinoic Acid-Inducible Gene-I Promotes Apoptosis and Delays Cell Cycle Transition in Cervical Cancer Cells.
hsa-mir-34a	cervical cancer
hsa-mir-34a	cervical carcinoma	down	MicroRNA-34a s
hsa-mir-34a	cholangiocarcinoma
hsa-mir-34a	cholangiocarcinoma
hsa-mir-34a	choriocarcinoma	down	MicroRNA-34a s
hsa-mir-34a	choriocarcinoma	down	MicroRNA-34a is a tumor s
hsa-mir-34a	clear cell renal cell cancer
hsa-mir-34a	colon cancer
hsa-mir-34a	colon cancer
hsa-mir-34a	colon cancer
hsa-mir-34a	colorectal cancer
hsa-mir-34a	colorectal cancer
hsa-mir-34a	colorectal cancer
hsa-mir-34a	colorectal cancer	down	MicroRNA-34a targets FMNL2 and E2F5 and s
hsa-mir-34a	colorectal cancer
hsa-mir-34a	colorectal cancer	down	MicroRNA-34a s
hsa-mir-34a	colorectal cancer
hsa-mir-34a	endometrial cancer	down	Role of miR-34a as a s
hsa-mir-34a	endometrial cancer
hsa-mir-34a	endometrial cancer
hsa-mir-34a	esophageal cancer
hsa-mir-34a	esophageal squamous cell carcinoma
hsa-mir-34a	esophageal squamous cell carcinoma	down	Tumor s
hsa-mir-34a	esophageal squamous cell carcinoma	down	MicroRNA-34a s
hsa-mir-34a	esophageal squamous cell carcinoma
hsa-mir-34a	extrahepatic cholangiocarcinoma
hsa-mir-34a	gastric cancer
hsa-mir-34a	gastric cancer
hsa-mir-34a	gastric cancer
hsa-mir-34a	gastric cancer
hsa-mir-34a	gastric cancer
hsa-mir-34a	gastric cancer
hsa-mir-34a	gastric cancer
hsa-mir-34a	gastric cancer
hsa-mir-34a	gastric cancer
hsa-mir-34a	glioblastoma
hsa-mir-34a	glioblastoma
hsa-mir-34a	glioblastoma	down	miR-34a functions as a tumor s
hsa-mir-34a	glioma
hsa-mir-34a	glioma	down	microRNA-34a is tumor s
hsa-mir-34a	glioma
hsa-mir-34a	head and neck squamous cell carcinoma
hsa-mir-34a	hepatoblastoma
hsa-mir-34a	hepatocellular carcinoma
hsa-mir-34a	hepatocellular carcinoma
hsa-mir-34a	hepatocellular carcinoma
hsa-mir-34a	hepatocellular carcinoma
hsa-mir-34a	hepatocellular carcinoma
hsa-mir-34a	hepatocellular carcinoma
hsa-mir-34a	hepatocellular carcinoma
hsa-mir-34a	hepatocellular carcinoma
hsa-mir-34a	hepatocellular carcinoma	down	Oncolytic adenovirus co-expressing miRNA-34a and IL-24 induces s
hsa-mir-34a	hepatocellular carcinoma
hsa-mir-34a	hepatocellular carcinoma
hsa-mir-34a	hepatocellular carcinoma
hsa-mir-34a	laryngeal cancer
hsa-mir-34a	laryngeal carcinoma
hsa-mir-34a	liver cancer
hsa-mir-34a	lung cancer	down	Development of a lung cancer therapeutic based on the tumor s
hsa-mir-34a	malignant melanoma
hsa-mir-34a	malignant melanoma
hsa-mir-34a	malignant melanoma	down	Overexpression of the miR-34 family s
hsa-mir-34a	malignant melanoma
hsa-mir-34a	medullary thyroid carcinoma
hsa-mir-34a	neuroblastoma
hsa-mir-34a	neuroblastoma	down	MicroRNA-34a functions as a potential tumor s
hsa-mir-34a	neuroblastoma	down	A functional screen identifies miR-34a as a candidate neuroblastoma tumor s
hsa-mir-34a	non-small cell lung cancer
hsa-mir-34a	non-small cell lung cancer
hsa-mir-34a	non-small cell lung cancer
hsa-mir-34a	non-small cell lung cancer
hsa-mir-34a	oral cancer
hsa-mir-34a	oral squamous cell carcinoma
hsa-mir-34a	oropharyngeal cancer
hsa-mir-34a	osteosarcoma
hsa-mir-34a	osteosarcoma
hsa-mir-34a	osteosarcoma
hsa-mir-34a	osteosarcoma
hsa-mir-34a	osteosarcoma
hsa-mir-34a	osteosarcoma
hsa-mir-34a	osteosarcoma	down	MicroRNA-34a promotes cell cycle arrest and apoptosis and s
hsa-mir-34a	ovarian cancer
hsa-mir-34a	ovarian cancer
hsa-mir-34a	ovarian cancer	down	MiR-34a s
hsa-mir-34a	ovarian cancer	down	MicroRNA-34 s
hsa-mir-34a	pancreatic adenocarcinoma	down	Simultaneous overexpression of miR-126 and miR-34a induces a s
hsa-mir-34a	pancreatic cancer
hsa-mir-34a	pancreatic cancer
hsa-mir-34a	pancreatic cancer
hsa-mir-34a	pancreatic cancer	down	Genistein inhibits cell growth and induces apoptosis through
hsa-mir-34a	pancreatic ductal adenocarcinoma
hsa-mir-34a	pancreatic ductal adenocarcinoma	down	EZH2 co
hsa-mir-34a	papillary thyroid carcinoma
hsa-mir-34a	prostate cancer
hsa-mir-34a	prostate cancer	down	MicroRNA-34a modulates c-Myc transcriptional complexes to s
hsa-mir-34a	prostate cancer
hsa-mir-34a	prostate cancer
hsa-mir-34a	prostate cancer
hsa-mir-34a	prostate cancer	down	Methylation-induced silencing of miR-34a enhances chemoresistance by directly
hsa-mir-34a	prostate cancer
hsa-mir-34a	prostate cancer
hsa-mir-34a	prostate cancer
hsa-mir-34a	renal cell carcinoma	down	MicroRNA-34a s
hsa-mir-34a	renal cell carcinoma	down	Tumor s
hsa-mir-34a	renal cell carcinoma	down	MicroRNA-34a s
hsa-mir-34a	retinoblastoma	down	Differential microRNA-34a expression and tumor s
hsa-mir-34a	retinoblastoma	down	Shikonin-mediated
hsa-mir-34a	squamous carcinoma
hsa-mir-34a	thyroid cancer
hsa-mir-34a	uveal melanoma
hsa-mir-34a-5p	colorectal cancer	down	miR-34a-5p s
hsa-mir-34a-5p	glioma	down	MicroRNA-34a-5p s
hsa-mir-34a-5p	hepatocellular carcinoma
hsa-mir-34a-5p	nasopharyngeal carcinoma
hsa-mir-34a-5p	papillary thyroid carcinoma
hsa-mir-34b	breast cancer	down	MicroRNA-34 s
hsa-mir-34b	breast cancer
hsa-mir-34b	chronic lymphocytic leukemia
hsa-mir-34b	endometrial serous adenocarcinoma	down	MicroRNA-34b functions as a potential tumor s
hsa-mir-34b	gastric cancer
hsa-mir-34b	hepatoblastoma
hsa-mir-34b	hepatocellular carcinoma
hsa-mir-34b	lung cancer	down	Development of a lung cancer therapeutic based on the tumor s
hsa-mir-34b	nasopharyngeal carcinoma
hsa-mir-34b	nasopharyngeal carcinoma
hsa-mir-34b	non-small cell lung cancer	down	MicroRNA-34b functions as a tumor s
hsa-mir-34b	osteosarcoma
hsa-mir-34b	ovarian cancer
hsa-mir-34b	ovarian cancer	down	MicroRNA-34 s
hsa-mir-34b	ovarian carcinoma
hsa-mir-34b	pancreatic cancer
hsa-mir-34b	pancreatic cancer
hsa-mir-34b	pancreatic cancer
hsa-mir-34b	papillary thyroid carcinoma
hsa-mir-34b	papillary thyroid carcinoma
hsa-mir-34b	uveal melanoma	down	MicroRNA-34b/c s
hsa-mir-34b-3p	prostate cancer
hsa-mir-34b-5p	malignant melanoma
hsa-mir-34c	breast cancer	down	MicroRNA-34c S
hsa-mir-34c	breast cancer	down	MicroRNA-34 s
hsa-mir-34c	breast cancer
hsa-mir-34c	breast cancer
hsa-mir-34c	chronic lymphocytic leukemia
hsa-mir-34c	colon cancer
hsa-mir-34c	colorectal cancer	down	Interr
hsa-mir-34c	endometrial cancer
hsa-mir-34c	endometrial cancer	down	miR-34c plays a role of tumor s
hsa-mir-34c	gastric cancer
hsa-mir-34c	hepatoblastoma
hsa-mir-34c	lung cancer	down	Uncovering growth-s
hsa-mir-34c	lung cancer	down	Development of a lung cancer therapeutic based on the tumor s
hsa-mir-34c	malignant melanoma	down	Overexpression of the miR-34 family s
hsa-mir-34c	medulloblastoma
hsa-mir-34c	nasopharyngeal carcinoma	down	MiR-34c s
hsa-mir-34c	nasopharyngeal carcinoma
hsa-mir-34c	non-small cell lung cancer	down	MiR-34c acts as a tumor s
hsa-mir-34c	osteosarcoma
hsa-mir-34c	osteosarcoma
hsa-mir-34c	ovarian cancer
hsa-mir-34c	ovarian cancer	down	MicroRNA-34 s
hsa-mir-34c	ovarian carcinoma
hsa-mir-34c	pancreatic cancer
hsa-mir-34c	pancreatic cancer
hsa-mir-34c	prostate cancer	down	miR-34c is downregulated in prostate cancer and exerts tumor s
hsa-mir-34c	uveal melanoma	down	MicroRNA-34b/c s
hsa-mir-34c-3p	hepatocellular carcinoma
hsa-mir-34c-3p	nasopharyngeal carcinoma
hsa-mir-34c-3p	non-small cell lung cancer	down	MiR-34c-3p s
hsa-mir-34c-3p	non-small cell lung cancer
hsa-mir-34c-5p	colorectal cancer	down	SATB2 targeted by methylated miR-34c-5p s
hsa-mir-3607	lung adenocarcinoma
hsa-mir-3607-3p	non-small cell lung cancer	down	miR-3607-3p s
hsa-mir-361	osteosarcoma
hsa-mir-361-3p	non-small cell lung cancer	down	MicroRNA-361-3p s
hsa-mir-361-3p	non-small cell lung cancer
hsa-mir-361-3p	retinoblastoma
hsa-mir-361-5p	breast cancer
hsa-mir-361-5p	colorectal cancer
hsa-mir-361-5p	gastric cancer
hsa-mir-361-5p	gastric cancer	down	MiR-361-5p inhibits the mobility of gastric cancer cells through s
hsa-mir-361-5p	glioma
hsa-mir-361-5p	glioma
hsa-mir-361-5p	hepatocellular carcinoma
hsa-mir-361-5p	lung cancer	down	miR-361-5p s
hsa-mir-361-5p	non-small cell lung cancer
hsa-mir-361-5p	papillary thyroid carcinoma
hsa-mir-361-5p	retinoblastoma
hsa-mir-3613	papillary thyroid carcinoma
hsa-mir-3619-5p	bladder cancer	down	MicroRNA-3619-5p s
hsa-mir-3619-5p	prostate cancer
hsa-mir-362	colorectal cancer
hsa-mir-362	lung cancer
hsa-mir-362	non-small cell lung cancer
hsa-mir-362	renal cell carcinoma
hsa-mir-362-3p	breast cancer
hsa-mir-362-3p	cervical adenocarcinoma	down	MiR-362-3p functions as a tumor s
hsa-mir-362-3p	gastric cancer
hsa-mir-362-3p	gastric cancer
hsa-mir-362-3p	glioma
hsa-mir-362-3p	hepatocellular carcinoma
hsa-mir-362-3p	renal cell carcinoma	down	miR-362-3p targets nemo-like kinase and functions as a tumor s
hsa-mir-362-5p	hepatocellular carcinoma
hsa-mir-362-5p	neuroblastoma
hsa-mir-363	gastric cancer
hsa-mir-363	head and neck cancer
hsa-mir-363	head and neck squamous cell carcinoma
hsa-mir-363	hepatocellular carcinoma
hsa-mir-363	hepatocellular carcinoma
hsa-mir-363	osteosarcoma	down	microRNA-363 plays a tumor s
hsa-mir-363	ovarian cancer
hsa-mir-363-3p	acute myeloid leukemia
hsa-mir-363-3p	colorectal cancer	down	MiR-363-3p s
hsa-mir-363-3p	colorectal cancer	down	MiR-363-3p inhibits the epithelial-to-mesenchymal transition and s
hsa-mir-363-3p	gastric cancer	down	Identification and characterization of tumor s
hsa-mir-363-3p	hepatocellular carcinoma
hsa-mir-363-3p	lung adenocarcinoma
hsa-mir-363-3p	osteosarcoma
hsa-mir-363-3p	papillary thyroid carcinoma
hsa-mir-363-3p	papillary thyroid carcinoma	down	MicroRNA-363-3p s
hsa-mir-365	breast cancer
hsa-mir-365	breast cancer
hsa-mir-365	cholangiocarcinoma	down	MiR-365 s
hsa-mir-365	esophageal cancer	down	MicroRNA-365 s
hsa-mir-365	esophageal squamous cell carcinoma	down	MicroRNA-365 s
hsa-mir-365	glioblastoma	down	MicroRNA-365 s
hsa-mir-365	hepatocellular carcinoma
hsa-mir-365	hepatocellular carcinoma	down	miR-365 targets ADAM10 and s
hsa-mir-365	hepatocellular carcinoma
hsa-mir-365	hepatocellular carcinoma
hsa-mir-365	malignant melanoma
hsa-mir-365	non-small cell lung cancer
hsa-mir-365	non-small cell lung cancer
hsa-mir-365	non-small cell lung cancer
hsa-mir-365	oral squamous cell carcinoma
hsa-mir-365	osteosarcoma	down	miR-365 functions as a tumor s
hsa-mir-365	ovarian cancer
hsa-mir-3650	hepatocellular carcinoma	down	Tumor-s
hsa-mir-3653	colon cancer
hsa-mir-3658	bladder cancer
hsa-mir-365a-3p	laryngeal squamous cell carcinoma
hsa-mir-365a-3p	lung adenocarcinoma
hsa-mir-3662	hepatocellular carcinoma	down	MiR-3662 s
hsa-mir-3662	lung cancer
hsa-mir-3663-3p	glioma
hsa-mir-367	gastric cancer
hsa-mir-367	hepatocellular carcinoma
hsa-mir-367	medulloblastoma
hsa-mir-367	non-small cell lung cancer
hsa-mir-367	osteosarcoma
hsa-mir-367	pancreatic cancer
hsa-mir-367	uveal melanoma
hsa-mir-369-3p	glioblastoma
hsa-mir-369-3p	thyroid cancer
hsa-mir-369-5p	pancreatic ductal adenocarcinoma
hsa-mir-3691-5p	hepatocellular carcinoma
hsa-mir-370	acute myeloid leukemia
hsa-mir-370	bladder cancer	down	Up-regulation of p21(WAF1/CIP1) by miRNAs and its implications in bladder cancer cells.
hsa-mir-370	breast cancer
hsa-mir-370	breast cancer
hsa-mir-370	colonic adenocarcinoma
hsa-mir-370	esophageal squamous cell carcinoma
hsa-mir-370	gastric cancer
hsa-mir-370	gastric cancer
hsa-mir-370	gastric cancer	down	Upregulation of microRNA-370 promotes cell apoptosis and inhibits proliferation by targeting PTEN in human gastric cancer.
hsa-mir-370	glioma
hsa-mir-370	hepatocellular carcinoma
hsa-mir-370	laryngeal squamous cell carcinoma	down	miR-370 targeted FoxM1 functions as a tumor s
hsa-mir-370	liver cancer
hsa-mir-370	malignant melanoma
hsa-mir-370	non-small cell lung cancer
hsa-mir-370	oral squamous cell carcinoma
hsa-mir-370	osteosarcoma
hsa-mir-370	osteosarcoma
hsa-mir-370	primary cns lymphomas
hsa-mir-370-3p	glioma
hsa-mir-371	hepatocellular carcinoma
hsa-mir-371-5p	gastric cancer
hsa-mir-371-5p	hepatocellular carcinoma
hsa-mir-371-5p	nasopharyngeal carcinoma	down	miR-371-5p s
hsa-mir-372	breast cancer
hsa-mir-372	colorectal cancer
hsa-mir-372	endometrial cancer
hsa-mir-372	epithelial ovarian cancer
hsa-mir-372	glioma
hsa-mir-372	head and neck squamous cell carcinoma
hsa-mir-372	hepatocellular carcinoma
hsa-mir-372	hepatocellular carcinoma
hsa-mir-372	oral squamous cell carcinoma
hsa-mir-372	ovarian carcinoma
hsa-mir-372	prostate cancer	down	microRNA-372 S
hsa-mir-372	renal cell carcinoma	down	miR-372 s
hsa-mir-372-3p	breast carcinoma
hsa-mir-372-3p	lung squamous cell carcinoma
hsa-mir-372-3p	osteosarcoma
hsa-mir-372-5p	oral squamous cell carcinoma
hsa-mir-373	bladder cancer	down	Enhancing E-cadherin expression via promoter-targeted miR-373 s
hsa-mir-373	breast cancer
hsa-mir-373	breast cancer
hsa-mir-373	breast cancer
hsa-mir-373	breast cancer
hsa-mir-373	cervical carcinoma
hsa-mir-373	colon cancer
hsa-mir-373	endometrial cancer
hsa-mir-373	epithelial ovarian cancer
hsa-mir-373	esophageal squamous cell carcinoma
hsa-mir-373	esophageal squamous cell carcinoma
hsa-mir-373	gastric cancer	down	miR-373 s
hsa-mir-373	glioblastoma
hsa-mir-373	glioma
hsa-mir-373	glioma
hsa-mir-373	lung cancer
hsa-mir-373	malignant melanoma
hsa-mir-373	non-small cell lung cancer
hsa-mir-373	non-small cell lung cancer
hsa-mir-373	oral squamous cell carcinoma
hsa-mir-373	oral squamous cell carcinoma
hsa-mir-373	osteosarcoma
hsa-mir-373	pancreatic cancer
hsa-mir-373-3p	esophageal squamous cell carcinoma
hsa-mir-373-3p	lung adenocarcinoma
hsa-mir-373-3p	prostate cancer
hsa-mir-374a	bladder cancer	down	MicroRNA-374a Inhibits Aggressive Tumor Biological Behavior in Bladder Carcinoma by S
hsa-mir-374a	breast cancer
hsa-mir-374a	colon cancer	down	microRNA-374a s
hsa-mir-374a	esophageal cancer
hsa-mir-374a	glioma
hsa-mir-374a	glioma
hsa-mir-374a	hepatocellular carcinoma
hsa-mir-374a	lung adenocarcinoma	down	MiR-374a s
hsa-mir-374a	pancreatic cancer
hsa-mir-374a-5p	gastric cancer
hsa-mir-374a-5p	osteosarcoma
hsa-mir-374b	cervical cancer
hsa-mir-374b	cervical cancer
hsa-mir-374b	colon cancer
hsa-mir-374b	gastrointestinal stromal tumor
hsa-mir-374b	glioma
hsa-mir-374b	glioma
hsa-mir-374b	liver cancer
hsa-mir-374b	prostate cancer
hsa-mir-374b	t-cell lymphoblastic lymphoma	down	MicroRNA-374b s
hsa-mir-374b-5p	bladder cancer	down	MiR-454-3p and miR-374b-5p s
hsa-mir-374c-5p	cervical cancer
hsa-mir-375	brain cancer
hsa-mir-375	breast cancer
hsa-mir-375	cervical squamous cell carcinoma
hsa-mir-375	colon cancer
hsa-mir-375	colorectal cancer	down	MicroRNA-375 s
hsa-mir-375	colorectal cancer
hsa-mir-375	colorectal cancer
hsa-mir-375	colorectal cancer
hsa-mir-375	colorectal cancer
hsa-mir-375	colorectal cancer
hsa-mir-375	colorectal cancer
hsa-mir-375	colorectal cancer
hsa-mir-375	esophageal adenocarcinoma
hsa-mir-375	esophageal cancer	down	MicroRNA-375 s
hsa-mir-375	esophageal cancer
hsa-mir-375	esophageal cancer
hsa-mir-375	esophageal squamous cell carcinoma
hsa-mir-375	esophageal squamous cell carcinoma
hsa-mir-375	esophageal squamous cell carcinoma
hsa-mir-375	esophageal squamous cell carcinoma	down	MiR-375 s
hsa-mir-375	esophageal squamous cell carcinoma
hsa-mir-375	esophageal squamous cell carcinoma
hsa-mir-375	esophageal squamous cell carcinoma
hsa-mir-375	gastric cancer
hsa-mir-375	gastric cancer
hsa-mir-375	gastric cancer
hsa-mir-375	gastric cancer	down	MicroRNA-375 Functions as a Tumor-S
hsa-mir-375	gastric cancer
hsa-mir-375	gastric cancer
hsa-mir-375	gastric cancer
hsa-mir-375	gastric cancer
hsa-mir-375	gastric cancer
hsa-mir-375	gastric cancer
hsa-mir-375	gastric cancer
hsa-mir-375	glioma
hsa-mir-375	glioma
hsa-mir-375	glioma
hsa-mir-375	head and neck squamous cell carcinoma
hsa-mir-375	head and neck squamous cell carcinoma	down	MicroRNA-375 S
hsa-mir-375	head and neck squamous cell carcinoma
hsa-mir-375	hepatocellular carcinoma
hsa-mir-375	hepatocellular carcinoma
hsa-mir-375	hepatocellular carcinoma
hsa-mir-375	hepatocellular carcinoma	down	MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and s
hsa-mir-375	hepatocellular carcinoma
hsa-mir-375	laryngeal cancer
hsa-mir-375	laryngeal squamous cell carcinoma	down	miR-375 S
hsa-mir-375	laryngeal squamous cell carcinoma
hsa-mir-375	liver cancer	down	Upregulation of miR-375 inhibits human liver cancer cell growth by modulating cell proliferation and apoptosis via targeting ErbB2.
hsa-mir-375	medullary thyroid carcinoma
hsa-mir-375	multiple myeloma
hsa-mir-375	nasopharyngeal carcinoma
hsa-mir-375	non-small cell lung cancer
hsa-mir-375	non-small cell lung cancer
hsa-mir-375	non-small cell lung cancer
hsa-mir-375	oral cancer
hsa-mir-375	oral cancer	down	Anti-Cancer Drugs Reactivate Tumor S
hsa-mir-375	oral carcinoma
hsa-mir-375	oral squamous cell carcinoma
hsa-mir-375	oral squamous cell carcinoma
hsa-mir-375	oropharyngeal cancer
hsa-mir-375	osteosarcoma	down	MicroRNA-375 functions as a tumor s
hsa-mir-375	pancreatic cancer
hsa-mir-375	pancreatic cancer
hsa-mir-375	pancreatic cancer
hsa-mir-375	pancreatic carcinoma	down	MicroRNA-375 targets PDK1 in pancreatic carcinoma and s
hsa-mir-375	pancreatic ductal adenocarcinoma
hsa-mir-375	pancreatic ductal adenocarcinoma
hsa-mir-375	papillary thyroid carcinoma
hsa-mir-375	squamous carcinoma	down	Tumor s
hsa-mir-376a	breast cancer
hsa-mir-376a	chondrosarcoma
hsa-mir-376a	gastric cancer
hsa-mir-376a	glioblastoma
hsa-mir-376a	hepatocellular carcinoma	down	miR-376a s
hsa-mir-376a	malignant melanoma
hsa-mir-376a	non-small cell lung cancer	down	MiR-376a s
hsa-mir-376a	ovarian cancer
hsa-mir-376a	pancreatic ductal adenocarcinoma
hsa-mir-376a	renal cell carcinoma	down	MiR-376a functions as tumor s
hsa-mir-376b	breast cancer
hsa-mir-376c	cervical cancer
hsa-mir-376c	gastric cancer
hsa-mir-376c	malignant melanoma
hsa-mir-376c	non-small cell lung cancer	down	MicroRNA-376c s
hsa-mir-376c	osteosarcoma
hsa-mir-376c	osteosarcoma
hsa-mir-376c-3p	gastric adenocarcinoma
hsa-mir-377	cervical cancer
hsa-mir-377	gastric cancer	down	MiR-377 s
hsa-mir-377	gastric cancer
hsa-mir-377	gastric cancer
hsa-mir-377	hepatocellular carcinoma	down	MicroRNA-377 S
hsa-mir-377	hepatocellular carcinoma
hsa-mir-377	non-small cell lung cancer
hsa-mir-377	oral squamous cell carcinoma
hsa-mir-377	pancreatic ductal adenocarcinoma
hsa-mir-377	renal clear cell carcinoma	down	miR-377 functions as a tumor s
hsa-mir-377-3p	colorectal cancer
hsa-mir-377-3p	ovarian cancer
hsa-mir-378	acute myeloid leukemia
hsa-mir-378	basal cell carcinoma
hsa-mir-378	breast cancer
hsa-mir-378	chronic myelogenous leukemia
hsa-mir-378	colorectal cancer
hsa-mir-378	colorectal cancer
hsa-mir-378	colorectal cancer
hsa-mir-378	gastric cancer
hsa-mir-378	gastric cancer
hsa-mir-378	gastric cancer	down	MicroRNA-195 and microRNA-378 mediate tumor growth s
hsa-mir-378	glioma
hsa-mir-378	lung cancer
hsa-mir-378	nasopharyngeal carcinoma
hsa-mir-378	oral squamous cell carcinoma
hsa-mir-378	ovarian cancer
hsa-mir-378	ovarian cancer
hsa-mir-378	prostate cancer	down	MiR-378 s
hsa-mir-378	renal cell carcinoma
hsa-mir-378a-3p	colorectal cancer
hsa-mir-378a-3p	pancreatic cancer
hsa-mir-378a-5p	colorectal cancer
hsa-mir-378a-5p	colorectal cancer
hsa-mir-379	breast cancer
hsa-mir-379	cervical cancer	down	MicroRNA-379 S
hsa-mir-379	gastric cancer
hsa-mir-379	glioma
hsa-mir-379	laryngeal carcinoma
hsa-mir-379	osteosarcoma	down	MicroRNA-379 s
hsa-mir-379-5p	hepatocellular carcinoma
hsa-mir-381	breast cancer	down	miR-381 s
hsa-mir-381	breast cancer
hsa-mir-381	colon cancer	down	Down-regulation of MicroRNA-381 promotes cell proliferation and invasion in colon cancer through
hsa-mir-381	colon cancer
hsa-mir-381	colorectal cancer	down	MiR-381 functions as a tumor s
hsa-mir-381	endometrial cancer
hsa-mir-381	esophageal squamous cell carcinoma
hsa-mir-381	gastric cancer
hsa-mir-381	gastric cancer
hsa-mir-381	hepatocellular carcinoma	down	MicroRNA-381 s
hsa-mir-381	lung adenocarcinoma
hsa-mir-381	non-small cell lung cancer	down	microRNA-381 s
hsa-mir-381	osteosarcoma	down	MicroRNA-381 s
hsa-mir-381	renal cell carcinoma
hsa-mir-382	colorectal cancer	down	MiR-382 functions as tumor s
hsa-mir-382	colorectal cancer
hsa-mir-382	colorectal cancer
hsa-mir-382	non-small cell lung cancer
hsa-mir-382	non-small cell lung cancer
hsa-mir-382	osteosarcoma
hsa-mir-382	osteosarcoma
hsa-mir-382	ovarian cancer
hsa-mir-382	prostate cancer	down	MicroRNA-382 inhibits prostate cancer cell proliferation and metastasis through targeting COUP-TFII.
hsa-mir-382-5p	acute myeloid leukemia
hsa-mir-382-5p	esophageal adenocarcinoma
hsa-mir-383	breast cancer
hsa-mir-383	colon cancer	down	MicroRNA-383 acts as a tumor s
hsa-mir-383	colorectal cancer	down	MicroRNA-383 s
hsa-mir-383	gastric cancer
hsa-mir-383	glioma
hsa-mir-383	glioma
hsa-mir-383	hepatocellular carcinoma
hsa-mir-383	lung cancer	down	MicroRNA-383 is a tumor s
hsa-mir-383	medulloblastoma
hsa-mir-383	non-small cell lung cancer	down	MicroRNA-383 is a tumor s
hsa-mir-383	non-small cell lung cancer
hsa-mir-383-5p	gastric cancer
hsa-mir-383-5p	ovarian cancer	down	Up-regulation of miR-383-5p s
hsa-mir-384	breast cancer
hsa-mir-384	colorectal cancer
hsa-mir-384	esophageal squamous cell carcinoma
hsa-mir-384	glioma
hsa-mir-384	hepatocellular carcinoma	down	MiR-384 regulated IRS1 expression and s
hsa-mir-384	non-small cell lung cancer
hsa-mir-384	renal cell carcinoma
hsa-mir-384	renal cell carcinoma	down	miR-384 s
hsa-mir-3908	glioblastoma
hsa-mir-3910	hepatocellular carcinoma
hsa-mir-3928	osteosarcoma
hsa-mir-3934-5p	non-small cell lung cancer
hsa-mir-3940-5p	non-small cell lung cancer	down	miR-3940-5p Functions as a Tumor S
hsa-mir-409-3p	bladder cancer
hsa-mir-409-3p	breast cancer	down	miR-409-3p s
hsa-mir-409-3p	cervical carcinoma
hsa-mir-409-3p	colon cancer
hsa-mir-409-3p	colorectal cancer	down	MicroRNA-409-3p s
hsa-mir-409-3p	colorectal cancer
hsa-mir-409-3p	gastric cancer	down	MicroRNA-409 s
hsa-mir-409-3p	gastric cancer
hsa-mir-409-3p	glioma	down	MicroRNA-409-3p Represses Glioma Cell Invasion and Proliferation by Targeting High-mobility Gro
hsa-mir-409-3p	lung adenocarcinoma	down	MicroRNA-409-3p functions as a tumor s
hsa-mir-409-3p	osteosarcoma
hsa-mir-409-3p	osteosarcoma
hsa-mir-409-3p	ovarian cancer
hsa-mir-409-3p	papillary thyroid carcinoma	down	MicroRNA-409-3p s
hsa-mir-410	acute lymphoblastic leukemia
hsa-mir-410	colon cancer
hsa-mir-410	colorectal cancer
hsa-mir-410	gastric cancer	down	MicroRNA-410 S
hsa-mir-410	glioma
hsa-mir-410	non-small cell lung cancer
hsa-mir-410	oral squamous cell carcinoma
hsa-mir-410	pancreatic cancer	down	MicroRNA-410 functions as a tumor s
hsa-mir-410-3p	breast cancer	down	miR-410-3p s
hsa-mir-410-3p	prostate cancer
hsa-mir-411	cervical cancer
hsa-mir-411	colorectal cancer
hsa-mir-411	gastric cancer
hsa-mir-411	lung cancer
hsa-mir-411	osteosarcoma
hsa-mir-411	ovarian cancer
hsa-mir-411	renal cell carcinoma	down	MiR-411 functions as a tumor s
hsa-mir-411-5p	breast cancer
hsa-mir-421	breast cancer
hsa-mir-421	gastric cancer
hsa-mir-421	gastric cancer
hsa-mir-421	gastric cancer
hsa-mir-421	gastric cancer
hsa-mir-421	glioma
hsa-mir-421	nasopharyngeal carcinoma
hsa-mir-421	neuroblastoma
hsa-mir-421	non-small cell lung cancer
hsa-mir-421	non-small cell lung cancer
hsa-mir-421	osteosarcoma
hsa-mir-422a	colorectal cancer
hsa-mir-422a	colorectal cancer
hsa-mir-422a	colorectal cancer
hsa-mir-422a	colorectal cancer	down	miR-422a is an independent prognostic factor and functions as a potential tumor s
hsa-mir-422a	glioblastoma	down	MiR-422a acts as a tumor s
hsa-mir-422a	glioma
hsa-mir-422a	head and neck squamous cell carcinoma
hsa-mir-422a	hepatocellular carcinoma
hsa-mir-422a	non-small cell lung cancer	down	MicroRNA-422a functions as a tumor s
hsa-mir-422a	osteosarcoma
hsa-mir-422a	thyroid cancer	down	Iodine Promotes Tumorigenesis of Thyroid Cancer by S
hsa-mir-423	breast cancer
hsa-mir-423	hepatocellular carcinoma
hsa-mir-423-3p	colorectal cancer
hsa-mir-423-3p	glioma
hsa-mir-423-3p	laryngeal carcinoma
hsa-mir-423-5p	colon cancer
hsa-mir-423-5p	glioma
hsa-mir-423-5p	hepatocellular carcinoma
hsa-mir-423-5p	non-small cell lung cancer
hsa-mir-423-5p	oral cancer
hsa-mir-423-5p	osteosarcoma
hsa-mir-423-5p	ovarian cancer
hsa-mir-424	acute myeloid leukemia
hsa-mir-424	bladder cancer	down	DNMT1-dependent s
hsa-mir-424	cervical cancer	down	S
hsa-mir-424	chronic lymphocytic leukemia
hsa-mir-424	chronic myelogenous leukemia
hsa-mir-424	colon cancer	down	MiR-424/503-Mediated Rictor Upregulation Promotes Tumor Progression.
hsa-mir-424	colorectal cancer
hsa-mir-424	colorectal cancer	down	miR-424 targets AKT3 and PSAT1 and has a tumor-s
hsa-mir-424	endometrial cancer	down	MicroRNA-424 may function as a tumor s
hsa-mir-424	endometrial cancer	down	MicroRNA-424 s
hsa-mir-424	endometrial cancer
hsa-mir-424	esophageal squamous cell carcinoma
hsa-mir-424	glioma	down	MiR-424 functions as a tumor s
hsa-mir-424	hepatocellular carcinoma
hsa-mir-424	hepatocellular carcinoma	down	MicroRNA-424 is down-regulated in hepatocellular carcinoma and s
hsa-mir-424	hepatocellular carcinoma
hsa-mir-424	non-small cell lung cancer
hsa-mir-424	osteosarcoma	down	Tumor s
hsa-mir-424	osteosarcoma	down	The microRNAs miR-449a and miR-424 s
hsa-mir-424	ovarian cancer
hsa-mir-424-5p	esophageal squamous cell carcinoma
hsa-mir-424-5p	gastric cancer
hsa-mir-424-5p	hepatocellular carcinoma
hsa-mir-424-5p	hepatocellular carcinoma	down	MiR-424-5p reversed epithelial-mesenchymal transition of anchorage-independent HCC cells by directly targeting ICAT and s
hsa-mir-424-5p	intrahepatic cholangiocarcinoma
hsa-mir-424-5p	liver cancer
hsa-mir-424-5p	ovarian cancer
hsa-mir-424-5p	pancreatic cancer
hsa-mir-425	breast cancer
hsa-mir-425	esophageal squamous cell carcinoma
hsa-mir-425	gastric cancer
hsa-mir-425	lung adenocarcinoma
hsa-mir-425	malignant melanoma
hsa-mir-425	nasopharyngeal carcinoma
hsa-mir-425-5p	acute myeloid leukemia
hsa-mir-425-5p	cervical cancer
hsa-mir-425-5p	cervical cancer
hsa-mir-425-5p	colorectal cancer
hsa-mir-425-5p	gastric cancer
hsa-mir-425-5p	gastric cancer
hsa-mir-425-5p	gastric cancer
hsa-mir-425-5p	osteosarcoma	down	miR-425-5p decreases LncRNA MALAT1 and TUG1 expressions and s
hsa-mir-4260	colorectal cancer
hsa-mir-4261	colorectal cancer
hsa-mir-4262	hepatocellular carcinoma
hsa-mir-4262	non-small cell lung cancer
hsa-mir-4268	gastric cancer
hsa-mir-4270	non-small cell lung cancer
hsa-mir-4282	colorectal carcinoma	down	MiR-4282 s
hsa-mir-4286	esophageal carcinoma
hsa-mir-429	astrocytoma
hsa-mir-429	bladder cancer
hsa-mir-429	bladder cancer
hsa-mir-429	breast cancer
hsa-mir-429	breast cancer
hsa-mir-429	cervical cancer	down	miR-429 is involved in regulation of NF-?B activity by targeting IKK? and s
hsa-mir-429	colon cancer
hsa-mir-429	colorectal cancer
hsa-mir-429	colorectal cancer	down	MiR-200 s
hsa-mir-429	colorectal cancer
hsa-mir-429	colorectal cancer
hsa-mir-429	colorectal carcinoma
hsa-mir-429	gastric cancer
hsa-mir-429	gastric cancer
hsa-mir-429	gastric cancer
hsa-mir-429	gastric cancer
hsa-mir-429	gastric cancer
hsa-mir-429	gastric cancer	down	miR-429 functions as a tumor s
hsa-mir-429	glioblastoma	down	MiR-429 s
hsa-mir-429	glioblastoma
hsa-mir-429	glioma	down	miR-429 inhibits glioma invasion through BMK1 s
hsa-mir-429	glioma
hsa-mir-429	hepatocellular carcinoma
hsa-mir-429	hepatocellular carcinoma	down	miR-429 s
hsa-mir-429	hepatocellular carcinoma
hsa-mir-429	hepatocellular carcinoma
hsa-mir-429	hepatocellular carcinoma	down	Upregulated microRNA-429 inhibits the migration of HCC cells by targeting TRAF6 through the NF-?B pathway.
hsa-mir-429	lung adenocarcinoma
hsa-mir-429	lung cancer
hsa-mir-429	malignant melanoma
hsa-mir-429	malignant melanoma
hsa-mir-429	mesenchymal cancer
hsa-mir-429	nephroblastoma
hsa-mir-429	oral cancer
hsa-mir-429	oral squamous cell carcinoma
hsa-mir-429	osteosarcoma	down	Tumor-S
hsa-mir-429	osteosarcoma	down	MiR-429 s
hsa-mir-429	ovarian cancer
hsa-mir-429	ovarian cancer
hsa-mir-429	ovarian cancer
hsa-mir-429	pancreatic ductal adenocarcinoma	down	MiR-429 s
hsa-mir-429	prostate cancer
hsa-mir-4295	anaplastic thyroid carcinoma
hsa-mir-4295	bladder cancer
hsa-mir-4295	bladder cancer
hsa-mir-4295	gastric cancer
hsa-mir-4295	glioma
hsa-mir-4301	breast cancer
hsa-mir-4301	lung cancer
hsa-mir-431	colorectal cancer
hsa-mir-431	colorectal cancer
hsa-mir-431	hepatocellular carcinoma
hsa-mir-431	lung cancer	down	MiR-431 s
hsa-mir-431	pancreatic cancer
hsa-mir-431	papillary thyroid carcinoma
hsa-mir-431-5p	hepatocellular carcinoma
hsa-mir-4316	papillary thyroid carcinoma	down	DNA copy number gain-mediated lncRNA LINC01061
hsa-mir-4317	gastric cancer
hsa-mir-4317	gastric cancer	down	miRNA-4317 S
hsa-mir-4317	non-small cell lung cancer	down	miR-4317 s
hsa-mir-4319	colorectal cancer	down	MiR-4319 s
hsa-mir-432	cervical cancer
hsa-mir-432	lung adenocarcinoma	down	MicroRNA-432 functions as a tumor s
hsa-mir-432	osteosarcoma
hsa-mir-432	ovarian cancer
hsa-mir-432-3p	esophageal squamous cell carcinoma
hsa-mir-432-5p	bladder cancer
hsa-mir-4326	lung cancer
hsa-mir-4328	mucinous cystadenocarcinoma
hsa-mir-433	breast cancer
hsa-mir-433	breast cancer
hsa-mir-433	cervical cancer
hsa-mir-433	colon cancer
hsa-mir-433	colorectal cancer
hsa-mir-433	colorectal cancer
hsa-mir-433	gastric cancer
hsa-mir-433	gastric cancer	down	The Tumor S
hsa-mir-433	hepatocellular carcinoma
hsa-mir-433	liver cancer
hsa-mir-433	non-small cell lung cancer	down	miR-433 s
hsa-mir-433	oral squamous cell carcinoma
hsa-mir-433	oral squamous cell carcinoma
hsa-mir-433	osteosarcoma
hsa-mir-433	ovarian cancer
hsa-mir-433	retinoblastoma	down	MiR-433 inhibits retinoblastoma malignancy by s
hsa-mir-433-3p	glioma	down	MiR-433-3p s
hsa-mir-4417	hepatocellular carcinoma
hsa-mir-4423	lung cancer
hsa-mir-4429	papillary thyroid carcinoma
hsa-mir-4443	osteosarcoma	down	Long non-coding RNA FEZF1-AS1 promotes osteosarcoma progression by regulating miR-4443/NUPR1 axis.
hsa-mir-4443	ovarian cancer
hsa-mir-4458	colon cancer	down	miR-4458 s
hsa-mir-4458	hepatocellular carcinoma	down	Tumor-s
hsa-mir-4458	non-small cell lung cancer	down	MicroRNA-4458 s
hsa-mir-4465	non-small cell lung cancer	down	MicroRNA-4465 s
hsa-mir-448	breast cancer
hsa-mir-448	colorectal cancer	down	miR-448 s
hsa-mir-448	gastric cancer	down	miR-448 s
hsa-mir-448	gastric cancer
hsa-mir-448	glioma
hsa-mir-448	hepatocellular carcinoma
hsa-mir-448	hepatocellular carcinoma
hsa-mir-448	lung squamous cell carcinoma
hsa-mir-448	non-small cell lung cancer
hsa-mir-448	osteosarcoma
hsa-mir-448	osteosarcoma	down	MicroRNA-448 s
hsa-mir-448	ovarian cancer
hsa-mir-448	pancreatic ductal adenocarcinoma	down	MicroRNA-448 s
hsa-mir-4484	glioblastoma	down	Impact of somatic copy number alterations on the glioblastoma miRNome: miR-4484 is a genomically deleted tumour s
hsa-mir-4487	colorectal cancer
hsa-mir-449	gastric cancer
hsa-mir-4493	glioma	down	Circ-ZNF264 Promotes the Growth of Glioma Cells by Upregulating the Expression of miR-4493 Target Gene Apelin.
hsa-mir-4497	laryngeal squamous cell carcinoma	down	MicroRNA-4497 functions as a tumor s
hsa-mir-449a	breast cancer	down	MiR-449a s
hsa-mir-449a	breast cancer
hsa-mir-449a	breast cancer
hsa-mir-449a	colorectal cancer
hsa-mir-449a	colorectal cancer
hsa-mir-449a	endometrial cancer	down	S
hsa-mir-449a	endometrial cancer	down	MiR-449a functions as a tumor s
hsa-mir-449a	endometrial cancer
hsa-mir-449a	gastric adenocarcinoma	down	microRNA-449a functions as a tumor-s
hsa-mir-449a	gastric cancer
hsa-mir-449a	gastric cancer
hsa-mir-449a	gastric cancer
hsa-mir-449a	glioblastoma	down	MiR-449a exerts tumor-s
hsa-mir-449a	hepatocellular carcinoma
hsa-mir-449a	hepatocellular carcinoma
hsa-mir-449a	hepatocellular carcinoma
hsa-mir-449a	hepatocellular carcinoma	down	MicroRNA-449a s
hsa-mir-449a	liver cancer
hsa-mir-449a	lung cancer
hsa-mir-449a	lung cancer
hsa-mir-449a	lung cancer	down	MiR-449a S
hsa-mir-449a	nasopharyngeal carcinoma
hsa-mir-449a	neuroblastoma	down	microRNA-449a functions as a tumor s
hsa-mir-449a	non-small cell lung cancer
hsa-mir-449a	non-small cell lung cancer	down	microRNA-449a S
hsa-mir-449a	non-small cell lung cancer	down	MiR-449a s
hsa-mir-449a	osteosarcoma	down	The microRNAs miR-449a and miR-424 s
hsa-mir-449a	osteosarcoma
hsa-mir-449a	ovarian cancer
hsa-mir-449a	pancreatic cancer	down	MicroRNA-449a functions as a tumor s
hsa-mir-449a	prostate cancer
hsa-mir-449a	prostate cancer
hsa-mir-449b	lung cancer
hsa-mir-449b	non-small cell lung cancer
hsa-mir-449b-3p	nasopharyngeal carcinoma
hsa-mir-449b-5p	breast cancer	down	MicroRNA-449b-5p s
hsa-mir-449c	gastric cancer
hsa-mir-449c	gastric cancer
hsa-mir-4500	glioma
hsa-mir-4500	non-small cell lung cancer
hsa-mir-4500	papillary thyroid carcinoma
hsa-mir-450a	hepatocellular carcinoma
hsa-mir-450a	oral squamous cell carcinoma
hsa-mir-450b-3p	breast cancer	down	Targeting HER3 with miR-450b-3p s
hsa-mir-450b-3p	hepatocellular carcinoma
hsa-mir-450b-5p	colorectal cancer	down	miR-450b-5p S
hsa-mir-450b-5p	colorectal cancer
hsa-mir-451	acute myeloid leukemia
hsa-mir-451	bladder cancer
hsa-mir-451	bladder cancer	down	miR-451 s
hsa-mir-451	breast cancer
hsa-mir-451	breast cancer
hsa-mir-451	chronic myelogenous leukemia	down	microRNA expression profiling as s
hsa-mir-451	colon cancer	down	The tumour s
hsa-mir-451	colon cancer
hsa-mir-451	colorectal carcinoma
hsa-mir-451	esophageal carcinoma
hsa-mir-451	gastric cancer
hsa-mir-451	glioma	down	MiRNA-451 plays a role as tumor s
hsa-mir-451	glioma
hsa-mir-451	glioma
hsa-mir-451	glioma
hsa-mir-451	head and neck squamous cell carcinoma	down	MicoRNA-451 is a novel tumor s
hsa-mir-451	hepatocellular carcinoma	down	miR-451 Inhibits Cell Proliferation in Human Hepatocellular Carcinoma through Direct S
hsa-mir-451	hepatocellular carcinoma	down	miR-451: Potential role as tumor s
hsa-mir-451	hepatocellular carcinoma
hsa-mir-451	hepatocellular carcinoma
hsa-mir-451	lung adenocarcinoma
hsa-mir-451	mucinous cystadenocarcinoma
hsa-mir-451	nasopharyngeal carcinoma
hsa-mir-451	non-small cell lung cancer	down	MicroRNA-451 functions as a tumor s
hsa-mir-451	non-small cell lung cancer
hsa-mir-451	non-small cell lung cancer
hsa-mir-451	non-small cell lung cancer
hsa-mir-451	osteosarcoma	down	Tumor-S
hsa-mir-451	osteosarcoma
hsa-mir-451	osteosarcoma	down	S
hsa-mir-451	pancreatic cancer
hsa-mir-451	papillary thyroid carcinoma
hsa-mir-4513	breast cancer
hsa-mir-4513	gastric cancer
hsa-mir-451a	acute myeloid leukemia
hsa-mir-451a	basal cell carcinoma	down	MicroRNA-451a acts as tumor s
hsa-mir-451a	breast cancer
hsa-mir-451a	chronic myelogenous leukemia
hsa-mir-451a	colorectal cancer	down	MiR-451a s
hsa-mir-451a	hypopharyngeal squamous cell carcinoma	down	Identification of tumour s
hsa-mir-451a	non-small cell lung cancer
hsa-mir-451a	non-small cell lung cancer	down	MiR-451a s
hsa-mir-451a	osteosarcoma
hsa-mir-451a	papillary thyroid carcinoma
hsa-mir-452	breast cancer	down	Tumor-s
hsa-mir-452	breast cancer	down	Downregulation of tumor s
hsa-mir-452	colorectal cancer
hsa-mir-452	colorectal cancer	down	Decreased miR-452 expression in human colorectal cancer and its tumor s
hsa-mir-452	esophageal cancer
hsa-mir-452	glioma
hsa-mir-452	hepatocellular carcinoma
hsa-mir-452	non-small cell lung cancer	down	Up-Regulation of MiR-452 Inhibits Metastasis of Non-Small Cell Lung Cancer by Regulating BMI1.
hsa-mir-452	osteosarcoma
hsa-mir-452	prostate cancer
hsa-mir-452-5p	renal cell carcinoma
hsa-mir-4530	breast carcinoma
hsa-mir-454	esophageal cancer
hsa-mir-454	gastric cancer
hsa-mir-454	glioblastoma	down	MiR-454 inhibited cell proliferation of human glioblastoma cells by s
hsa-mir-454	hepatocellular carcinoma
hsa-mir-454	hepatocellular carcinoma
hsa-mir-454	non-small cell lung cancer
hsa-mir-454	osteosarcoma	down	miR-454 is down-regulated in osteosarcomas and s
hsa-mir-454	prostate cancer
hsa-mir-454	uveal melanoma
hsa-mir-454-3p	bladder cancer	down	MiR-454-3p and miR-374b-5p s
hsa-mir-454-3p	cervical cancer
hsa-mir-454-3p	cervical cancer
hsa-mir-454-3p	glioma	down	miR-454-3p Is an Exosomal Biomarker and Functions as a Tumor S
hsa-mir-454-3p	hepatocellular carcinoma
hsa-mir-454-3p	non-small cell lung cancer	down	Downregulation of Calbindin 1 by miR-454-3p S
hsa-mir-455	breast cancer
hsa-mir-455	colon cancer
hsa-mir-455	colorectal cancer	down	MicroRNA-455 s
hsa-mir-455	colorectal cancer	down	MiR-455 functions as a tumor s
hsa-mir-455	gastric cancer
hsa-mir-455	hepatocellular carcinoma
hsa-mir-455	hepatocellular carcinoma
hsa-mir-455	non-small cell lung cancer	down	MicroRNA-455 s
hsa-mir-455-3p	basal cell carcinoma
hsa-mir-455-3p	breast cancer
hsa-mir-455-3p	esophageal squamous cell carcinoma
hsa-mir-455-3p	esophageal squamous cell carcinoma
hsa-mir-455-3p	non-small cell lung cancer
hsa-mir-455-3p	pancreatic cancer
hsa-mir-455-5p	basal cell carcinoma
hsa-mir-455-5p	colon cancer
hsa-mir-455-5p	colorectal cancer
hsa-mir-455-5p	esophageal squamous cell carcinoma
hsa-mir-455-5p	gastric cancer	down	MiR-455-5p acts as a novel tumor s
hsa-mir-455-5p	malignant melanoma
hsa-mir-455-5p	non-small cell lung cancer
hsa-mir-4649-3p	nasopharyngeal carcinoma
hsa-mir-466	colorectal cancer	down	MicroRNA-466 (miR-466) functions as a tumor s
hsa-mir-466	hepatocellular carcinoma
hsa-mir-466	osteosarcoma
hsa-mir-466	prostate cancer
hsa-mir-4723-5p	prostate cancer
hsa-mir-4732-5p	breast cancer
hsa-mir-4735-3p	non-small cell lung cancer
hsa-mir-4775	colorectal cancer
hsa-mir-4782-3p	non-small cell lung cancer
hsa-mir-4787-5p	pancreatic ductal adenocarcinoma
hsa-mir-4792	nasopharyngeal carcinoma
hsa-mir-483	breast cancer	down	MiR-483 s
hsa-mir-483	colon cancer
hsa-mir-483	colorectal cancer
hsa-mir-483-3p	adrenal cortical carcinoma
hsa-mir-483-3p	esophageal squamous cell carcinoma
hsa-mir-483-3p	hepatocellular carcinoma
hsa-mir-483-5p	adrenal cortical carcinoma
hsa-mir-483-5p	adrenal cortical carcinoma
hsa-mir-483-5p	adrenal cortical carcinoma
hsa-mir-483-5p	adrenal cortical carcinoma
hsa-mir-483-5p	adrenal cortical carcinoma
hsa-mir-483-5p	glioblastoma	down	MiR-483-5p s
hsa-mir-483-5p	glioma	down	MiR-483-5p s
hsa-mir-483-5p	hepatocellular carcinoma
hsa-mir-483-5p	hepatocellular carcinoma
hsa-mir-483-5p	hepatocellular carcinoma
hsa-mir-483-5p	oral squamous cell carcinoma
hsa-mir-483-5p	prostate cancer
hsa-mir-484	cervical cancer	down	miR-484 s
hsa-mir-484	colon cancer
hsa-mir-485	colorectal cancer	down	MicroRNA-485 plays tumour-s
hsa-mir-485	hepatocellular carcinoma
hsa-mir-485	lung adenocarcinoma
hsa-mir-485-3p	breast cancer	down	MiR-485-3p and miR-485-5p s
hsa-mir-485-3p	glioblastoma
hsa-mir-485-3p	glioblastoma
hsa-mir-485-3p	hepatocellular carcinoma
hsa-mir-485-5p	acute myeloid leukemia	down	MiRNA-485-5p s
hsa-mir-485-5p	breast cancer	down	MiR-485-3p and miR-485-5p s
hsa-mir-485-5p	breast cancer	down	miR-485-5p s
hsa-mir-485-5p	colorectal cancer
hsa-mir-485-5p	colorectal cancer	down	microRNA-485-5p Functions as a Tumor S
hsa-mir-485-5p	gastric cancer
hsa-mir-485-5p	gastric cancer
hsa-mir-485-5p	glioblastoma
hsa-mir-485-5p	hepatocellular carcinoma	down	MicroRNA-485-5p s
hsa-mir-485-5p	hepatocellular carcinoma
hsa-mir-485-5p	malignant melanoma	down	MicroRNA-485-5p represses melanoma cell invasion and proliferation by s
hsa-mir-485-5p	non-small cell lung cancer	down	MicroRNA-485-5p s
hsa-mir-486	colorectal cancer
hsa-mir-486	esophageal cancer
hsa-mir-486	glioma
hsa-mir-486-3p	breast cancer
hsa-mir-486-3p	oral cancer	down	MicroRNA-486-3p functions as a tumor s
hsa-mir-486-3p	retinoblastoma
hsa-mir-486-5p	acute myeloid leukemia
hsa-mir-486-5p	cervical cancer
hsa-mir-486-5p	colorectal cancer
hsa-mir-486-5p	esophageal squamous cell carcinoma	down	Downregulated miR-486-5p acts as a tumor s
hsa-mir-486-5p	hepatocellular carcinoma
hsa-mir-486-5p	lung cancer
hsa-mir-486-5p	non-small cell lung cancer	down	Direct repression of the oncogene CDK4 by the tumor s
hsa-mir-486-5p	non-small cell lung cancer
hsa-mir-486-5p	non-small cell lung cancer
hsa-mir-486-5p	non-small cell lung cancer
hsa-mir-486-5p	non-small cell lung cancer
hsa-mir-486-5p	non-small cell lung cancer
hsa-mir-486-5p	papillary thyroid carcinoma
hsa-mir-486-5p	prostate cancer	down	miR-486-5p s
hsa-mir-486-5p	prostate cancer
hsa-mir-487a	esophageal cancer
hsa-mir-487a	hepatocellular carcinoma
hsa-mir-487b-3p	colonic adenocarcinoma
hsa-mir-488	gastric cancer	down	miR-488 acts as a tumor s
hsa-mir-488	hepatocellular carcinoma	down	MiR-488 s
hsa-mir-488	osteosarcoma
hsa-mir-488	ovarian cancer
hsa-mir-488	prostate cancer
hsa-mir-488	renal cell carcinoma
hsa-mir-488-3p	esophageal squamous cell carcinoma
hsa-mir-489	breast cancer
hsa-mir-489	breast cancer
hsa-mir-489	cervical cancer
hsa-mir-489	colorectal cancer	down	MiR-489 s
hsa-mir-489	hepatocellular carcinoma
hsa-mir-489-3p	osteosarcoma
hsa-mir-489-5p	breast cancer
hsa-mir-489-5p	breast cancer
hsa-mir-490	breast cancer
hsa-mir-490	gastric cancer
hsa-mir-490-3p	colorectal cancer
hsa-mir-490-3p	colorectal cancer
hsa-mir-490-3p	colorectal cancer	down	MiR-490-3p Functions As a Tumor S
hsa-mir-490-3p	gastric cancer
hsa-mir-490-3p	gastric cancer
hsa-mir-490-3p	glioma	down	miR-490-3p functions as a tumor s
hsa-mir-490-3p	hepatocellular carcinoma
hsa-mir-490-3p	hepatocellular carcinoma
hsa-mir-490-3p	hepatocellular carcinoma
hsa-mir-490-3p	lung cancer
hsa-mir-490-3p	osteosarcoma
hsa-mir-490-3p	osteosarcoma
hsa-mir-490-5p	bladder cancer
hsa-mir-490-5p	bladder cancer
hsa-mir-490-5p	bladder cancer	down	MicroRNA-490-5p is a novel tumor s
hsa-mir-490-5p	hepatocellular carcinoma	down	MiR-490-5p S
hsa-mir-490-5p	renal cell carcinoma	down	miR-490-5p s
hsa-mir-491	esophageal cancer
hsa-mir-491	osteosarcoma
hsa-mir-491-5p	cervical cancer	down	MicroRNA-491-5p s
hsa-mir-491-5p	colorectal cancer	down	miR-491-5p functions as a tumor s
hsa-mir-491-5p	gastric cancer
hsa-mir-491-5p	nasopharyngeal carcinoma	down	miR-491-5p s
hsa-mir-491-5p	non-small cell lung cancer	down	MicroRNAs-491-5p s
hsa-mir-491-5p	osteosarcoma
hsa-mir-491-5p	prostate cancer
hsa-mir-492	hepatoblastoma
hsa-mir-493	bladder cancer	down	Tumor s
hsa-mir-493	gastric cancer	down	MiR-493 s
hsa-mir-493	hepatocellular carcinoma	down	MicroRNA-493 s
hsa-mir-493	hepatocellular carcinoma	down	MicroRNA-493 s
hsa-mir-493	malignant melanoma	down	Downregulation of miR-493 promoted melanoma proliferation by s
hsa-mir-493	pancreatic cancer
hsa-mir-493	pituitary carcinoma
hsa-mir-493	prostate cancer
hsa-mir-493-3p	prostate cancer	down	Downregulation of N6-methyladenosine binding YTHDF2 protein mediated by miR-493-3p s
hsa-mir-493-5p	hepatocellular carcinoma	down	miR-493-5p s
hsa-mir-493-5p	liver cancer	down	MicroRNA-493-5p promotes apoptosis and s
hsa-mir-494	acute myeloid leukemia	down	MicroRNA-494 Activation S
hsa-mir-494	breast cancer
hsa-mir-494	breast cancer
hsa-mir-494	breast cancer	down	miR-494 s
hsa-mir-494	cervical cancer
hsa-mir-494	cervical cancer	down	miR-494 inhibits cervical cancer cell proliferation through
hsa-mir-494	colorectal cancer
hsa-mir-494	colorectal cancer
hsa-mir-494	colorectal cancer
hsa-mir-494	esophageal cancer
hsa-mir-494	esophageal squamous cell carcinoma	down	Upregulation of miR-494 Inhibits Cell Growth and Invasion and Induces Cell Apoptosis by Targeting Cleft Lip and Palate Transmembrane 1-Like in Esophageal Squamous Cell Carcinoma.
hsa-mir-494	gastric cancer
hsa-mir-494	gastric cancer
hsa-mir-494	gastric cancer
hsa-mir-494	gastrointestinal stromal tumor
hsa-mir-494	glioma
hsa-mir-494	hepatocellular carcinoma
hsa-mir-494	hepatocellular carcinoma
hsa-mir-494	malignant melanoma
hsa-mir-494	nasopharyngeal carcinoma	down	Upregulation of miR-21 and downregulation of miR-494 may serve as emerging molecular biomarkers for prediagnostic samples of subjects who developed nasopharyngeal carcinoma associates with lymph node
hsa-mir-494	non-small cell lung cancer
hsa-mir-494	non-small cell lung cancer
hsa-mir-494	non-small cell lung cancer
hsa-mir-494	non-small cell lung cancer
hsa-mir-494	oral cancer
hsa-mir-494	ovarian cancer
hsa-mir-494	ovarian cancer
hsa-mir-494	pancreatic cancer
hsa-mir-494	pancreatic ductal adenocarcinoma
hsa-mir-494-3p	hepatocellular carcinoma
hsa-mir-495	bladder cancer
hsa-mir-495	breast cancer
hsa-mir-495	colorectal cancer
hsa-mir-495	endometrial cancer
hsa-mir-495	esophageal squamous cell carcinoma
hsa-mir-495	gastric cancer	down	MicroRNA-495 Inhibits Gastric Cancer Cell Migration and Invasion Possibly via Targeting High Mobility Gro
hsa-mir-495	gastric cancer
hsa-mir-495	glioma
hsa-mir-495	glioma
hsa-mir-495	glioma	down	Hsa-miR-495 acts as a tumor s
hsa-mir-495	hepatocellular carcinoma
hsa-mir-495	hepatocellular carcinoma	down	MicroRNA-495 s
hsa-mir-495	lung cancer
hsa-mir-495	medulloblastoma
hsa-mir-495	non-small cell lung cancer	down	miR-199a-5p and miR-495 target GRP78 within UPR pathway of lung cancer.
hsa-mir-495	non-small cell lung cancer
hsa-mir-495	oral squamous cell carcinoma
hsa-mir-495	osteosarcoma	down	Overexpression of microRNA-495 s
hsa-mir-495	renal cell carcinoma	down	MicroRNA-495 s
hsa-mir-495-3p	gastric cancer	down	MicroRNA-495-3p functions as a tumour s
hsa-mir-496	acute myeloid leukemia
hsa-mir-496	colorectal cancer
hsa-mir-496	non-small cell lung cancer	down	miR-496 s
hsa-mir-497	adrenal cortical carcinoma
hsa-mir-497	breast cancer
hsa-mir-497	breast cancer
hsa-mir-497	breast cancer
hsa-mir-497	breast carcinoma	down	miR-497 s
hsa-mir-497	breast carcinoma
hsa-mir-497	cervical cancer	down	MicroRNA-497 is a potential prognostic marker in human cervical cancer and functions as a tumor s
hsa-mir-497	colorectal cancer	down	MicroRNA-497 targets insulin-like growth factor 1 receptor and has a tumour s
hsa-mir-497	colorectal cancer
hsa-mir-497	colorectal cancer
hsa-mir-497	colorectal cancer
hsa-mir-497	colorectal cancer
hsa-mir-497	colorectal cancer	down	miR-497 s
hsa-mir-497	colorectal cancer
hsa-mir-497	colorectal cancer
hsa-mir-497	gastric cancer	down	The putative tumor s
hsa-mir-497	gastric cancer
hsa-mir-497	glioma
hsa-mir-497	glioma
hsa-mir-497	glioma
hsa-mir-497	hepatocellular carcinoma
hsa-mir-497	hepatocellular carcinoma	down	MiR-497 s
hsa-mir-497	hepatocellular carcinoma
hsa-mir-497	kidney cancer
hsa-mir-497	multiple myeloma	down	MicroRNA-497 s
hsa-mir-497	multiple myeloma
hsa-mir-497	nasopharyngeal carcinoma	down	The potent tumor s
hsa-mir-497	non-small cell lung cancer
hsa-mir-497	non-small cell lung cancer	down	miR-145 and miR-497 s
hsa-mir-497	non-small cell lung cancer
hsa-mir-497	non-small cell lung cancer	down	MiR-497 S
hsa-mir-497	oral squamous cell carcinoma
hsa-mir-497	osteosarcoma	down	MicroRNA-497 s
hsa-mir-497	osteosarcoma
hsa-mir-497	osteosarcoma	down	Downregulation of microRNA-497 is associated with
hsa-mir-497	osteosarcoma	down	MicroRNA-497 s
hsa-mir-497	osteosarcoma
hsa-mir-497	ovarian cancer
hsa-mir-497	ovarian cancer	down	MicroRNA-497 s
hsa-mir-497	pancreatic cancer
hsa-mir-497	pancreatic cancer
hsa-mir-497	prostate cancer	down	MicroRNA-497 S
hsa-mir-497	prostate cancer	down	Tumor-s
hsa-mir-497	renal cell carcinoma	down	MicroRNA-497 s
hsa-mir-497	thyroid cancer	down	MicroRNA-497 inhibits thyroid cancer tumor growth and invasion by s
hsa-mir-497-5p	breast cancer
hsa-mir-497-5p	colorectal cancer	down	Up-regulation of microRNA-497-5p inhibits colorectal cancer cell proliferation and invasion via targeting PTPN3.
hsa-mir-497-5p	gastric cancer
hsa-mir-497-5p	hepatocellular carcinoma
hsa-mir-497-5p	hepatocellular carcinoma
hsa-mir-497-5p	non-small cell lung cancer
hsa-mir-498	breast cancer
hsa-mir-498	breast cancer
hsa-mir-498	cervical cancer
hsa-mir-498	colorectal cancer
hsa-mir-498	esophageal squamous cell carcinoma
hsa-mir-498	gastric cancer	down	Upregulating microRNA-498 inhibits gastric cancer proliferation invasion and chemoresistance through inverse interaction of Bmi1.
hsa-mir-498	non-small cell lung cancer
hsa-mir-498	non-small cell lung cancer
hsa-mir-498	ovarian cancer
hsa-mir-498	ovarian cancer
hsa-mir-498	retinoblastoma
hsa-mir-499-5p	colorectal cancer
hsa-mir-499-5p	non-small cell lung cancer
hsa-mir-499a-5p	glioma	down	Knockdown of LncRNA SCAMP1 s
hsa-mir-499a-5p	oral squamous cell carcinoma
hsa-mir-499a-5p	osteosarcoma
hsa-mir-500	gastric cancer
hsa-mir-500	hepatocellular carcinoma
hsa-mir-500	prostate cancer
hsa-mir-500	prostate cancer
hsa-mir-5003-3p	breast cancer
hsa-mir-500a	hepatocellular carcinoma
hsa-mir-500a	hepatocellular carcinoma
hsa-mir-500a-3p	hepatocellular carcinoma
hsa-mir-500a-3p	non-small cell lung cancer
hsa-mir-500a-5p	colorectal cancer
hsa-mir-501	hepatocellular carcinoma
hsa-mir-501	hepatocellular carcinoma
hsa-mir-501-3p	hepatocellular carcinoma	down	microRNA-501-3p s
hsa-mir-501-3p	prostate cancer
hsa-mir-501-3p	prostate cancer
hsa-mir-501-5p	gastric cancer
hsa-mir-501-5p	hepatocellular carcinoma
hsa-mir-501-5p	lung adenocarcinoma
hsa-mir-502	colon cancer
hsa-mir-502	hepatocellular carcinoma	down	miR-502 inhibits cell proliferation and tumor growth in hepatocellular carcinoma through s
hsa-mir-502-5p	breast cancer	down	S
hsa-mir-502-5p	gastric cancer
hsa-mir-503	breast cancer
hsa-mir-503	cervical cancer	down	miR-503 expression is downregulated in cervical cancer and s
hsa-mir-503	colon cancer	down	MiR-424/503-Mediated Rictor Upregulation Promotes Tumor Progression.
hsa-mir-503	colorectal cancer
hsa-mir-503	colorectal cancer
hsa-mir-503	colorectal cancer
hsa-mir-503	esophageal cancer
hsa-mir-503	esophageal squamous cell carcinoma
hsa-mir-503	gastric cancer	down	MiR-503 s
hsa-mir-503	gastric cancer
hsa-mir-503	gastric cancer
hsa-mir-503	glioblastoma	down	MicroRNA-503 acts as a tumor s
hsa-mir-503	glioblastoma
hsa-mir-503	glioma
hsa-mir-503	hepatocellular carcinoma
hsa-mir-503	hepatocellular carcinoma
hsa-mir-503	hepatocellular carcinoma	down	miR-503 s
hsa-mir-503	laryngeal carcinoma
hsa-mir-503	lung cancer
hsa-mir-503	non-small cell lung cancer
hsa-mir-503	non-small cell lung cancer
hsa-mir-503	oral squamous cell carcinoma
hsa-mir-503	osteosarcoma	down	MicroRNA-503 acts as a tumor s
hsa-mir-503	osteosarcoma
hsa-mir-503	osteosarcoma	down	miR-503 is down-regulated in osteosarcoma and s
hsa-mir-503	osteosarcoma
hsa-mir-503	osteosarcoma	down	MicroRNA-503 s
hsa-mir-503	ovarian cancer
hsa-mir-503	prostate cancer	down	miR-503 s
hsa-mir-503	prostate cancer
hsa-mir-503	retinoblastoma
hsa-mir-503-3p	breast cancer
hsa-mir-503-3p	lung cancer
hsa-mir-504	glioblastoma
hsa-mir-504	glioblastoma	down	miR-504 s
hsa-mir-504	hypopharyngeal squamous cell carcinoma
hsa-mir-504	hypopharyngeal squamous cell carcinoma
hsa-mir-504	osteosarcoma
hsa-mir-504	osteosarcoma
hsa-mir-504-3p	acute myeloid leukemia	down	Upregulation of miR-504-3p is associated with favorable prognosis of acute myeloid leukemia and may serve as a tumor s
hsa-mir-505	endometrial cancer	down	MicroRNA-505 functions as a tumor s
hsa-mir-505	gastric cancer	down	MicroRNA-505 s
hsa-mir-505	glioblastoma
hsa-mir-505	hepatocellular carcinoma	down	MiR-505 s
hsa-mir-505	hepatocellular carcinoma	down	MicroRNA-505 s
hsa-mir-505	hepatocellular carcinoma
hsa-mir-505	hepatocellular carcinoma
hsa-mir-505	renal cell carcinoma	down	microRNA-505 negatively regulates HMGB1 to s
hsa-mir-505-5p	cervical cancer	down	MicroRNA-505-5p functions as a tumor s
hsa-mir-506	breast cancer	down	Up-regulation of miR-506 inhibits cell growth and disr
hsa-mir-506	cervical cancer	down	S
hsa-mir-506	cervical cancer	down	miR-506 s
hsa-mir-506	colon cancer	down	MicroRNA-506 s
hsa-mir-506	colon cancer
hsa-mir-506	colorectal cancer
hsa-mir-506	colorectal cancer	down	MiR-506 S
hsa-mir-506	colorectal cancer
hsa-mir-506	esophageal cancer
hsa-mir-506	gastric cancer
hsa-mir-506	gastric cancer
hsa-mir-506	gastric cancer
hsa-mir-506	glioblastoma
hsa-mir-506	glioma	down	miR-506 functions as a tumor s
hsa-mir-506	hepatocellular carcinoma	down	MiR-506 s
hsa-mir-506	hepatocellular carcinoma	down	MiR-506 s
hsa-mir-506	liver cancer	down	MiR-506 s
hsa-mir-506	lung cancer
hsa-mir-506	nasopharyngeal carcinoma
hsa-mir-506	nasopharyngeal carcinoma	down	MiR-506 s
hsa-mir-506	neuroblastoma	down	miR-506 s
hsa-mir-506	oral squamous cell carcinoma	down	MicroRNA-506 s
hsa-mir-506	osteosarcoma	down	Overexpression of miR-506 s
hsa-mir-506	pancreatic cancer
hsa-mir-506	pancreatic ductal adenocarcinoma
hsa-mir-506	papillary thyroid carcinoma	down	MiR-506 s
hsa-mir-506	renal clear cell carcinoma
hsa-mir-506	renal clear cell carcinoma
hsa-mir-506-3p	osteosarcoma	down	MicroRNA-506-3p inhibits osteosarcoma cell proliferation and metastasis by s
hsa-mir-508	renal clear cell carcinoma	down	MicroRNA-508 is downregulated in clear cell renal cell carcinoma and targets ZEB1 to s
hsa-mir-508-3p	gastric cancer
hsa-mir-508-3p	kidney cancer
hsa-mir-508-5p	gastric cancer	down	MicroRNA-508-5p s
hsa-mir-508-5p	glioma
hsa-mir-508-5p	hepatocellular carcinoma
hsa-mir-509-3p	gastric cancer	down	MicroRNA-509-3p inhibits cancer cell proliferation and migration via
hsa-mir-509-3p	glioma
hsa-mir-509-3p	kidney cancer
hsa-mir-509-3p	ovarian cancer
hsa-mir-509-3p	ovarian cancer
hsa-mir-509-3p	renal cell carcinoma
hsa-mir-509-5p	non-small cell lung cancer	down	The Tumor S
hsa-mir-509-5p	pancreatic cancer
hsa-mir-509-5p	papillary thyroid carcinoma
hsa-mir-509-5p	prostate cancer
hsa-mir-5095	non-small cell lung cancer
hsa-mir-510	breast cancer
hsa-mir-510	non-small cell lung cancer
hsa-mir-510-5p	renal cell carcinoma	down	Downregulated microRNA-510-5p acts as a tumor s
hsa-mir-5100	lung cancer
hsa-mir-5100	lung cancer
hsa-mir-511	colorectal cancer
hsa-mir-511	hepatocellular carcinoma
hsa-mir-511	lung adenocarcinoma
hsa-mir-511-5p	colorectal cancer	down	MiR-511-5p functions as a tumor s
hsa-mir-512-3p	non-small cell lung cancer	down	Inhibition of RAC1-GEF DOCK3 by miR-512-3p contributes to s
hsa-mir-512-5p	breast cancer
hsa-mir-512-5p	non-small cell lung cancer
hsa-mir-513a-5p	osteosarcoma
hsa-mir-513a-5p	osteosarcoma
hsa-mir-514	ovarian cancer
hsa-mir-514a-3p	renal cell carcinoma	down	miR-514a-3p functions as a tumor s
hsa-mir-514a-3p	renal clear cell carcinoma
hsa-mir-514b-3p	colorectal cancer
hsa-mir-515-5p	prostate cancer	down	MiR-515-5p acts as a tumor s
hsa-mir-516a-3p	breast cancer
hsa-mir-516a-5p	non-small cell lung cancer
hsa-mir-516b	esophageal squamous cell carcinoma	down	miR-516b functions as a tumor s
hsa-mir-516b	non-small cell lung cancer	down	Clinical Significance and Tumor-S
hsa-mir-517a	breast cancer
hsa-mir-517a	colorectal cancer
hsa-mir-517a	glioma
hsa-mir-517a	hepatocellular carcinoma
hsa-mir-517c	glioblastoma	down	MIR517C inhibits autophagy and the epithelial-to-mesenchymal (-like) transition phenotype in human glioblastoma through KPNA2-dependent disr
hsa-mir-518a-3p	colorectal cancer
hsa-mir-5195-3p	osteosarcoma	down	miR-5195-3p S
hsa-mir-5195-3p	ovarian cancer
hsa-mir-519a	glioblastoma
hsa-mir-519a	glioblastoma	down	MiR-519a functions as a tumor s
hsa-mir-519a	glioma	down	MiR-519a functions as a tumor s
hsa-mir-519a	hepatocellular carcinoma
hsa-mir-519a	ovarian cancer
hsa-mir-519b-3p	colorectal cancer
hsa-mir-519c-3p	hepatocellular carcinoma
hsa-mir-519d	breast cancer	down	MiR-519d s
hsa-mir-519d	breast cancer	down	miR-519d-mediated downregulation of STAT3 s
hsa-mir-519d	gastric cancer	down	MIR-519d s
hsa-mir-519d	hepatocellular carcinoma	down	MicroRNA-519d targets MKi67 and s
hsa-mir-519d	lung adenocarcinoma
hsa-mir-519d	malignant melanoma
hsa-mir-519d	oral squamous cell carcinoma
hsa-mir-519d	osteosarcoma
hsa-mir-519d	ovarian cancer
hsa-mir-519d-3p	breast cancer	down	MiR-519d-3p s
hsa-mir-519d-3p	cervical cancer
hsa-mir-519d-3p	colorectal cancer
hsa-mir-519d-3p	gastric cancer
hsa-mir-520a	hepatocellular carcinoma
hsa-mir-520a-3p	breast cancer	down	S
hsa-mir-520a-3p	non-small cell lung cancer
hsa-mir-520a-3p	small cell lung cancer
hsa-mir-520b	breast cancer
hsa-mir-520b	colorectal cancer	down	MicroRNA-520b Functions as a Tumor S
hsa-mir-520b	glioma
hsa-mir-520b	hepatocellular carcinoma	down	MiR-520b s
hsa-mir-520b	lung cancer
hsa-mir-520b	non-small cell lung cancer
hsa-mir-520b	non-small cell lung cancer
hsa-mir-520b	ovarian cancer
hsa-mir-520c	breast cancer
hsa-mir-520c	glioma	down	MicroRNA-520c inhibits glioma cell migration and invasion by the s
hsa-mir-520c-3p	gastric cancer
hsa-mir-520c-3p	hepatocellular carcinoma
hsa-mir-520c-3p	hepatocellular carcinoma
hsa-mir-520c-3p	papillary thyroid carcinoma
hsa-mir-520d-3p	breast cancer
hsa-mir-520d-3p	hepatocellular carcinoma
hsa-mir-520d-3p	osteosarcoma
hsa-mir-520d-5p	colorectal cancer	down	SP1-mediated microRNA-520d-5p s
hsa-mir-520d-5p	glioma
hsa-mir-520e	glioma
hsa-mir-520f	gastric cancer	down	MicroRNA-520f s
hsa-mir-520f	hepatocellular carcinoma
hsa-mir-520f	lung cancer
hsa-mir-520g	breast cancer
hsa-mir-520g	hepatocellular carcinoma
hsa-mir-522	endometrial cancer
hsa-mir-522	hepatocellular carcinoma
hsa-mir-522	hepatocellular carcinoma
hsa-mir-522-3p	colorectal cancer
hsa-mir-524	glioma
hsa-mir-524	osteosarcoma
hsa-mir-524	thyroid cancer
hsa-mir-524-5p	gastric cancer	down	Upregulation of microRNA-524-5p enhances the cisplatin sensitivity of gastric cancer cells by modulating proliferation and metastasis via targeting SOX9.
hsa-mir-524-5p	gastric cancer	down	MicroRNA-524-5p s
hsa-mir-525-3p	liver cancer
hsa-mir-525-5p	laryngeal cancer
hsa-mir-526b	breast cancer
hsa-mir-526b	breast cancer
hsa-mir-526b	gastric cancer
hsa-mir-526b	hepatocellular carcinoma	down	microRNA-526b servers as a prognostic factor and exhibits tumor s
hsa-mir-526b-3p	colon cancer	down	miR-526b-3p functions as a tumor s
hsa-mir-527	glioma
hsa-mir-532	colorectal cancer	down	microRNA-532 s
hsa-mir-532	gastric cancer
hsa-mir-532	ovarian cancer
hsa-mir-532-3p	hepatocellular carcinoma
hsa-mir-532-3p	ovarian cancer
hsa-mir-532-5p	bladder cancer
hsa-mir-532-5p	colorectal cancer
hsa-mir-532-5p	gastric cancer
hsa-mir-532-5p	kidney cancer	down	MiR-532-5p s
hsa-mir-532-5p	malignant melanoma
hsa-mir-532-5p	ovarian carcinoma
hsa-mir-532-5p	retinoblastoma
hsa-mir-539	breast cancer	down	miR-539 acts as a tumor s
hsa-mir-539	colorectal cancer
hsa-mir-539	colorectal cancer
hsa-mir-539	gastric cancer
hsa-mir-539	glioma
hsa-mir-539	hepatocellular carcinoma	down	microRNA-539 s
hsa-mir-539	hepatocellular carcinoma	down	miR-539 inhibits FSCN1 expression and s
hsa-mir-539	hepatocellular carcinoma
hsa-mir-539	nasopharyngeal carcinoma
hsa-mir-539	osteosarcoma	down	MicroRNA-539 s
hsa-mir-539	pancreatic cancer	down	MiR-539 functions as a tumor s
hsa-mir-539	papillary thyroid carcinoma	down	microRNA-539 functions as a tumor s
hsa-mir-539	prostate cancer
hsa-mir-539	thyroid cancer
hsa-mir-539-5p	glioma
hsa-mir-541	pancreatic ductal adenocarcinoma
hsa-mir-541-3p	non-small cell lung cancer
hsa-mir-542-3p	astrocytoma	down	MicroRNA-542-3p S
hsa-mir-542-3p	bladder cancer	down	MicroRNA-542-3p s
hsa-mir-542-3p	colorectal cancer
hsa-mir-542-3p	gastric cancer	down	MicroRNA-542-3p s
hsa-mir-542-3p	glioblastoma	down	MicroRNA-542-3p S
hsa-mir-542-3p	hepatocellular carcinoma
hsa-mir-542-3p	hepatocellular carcinoma	down	MicroRNA-542-3p functions as a tumor s
hsa-mir-542-3p	hepatocellular carcinoma
hsa-mir-542-3p	non-small cell lung cancer	down	MiR-542-3p exerts tumor s
hsa-mir-542-3p	oral squamous cell carcinoma
hsa-mir-542-3p	oral squamous cell carcinoma
hsa-mir-542-3p	osteosarcoma
hsa-mir-542-5p	basal cell carcinoma
hsa-mir-542-5p	non-small cell lung cancer	down	The s
hsa-mir-542-5p	osteosarcoma
hsa-mir-543	colorectal cancer
hsa-mir-543	endometrial cancer	down	MicroRNA-543 s
hsa-mir-543	gastric cancer
hsa-mir-543	gastric cancer
hsa-mir-543	glioma	down	miR-543 functions as a tumor s
hsa-mir-543	liver cancer	down	MicroRNA-543 s
hsa-mir-543	osteosarcoma
hsa-mir-543	prostate cancer
hsa-mir-543	prostate cancer	down	MicroRNA-335 and -543 s
hsa-mir-543	renal cell carcinoma
hsa-mir-544	breast cancer
hsa-mir-544	cervical cancer
hsa-mir-544	colorectal cancer
hsa-mir-544	gastric cancer
hsa-mir-544	liver cancer
hsa-mir-544a	breast cancer
hsa-mir-544a	lung cancer
hsa-mir-544a	lung cancer
hsa-mir-545	gastric cancer
hsa-mir-545	hepatocellular carcinoma
hsa-mir-545	lung cancer	down	MicroRNA-545 S
hsa-mir-548a-5p	hepatocellular carcinoma
hsa-mir-548b	glioma
hsa-mir-548c	ovarian cancer
hsa-mir-548c-3p	glioma
hsa-mir-548c-3p	papillary thyroid carcinoma	down	MiR-548c-3p s
hsa-mir-548c-5p	colorectal cancer
hsa-mir-548d-3p	oral squamous cell carcinoma
hsa-mir-548d-3p	osteosarcoma
hsa-mir-548k	esophageal squamous cell carcinoma
hsa-mir-548p	hepatocellular carcinoma	down	MicroRNA-548p s
hsa-mir-550a-3p	non-small cell lung cancer
hsa-mir-551a	colorectal cancer
hsa-mir-551a	ovarian cancer	down	Demethoxycurcumin inhibited human epithelia ovarian cancer cells' growth via
hsa-mir-551b	colorectal cancer
hsa-mir-551b	gastric cancer
hsa-mir-551b-3p	gastric cancer
hsa-mir-551b-3p	gastric cancer	down	Identification and characterization of tumor s
hsa-mir-551b-3p	ovarian cancer
hsa-mir-552	colorectal cancer
hsa-mir-552	colorectal cancer
hsa-mir-552	colorectal cancer
hsa-mir-552	hepatocellular carcinoma
hsa-mir-552	osteosarcoma
hsa-mir-552-5p	osteosarcoma
hsa-mir-556-3p	esophageal cancer
hsa-mir-558	gastric cancer
hsa-mir-558	neuroblastoma
hsa-mir-5590-3p	gastric cancer
hsa-mir-561	gastric cancer
hsa-mir-562	glioblastoma
hsa-mir-564	gastric cancer
hsa-mir-564	glioblastoma
hsa-mir-564	hepatocellular carcinoma
hsa-mir-564	lung cancer	down	MiR-564 functions as a tumor s
hsa-mir-564	osteosarcoma
hsa-mir-566	glioma
hsa-mir-566	renal cell carcinoma
hsa-mir-5692a	hepatocellular carcinoma
hsa-mir-5692a	hepatocellular carcinoma
hsa-mir-570	chronic myelogenous leukemia
hsa-mir-570	hepatocellular carcinoma
hsa-mir-570	lung cancer
hsa-mir-5703	ovarian cancer
hsa-mir-572	basal cell carcinoma
hsa-mir-572	ovarian cancer
hsa-mir-572	renal cell carcinoma
hsa-mir-573	hepatocellular carcinoma
hsa-mir-573	malignant melanoma
hsa-mir-573	prostate cancer
hsa-mir-574	chronic myelogenous leukemia	down	microRNA expression profiling as s
hsa-mir-574-3p	breast cancer
hsa-mir-574-3p	chronic myelogenous leukemia	down	Overexpression of miR-574-3p s
hsa-mir-574-3p	esophageal cancer
hsa-mir-574-3p	gastric cancer
hsa-mir-574-3p	hepatocellular carcinoma
hsa-mir-574-3p	osteosarcoma
hsa-mir-574-5p	colorectal cancer	down	Hsa-miR-574-5p negatively regulates MACC-1 expression to s
hsa-mir-574-5p	colorectal cancer
hsa-mir-575	gastric cancer
hsa-mir-575	hepatocellular carcinoma
hsa-mir-576-3p	bladder cancer
hsa-mir-576-3p	bladder cancer
hsa-mir-576-5p	glioblastoma
hsa-mir-577	colorectal cancer	down	microRNA-577 s
hsa-mir-577	gastric cancer
hsa-mir-577	gastric cancer
hsa-mir-577	glioblastoma
hsa-mir-577	hepatocellular carcinoma
hsa-mir-577	non-small cell lung cancer	down	miR-577 s
hsa-mir-582	colorectal cancer
hsa-mir-582-3p	prostate cancer	down	miR-582-3p and miR-582-5p S
hsa-mir-582-5p	colorectal cancer
hsa-mir-582-5p	gastric cancer	down	MicroRNA-582-5p s
hsa-mir-582-5p	hepatocellular carcinoma
hsa-mir-582-5p	non-small cell lung cancer	down	miR-582-5p is a potential prognostic marker in human non-small cell lung cancer and functions as a tumor s
hsa-mir-582-5p	non-small cell lung cancer	down	MicroRNA-582-5p s
hsa-mir-582-5p	prostate cancer	down	miR-582-3p and miR-582-5p S
hsa-mir-584	anaplastic thyroid carcinoma
hsa-mir-584	esophageal squamous cell carcinoma
hsa-mir-584	glioma	down	MicroRNA-584 functions as a tumor s
hsa-mir-584	glioma
hsa-mir-584	non-small cell lung cancer
hsa-mir-584-3p	colorectal cancer
hsa-mir-584-3p	gastric cancer
hsa-mir-585	gastric cancer	down	MicroRNA-585 s
hsa-mir-585	non-small cell lung cancer	down	MicroRNA-585 acts as a tumor s
hsa-mir-588	breast cancer
hsa-mir-588	lung squamous cell carcinoma	down	MicroRNA-588 s
hsa-mir-588	prostate cancer
hsa-mir-589	gastric cancer
hsa-mir-589	non-small cell lung cancer	down	Hypermethylation of miRNA-589 promoter leads to
hsa-mir-589-5p	hepatocellular carcinoma
hsa-mir-589-5p	hepatocellular carcinoma	down	miR-589-5p inhibits MAP3K8 and s
hsa-mir-590	non-small cell lung cancer	down	microRNA-590 s
hsa-mir-590-3p	breast cancer
hsa-mir-590-3p	colon cancer
hsa-mir-590-3p	colon cancer
hsa-mir-590-3p	colon cancer
hsa-mir-590-3p	colon cancer
hsa-mir-590-3p	glioblastoma
hsa-mir-590-3p	glioma
hsa-mir-590-3p	hepatocellular carcinoma
hsa-mir-590-3p	hepatocellular carcinoma	down	MiR-590-3p s
hsa-mir-590-3p	osteosarcoma	down	miR-590-3p is a novel microRNA which s
hsa-mir-590-3p	ovarian cancer
hsa-mir-590-3p	prostate cancer
hsa-mir-590-5p	breast cancer
hsa-mir-590-5p	cervical cancer
hsa-mir-590-5p	colorectal cancer
hsa-mir-590-5p	colorectal cancer
hsa-mir-590-5p	gastric cancer
hsa-mir-590-5p	hepatocellular carcinoma
hsa-mir-590-5p	hepatocellular carcinoma
hsa-mir-590-5p	liver cancer
hsa-mir-590-5p	malignant melanoma
hsa-mir-590-5p	non-small cell lung cancer	down	MicroRNA-590-5p s
hsa-mir-591	breast cancer	down	MiR-591 functions as tumor s
hsa-mir-591	hepatocellular carcinoma	down	MicroRNA-591 Functions as a Tumor S
hsa-mir-592	acute myeloid leukemia	down	MiR-592 functions as a tumor s
hsa-mir-592	breast cancer	down	S
hsa-mir-592	colorectal cancer
hsa-mir-592	colorectal cancer
hsa-mir-592	glioma	down	MiR-592 s
hsa-mir-592	glioma	down	MiR-592 functions as a tumor s
hsa-mir-592	hepatocellular carcinoma	down	MicroRNA-592 targets DEK oncogene and s
hsa-mir-592	hepatocellular carcinoma
hsa-mir-592	non-small cell lung cancer	down	miR-592 functions as a tumor s
hsa-mir-593	colon cancer
hsa-mir-593-5p	gastric cancer
hsa-mir-595	glioblastoma
hsa-mir-595	ovarian cancer
hsa-mir-596	gastric cancer	down	MicroRNA-596 acts as a tumor s
hsa-mir-597	nasopharyngeal carcinoma
hsa-mir-597-5p	colon cancer
hsa-mir-598	colorectal cancer	down	miR-598 inhibits metastasis in colorectal cancer by s
hsa-mir-598	gastric cancer	down	miR-598 acts as a tumor s
hsa-mir-598	glioblastoma
hsa-mir-598	non-small cell lung cancer	down	MiR-598 S
hsa-mir-598	osteosarcoma	down	MiR-598: A tumor s
hsa-mir-598	ovarian cancer
hsa-mir-599	breast cancer	down	Hsa-miR-599 s
hsa-mir-599	gastric cancer
hsa-mir-599	glioma
hsa-mir-599	glioma
hsa-mir-599	glioma	down	MicroRNA-599 s
hsa-mir-600	acute myeloid leukemia
hsa-mir-600	colorectal cancer
hsa-mir-600	lung cancer
hsa-mir-600	non-small cell lung cancer
hsa-mir-601	breast cancer	down	miR-601 is a prognostic marker and s
hsa-mir-601	esophageal squamous cell carcinoma
hsa-mir-601	gastric cancer
hsa-mir-603	glioma
hsa-mir-603	osteosarcoma
hsa-mir-603	ovarian cancer
hsa-mir-605	glioblastoma
hsa-mir-605	malignant melanoma	down	MicroRNA-605 functions as a tumor s
hsa-mir-605-3p	glioma
hsa-mir-608	colon cancer
hsa-mir-608	glioblastoma
hsa-mir-608	hepatocellular carcinoma
hsa-mir-608	prostate cancer	down	Nonconserved miR-608 s
hsa-mir-610	colorectal cancer
hsa-mir-610	hepatocellular carcinoma
hsa-mir-610	lung cancer	down	[miR-610 s
hsa-mir-610	malignant melanoma
hsa-mir-610	oral squamous cell carcinoma	down	MiR-610 functions as a tumor s
hsa-mir-610	osteosarcoma	down	MicroRNA-610 s
hsa-mir-612	hepatocellular carcinoma	down	miR-612 s
hsa-mir-613	bladder cancer
hsa-mir-613	breast cancer
hsa-mir-613	breast cancer
hsa-mir-613	cervical cancer
hsa-mir-613	colorectal cancer	down	MicroRNA-613 targets FMNL2 and s
hsa-mir-613	esophageal squamous cell carcinoma
hsa-mir-613	gastric cancer
hsa-mir-613	gastric cancer
hsa-mir-613	gastric cancer
hsa-mir-613	gastric cancer
hsa-mir-613	glioma
hsa-mir-613	glioma	down	Role of miR-613 as a tumor s
hsa-mir-613	hepatocellular carcinoma	down	MiR-613 functions as tumor s
hsa-mir-613	hepatocellular carcinoma
hsa-mir-613	hepatocellular carcinoma
hsa-mir-613	laryngeal squamous cell carcinoma	down	MiR-613 s
hsa-mir-613	nasopharyngeal carcinoma
hsa-mir-613	osteosarcoma	down	CXCR4-mediated osteosarcoma growth and pulmonary metastasis is s
hsa-mir-613	ovarian cancer
hsa-mir-613	pancreatic cancer
hsa-mir-613	papillary thyroid carcinoma
hsa-mir-613	prostate cancer
hsa-mir-614	lung cancer
hsa-mir-614	ovarian cancer
hsa-mir-615	prostate cancer
hsa-mir-615-3p	gastric cancer
hsa-mir-615-3p	non-small cell lung cancer
hsa-mir-615-3p	non-small cell lung cancer	down	Identification of microRNA-615-3p as a novel tumor s
hsa-mir-615-5p	hepatocellular carcinoma
hsa-mir-615-5p	hepatocellular carcinoma
hsa-mir-615-5p	pancreatic cancer	down	MiRNA-615-5p functions as a tumor s
hsa-mir-615-5p	pancreatic ductal adenocarcinoma	down	miR-615-5p is epigenetically inactivated and functions as a tumor s
hsa-mir-615-5p	pancreatic ductal adenocarcinoma	down	Correction: MiRNA-615-5p Functions as a Tumor S
hsa-mir-616	glioma
hsa-mir-616	non-small cell lung cancer
hsa-mir-616*	gastric cancer
hsa-mir-616-3p	gastric cancer
hsa-mir-618	gastric cancer	down	miR-618 S
hsa-mir-618	prostate cancer
hsa-mir-620	hepatocellular carcinoma
hsa-mir-621	bladder cancer	down	MicroRNA-621 inhibits cell proliferation and metastasis in bladder cancer by s
hsa-mir-621	hepatocellular carcinoma
hsa-mir-621	hepatocellular carcinoma
hsa-mir-622	colorectal cancer
hsa-mir-622	colorectal cancer
hsa-mir-622	colorectal cancer	down	miR-622 inhibits angiogenesis by s
hsa-mir-622	esophageal squamous cell carcinoma	down	MiR-622 functions as a tumor s
hsa-mir-622	gastric cancer
hsa-mir-622	hepatocellular carcinoma	down	microRNA-622 acts as a tumor s
hsa-mir-622	papillary thyroid carcinoma	down	miR-622 s
hsa-mir-623	hepatocellular carcinoma	down	Overexpression of miR-623 s
hsa-mir-623	lung adenocarcinoma	down	Correction to: Hsa-miR-623 s
hsa-mir-623	lung adenocarcinoma	down	Hsa-miR-623 s
hsa-mir-623	lung adenocarcinoma	down	Hsa-miR-623 s
hsa-mir-625	breast cancer	down	miR-625 s
hsa-mir-625	colorectal cancer
hsa-mir-625	gastric cancer	down	Down-regulated miR-625 s
hsa-mir-625	gastric cancer
hsa-mir-625	glioma
hsa-mir-625	hepatocellular carcinoma	down	miR-625 s
hsa-mir-625	hepatocellular carcinoma	down	miR-625 s
hsa-mir-625	laryngeal squamous cell carcinoma
hsa-mir-625*	non-small cell lung cancer
hsa-mir-625-3p	colorectal cancer
hsa-mir-625-3p	colorectal carcinoma
hsa-mir-625-3p	oral squamous cell carcinoma
hsa-mir-626	glioblastoma
hsa-mir-627	colonic adenocarcinoma	down	MicroRNA-627 Mediates the Epigenetic Mechanisms of Vitamin D to S
hsa-mir-627	gastric cancer
hsa-mir-627-3p	osteosarcoma
hsa-mir-627-5p	glioma
hsa-mir-628	acute myeloid leukemia
hsa-mir-628	prostate cancer
hsa-mir-628-5p	glioma
hsa-mir-628-5p	prostate cancer
hsa-mir-629	gastric cancer
hsa-mir-629	ovarian cancer
hsa-mir-629	pancreatic cancer
hsa-mir-629-5p	hepatocellular carcinoma
hsa-mir-630	breast cancer	down	MiR-630 s
hsa-mir-630	breast cancer
hsa-mir-630	colorectal cancer
hsa-mir-630	esophageal squamous cell carcinoma
hsa-mir-630	gastric cancer	down	MicroRNA-630 S
hsa-mir-630	gastric cancer
hsa-mir-630	glioma
hsa-mir-630	hepatocellular carcinoma
hsa-mir-630	hepatocellular carcinoma	down	MicroRNA-630 s
hsa-mir-630	kidney cancer
hsa-mir-630	non-small cell lung cancer
hsa-mir-630	ovarian cancer
hsa-mir-630	pancreatic cancer	down	Upregulation of miR-150* and miR-630 Induces Apoptosis in Pancreatic Cancer Cells by Targeting IGF-1R.
hsa-mir-630	renal clear cell carcinoma
hsa-mir-632	gastric cancer
hsa-mir-632	oral squamous cell carcinoma
hsa-mir-634	cervical cancer
hsa-mir-634	glioma
hsa-mir-634	hepatocellular carcinoma
hsa-mir-634	hepatocellular carcinoma
hsa-mir-634	pancreatic cancer	down	MicroRNA-634 functions as a tumor s
hsa-mir-635	non-small cell lung cancer	down	The microRNA-635 s
hsa-mir-637	hepatocellular carcinoma
hsa-mir-637	hepatocellular carcinoma	down	Primate-specific microRNA-637 inhibits tumorigenesis in hepatocellular carcinoma by disr
hsa-mir-637	malignant melanoma	down	MiR-637 s
hsa-mir-637	pancreatic ductal adenocarcinoma	down	Primate-specific miRNA-637 inhibited tumorigenesis in human pancreatic ductal adenocarcinoma cells by s
hsa-mir-638	basal cell carcinoma
hsa-mir-638	breast cancer
hsa-mir-638	breast cancer
hsa-mir-638	breast cancer
hsa-mir-638	cervical cancer
hsa-mir-638	esophageal squamous cell carcinoma
hsa-mir-638	gastric cancer
hsa-mir-638	gastric cancer	down	miR-638 S
hsa-mir-638	gastric cancer
hsa-mir-638	gastric cancer	down	MiR-638 acts as a tumor s
hsa-mir-638	hepatocellular carcinoma
hsa-mir-638	hepatocellular carcinoma
hsa-mir-638	malignant melanoma
hsa-mir-638	osteosarcoma	down	MicroRNA-638 inhibits cell proliferation by targeting s
hsa-mir-638	osteosarcoma
hsa-mir-639	bladder cancer
hsa-mir-639	thyroid cancer
hsa-mir-641	lung cancer	down	MiR-641 Functions as a Tumor S
hsa-mir-644a	esophageal squamous cell carcinoma
hsa-mir-644a	gastric cancer	down	miR-644a inhibits cellular proliferation and invasion via s
hsa-mir-644a	hepatocellular carcinoma
hsa-mir-645	breast cancer
hsa-mir-645	colorectal cancer
hsa-mir-645	osteosarcoma
hsa-mir-645	renal clear cell carcinoma
hsa-mir-646	colorectal cancer
hsa-mir-646	esophageal cancer
hsa-mir-646	gastric cancer
hsa-mir-646	oral squamous cell carcinoma
hsa-mir-646	osteosarcoma	down	miRNA-646 s
hsa-mir-646	renal cell carcinoma
hsa-mir-647	gastric cancer	down	MicroRNA-647 Targets SRF-MYH9 Axis to S
hsa-mir-647	gastric cancer	down	Role of miR-647 in human gastric cancer s
hsa-mir-647	non-small cell lung cancer
hsa-mir-650	acute myeloid leukemia
hsa-mir-650	chronic lymphocytic leukemia
hsa-mir-650	colorectal cancer
hsa-mir-650	gastric cancer
hsa-mir-650	glioma
hsa-mir-650	hepatocellular carcinoma
hsa-mir-652	endometrial cancer
hsa-mir-652	gastric cancer
hsa-mir-652	glioblastoma	down	MicroRNA-652 s
hsa-mir-652	prostate cancer
hsa-mir-652-3p	breast cancer
hsa-mir-652-3p	non-small cell lung cancer
hsa-mir-653	breast cancer
hsa-mir-654-5p	gastric cancer
hsa-mir-655	breast cancer
hsa-mir-655	esophageal squamous cell carcinoma
hsa-mir-655	esophageal squamous cell carcinoma	down	Low levels of tumour s
hsa-mir-655	esophageal squamous cell carcinoma	down	Mir-655
hsa-mir-655	ovarian cancer
hsa-mir-655	retinoblastoma	down	MicroRNA-655 attenuates the malignant biological behaviours of retinoblastoma cells by directly targeting PAX6 and s
hsa-mir-655-3p	hepatocellular carcinoma	down	MicroRNA-655-3p functions as a tumor s
hsa-mir-655-3p	non-small cell lung cancer
hsa-mir-656	glioma
hsa-mir-657	hepatocellular carcinoma
hsa-mir-660	gastric cancer
hsa-mir-660	lung cancer
hsa-mir-660	lung cancer
hsa-mir-660-5p	breast cancer
hsa-mir-660-5p	non-small cell lung cancer
hsa-mir-661	non-small cell lung cancer
hsa-mir-661	non-small cell lung cancer
hsa-mir-661	non-small cell lung cancer
hsa-mir-661	ovarian cancer
hsa-mir-661	pancreatic ductal adenocarcinoma
hsa-mir-663	gastric cancer	down	Tumor-s
hsa-mir-663	glioblastoma	down	miR-663 s
hsa-mir-663	hepatocellular carcinoma
hsa-mir-663	lung cancer
hsa-mir-663	nasopharyngeal carcinoma
hsa-mir-663	papillary thyroid carcinoma	down	MicroRNA-663 s
hsa-mir-663a	hepatocellular carcinoma
hsa-mir-663a	hepatocellular carcinoma
hsa-mir-663a	non-small cell lung cancer
hsa-mir-663a	pancreatic ductal adenocarcinoma
hsa-mir-663a	renal cell carcinoma
hsa-mir-663b	nasopharyngeal carcinoma
hsa-mir-663b	osteosarcoma
hsa-mir-663b	pancreatic cancer	down	Epigenetic inhibition of miR-663b by long non-coding RNA HOTAIR promotes pancreatic cancer cell proliferation via
hsa-mir-664	cervical cancer	down	MicroRNA-664 s
hsa-mir-664	cervical cancer	down	Up-regulation of microRNA-664 inhibits cell growth and increases cisplatin sensitivity in cervical cancer.
hsa-mir-664	cervical cancer
hsa-mir-664	hepatocellular carcinoma
hsa-mir-664	osteosarcoma
hsa-mir-664a-3p	gastric cancer
hsa-mir-665	breast cancer
hsa-mir-665	neuroblastoma
hsa-mir-665	osteosarcoma	down	MicroRNA-665 s
hsa-mir-665	retinoblastoma	down	MicroRNA-665 inhibits the oncogenicity of retinoblastoma by directly targeting high-mobility gro
hsa-mir-668	oral squamous cell carcinoma
hsa-mir-671	prostate cancer
hsa-mir-671-5p	breast cancer
hsa-mir-671-5p	gastric cancer
hsa-mir-671-5p	invasive ductal carcinoma
hsa-mir-671-5p	osteosarcoma
hsa-mir-6716-5p	colorectal cancer
hsa-mir-675	breast cancer
hsa-mir-675	colon cancer
hsa-mir-675	gastric cancer
hsa-mir-675	gastric cancer
hsa-mir-675	glioma
hsa-mir-675	head and neck squamous cell carcinoma
hsa-mir-675	hepatocellular carcinoma
hsa-mir-675	hepatocellular carcinoma
hsa-mir-675	pancreatic ductal adenocarcinoma
hsa-mir-675	retinoblastoma
hsa-mir-675-5p	colon cancer
hsa-mir-675-5p	gastric cancer
hsa-mir-675-5p	non-small cell lung cancer
hsa-mir-675-5p	non-small cell lung cancer
hsa-mir-6775-3p	esophageal squamous cell carcinoma	down	Tumor s
hsa-mir-6778-5p	colorectal cancer
hsa-mir-6868-5p	colorectal cancer
hsa-mir-6883-5p	colorectal cancer
hsa-mir-7	breast cancer
hsa-mir-7	breast cancer	down	Inhibition of breast cancer growth via miR-7 s
hsa-mir-7	cervical cancer
hsa-mir-7	cervical cancer
hsa-mir-7	colorectal cancer
hsa-mir-7	colorectal cancer
hsa-mir-7	epithelial ovarian cancer
hsa-mir-7	gastric cancer
hsa-mir-7	gastric cancer
hsa-mir-7	glioblastoma
hsa-mir-7	glioblastoma
hsa-mir-7	glioblastoma
hsa-mir-7	glioma
hsa-mir-7	glioma
hsa-mir-7	hepatocellular carcinoma
hsa-mir-7	hepatocellular carcinoma	down	Downregulation of miR-7
hsa-mir-7	hepatocellular carcinoma
hsa-mir-7	hepatocellular carcinoma
hsa-mir-7	hepatocellular carcinoma
hsa-mir-7	laryngeal squamous cell carcinoma
hsa-mir-7	lung cancer
hsa-mir-7	lung cancer	down	Promoter mutation of tumor s
hsa-mir-7	non-small cell lung cancer
hsa-mir-7	osteosarcoma	down	Upregulation of microRNA-7 contributes to inhibition of the growth and metastasis of osteosarcoma cells through the inhibition of IGF1R.
hsa-mir-7	pancreatic cancer
hsa-mir-7	pancreatic cancer	down	miR-7 S
hsa-mir-7	pancreatic carcinoma	down	MicroRNA-7 functions as a tumor-s
hsa-mir-7	prostate cancer
hsa-mir-7	renal cell carcinoma
hsa-mir-7-5p	colorectal cancer
hsa-mir-7-5p	glioblastoma
hsa-mir-7-5p	glioblastoma
hsa-mir-7-5p	glioblastoma
hsa-mir-7-5p	glioblastoma
hsa-mir-7-5p	glioma
hsa-mir-7-5p	malignant melanoma
hsa-mir-7-5p	malignant melanoma	down	microRNA-7-5p inhibits melanoma cell proliferation and metastasis by s
hsa-mir-7-5p	pancreatic ductal adenocarcinoma	down	MiR-7-5p functions as a tumor s
hsa-mir-708	bladder cancer
hsa-mir-708	colorectal cancer
hsa-mir-708	gastric cancer
hsa-mir-708	gastric cancer	down	Tumor s
hsa-mir-708	hepatocellular carcinoma
hsa-mir-708	hepatocellular carcinoma	down	miRNA-708 functions as a tumour s
hsa-mir-708	hepatocellular carcinoma	down	MicroRNA-708 is downregulated in hepatocellular carcinoma and s
hsa-mir-708	lung cancer
hsa-mir-708	prostate cancer
hsa-mir-708	renal cell carcinoma
hsa-mir-708-3p	breast cancer
hsa-mir-708-5p	non-small cell lung cancer
hsa-mir-708-5p	osteosarcoma
hsa-mir-708-5p	pancreatic ductal adenocarcinoma
hsa-mir-718	esophageal squamous cell carcinoma
hsa-mir-718	gastric cancer
hsa-mir-720	acute myeloid leukemia
hsa-mir-720	breast cancer
hsa-mir-720	cervical cancer
hsa-mir-720	colorectal cancer
hsa-mir-720	renal cell carcinoma
hsa-mir-744	colorectal cancer
hsa-mir-744	gastric cancer
hsa-mir-744	glioblastoma
hsa-mir-744	glioblastoma
hsa-mir-744	nasopharyngeal carcinoma
hsa-mir-744	nasopharyngeal carcinoma
hsa-mir-744	pancreatic cancer
hsa-mir-744	prostate cancer
hsa-mir-744	prostate cancer
hsa-mir-7515	lung cancer
hsa-mir-758	cervical cancer
hsa-mir-758	cervical cancer
hsa-mir-758-3p	papillary thyroid carcinoma
hsa-mir-760	colorectal cancer	down	MiR-760 s
hsa-mir-760	glioma
hsa-mir-760	hepatocellular carcinoma
hsa-mir-760	non-small cell lung cancer	down	Correction to: MiR-760 s
hsa-mir-760	non-small cell lung cancer	down	MiR-760 s
hsa-mir-760	non-small cell lung cancer
hsa-mir-760	ovarian cancer
hsa-mir-761	breast cancer
hsa-mir-761	colorectal cancer
hsa-mir-761	colorectal cancer
hsa-mir-761	colorectal cancer
hsa-mir-761	gastric cancer
hsa-mir-761	hepatocellular carcinoma
hsa-mir-761	non-small cell lung cancer
hsa-mir-761	ovarian carcinoma
hsa-mir-762	breast cancer
hsa-mir-765	esophageal squamous cell carcinoma
hsa-mir-765	hepatocellular carcinoma
hsa-mir-765	osteosarcoma
hsa-mir-765	osteosarcoma
hsa-mir-766	colon cancer
hsa-mir-766	colorectal cancer
hsa-mir-766	hepatocellular carcinoma
hsa-mir-766-3p	hepatocellular carcinoma
hsa-mir-766-3p	renal cell carcinoma
hsa-mir-767	malignant melanoma
hsa-mir-767-3p	lung adenocarcinoma
hsa-mir-769	colorectal cancer
hsa-mir-769	colorectal cancer
hsa-mir-769	malignant melanoma
hsa-mir-770	glioma
hsa-mir-770	glioma	down	Overexpression of miR-770 indicates a favorable prognosis and s
hsa-mir-770	hepatocellular carcinoma
hsa-mir-770	non-small cell lung cancer
hsa-mir-770	non-small cell lung cancer
hsa-mir-7702	colorectal cancer
hsa-mir-802	breast cancer	down	MicroRNA-802 s
hsa-mir-802	cervical cancer
hsa-mir-802	gastric cancer	down	Upregulation of miR-802 s
hsa-mir-802	osteosarcoma
hsa-mir-802	prostate cancer
hsa-mir-873	breast cancer
hsa-mir-873	colorectal cancer
hsa-mir-873	esophageal cancer	down	MicroRNA-873 acts as a tumor s
hsa-mir-873	glioblastoma	down	MiRNA-873 Inhibits Glioblastoma Tumorigenesis and Metastasis by S
hsa-mir-873	hepatocellular carcinoma
hsa-mir-873	pancreatic ductal adenocarcinoma
hsa-mir-873-5p	colon cancer	down	miR-873-5p inhibits the progression of colon cancer via repression of tumor s
hsa-mir-873-5p	colorectal cancer	down	MiR-873-5p s
hsa-mir-873-5p	gastric cancer
hsa-mir-874	breast cancer
hsa-mir-874	colorectal cancer
hsa-mir-874	colorectal cancer	down	Decreased expression of miR-874 and its tumor s
hsa-mir-874	gastric cancer	down	Correction: miR-874 functions as a tumor s
hsa-mir-874	gastric cancer	down	miR-874 functions as a tumor s
hsa-mir-874	head and neck squamous cell carcinoma	down	Tumour-s
hsa-mir-874	hepatocellular carcinoma	down	microRNA-874 s
hsa-mir-874	hepatocellular carcinoma
hsa-mir-874	osteosarcoma
hsa-mir-874	osteosarcoma	down	Decreased expression of tumor s
hsa-mir-874	rhabdomyosarcoma	down	MicroRNA-874 functions as a tumor s
hsa-mir-874-3p	hepatocellular carcinoma
hsa-mir-874-3p	nasopharyngeal carcinoma	down	MiR-874-3p s
hsa-mir-875	non-small cell lung cancer
hsa-mir-875-5p	hepatocellular carcinoma
hsa-mir-876	breast cancer
hsa-mir-876-3p	gastric cancer
hsa-mir-876-3p	pancreatic adenocarcinoma	down	MicroRNA-876-3p functions as a tumor s
hsa-mir-876-5p	breast cancer	down	miR-876-5p s
hsa-mir-876-5p	head and neck squamous cell carcinoma
hsa-mir-877	hepatocellular carcinoma	down	Up-regulation of miR-877 induced by paclitaxel inhibits hepatocellular carcinoma cell proliferation though targeting FOXM1.
hsa-mir-877	non-small cell lung cancer
hsa-mir-877	oral squamous cell carcinoma
hsa-mir-885-5p	hepatocellular carcinoma	down	miR-885-5p s
hsa-mir-885-5p	hepatocellular carcinoma
hsa-mir-885-5p	laryngeal cancer
hsa-mir-885-5p	osteosarcoma
hsa-mir-885-5p	renal clear cell carcinoma
hsa-mir-886-3p	small cell lung cancer	down	MicroRNA-886-3P functions as a tumor s
hsa-mir-886-5p	cervical carcinoma
hsa-mir-887-5p	endometrial cancer
hsa-mir-888	colorectal cancer
hsa-mir-888	hepatocellular carcinoma
hsa-mir-888-5p	hepatocellular carcinoma
hsa-mir-889	cervical cancer
hsa-mir-889	colorectal cancer
hsa-mir-889	non-small cell lung cancer
hsa-mir-889-3p	osteosarcoma
hsa-mir-892a	colorectal cancer
hsa-mir-892a	hepatocellular carcinoma
hsa-mir-892b	breast cancer
hsa-mir-9	acute lymphoblastic leukemia	down	MicroRNA-9 s
hsa-mir-9	acute myeloid leukemia	down	MiR-9 functions as a tumor s
hsa-mir-9	bladder cancer
hsa-mir-9	breast cancer
hsa-mir-9	cervical adenocarcinoma
hsa-mir-9	cervical cancer
hsa-mir-9	colorectal cancer	down	MicroRNA-9 s
hsa-mir-9	colorectal cancer
hsa-mir-9	esophageal squamous cell carcinoma
hsa-mir-9	esophageal squamous cell carcinoma
hsa-mir-9	esophageal squamous cell carcinoma
hsa-mir-9	gastric adenocarcinoma
hsa-mir-9	gastric adenocarcinoma
hsa-mir-9	gastric cancer
hsa-mir-9	gastric cancer
hsa-mir-9	gastric cancer
hsa-mir-9	gastric cancer
hsa-mir-9	glioblastoma	down	MiR-9 Promotes Apoptosis Via S
hsa-mir-9	glioma
hsa-mir-9	glioma
hsa-mir-9	glioma
hsa-mir-9	glioma
hsa-mir-9	glioma
hsa-mir-9	hepatocellular carcinoma
hsa-mir-9	hepatocellular carcinoma	down	Comprehensive profiling of novel microRNA-9 targets and a tumor s
hsa-mir-9	hepatocellular carcinoma
hsa-mir-9	hepatocellular carcinoma	down	Yin Yang 1-mediated epigenetic silencing of tumour-s
hsa-mir-9	hepatocellular carcinoma
hsa-mir-9	laryngeal squamous cell carcinoma
hsa-mir-9	malignant melanoma	down	MicroRNA-9
hsa-mir-9	malignant melanoma
hsa-mir-9	medulloblastoma
hsa-mir-9	multiple myeloma
hsa-mir-9	nasopharyngeal carcinoma	down	miR-9 targets CXCR4 and functions as a potential tumor s
hsa-mir-9	nasopharyngeal carcinoma
hsa-mir-9	non-small cell lung cancer
hsa-mir-9	non-small cell lung cancer
hsa-mir-9	non-small cell lung cancer
hsa-mir-9	oral squamous cell carcinoma	down	MicroRNA-9 inhibits the proliferation of oral squamous cell carcinoma cells by s
hsa-mir-9	oral squamous cell carcinoma
hsa-mir-9	osteosarcoma
hsa-mir-9	osteosarcoma
hsa-mir-9	ovarian cancer
hsa-mir-9	ovarian cancer
hsa-mir-9	ovarian cancer
hsa-mir-9	pancreatic ductal adenocarcinoma
hsa-mir-9	uveal melanoma	down	MicroRNA-9 s
hsa-mir-9-3p	gastric cancer	down	Transcriptome profiling reveals miR-9-3p as a novel tumor s
hsa-mir-9-3p	hepatocellular carcinoma	down	Exosomal miR-9-3p s
hsa-mir-9-3p	hepatocellular carcinoma
hsa-mir-9-3p	medullary thyroid carcinoma
hsa-mir-9-5p	colorectal cancer	down	MiR-9-5p s
hsa-mir-9-5p	non-small cell lung cancer
hsa-mir-9-5p	prostate cancer
hsa-mir-92	bladder cancer
hsa-mir-92	colorectal cancer
hsa-mir-92	gastric cancer
hsa-mir-92	gastric cancer
hsa-mir-92	gastric cancer	down	MiR-92 s
hsa-mir-92	medulloblastoma
hsa-mir-92	neuroblastoma
hsa-mir-92	pancreatic cancer
hsa-mir-922	hepatocellular carcinoma
hsa-mir-92a	acute myeloid leukemia
hsa-mir-92a	acute promyelocytic leukemia
hsa-mir-92a	breast cancer
hsa-mir-92a	breast cancer
hsa-mir-92a	breast cancer
hsa-mir-92a	breast carcinoma
hsa-mir-92a	cervical cancer
hsa-mir-92a	cervical cancer
hsa-mir-92a	cervical cancer
hsa-mir-92a	cervical cancer
hsa-mir-92a	cholangiocarcinoma
hsa-mir-92a	chronic myelogenous leukemia
hsa-mir-92a	colorectal cancer
hsa-mir-92a	colorectal cancer
hsa-mir-92a	colorectal cancer
hsa-mir-92a	colorectal cancer
hsa-mir-92a	colorectal cancer
hsa-mir-92a	colorectal cancer
hsa-mir-92a	colorectal cancer
hsa-mir-92a	colorectal cancer
hsa-mir-92a	colorectal cancer
hsa-mir-92a	endometrial cancer
hsa-mir-92a	esophageal squamous cell carcinoma
hsa-mir-92a	esophageal squamous cell carcinoma
hsa-mir-92a	glioma
hsa-mir-92a	hepatocellular carcinoma
hsa-mir-92a	hepatocellular carcinoma
hsa-mir-92a	hepatocellular carcinoma
hsa-mir-92a	hepatocellular carcinoma
hsa-mir-92a	lung cancer
hsa-mir-92a	malignant melanoma
hsa-mir-92a	mantle cell lymphoma
hsa-mir-92a	nasopharyngeal carcinoma
hsa-mir-92a	non-small cell lung cancer
hsa-mir-92a	oral squamous cell carcinoma
hsa-mir-92a	osteosarcoma
hsa-mir-92a	osteosarcoma
hsa-mir-92a	ovarian cancer
hsa-mir-92a-3p	breast cancer
hsa-mir-92a-3p	colorectal cancer
hsa-mir-92a-3p	glioma
hsa-mir-92a-3p	glioma
hsa-mir-92b	cholangiocarcinoma
hsa-mir-92b	glioblastoma
hsa-mir-92b	glioma
hsa-mir-92b	hepatocellular carcinoma
hsa-mir-92b	nasopharyngeal cancer
hsa-mir-92b	non-small cell lung cancer
hsa-mir-92b	non-small cell lung cancer
hsa-mir-92b	oral squamous cell carcinoma
hsa-mir-92b	osteosarcoma
hsa-mir-93	basal cell carcinoma
hsa-mir-93	bladder cancer
hsa-mir-93	colon cancer
hsa-mir-93	colorectal cancer
hsa-mir-93	colorectal carcinoma	down	MicroRNA-93 s
hsa-mir-93	endometrial cancer
hsa-mir-93	endometrial cancer
hsa-mir-93	esophageal squamous cell carcinoma
hsa-mir-93	gastric cancer
hsa-mir-93	glioma
hsa-mir-93	glioma
hsa-mir-93	glioma
hsa-mir-93	glioma
hsa-mir-93	glioma
hsa-mir-93	head and neck squamous cell carcinoma
hsa-mir-93	head and neck squamous cell carcinoma
hsa-mir-93	hepatocellular carcinoma
hsa-mir-93	hepatocellular carcinoma
hsa-mir-93	hepatocellular carcinoma
hsa-mir-93	hepatocellular carcinoma
hsa-mir-93	hepatocellular carcinoma
hsa-mir-93	laryngeal squamous cell carcinoma
hsa-mir-93	lung cancer
hsa-mir-93	nasopharyngeal carcinoma
hsa-mir-93	nasopharyngeal carcinoma
hsa-mir-93	osteosarcoma
hsa-mir-93	osteosarcoma
hsa-mir-93	osteosarcoma
hsa-mir-93	ovarian carcinoma
hsa-mir-93-5p	breast cancer
hsa-mir-93-5p	cervical cancer
hsa-mir-93-5p	esophageal cancer
hsa-mir-93-5p	gastric cancer
hsa-mir-93-5p	gastric cancer
hsa-mir-93-5p	hepatocellular carcinoma
hsa-mir-93-5p	hepatocellular carcinoma
hsa-mir-93-5p	non-small cell lung cancer
hsa-mir-93-5p	ovarian cancer
hsa-mir-934	bladder cancer
hsa-mir-934	ovarian cancer
hsa-mir-935	gastric cancer	down	miR-935 s
hsa-mir-935	gastric cancer
hsa-mir-935	liver cancer
hsa-mir-936	glioma
hsa-mir-936	non-small cell lung cancer	down	Overexpression of microRNA-936 s
hsa-mir-937	breast cancer
hsa-mir-937	gastric cancer
hsa-mir-937	lung cancer
hsa-mir-938	colorectal cancer
hsa-mir-939-3p	lung cancer
hsa-mir-940	bladder cancer
hsa-mir-940	colorectal cancer
hsa-mir-940	esophageal cancer
hsa-mir-940	gastric cancer
hsa-mir-940	gastric cancer
hsa-mir-940	glioma
hsa-mir-940	hepatocellular carcinoma
hsa-mir-940	hepatocellular carcinoma	down	miR-940 S
hsa-mir-940	non-small cell lung cancer
hsa-mir-940	pancreatic carcinoma
hsa-mir-940	prostate cancer	down	MicroRNA-940 s
hsa-mir-941	hepatocellular carcinoma
hsa-mir-942	colorectal cancer
hsa-mir-942	esophageal squamous cell carcinoma
hsa-mir-944	breast cancer
hsa-mir-944	cervical cancer
hsa-mir-944	cervical cancer
hsa-mir-944	colon cancer
hsa-mir-944	colorectal cancer	down	Primate-specific miR-944 activates p53-dependent tumor s
hsa-mir-944	colorectal cancer
hsa-mir-944	endometrial cancer
hsa-mir-944	hepatocellular carcinoma
hsa-mir-944	lung adenocarcinoma
hsa-mir-944	lung cancer
hsa-mir-944	non-small cell lung cancer
hsa-mir-95	colorectal cancer
hsa-mir-95	colorectal carcinoma
hsa-mir-95	gastric cancer
hsa-mir-95	gastric cancer
hsa-mir-95	non-small cell lung cancer
hsa-mir-95-3p	hepatocellular carcinoma
hsa-mir-95-3p	osteosarcoma	down	Upregulation of miR?95-3p inhibits growth of osteosarcoma by targeting HDGF.
hsa-mir-95-3p	osteosarcoma
hsa-mir-9500	lung cancer
hsa-mir-96	bladder cancer
hsa-mir-96	bladder cancer
hsa-mir-96	bladder cancer
hsa-mir-96	breast cancer
hsa-mir-96	breast cancer
hsa-mir-96	breast cancer
hsa-mir-96	breast cancer
hsa-mir-96	chronic myelogenous leukemia
hsa-mir-96	colorectal cancer
hsa-mir-96	esophageal cancer
hsa-mir-96	glioma
hsa-mir-96	glioma
hsa-mir-96	glioma
hsa-mir-96	hepatocellular carcinoma
hsa-mir-96	hepatocellular carcinoma
hsa-mir-96	hepatocellular carcinoma
hsa-mir-96	nasopharyngeal carcinoma	down	MicroRNA-183 s
hsa-mir-96	non-small cell lung cancer
hsa-mir-96	non-small cell lung cancer
hsa-mir-96	non-small cell lung cancer
hsa-mir-96	osteosarcoma	down	microRNA-96 acts as a tumor s
hsa-mir-96	ovarian cancer
hsa-mir-96	ovarian cancer
hsa-mir-96	pancreatic cancer	down	miRNA-96 s
hsa-mir-96	prostate cancer
hsa-mir-96	prostate cancer
hsa-mir-96	prostate cancer
hsa-mir-96	renal cell carcinoma	down	miR-96 s
hsa-mir-96-5p	breast cancer
hsa-mir-96-5p	colorectal cancer
hsa-mir-96-5p	head and neck squamous cell carcinoma
hsa-mir-96-5p	hepatocellular carcinoma
hsa-mir-98	bladder cancer
hsa-mir-98	breast cancer
hsa-mir-98	breast cancer
hsa-mir-98	colon cancer	down	let-7 microRNA functions as a potential growth s
hsa-mir-98	colon cancer	down	MicroRNA-98 S
hsa-mir-98	colon cancer
hsa-mir-98	esophageal squamous cell carcinoma
hsa-mir-98	esophageal squamous cell carcinoma
hsa-mir-98	esophageal squamous cell carcinoma
hsa-mir-98	gastric cancer
hsa-mir-98	gastric cancer
hsa-mir-98	glioma	down	MiR-98 Promotes Apoptosis of Glioma Cells via S
hsa-mir-98	glioma	down	Overexpression of RKIP inhibits cell invasion in glioma cell lines through
hsa-mir-98	glioma
hsa-mir-98	glioma	down	Methylation-induced downregulation and tumor-s
hsa-mir-98	hepatocellular carcinoma	down	miR-98 inhibits hepatocellular carcinoma cell proliferation via targeting EZH2 and s
hsa-mir-98	hepatocellular carcinoma	down	MicroRNA-98 acts as a tumor s
hsa-mir-98	hepatocellular carcinoma
hsa-mir-98	hepatocellular carcinoma	down	MiR-98 s
hsa-mir-98	lung cancer
hsa-mir-98	lung cancer
hsa-mir-98	lung cancer	down	Let-7a elevates p21(WAF1) levels by targeting of NIRF and s
hsa-mir-98	malignant melanoma	down	miR-98 s
hsa-mir-98	nasopharyngeal carcinoma	down	MicroRNA let-7 s
hsa-mir-98	nasopharyngeal carcinoma
hsa-mir-98	neuroblastoma	down	LIN28B induces neuroblastoma and enhances MYCN levels via let-7 s
hsa-mir-98	non-small cell lung cancer
hsa-mir-98	non-small cell lung cancer	down	MicroRNA-98 plays a s
hsa-mir-98	non-small cell lung cancer
hsa-mir-98	oral squamous cell carcinoma	down	miR-98 s
hsa-mir-98	ovarian cancer
hsa-mir-98	pancreatic ductal adenocarcinoma
hsa-mir-98	papillary thyroid carcinoma
hsa-mir-98	squamous carcinoma
hsa-mir-98-5p	hepatocellular carcinoma
hsa-mir-98-5p	non-small cell lung cancer
hsa-mir-98-5p	non-small cell lung cancer
hsa-mir-98-5p	osteosarcoma
hsa-mir-98-5p	pancreatic ductal adenocarcinoma
hsa-mir-99a	acute myeloid leukemia
hsa-mir-99a	bladder cancer
hsa-mir-99a	bladder cancer	down	microRNA-99a acts as a tumor s
hsa-mir-99a	breast cancer
hsa-mir-99a	breast cancer
hsa-mir-99a	breast cancer
hsa-mir-99a	cervical cancer
hsa-mir-99a	cervical carcinoma
hsa-mir-99a	endometrial cancer	down	A dual PI3K/AKT/mTOR signaling inhibitor miR-99a s
hsa-mir-99a	esophageal squamous cell carcinoma
hsa-mir-99a	gastric cancer
hsa-mir-99a	glioma
hsa-mir-99a	hepatocellular carcinoma
hsa-mir-99a	hepatocellular carcinoma
hsa-mir-99a	hepatocellular carcinoma
hsa-mir-99a	liver cancer
hsa-mir-99a	lung adenocarcinoma
hsa-mir-99a	lung adenocarcinoma
hsa-mir-99a	mesenchymal cancer
hsa-mir-99a	nasopharyngeal carcinoma	down	MiR-99a s
hsa-mir-99a	nasopharyngeal carcinoma
hsa-mir-99a	non-small cell lung cancer	down	miR-99a s
hsa-mir-99a	oral squamous cell carcinoma
hsa-mir-99a	osteosarcoma	down	Tumor-s
hsa-mir-99a	ovarian cancer	down	MiR-99a s
hsa-mir-99a	pancreatic cancer
hsa-mir-99a	prostate cancer
hsa-mir-99a-5p	bladder cancer
hsa-mir-99a-5p	breast cancer	down	MicroRNA-99a-5p s
hsa-mir-99b	cervical cancer	down	MicroRNA-99b s
hsa-mir-99b	cervical cancer
hsa-mir-99b	cervical carcinoma
hsa-mir-99b	esophageal cancer
hsa-mir-99b	esophageal squamous cell carcinoma
hsa-mir-99b	glioma
hsa-mir-99b	hepatocellular carcinoma
hsa-mir-99b	hepatocellular carcinoma
hsa-mir-99b	lung cancer	down	microRNA-99b acts as a tumor s
hsa-mir-99b-3p	hepatocellular carcinoma
hsa-mir-99b-3p	oral squamous cell carcinoma	down	miRNA-99b-3p functions as a potential tumor s
hsa-mir-99b-5p	ovarian cancer
mir-17	breast carcinoma
mir-17	chronic myelogenous leukemia
mir-17	colorectal cancer
mir-17	esophageal squamous cell carcinoma
mir-17	hepatocellular carcinoma
mir-17	lung cancer
mir-17	mantle cell lymphoma
mir-17	osteosarcoma
mir-17	osteosarcoma
mir-18a	breast carcinoma
mir-18a	chronic myelogenous leukemia
mir-18a	colorectal cancer
mir-18a	esophageal squamous cell carcinoma
mir-18a	hepatocellular carcinoma
mir-18a	lung cancer
mir-18a	mantle cell lymphoma
mir-18a	osteosarcoma
mir-18a	osteosarcoma
mir-19a	breast carcinoma
mir-19a	chronic myelogenous leukemia
mir-19a	colorectal cancer
mir-19a	esophageal squamous cell carcinoma
mir-19a	hepatocellular carcinoma
mir-19a	lung cancer
mir-19a	mantle cell lymphoma
mir-19a	osteosarcoma
mir-19a	osteosarcoma
mir-19b	breast carcinoma
mir-19b	chronic myelogenous leukemia
mir-19b	colorectal cancer
mir-19b	esophageal squamous cell carcinoma
mir-19b	hepatocellular carcinoma
mir-19b	lung cancer
mir-19b	mantle cell lymphoma
mir-19b	osteosarcoma
mir-19b	osteosarcoma
mir-20a	breast carcinoma
mir-20a	chronic myelogenous leukemia
mir-20a	colorectal cancer
mir-20a	esophageal squamous cell carcinoma
mir-20a	hepatocellular carcinoma
mir-20a	lung cancer
mir-20a	mantle cell lymphoma
mir-20a	osteosarcoma
mir-20a	osteosarcoma
mir-92a	breast carcinoma
mir-92a	chronic myelogenous leukemia
mir-92a	colorectal cancer
mir-92a	esophageal squamous cell carcinoma
mir-92a	hepatocellular carcinoma
mir-92a	lung cancer
mir-92a	mantle cell lymphoma
mir-92a	osteosarcoma
mir-92a	osteosarcoma
mmu-mir-290-3p	breast cancer	down	Inherited variation in miR-290 expression s
mmu-mir-290-5p	breast cancer	down	Inherited variation in miR-290 expression s
